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Abstract 
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Abstract 
 
Frontotemporal dementia (FTD) is a progressive neurodegenerative disease 
associated with preferential atrophic degeneration of the frontal and temporal 
lobes of the brain. It is the second most prevalent early onset dementia, after 
Alzheimer’s disease, displaying an average age of onset between 45 and 65 
years. FTD has a strong genetic association, with a positive familial history in 
approximately 50% of cases and autosomal dominance in up to 20%. One gene 
associated with the disease is Chromatin Modifying Protein 2B (CHMP2B). 
CHMP2B encodes a key component of Endosomal Sorting Complex Required 
for Transport III (ESCRT-III), which in turn is involved in the biogenesis of 
multivesicular bodies at the late endosome. Here we demonstrate Rab8 
mutants dominantly enhance toxicity of the FTD CHMP2B mutation 
CHMP2BIntron5, when expressed in the Drosophila eye. Characterisation of 
neuronal morphology, at the larval neuromuscular junction, reveals Rab8 
mutants display significant synaptic overgrowth, coupled with a reduction in 
synaptic bouton size. This abnormal morphology can be rescued by 
overexpressing wildtype Rab8 pre-synaptically, demonstrating a neuronal 
complement of Rab8 to be essential for normal synaptic growth. We also 
demonstrate that TGF-β signalling and JNK signalling, known regulators of 
synaptic assembly and function, are necessary for the unrestricted synaptic 
growth seen. Furthermore we identify the endosomal JNK scaffold POSH and 
the JNKKK TAK1 as a novel regulators of synaptic growth. Taken together 
these findings implicate Rab8 as a novel enhancer of CHMP2BIntron5 toxicity in a 
Drosophila model of FTD and as a potent regulator of synaptic growth. In 
addition they suggest a potential role for innate immune responses in the 
regulation of synaptic development. !
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1. Introduction 
 
1.1.Rationale !!
Frontotemporal dementia (FTD) is, after Alzheimer’s disease (AD), the second 
most prevalent form of early onset dementia (Ratnavalli et al., 2002). There are 
estimated to be 800,000 dementia sufferers in the UK, creating a financial 
burden of approximately £23 billion per year and putting a significant strain 
upon the NHS (Kane and Cook, 2013; Lakey et al., 2012). One quarter of all 
hospital beds are occupied by someone with dementia (Kane and Cook, 2013; 
Lakey et al., 2012). With an increasing life expectancy, associated with 
improved health care, these figures are set to increase dramatically with the 
number of dementia sufferers expected to reach 1 million by 2021 costing £50 
billion per year by 2038 (Kane and Cook, 2013; Knapp, 2007; Lakey et al., 
2012). As such there is a real demand for greater understanding of the 
molecular and genetic mechanisms underlying dementia pathology, in order to 
develop new therapeutic options and combat the burden of dementia. In this 
investigation a Drosophila model of FTD, associated with a mutation in the 
Chromatin modifying protein 2B (CHMP2B) gene locus, was used to identify 
novel factors that influence disease pathology. In addition analysis looked to 
elucidate the molecular mechanisms in which these factors are involved. One 
such factor identified was the small GTPase Rab8 (Ras-related proteins in brain 
8). The main aim of this investigation was to characterise the role of Rab8 in the 
regulation of neuronal development and identify the mechanisms contributing 
towards the unregulated synaptic growth phenotype displayed in Rab8 mutants. 
In addition this investigation looks to determine whether these mechanisms 
contribute towards the Role of Rab8 as a modifier of CHMP2B.  !!!!!!
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1.2. Frontotemporal Dementia 
 
1.2.1. Clinical Characteristics of Frontotemporal Dementia !
 
Frontotemporal Dementia is a comprehensive term referring to a group of 
distinct clinical syndromes affiliated with frontotemporal lobar degeneration 
(FTLD), a progressive neurodegenerative disease associated with preferential 
atrophic degeneration of the frontal and temporal lobes of the brain (Chauvire et 
al., 2007; Fukui, 2009; Quaid, 2011). Clinical variants of FTD display highly 
heterogeneous symptoms, associated with the broad clinico-pathological 
spectrum of the disease (Seelaar et al., 2011). As such FTD syndromes are 
commonly classified, based upon the most predominant and earliest presenting 
syndromes, into three distinct categories; behavioural variant FTD (bvFTD), 
semantic dementia (SD) and progressive non-fluent aphasia (PNFA) (Josephs 
et al., 2011; Pan and Chen, 2013). These three syndromes show distinct clinical 
traits, characterised by behavioural aberrations including disinhibition and loss 
of volition, progressive decline in word association and semantic memory, and 
disturbances to motor speech and syntax, for bvFTD, SD and PNFA 
respectively (Chauvire et al., 2007; Ichikawa and Kawamura, 2009; Leyton and 
Hodges, 2010). In addition to these main classifications the FTD spectrum may 
also present with additional phenotypes associated with progressive 
supranuclear palsy (PSP), corticobasal degeneration (CBD) and Frontotemporal 
dementia with motor neuron disease (FTD-MND) (Josephs et al., 2006; Pan 
and Chen, 2013; Seelaar et al., 2007). 
 
The most prevalent variant of FTD, estimated to account for 50 % of all FTD 
cases, is bvFTD (Piguet et al., 2011). It most commonly presents with insidious 
behavioural and personality alterations including apathy, disinhibition, emotional 
blunting, loss of empathy, irritability, neglect for personal hygiene and 
aggression (Bathgate et al., 2001; Merrilees et al., 2010; Piguet et al., 2011; 
Snowden et al., 2001). Whilst typically less pronounced than behavioural 
aberrations patients may also present with deterioration of cognitive function, 
most notably displaying deficits in executive function (Diehl-Schmid et al., 2011; 
Rascovsky et al., 2011). Additionally patients may display impaired working 
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memory whilst, in contrast to Alzheimer’s disease, visuospatial function is 
conserved (Rascovsky et al., 2011). Clinical presentation of bvFTD displays a 
distinct overlap with that of motor neurone disease (MND) with ~ 40 % of MND 
patients presenting behavioural and cognitive deficits associated with bvFTD 
and 15 % of bvFTD patients also presenting with MND (Bak and Hodges, 2001; 
Lomen-Hoerth, 2004). In contrast to bvFTD SD and PNFA, collectively termed 
primary progressive aphasias, are classified as language variants of FTD. SD or 
temporal variant FTD is typically characterised by asymmetric atrophy of the 
anterior temporal lobes (Chan et al., 2001; Rosen et al., 2002). Patients 
displaying predominantly left-sided atrophy typically present with fluent aphasia 
manifesting in a progressive decline in word association and comprehension 
associated with semantic memory, whilst retaining syntax (Chan et al., 2001; 
Seeley et al., 2005). Those suffering from predominantly right-sided atrophy 
present with behavioural perturbations that overlap with bvFTD (Seeley et al., 
2005). Progressive atrophic degeneration typically spreads to affect 
contralateral temporal lobes after an average of 3 years, resulting in 
presentation of a range of symptoms associated with degeneration of both 
lobes (Brambati et al., 2009; Maguire et al., 2010; Seeley et al., 2005).  In 
contrast to SD, patients presenting with PNFA show conservation of semantic 
memory and display limited behavioural aberrations. PNFA is, instead, 
characterised by a progressive decline in motor speech and syntax, displaying 
speech apraxia and expressive agrammatism (Rohrer et al., 2010).   
 
Despite distinct classification criteria it is apparent that significant overlap in 
clinical presentation can occur between disease variants, with more significant 
overlap occurring in latter stages of disease progression. Such presentation can 
be attributed to increasingly diffuse atrophic degeneration occurring throughout 
the frontal and temporal lobes as the disease progresses. 
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1.2.2. Neuropathology of Frontotemporal Dementia 
 
All FTD variants are characterised by distinct FTLD associated pathology, the 
major hallmark of which is selective focal atrophy of the frontal and temporal 
cortices of the brain (Janssen et al., 2005). Such gross atrophy displays 
progressive neuronal loss, spongiosis and variable degrees of gliosis 
throughout layers II and III of the frontal and temporal cortices (Holm et al., 
2007; Mackenzie et al., 2006; Mann, 1998; Vanderzeypen et al., 2003). 
Adjacent regions of white matter may also display axonal and myelin loss 
accompanied by gliosis. Variability within the topographical patterns of focal 
atrophy seen in FTLD can, in part, be implicated in the heterogeneity of clinical 
symptoms presenting in FTD. However neuropathology in FTD shows further 
heterogeneity in the accumulation of distinctive proteins into neuronal inclusions 
within the brain (Mackenzie et al., 2010; Urwin et al., 2010b). The presence of 
such inclusions leads to further sub-classification of FTD, based on the 
predominant component of the neuronal inclusions seen, into 3 main 
categories; Tau-Positive FTLD (FTLD-Tau), Trans-activation response (TAR) 
DNA-binding protein 43 (TDP-43) positive FTLD (FTLD-TDP) and Fused in 
sarcoma (FUS) positive FTLD (FTLD-FUS) (Mackenzie et al., 2010; Urwin et al., 
2010b). 
 
FTLD-TDP, currently believed to be the most prevalent subtype of FTD, 
accounts for approximately 50 % of all FTD cases (Goedert et al., 2012). It is 
characterised by the presence of tau-negative, TDP-43- and ubiquitin-positive 
neuronal inclusions, occurring most prevalently in layer II neurons of the frontal 
and temporal cortices, as well as abundantly in the hippocampal dentate gyrus 
(Armstrong et al., 2012; Mackenzie et al., 2011). It is estimated that 50 % of 
bvFTD cases are associated with FTLD-TDP (Josephs et al., 2011). FTLD-Tau, 
characterised by the presence of neuronal inclusions composed predominantly 
of hyperphosphorylated tau protein, is the second most prevalent subtype of 
FTD, accounting for approximately 45 % of all cases (Boxer et al., 2013). It is 
implicated in ~ 40 % of bvFTD cases and ~ 70 % of PNFA cases (Josephs et 
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al., 2011). FTLD-FUS is considerably less prevalent, accounting for less than 10 
% of FTD cases (Goedert et al., 2012). FTLD-FUS inclusions show a 
distribution and morphology pattern similar to that seen in FTLD-TDP 
(Rabinovici and Miller, 2010). FTLD-FUS cases, however, show significant focal 
atrophy within the caudate region of the brain and display a very early onset of 
symptoms, with a mean onset of 38 years of age (Josephs et al., 2010; 
Neumann et al., 2009). Whilst FTLD-TDP, FTLD-Tau and FTLD-FUS are the 3 
major sub-classes a small number of FTD cases have been identified in which 
inclusions show tau-, TDP-43- and FUS-negative, ubiquitin-positive inclusions, 
termed FTD-UPS, or show no discernable inclusions, termed FTLD-ni (Urwin et 
al., 2010b). 
 
 
1.2.3. Epidemiology and Aetiology of Frontotemporal Dementia 
 
FTD is commonly implicated as the second most prevalent form of early onset 
dementia, occurring under 65 years of age, with an average age of onset 
between 46 and 65 and the youngest reported case being just 21 (Snowden et 
al., 2004)(Snowden et al., 2002). Epidemiological studies estimate incidence 
rates to range from between 2.7 and 15.1 cases per 100 000 adults aged under 
65 (Ratnavalli et al., 2002). Interestingly a number of these studies have 
proposed incidence levels to be greater than previously thought, including a 
significant prevalence amongst those of advanced age. Cases in individuals 
over 65 account for 20 - 25 % of all cases (Ahmad et al., 2009; Arvanitakis, 
2010; Borroni et al., 2010; Galimberti and Scarpini, 2010). Taken together this 
suggests FTD to be an under-diagnosed cause of dementia. 
 
The aetiology of FTD remains largely unknown with the majority of cases being 
sporadic, without defined cause. However despite this, unlike Alzheimer’s 
disease, FTD shows a strong genetic association with 40 - 50 % of cases 
showing a familial history of the disease and ~ 20 % of cases showing an 
autosomal dominant mode of inheritance (Chow et al., 1999a; Rosso et al., 
2003a; Talbot and Ansorge, 2006). Of all the variants of FTD bvFTD shows the 
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strongest familial history whilst SD shows the least familial association 
(Goldman et al., 2005).   
 
 
1.2.4. Genetic Causes of Frontotemporal Dementia 
 
To date 7 predominant gene loci have been implicated in FTD of which 3 are 
believed to account for the majority of familial FTD cases; the Microtubule 
Associated Protein Tau (MAPT), Progranulin (GRN) and Chromosome 9 Open 
Reading Frame 72 (C9ORF72) gene loci (Baker et al., 2006; Cruts et al., 2006; 
DeJesus-Hernandez et al., 2011; Hutton et al., 1998; Renton et al., 2011). A 
much smaller subset of FTD cases are associated with mutations in 4 other loci; 
the Valosin Containing Protein (VCP), TAR DNA Binding protein 43 (TARDBP) 
Fused in Sarcoma (FUS) and Charged Multivesicular Body Protein 2B 
(CHMP2B) genes (Borroni et al., 2009; Skibinski et al., 2005; Van Langenhove 
et al., 2010; Watts et al., 2004). There has also been reported possible 
involvement of the Apolipoprotein E (ApoE) and Presenillin-1 (PSEN1) gene loci 
(Bernardi et al., 2011; Seripa et al., 2011). 
 
 
1.2.5 CHMP2B a Core Component of The Endosomal Sorting 
Complex Required for Transport III (ESCRT-III) 
 
Mutations in the CHMP2B gene locus have been associated with rare 
autosomal dominant cases of FTD linked to chromosome 3 (FTD-3) (Skibinski 
et al., 2005). During the course of this investigation focus will, predominantly, be 
upon on FTD associated with mutations in this CHMP2B gene. In addition this 
investigation looks to determine the role of CHMP2B in the regulation of cellular 
processes involved in the development and function of neurons, in both healthy 
and diseased states. CHMP2B encodes a core component of the Endosomal 
Sorting Complex Required for Transport III (ESCRT-III), one of 4 heteromeric 
ESCRT complexes (Table 1.1) that comprise the fundamental machinery 
involved in cargo-recognition and membrane-deformation events essential to a 
number of diverse cellular processes (Carlton, 2010; Skibinski et al., 2005; 
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Stuffers et al., 2009; Wollert et al., 2009b). These include cellular abscission, 
viral budding, exosome secretion, autophagy and the biogenesis of 
multivesicular bodies (MVB’s) (Ariumi et al., 2011; Elia et al., 2011; Filimonenko 
et al., 2007a; Tamai et al., 2010).  
 
Table 1.1. ESCRT Complexes and Their Constituent Components. 
* = Core component 
  Subunit 
  Yeast  Human  Drosophila 
ESCRT-0   Vps27  HRS/HGS  HRS 
  HSE1  STAM1 
STAM2 
 STAM 
ESCRT-I  Vps23  TSG101  TSG101 
  Vps28  H-Vps28  Vps28 
  Vps37  Vps37A 
Vps37B 
Vps37C 
Vps37D 
 Vps37A/Mod(r) 
Vps37B 
  MVB12  MVB12A 
MVB12B 
 CG7192 
ESCRT-II  Vps22  EAP30/Snf8  Lsn  
  Vps25  EAP20  Vps25 
  Vps36  EAP45  Vps36 
ESCRT-III  Vps46  CHMP1A 
CHMP1B 
  
CHMP1 
  Vps2*  CHMP2A* 
CHMP2B* 
 Vps2* 
CHMP2B* 
  Vps24*  CHMP3*  Vps24* 
  Vps32/Snf7*  CHMP4A*  Shrub* 
    CHMP4B*   
    CHMP4C*   
  Vps60  CHMP5  CG6259 
  Vps20*  CHMP6*  Vps20* 
 !!
MVB formation occurs through the sequential activity of ESCRT’s 0-III allowing 
the deformation, invagination and scission of the late endosome limiting 
membrane to form intraluminal vesicles (ILV’s) that act as segregation 
compartments into which ubiquitinylated endosomal cargo proteins can be 
sorted and loaded into (Fig. 1.1.) (Carlton, 2010; Filimonenko et al., 2007b; 
Gruenberg and Stenmark, 2004b; Piper and Katzmann, 2007b). This process 
forms a central point in both the endocytic and autophagic degradative 
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trafficking pathways (Fig. 1.2.) that, through targeted sorting and degradation of 
cellular components, are fundamental to normal cellular homeostasis. 
!
Figure 1.1. Multivesicular Body Biogenesis 
MVB biogenesis occurs through the sequential activity of ESCRT’s 0-III. First ESCRT-0 self 
assembles and clusters cargo at the early endosome (a). This is followed by recruitment of 
ESCRT’s I and II, which may prop open the membrane neck (b). ESCRT-II then recruits 
ESCRT-III, via the Vps20 subunit, allowing membrane scission to occur (c). Finally, post 
scission, cargo is internalized into intraluminal vesicles (ILV’s) and ESCRT-III remains on the 
external membrane until it is recycled by Vps4 (d). Reproduced from Wollert and Hurley, 2010 
(Wollert and Hurley, 2010). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2. Multivesicular Bodies Form a Central Point in Both the Endosomal-
Lysosomal and Autophagic Trafficking Pathways. 
Multivesicular body (MVB) biogenesis occurs through the sequential activity of ESCRT’s 0 – III 
acting to deform and invaginate the plasma membrane of early endosomes, forming MVB’s. 
MVB’s act as a nexus in both the endosomal-lysosomal and autophagic degradative pathways, 
which are essential for cellular homeostasis. In order to degrade endosomal cargo MVB’s fuse 
with the lysosome. Alternatively MVB’s can fuse with autophagosomes forming autolysosomes, 
where content is degraded. Autophagosomes can also fuse directly with the lysosome, however 
this typically occurs less frequently. Endosomal cargo can also be targeted for recycling to the 
recycling endosome either directly or via MVB formation.  
 
Early Endosome!
MVB!
Phagophore!
Autophagosome!
Amphisome! Autolysosome!
DEGRADATION!
Lysosome!
Lysosome!
DEGRADATION!
ESCRT 0-III!
To Recycling!
Endosome!
Lysosome!
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Of all the ESCRT complexes (Table 1.1.) both in vivo and in vitro studies 
suggest that ESCRT-III is arguably the most important, fundamental to 
membrane deformation and scission events and involved in all known ESCRT 
dependent processes (Henne et al., 2011; Henne et al., 2013; Schmidt and 
Teis, 2012; Wollert et al., 2009a). Unlike ESCRT’s 0-II ESCRT-III only 
transiently assembles upon the endosome and is unable to form a stable 
complex within the cytoplasm, where the core subunits (Table 1.1.) auto-inhibit, 
forming stable inactive monomers (Bajorek et al., 2009; Merrill and Hanson, 
2010; Teis et al., 2008; Zamborlini et al., 2006). Autoinhibition is achieved 
through conformational orientation in which the negative C-terminus, of each 
component, obstructs a 7nm hairpin structure that is essential for membrane 
binding and dimerisation (Bajorek et al., 2009; Merrill and Hanson, 2010; 
Zamborlini et al., 2006). ESCRT-III assembly, into an active filamentous 
structure, is initiated through ESCRT-II induced activation of CHMP6/Vps20 
leading to the cascading assembly of ESCRT-III (Teis et al., 2008). This occurs 
through a series of conformational changes that alleviate autoinhibition and 
promote oligomerisation and membrane association. Active ESCRT-III is then 
capable of recruiting deubiquitinases, allowing for ubiquitin recycling, and 
inducing membrane deformation events (Schmidt and Teis, 2012).  
 
 
Recent evidence suggests that CHMP2B not only promotes recruitment of other 
components to the plasma membrane, during MVB biogenesis, but also has a 
fundamental role in the membrane deformation events (Bodon et al., 2011b; 
Hanson et al., 2008). Bodon et al. (2011) demonstrate that over expression of 
CHMP2B promotes its recruitment to the plasma membrane where 
polymerization into protruding helical structures directly interacting with the 
inner leaflet of the membrane bilayer induces membrane constriction (Bodon et 
al., 2011b). This evidence supports previous hypotheses that suggest ESCRT-
III proteins act to catalyse membrane fission events through the formation of 
membrane deforming hemi-spherical structures during MVB biogenesis 
(Fabrikant et al., 2009). Despite this the exact mechanism by which CHMP2B 
and the ESCRT-III complex functions in membrane remodelling remains yet to 
be fully elucidated. 
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1.2.6. The Role of CHMP2B in Frontotemporal Dementia 
 
Biogenesis of MVB’s and normal trafficking through the endosomal-lysosomal 
and autophagic-lysosomal trafficking pathways, to which MVB’s act as a nexus 
(1.2.), are essential for the maintenance of normal cellular homeostasis and the 
regulation of diverse biological processes (Guillaumot et al., 2010; Ryter et al., 
2013; Schneider and Zhang, 2010). As such perturbation to normal MVB 
biogenesis and the ESCRT machinery, fundamental for their formation, has 
been implicated in a range of disease’s including cancer, infectious diseases 
and neurodegenerative disease, including Parkinson’s, Huntington’s and FTD 
(Schneider and Zhang, 2010; Stuffers et al., 2009; Urwin et al., 2010a; Wollert 
et al., 2009b). 
 
The first mutation implicating CHMP2B in FTD was identified in 2005 in a large 
Danish cohort suffering from autosomal dominant, familial frontotemporal 
dementia associated with chromosome 3 (FTD-3) (Skibinski et al., 2005). It was 
demonstrated that all affected members of this large cohort displayed the same 
G-to-C transition within the splice acceptor site of exon 6, of the CHMP2B gene 
(Lindquist et al., 2008; Skibinski et al., 2005). This mutation resulted in aberrant 
mRNA splicing, leading to the formation of two novel transcripts, CHMP2BΔ10 
and CHMP2BIntron5 (Lindquist et al., 2008; Skibinski et al., 2005). Furthermore 
these transcripts were shown to be present in the brains of patients at 10 % and 
35 % of wildtype CHMP2B transcript levels, respectively (Urwin et al., 2010a). 
Subsequently, upon translation these transcripts result in the formation of two 
aberrant, C-terminally truncated proteins with their terminal 36 amino acids 
replaced by either a 29 amino acid nonsense sequence, in CHMP2BΔ10, or a 
single valine residue, in CHMP2BIntron5 (Lindquist et al., 2008; Skibinski et al., 
2005). Subsequently further CHMP2B mutations have been identified in FTD 
patients outside of this original Danish kindred (Momeni et al., 2006; van der 
Zee et al., 2008). These include an autosomal dominant Belgian pedigree 
displaying the CHMP2B mutation CHMP2BQ165X and an Afrikaner family 
presenting with a potential disease causing mutation, CHMP2BR186X (Momeni et 
al., 2006; van der Zee et al., 2008). Interestingly the Afrikaner mutation 
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(CHMP2BR186X) was only observed in unaffected family members and not their 
affected relatives (Momeni et al., 2006). Therefore the pathogenesis of this 
mutation remains unclear. For the CHMP2BQ165X and CHMP2BR186X mutations 
Glutamine-165 or Arginine-186, respectively, are substituted for a premature 
stop codon. As such both mutations also result in the formation of novel C-
terminally truncated CHMP2B proteins, suggesting a common mechanism 
behind pathology associated with CHMP2B mutants; C-terminal truncation of 
the CHMP2B protein. Subsequent studies corroborate this hypothesis revealing 
a functional role of the CHMP2B C-terminus in CHMP2B’s interaction with the 
AAA ATPase Vacuolar Protein Sorting 4 (Vps4) (Stuchell-Brereton et al., 2007). 
This interaction occurs via association of Microtubule Interacting and Transport 
(MIT) domains on Vps4 with a MIT interacting motif (MIM) located in the C-
terminus of CHMP2B (Stuchell-Brereton et al., 2007). This subsequently 
promotes the recruitment of Vps4 which, in turn, catalyses the disassembly of 
the ESCRT-III complex. As such, the C-terminal truncation of CHMP2B results 
in a loss of the Vps4 interacting MIM, resulting in an aberrant failure of 
CHMP2B to dissociate from the ESCRT-III complex, maintaining ESCRT-III in 
an endosomally bound and “active” state. Substantiating this recent studies 
have shown that models of FTD, associated with the CHMP2BIntron5 mutation, 
show that CHMP2Bintron5 forms an abnormal complex with the ESCRT-III 
component mSnf7-2, leading to abnormal accumulation of autophagosomes 
and dendritic retraction prior to neurodegeneration (Lee et al., 2007). As 
previously stated the C-terminus of all the core ESCRT-III components, 
including CHMP2B, are also involved in autoinhibition of the inactive monomers 
located within the cytosol. As such it is reasonable to infer that C-terminally 
truncating CHMP2B mutations also prevent autoinhibition therefore further 
promoting activity of CHMP2B. 
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1.3. Using Drosophila to Model Frontotemporal Dementia 
Associated With CHMP2B Mutations 
 
1.3.1. Drosophila As a Model Organism 
 
Drosophila melanogaster, the common fruit fly, has been utilised as a model 
organism for over a century, since the pioneering work by Thomas Hunt Morgan 
at the University of Columbia, USA. During this time Drosophila have become 
the most extensively utilised genetic model organism and a powerful tool for the 
elucidation of complex cellular and molecular mechanisms involved in a broad 
range of biological processes. These include cellular signalling, the cell cycle, 
the development of the nervous system, behaviour, development and even 
human diseases, where it is estimated that “…about 75 % of known human 
disease genes have a recognizable match in the genome of fruit flies” (Reiter et 
al., 2001; Roote and Prokop, 2013). Furthermore due to the high degree of 
evolutionary conservation seen between Drosophila and mammalian systems, 
despite evolutionarily diverging ~ 700 million years ago, work in Drosophila has 
laid fundamental foundations for further progression of research in mammals (St 
Johnston, 2002).  Drosophila have become valued as a powerful research tool 
for a plethora of reasons. Firstly they are relatively cheap and easy to maintain 
under laboratory conditions. They display rapid generation times, ~ 10 - 12 days 
at room temperature, and produce large numbers of genetically identical 
progeny, facilitating high-throughput experiments. They have relatively short 
lifespans, 40 to 120 days depending upon diet and stress, allowing for easy 
study of age related disorders (Bonner and Boulianne, 2011). Furthermore they 
possess a complex and well characterised nervous system capable of 
displaying intricate behaviours, including learning and memory (Hirth, 2010; 
Margulies et al., 2005; McGuire et al., 2005; Ofstad et al., 2011). Finally, and 
perhaps most importantly, Drosophila’s greatest asset is it’s genetic potential. 
Not only has the entire Drosophila genome of ~13600 genes, located across 
just 4 chromosomes and displaying low redundancy, been sequenced since 
2000, but there exists a plethora of powerful genetic tools available to 
manipulate Drosophila in a way unrivalled in any other organism (Adams et al., 
2000).   
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1.3.2. Genetic Tools in Drosophila 
 
The genetic power and tractability of Drosophila is optimized by the 
sophisticated genetic toolbox available for their manipulation. Traditionally, prior 
to the sequencing of the Drosophila genome in 2000, genetic manipulation 
relied, predominantly, upon forward genetic approaches (St Johnston, 2002). 
Using such approaches mutations are randomly generated and then screened 
based upon a specific phenotype of interest. Random mutations can be induced 
by a number of methods. For example flies can be fed ethyl methane 
sulphonate (EMS), which typically induces point mutations, or subjected to 
ionizing radiation to induce chromosomal rearrangements (Lewis, 1968; Muller, 
1927). Alternatively one can use transposable elements, such as P-elements, to 
perform insertional mutagenesis in which transposable elements are “hopped” 
randomly into genes, disrupting their function (Ryder and Russell, 2003; St 
Johnston, 2002). This approach is often advantageous as the gene being 
affected can be easily identified using the P-element as a tag. However P-
elements are inefficient mutagens, favouring transcriptionally active genes 
where the chromatin is more open, therefore generating “hot-spots” and not 
saturating the genome (St Johnston, 2002).  
 
Whilst forward genetics has proven highly successful in the study of gene 
function, the sequencing of the Drosophila genome has led to an expansion of 
the Drosophila genetic toolbox through more favourable reverse genetic 
approaches (Adams and Sekelsky, 2002). Despite this forward genetics remain 
important due to their ability to generate allelic series of mutations, ranging from 
nulls (amorphs) to weak partial loss of function mutations (hypomorphs) (St 
Johnston, 2002). In contrast to forward genetics reverse genetics is based on 
the principle of mutating specific, known genes and observing the resultant 
phenotypes, thus allowing elucidation of gene function. Some reverse genetic 
approaches also rely upon forward genetic approaches, such as chemical or 
transposon mediated mutagenesis, that have been modified to allow targeting 
of specific genes. For example P-elements inserted near to a known gene of 
interest can be mobilized, allowing excision of the P-element and the generation 
of a double stranded DNA break (Adams and Sekelsky, 2002). Inaccurate repair 
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of such breaks will often occur, allowing deletion of the gene sequence flanking 
the P-element insertion site and generating a specific null mutant. In order to 
prevent loss of such mutations through homologous recombination 
Drosophilist’s utilise what are known as balancer chromosomes (See section 
1.3.4.). The use of transposable elements has proven highly versatile in 
Drosophila genetics with them also being utilized to allow misexpression of 
genes, using P[EP]-elements, or to characterize the temporal and spatial 
expression of genes through enhancer trapping (O'Kane and Gehring, 1987) 
(for reviews see Adams and Sekelsky, 2002 and Ryder and Russell, 2003). 
They also allow for the generation of transgenic fly lines via transposon 
mediated transformation (Rubin and Spradling, 1982). This process involves the 
insertion of a gene of interest into a plasmid between two p-element ends 
followed by the microinjection of this construct, along with a transposase, into 
syncytial blastoderm embryos (See section 2.5.). Typically the gene of interest 
will be inserted into a construct containing an Upstream Activator Sequence 
(UAS), allowing implementation of the Drosophila tissue specific expression 
system known as the UAS/GAL4 system (see section 1.3.3.). This system can 
also be used to implement alternative reverse genetic approaches, as opposed 
to those that rely upon modifications to classical forward genetic methods, for 
example RNA interference (RNAi) (Hammond et al., 2001). Based upon known 
gene sequences it is now possible to design double stranded RNA’s against 
specific genes, allowing for target silencing of homologous genes through RNAi 
mediated degradation of cognate messenger RNA (mRNA) (Dietzl et al., 2007). 
 
 
1.3.3. The UAS/GAL4 System 
 
The UAS/GAL4 system is a powerful genetic tool that allows the ectopic 
expression of any gene sequence with a remarkable degree of flexibility, 
allowing for precise study of gene expression. It was initially developed as a tool 
in Drosophila by Andrea Brand and Norbert Perrimon, in 1993, and has since 
become one of the most reliable and useful tools in Drosophila genetics (Brand 
and Perrimon, 1993). The system relies upon two components. Firstly GAL4, a 
transcriptional activator derived from yeast, that is expressed in a tissue or cell 
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specific manner and, secondly, a transgene under the control of the Upstream 
activator sequence (UAS) to which GAL4 binds, activating expression. Through 
expressing these two individual components in different flies they can easily be 
brought together, promoting controlled ectopic gene expression in a cell/tissue 
specific manner, through a straightforward cross (Fig. 1.3.). 
 
Progressive modifications and adaptations to the original GAL4 system have 
created a highly versatile and powerful suite of genetic tools that allow for highly 
regulated temporal and spatial control of gene expression within Drosophila. 
These include the abilities to selectively antagonize GAL4 using GAL80 and 
temperature sensitive GAL80’s, the ability to temporally regulate expression 
using a series of heat shock promoters associated with GAL4 or GAL80 and 
inducible Gal4’s which can be activated through feeding specific ligands to 
larvae (Elliott and Brand, 2008; Han et al., 2000; Matsumoto et al., 1978).  !!!!!!!!!!!!!!!
 
 
 
Figure 1.3. The UAS/GAL4 system Allows Ectopic Gene Expression in A Controlled 
Tissue Specific Manner 
The UAS/GAL4 system is a bipartite system in which one line expresses GAL4 under the 
control of a tissue specific promoter and the other contains a gene of interest (in this example 
CHMP2BIntron5) downstream of the UAS to which GAL4 binds. These 2 components are brought 
together by crossing the fly lines, giving progeny in which the gene of interest is expressed only 
in those cells or tissue types expressing the GAL4 protein. 
 
 
 
 
  1.Introduction          1.Introduction 
 
!
   16!
1.3.4. Balancer Chromosomes 
 
Balancer chromosomes have become an essential tool in Drosophila genetics, 
conveying 3 fundamental properties; they prevent homologous recombination, 
they are homozygously deleterious to survival and they carry dominant markers. 
The advantage of which is that they can be used to maintain a heterozygous 
mutation within a strain of Drosophila and that this mutation can be easily 
followed during mating schemes using the balancer chromosome markers on 
the alternative allele (for a review see Roote and Prokop, 2013) (Roote and 
Prokop, 2013). 
 
In order to prevent homologous recombination in Drosophila females (it does 
not occur in males) balancer chromosome contain multiply inverted 
chromosomal segments. These multiple inversions allow chromosomes to 
segregate normally, however prevent synapsis between homologous 
chromosomes. If recombination does occur the presence of chromosomal 
fragment duplication and deletions results in lethality. This property, along with 
the homozygous lethality of balancers, is essential for the maintenance of 
heterozygous mutations in Drosophila stocks. 
 
The second beneficial function of balancer chromosomes is that they convey 
dominant markers, characterised by a distinct phenotype, that allow researchers 
to easily follow a specific balancer and therefore the mutation that is on the 
alternative allele during a crossing scheme (Fig. 1.4). !!
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Figure 1.4. Balancer Chromosomes Allow Following of Mutations During Chromosomal 
Segregation 
Balancer chromosomes allow researchers to select flies of the desired genotype during crossing 
schemes. For example in this cross parent flies carrying the desired mutations are crossed 
together (A) with the goal of obtaining progeny processing both mutations (C). Parent flies (A) 
each possess one of the desired mutations on the second chromosome with the balancer 
chromosome CyO on the alternative allele. The CyO balancer carries a dominant marker giving 
adults curly wings. Therefore following crossing chromosomal segregation produces progeny 
possessing either curly (B & D) or straight (C) wings. Those with curly wings must possess the 
balancer chromosome whilst equally those with straight wings must be the desired genotype 
possessing both mutation 1 and mutation 2 (one on each allele of chromosome 2). As such 
balancers allow the researcher to follow alleles and obtain flies of the desired genotype during 
crossing schemes. !!!
1.3.5. Using Drosophila to Study Neurodegeneration and 
Human Neurodegenerative Disorders 
 
 
Whilst human genetic studies have contributed significantly in the identification 
of genetic loci implicated in neurodegenerative diseases they show limited 
potential in the dissection of molecular pathways contributing to disease 
development and progression. Furthermore there are a number of technical and 
ethical constrains that limit the use of human participants in the study of 
disease. The majority of studies that do use humans to study neuropathology 
occur post mortem, providing limited insight into early disease pathology. As 
such, in order to elucidate the underlying pathogenic mechanisms associated 
with disease and develop approaches to prevent, stop, ameliorate or even 
reverse disease progression we must develop reliable models of 
neurodegenerative diseases. As the most tractable and highly utilized genetic 
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model organism Drosophila have already proven highly successful in the study 
of neurodegenerative disorders including Alzheimer’s disease, Parkinson’s 
Disease, Lysosomal Storage Disorders (LSD’s), Huntington’s Disease, 
Trinucelotide repeat disorders, Hereditary Spastic Paraplegia and Amyotrophic 
lateral Sclerosis (ALS) (Cao et al., 2008; Chakraborty et al., 2011; Huang et al., 
2005; Jung and Bonini, 2007; Marsh et al., 2003; Milton et al., 2011; Moloney et 
al., 2010; Orso et al., 2005; Watson et al., 2008; Weiss et al., 2012; Whitworth, 
2011; Whitworth et al., 2006; Yu and Bonini, 2011). 
 
One of the strengths of Drosophila in the modelling of neurodegenerative 
diseases is the conservation of human disease causing genes within 
Drosophila. For example 5 of the 7 core loci implicated in FTD have a 
Drosophila orthologue (Table 1.2.). Furthermore Drosophila show limited 
genetic redundancy, allowing for a more specific dissection of gene function 
than in other metazoan organisms.  
 
Table 1.2. Conservation of Frontotemporal Dementia Disease Loci in Drosophila 
Human Loci  Drosophila Orthologue   % Homology (amino acids) 
MAPT  Tau   24 
GRN  -   - 
C9ORF72  -   - 
VCP  TER94   83.63 
CHMP2B  CHMP2B   52.75 
TARDBP  TBPH   56 
FUS  Caz   54.62 !
 
One system that has proven effective in the elucidation of genes that regulate 
neuronal development and function, with an emphasis on dissecting 
pathological mechanisms involved in neurodegenerative diseases, is the 
Drosophila neuromuscular junction (NMJ)   
 
 
1.3.6. The Drosophila Larval Neuromuscular Junction as a 
Model Synapse 
 
 
The Drosophila neuromuscular junction is a well characterised model synapse 
that has proven a highly amenable and successful tool for the study of synaptic 
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development and neurotransmission. Like with most Drosophila models this has 
been, in part, due to the unrivalled genetic tractability of the system, allowing 
precise manipulation and dissection of the molecular mechanisms involved in 
synaptic assembly and function. Furthermore, unlike vertebrate NMJ’s which 
are cholinergic, Drosophila NMJ’s are, like vertebrate central synapses, 
glutamatergic, showing significant conservation of molecular components 
(Broadie and Bate, 1993b; DiAntonio et al., 1999; Wu et al., 2010). However, in 
contrast to the vertebrate central synapse, each pre-synaptic motor neuron and 
it’s associated post-synaptic muscle are distinctly identifiable, accessible and 
invariable (Broadie and Bate, 1993b; DiAntonio et al., 1999; Johansen et al., 
1989; Wu et al., 2010). As well as this distinct pattern of distribution it is 
apparent that individual NMJ subtypes also display a largely archetypal 
structure characterized by stereotypical arborisation, size, bouton number and 
synaptic strength (Campbell and Ganetzky, 2012; Landgraf and Thor, 2006). As 
such specific NMJ’s can be easily identified and reliably compared between flies 
and, therefore, a number of specific NMJ’s have become standardized, well 
characterised model synapses. For example Muscle 6/7 in hemi-segment A3 
(Fig. 1.5), which is innervated by one of 5 RP neurons (RP1-5), RP3. 
 
Another benefit of the Drosophila NMJ is that it is highly amenable to analysis 
by well established physiological, genetic, anatomical and cell biological 
approaches. For example immunohistochemistry and electron microscopy allow 
for dissection of the structure and anatomy of the NMJ whilst the use of FM 
(frequency-modulated) dyes and classical electrophysiology provide insight into 
physiological function (Imlach and McCabe, 2009; Verstreken et al., 2008).  
 
Therefore the Drosophila NMJ provides an accessible, amenable model 
synapse, representative of the glutamatergic vertebrate central synapse, for the 
study and dissection of molecular mechanisms involved in normal synaptic 
development and neurotransmission in vivo. 
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1.3.7. Anatomy of the Drosophila NMJ 
 
 
The Drosophila larval body plan displays a predominantly segmented structure, 
comprised of 14 segments; 3 defining the head and mouthparts, 3 thoracic 
segments and 8 within the abdominal region (Fig. 1.5.A.) (Va et al., 2009; 
Wolpert, 2007). The development of these segments is strictly regulated and 
from segment A2-A7 this regulation shows a highly conserved molecular and 
genetic program, leading to the formation of 6 almost identically organized, 
bilaterally symmetrical segments (Hoang and Chiba, 2001; Keshishian et al., 
1996; Landgraf et al., 2003b). Each of these segments can be further divided 
into the two bilaterally symmetrical hemi-segments, comprised of 30 distinct 
syncytial muscles (Fig. 1.5.B) (Hoang and Chiba, 2001). Within this abdominal 
region (A2-7) the majority of motor neurons have been extensively 
characterized, starting from their developmental origins within the 
neuroectoderm (Budnik, 2006; Landgraf et al., 1997). As such individual motor 
neuronal connections, to specific muscles, and the morphological and structural 
characteristics of these NMJ’s have been well described, providing significant 
insights into the Drosophila larval motor neuronal system and, consequently, 
the regulation of synaptic assembly and function. 
 
 
 
 
 
 
 
Figure 1.5. The Drosophila Larval Neuromuscular Junction. 
(A) The Drosophila larval body plan is comprised of 14 segments, 3 defining the head and 
mouth, 3 thoracic segments (T1-T3) and 8 abdominal segments (A1-A3) (modified from Zhang 
and Stewart, 2010 (Zhang and Stewart, 2010)). (B) Each abdominal segment A2-A7 is 
7 
D 7 6 
A B 
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comprised of 2 bilaterally symmetrical hemi-segments containing 30 distinct muscles (modified 
from Hoang and Chiba, 2001 (Hoang and Chiba, 2001)). (C-D) Hemi-segments A2-A7 have 
been extensively studied with a number of specific NMJ’s, for example muscle 6/7 hemi-
segment A3 (c-d), becoming model synapses. 
 
 
Motor neuronal cell bodies are located proximally to the larval central nervous 
system (CNS), within the outer cortex of the ventral nerve cord (VNC). Each uni-
polar cell body presents two neuronal projections (neurites). The first projects 
into the neuropil region of the VNC where it forms a distinct dendritic arbour, 
that with other motor neuronal dendrites form a myotopic map, comparable to 
the motor columns seen in the vertebrate spinal cord (Landgraf et al., 2003a). 
The second projection is that of the axon which projects through one of 6 nerve 
branches (transverse nerve (TN), intersegmental nerve (ISN), segmental nerves 
(SN) a-d) (Fig. 1.5.B) before defasciculating in a stereotypical pattern to 
innervate its specific target muscle (Budnik, 2006; Hoang and Chiba, 2001). 32 
known and well characterised motor neurons have been demonstrated to 
innervate the 30 muscle of each abdominal hemi-segment (Fig. 1.5.B) (Budnik, 
2006; Collins and DiAntonio, 2007; Hoang and Chiba, 2001). The interface 
between the motor neuron and the target muscle is the NMJ and is 
characterized by a branched synaptic terminal comprised of a chain of 
varicosities known as synaptic boutons (Johansen et al., 1989). Each bouton, in 
turn, contains multiple pre-synaptic release sites known as active zones (Zito et 
al., 1999). The majority of NMJ’s in Drosophila are classical glutamatergic (type-
I) NMJ’s, capable of evoking an excitatory contractile response within the post-
synaptic muscle (Prokop, 2006). However there also exist non-classical type-II 
and type-III terminals, which display a functional role in neuromodulation, as 
well as other significantly less understood synaptic terminals (Prokop, 2006). In 
this investigation we are focusing upon classical type-I glutamatergic NMJ’s. 
 
The development of type-I glutamatergic NMJ’s, from here on in referred to 
simply as NMJ’s, is highly regulated, allowing for tight control of synapse 
number, and thus synaptic strength. As such NMJ’s display a well 
characterised, archetypal morphology with a relatively consistent pattern of 
branching, NMJ size and number of synaptic boutons for each specific muscle 
type. Such invariability allows for the application of quantitative approaches in 
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the characterization of NMJ morphology, allowing dissection of molecular 
mechanisms involved in the regulation of NMJ assembly and function through 
the identification of perturbations in specific Drosophila mutants. NMJ’s can be 
broadly classified into two populations based upon the morphology of their 
synaptic boutons, type-I small (type-Is) and type-I big (type-Ib) (Gramates and 
Budnik, 1999; Prokop, 2006). Type-Is NMJ’s are, as the name suggests, 
characterized by small synaptic boutons, typically 1-1.5 μm in diameter as 
opposed to the larger 3-5 μm diameter boutons of type-Ib terminals (Atwood et 
al., 1993; Prokop, 2006). In addition, type-Is boutons tend to contain a plethora 
of variable sized vesicles, including large clear and dense cored vesicles. In 
contrast type-II boutons predominantly contain small, 30-40 nm, clear vesicles 
(Prokop, 2006). In comparison to type-Is boutons type-Ib’s also display a 
greater number of mitochondria, are typically located closer to the NMJ branch 
point than type-Is boutons and present a larger subsynaptic reticulum (SSR) 
(Ataman et al., 2006b). The SSR is a feature characteristic to type-I NMJ’s 
(Ataman et al., 2006b). It is comprised of complex convolutions of the post-
synaptic muscle plasma membrane, which envelops the bouton, embedded with 
post-synaptic molecules, including glutamate receptors (GluR’s), cell adhesion 
molecules and scaffolding proteins (Ataman et al., 2006b). Whist the SSR 
remains poorly understood in terms of function, it has been implicated as a local 
site for GluR translation whilst Syndapin has been implicated in regulating its 
biogenesis (Ataman et al., 2006b; Kumar et al., 2009). 
 
 
 
1.3.8. Development and Plasticity of the NMJ 
 
 
Growth, development and maintenance of the Drosophila larval NMJ is a highly 
dynamic process, requiring continuous remodelling in response to both muscle 
growth and to exogenous signals, allowing for modulation of synaptic strength in 
an activity dependent manner (Fuentes-Medel et al., 2009). Remodelling of the 
NMJ is, like most developmental processes, highly regulated by a variety of 
interconnected, intricate and bi-directional signalling pathways from both the 
pre- and post-synaptic terminals. During development to the larval 3rd instar 
  1.Introduction          1.Introduction 
 
!
   23!
stage the muscle surface area will increase in size by approximately 100 times, 
with a 10 fold increase in bouton number between the first and third instar 
stages (Keshishian et al., 1993; Schuster et al., 1996). Throughout this growth 
process the larval NMJ must undergo a period of significant dynamic 
development, with growth paralleling that of the muscle. In contrast muscle 
growth is, with the exception of glutamate receptor clustering at the post 
synaptic density (PSD), relatively independent of innervation by the nervous 
system (Broadie and Bate, 1993a). 
 
The initial formation of the NMJ begins approximately 13 hours post egg laying 
(PEL) (at 25°C) when the axonal growth cone of the newly developing motor 
neuron contacts the myopodia of its specific target muscle (Broadie and Bate, 
1993b; Yoshihara et al., 1997). It is at approximately this time that the first 
electrical activity is detectable from central motor neurons (Baines and Bate, 
1998). Upon interaction the developing growth cone undergoes remodelling, 
initially expanding across a large surface area of the muscle, the pre varicosity 
stage (~ 16.5 - 18.5 hours PEL), before constricting to form a distinct branched 
mature NMJ structure, characterized by definitive varicosities (~ 18 - 19 hours 
PEL) (Broadie and Bate, 1993b; Yoshihara et al., 1997). Prior to the interaction 
between the developing axonal growth cone and the muscle the development of 
the pre- and post-synaptic components are autonomous of each other. For 
example it has been shown that functional glutamate receptors are present 
within the muscle in the absence of neuronal innervation whilst twist mutants, 
displaying a complete loss of muscles due to a failure in mesoderm formation, 
are still capable of axonal outgrowth and the formation of morphologically 
normal presynaptic active zones (Broadie and Bate, 1993b; Currie et al., 1995; 
Prokop et al., 1996). Subsequently, following interaction of the developing 
growth cone with it’s target muscle, the development and continuous 
homeostatic modulation of synaptic size and strength, in response to external 
cues, is regulated by a series of bi-directional pre- and post-synaptic signalling 
pathways. These include morphogenic signalling pathways such as wingless 
and transforming growth factor beta (TGFβ) signalling as well as intracellular 
signals such as mitogen-activated protein kinase (MAPK) cascades and the 
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regulation of signalling cascades by cell adhesion and scaffolding proteins such 
as Fasciclin II (Fas II) and Discs large (Dlg). 
 
 
 
1.3.9. TGFβ Signalling During NMJ Development  
 
TGF-β signaling has been demonstrated as fundamental to normal NMJ 
assembly and function, in Drosophila, with mutants defective in normal TGF-β 
signaling displaying synaptic undergrowth, whilst up-regulation of TGF-β 
signaling promotes an overgrowth phenotype (Aberle et al., 2002; Rawson et 
al., 2003; Sweeney and Davis, 2002). TGF-β signaling acts through a complex 
signaling cascade in which TGF-β ligands, including TGF-β’s, activins and bone 
morphogenic proteins (BMP’s) bind type II transmembrane receptors. These in 
turn recruit type I receptors, forming a tetrameric receptor complex in which type 
II receptors phosphorylate type I receptors. Activated type I receptors are then 
capable of activating receptor SMAD’s (R-SMADs) which, following association 
with a cofactor SMAD (co-SMAD), proceed to the nucleus to regulate gene 
transcription. The acronym SMAD is a portmanteau of Drosophila MAD 
(mothers against decapentaplegic (dpp)) and Caenorhabditis elegans SMA 
(small body size). In Drosophila there are 3 known type-I receptors (Thick 
Veins, Baboon and Saxophone), 2 type-II receptors (Punt and Wishful thinking), 
2 R-SMADs (MAD and SMAD on the X), 1 Co-SMAD (Medea), a single 
inhibitory SMAD (Daughters against DPP (dad)) and 7 TGFβ ligands (Marques, 
2005). The TGF-β ligand implicated in TGF-β signalling regulating NMJ 
development is glass bottom boat (gbb), a BMP family protein (Marques et al., 
2003; McCabe et al., 2003). Gbb is post-synaptically derived, being secreted by 
the muscle and providing a retrograde signal from the muscle to the motor 
neuron that allows coalescence of pre- and post-synaptic growth (Marques, 
2005; Marques et al., 2003; McCabe et al., 2003). Muscle secreted gbb binds 
pre-synaptic type-I receptors Thick veins (Tkv) and Saxophone (sax), signaling 
through the type-II receptor Wishful thinking (wit) and SMAD’s MAD and Medea 
(Fig. 1.6.) (Collins and DiAntonio, 2007; Marques, 2005; McCabe et al., 2003; 
Rawson et al., 2003). This pathway has been comprehensively dissected with 
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gbb, sax, Tkv, wit, MAD and Medea mutants all displaying a significant 
reduction in NMJ size coupled with perturbed synaptic transmission and 
aberrations to normal synaptic ultrastructure, including detachment of synaptic 
membranes and floating T-bars (Aberle et al., 2002; Marques et al., 2002; 
Marques et al., 2003; McCabe et al., 2004; Rawson et al., 2003; Sweeney and 
Davis, 2002). Furthermore it has been shown that these aberrations can be 
alleviated through pre-synaptic rescue experiments, confirming that gbb is 
acting retrogradely activating a TGFβ signaling cascade within the pre-synaptic 
motor neuron (McCabe et al., 2004).  This is further supported by observations 
that normal phospho-SMAD localization to the motor neuronal nucleus is 
perturbed in TGFβ signaling mutants (Marques et al., 2003). Conversely it has 
been demonstrated that mutations to genes that are likely involved in the down 
regulation of TGFβ signaling via endosomal-lysosomal trafficking, such as 
spinster (spin) show significant NMJ overgrowth that is dependent upon normal 
TGFβ signaling (Sweeney and Davis, 2002). As such there is significant 
evidence that the TGFβ signaling pathway, which shows clear conservation 
between flies and mammals, plays a fundamental role in coupling pre- and post-
synaptic growth, via retrograde signaling, during NMJ development.  
 
 
1.3.10. JNK Signalling During NMJ Development 
 
  
A number of mitogen activated protein kinase (MAPK) signalling cascades have 
been implicated in neuronal plasticity, with mutants in MAPK pathways 
displaying defects in learning and memory and long-term potentiation (LTP) 
(Kelleher et al., 2004; Moressis et al., 2009). Furthermore research has show 
these pathways play an important role in the regulation of synaptic 
development, including that of the Drosophila NMJ, where alterations in MAPK 
activity have been shown to influence NMJ size and strength (Collins et al., 
2006; Milton et al., 2011).  
 
One MAPK pathway identified as a potent regulator of synaptic growth and 
function, in Drosophila, is that of the Jun N-terminal kinase (JNK)/activator 
protein-1 (AP-1) signal transduction pathway (Fig. 1.6.) (Collins et al., 2006; 
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Milton et al., 2011). The central component of this pathway is JNK, which was 
initially identified as an evolutionarily conserved stress activated kinase (Hibi et 
al., 1993). The JNK pathway has been shown to be activated by a range of both 
endogenous and environmental insults including DNA damage, oxidative stress, 
immune challenges, UV irradiation and heat stress (Derijard et al., 1994; Hibi et 
al., 1993; Milton et al., 2011; Pantos et al., 2003; Silverman et al., 2003; 
Yoshida et al., 2005). For example recent work in the Sweeney lab has shown 
that reactive oxygen species (ROS) induce an activation of the JNK/AP-1 
pathway, promoting synaptic overgrowth in Drosophila (Milton et al., 2011). In 
response, individual stress stimuli have been shown to selectively activate 
specific JNK Kinase Kinase’s which, in turn, propagate a kinase cascade, 
through JNK kinases, leading to the phosphorylation and activation of JNK. JNK 
in turn has a number of downstream targets, including AP-1. AP-1 is a dileucine 
zipper transcription factor composed of hetero- or homo-dimers of Fos and Jun, 
which in Drosophila are termed kayak and jun-related antigen (Jra) respectively 
(Halazonetis et al., 1988; O'Shea et al., 1989; Rauscher et al., 1988). Upon 
activation AP-1 has been demonstrated to induce a variety of stimuli and tissue 
specific responses including apoptosis, autophagy and cell proliferation (Guo et 
al., 2012; Lauricella et al., 2006; Shaulian and Karin, 2001). As such the 
JNK/AP-1 pathway has been identified as a conserved a highly versatile stress 
response pathway. 
 
In Drosophila it has been shown that the JNK/AP-1 pathway is a potent 
regulator of NMJ assembly and function. For example Sanyal et al. 
demonstrated that increased motor neuronal, but not muscle, expression of Fos 
and Jun was sufficient to induce significant increases in bouton number (Sanyal 
et al., 2002). Similarly Etter at al. (2005) showed that neuronal overexpression 
of an activated JNK Kinase, Hemipterous, induced a 30 % increase in bouton 
number at the NMJ (Etter et al., 2005).  Furthermore it has also been shown 
that mutations in highwire (hiw), a neuronally expressed E3-ubiquitin ligase 
required for inhibition of the JNK Kinase Kinase wallenda (wnd), display 
significant synaptic overgrowth that can be alleviated by inhibition of wnd 
(Collins et al., 2006). As previously mentioned work in the Sweeney lab has 
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also shown that inhibition of the JNK/AP-1 pathway in both Spin mutants, which 
display an oxidative stress burden, and SOD mutants alleviates synaptic 
overgrowth phenotypes (Milton et al., 2011). These findings support previous 
hypotheses that suggest the JNK/AP-1 pathway may mediate synaptic 
development in response to stress stimuli such as oxidative stress. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 1.6. Signaling pathways regulating NMJ assembly and Development.  
During development of the Drosophila larval NMJ the pre-synaptic nerve terminal (pink) 
innervates abdominal muscles (light blue) in the larval body wall. Development of the NMJ is 
regulated by a series of bi-directional interconnected signalling pathways including TGFβ and 
JNK. In the TGFβ pathway the BMP ligand Gbb (orange) is secreted by the muscle, signalling 
retrogradely to the pre-synaptic nerve terminal via type-I (Tkv) and type-II (Wit) TGFβ receptors. 
Gbb mediated activation of the receptors promotes phosphorylation of downstream SMAD 
proteins, which translocate to the nucleus in order to regulate transcription of genes involved in 
NMJ development. JNK signalling also contributes towards regulated development of the NMJ, 
acting to promote NMJ growth. Evidence suggests that JNK signalling is regulated by the E3 
ubiquitin ligase hiw, which maintains restraint upon the JNK signalling pathway through 
targeting the JNKKK wnd for degradation by the proteasome. Reproduced from Collins and 
DiAntonio (2007) 
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1.3.11. Enhancer and Suppressor (Modifier) Screens 
 
 
One of the greatest strengths of Drosophila, as a model organism, is it’s ability 
to be utilised in high-throughput forward genetic screens that allow for the 
identification of genes involved in specific biological processes (for review see 
(St Johnston, 2002)). Drosophila screens were popularized by the revolutionary, 
Nobel prize winning, Heidelberg screens conducted by Christiane Nüsslein-
Volhard and Eric Wieschaus in which, through screening of embryonic mutant 
phenotypes, they identified a series of genes that are essential to embryonic 
patterning (Nusslein-Volhard and Wieschaus, 1980). Whilst revolutionary such 
traditional screening approaches, for embryonic homozygous lethal mutations, 
only allow for identification of the earliest phenotype of a mutation and so do not 
always allow for elucidation of more extensive signal transduction pathways. As 
such since the pioneering work of Nüsslein-Volhard and Wieschaus numerous 
more advanced, elegant screening approaches have been devised, including 
enhancer and suppressor screens. 
 
Enhancer and suppressor, or modifier, screens are based upon the principle 
that if a specific biological process is perturbed by a mutation then an organism 
may become “sensitised” to heterozygous mutations in secondary genes, 
affecting the same pathway, which would typically be recessive in a wildtype 
background (St Johnston, 2002). Generally loss of function mutations are 
recessive, with a 50% of wildtype complement usually being sufficient for 
normal development (St Johnston, 2002). However in a “sensitised” mutant 
background these same mutations may become dominant and therefore more 
easily identifiable. Using such an approach a mutation in a specific gene of 
interest, that gives a distinctive phenotype, can be the basis of large modifier 
screens in which second-site mutations that dominantly enhance or supress the 
primary mutant phenotype can be identified. This approach has a number of 
advantages over traditional genetic screens; firstly as mutants do not need to be 
made homozygous, as in traditional screens, an F1 instead of F3 screen can be 
performed, increasing both speed and throughput. Secondly mutations that are 
homozygously embryonic lethal can be screened to determine their functional 
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role in later developmental stages. Finally as no specific chromosomes have to 
be made homozygous there is no requirement for balancer chromosomes and 
so the entire Drosophila genome can be screened against the primary mutation. 
As such modifier screens have become a fundamental tool in the dissection of 
genetic interactions involved in specific pathways associated with an initial gene 
of interest. 
 
 
1.3.12. The Drosophila Eye as a Model System for Unbiased 
Modifier Screens 
 
The Drosophila eye has become one of the most popular and successful 
systems in which to conduct enhancer and suppressor screens (St Johnston, 
2002). Using the UAS/GAL4 system it has proven possible to express mutant 
transgenes within the Drosophila eye, under the control of eye specific 
promoters such as the glass multimer reporter (GMR). The advantages of this 
specific spatial expression can be seen as three fold. Firstly the eye has a 
highly regular, organized structure (Fig. 1.7.) meaning that even minor 
perturbations become amplified and therefore discernable as significant 
changes to cell patterning (Mishra and Knust, 2013). Such distinctive 
phenotypes can easily be quantified allowing for easy identification of 
enhancers and suppressors of this initial phenotype. Secondly the structure and 
neuronal connections of the eye are well studied and characterised allowing for 
analysis of neuronal morphology (Raghu and Borst, 2011). Finally, and perhaps 
of greatest significance, the eye is dispensable for normal viability and 
reproduction, under laboratory conditions (Sang and Jackson, 2005). Therefore 
mutations that induce significant pathogenesis or are typically lethal in the 
whole organism can be expressed in the eye and degeneration easily visualized 
without lethality. As such modifier screens have proven robust and successful in 
the identification of novel genetic interactions influencing diseases. For example 
Pandey et al. (2007) utilised the Drosophila eye to identify Histone deacetylase 
6 (HDAC6) as a modifier of neurodegeneration associated with Spinobulbar 
muscular atrophy (Pandey et al., 2007). Similarly Jackson et al (2002) 
demonstrated that tau hyperphosphorylation by Glycogen synthase kinase 3 
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(GSK-3) potentiated a tau eye model of neurodegeneration, a discovery that 
has proven important in the study of Alzheimer’s disease (Jackson et al., 2002).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7. The Drosophila Compound Eye Exhibits a Highly Regular and Organised 
Structure 
The Drosophila compound eye (A) consists of 760 virtually identical subunits termed ommatidia 
(B). Ommatidia are arranged into precise hexagonal arrays and each contains 8 photoreceptor 
cells, R1- R8 (C). Photoreceptor neurons are composed of 2 main sections, the cell body and 
the rhabdomeres. The rhabdomeres can be stained using phalloidin bound to a specific dye 
allowing visualisation of the eyes regular structure (D) only 7 of 8 rhabdomeres are distinctly 
visible as R7 lies directly above R8.  
 
 
1.4. Rab8, An Enhancer of Frontotemporal Dementia? 
 
In this investigation the Drosophila eye was used to perform modifier screens, 
looking for enhancers and suppressors of CHMP2BIntron5 toxicity associated with 
FTD. The majority of this investigation shall focus upon one potent enhancer, 
Rab8. 
 
 
1.4.1. Rab Proteins 
 
1.4.1.1. The Structure of Rab Proteins 
 
Rab (Ras related in brain) proteins are small (20-25 kDa), monomeric G-
proteins, constituting the largest subfamily of the Ras GTPase superfamily (Ng 
and Tang, 2008; Pfeffer, 2001; Stenmark, 2009; Zerial and McBride, 2001). In 
humans there are now more than 60 known Rabs, which can be divided into 14 
Rab subfamilies (Schwartz et al. 2007, Diekmann et al., 2011). Over the past 
decade the structure of many Rab proteins, in both their GTP-bound active and 
http://www.sciencephoto.com/media/369771/view!
Adapted from Neuroscience. 2nd edition.(Purves et al 2001)!
Adapted from Cagan & Ready (1989)!
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GDP-bound inactive states, have been determined, with the structure of at least 
one rab from each family having been elucidated (Hutagalung and Novick, 
2011). As such it has been determined that, on the whole, Rab proteins show a 
typically conserved core structure, that is generally conserved across the entire 
Ras superfamily. This includes the presence of a 20 kDa catalytic GTPase fold 
composed of a six-stranded β-sheet, comprising of 5 parallel and one anti-
parallel strands, flanked by 5 α-helices and containing 5 specific polypeptide 
loops that link the α-helices to the β-strands (Hutagalung and Novick, 2011; 
Pfeffer, 2005). These loops, classified as G1-G5, are the most highly conserved 
component of the GTPase fold and are functionally essential for guanine 
nucleotide binding and GTP hydrolysis (Okai et al., 2004). Within the catalytic 
domain there are also two distinct regions termed switch I and switch II which 
show nucleotide dependent conformational variability and are the only regions 
of Rab proteins to undergo conformational alterations essential to Rab function 
(Pfeffer, 2005). In a GDP-bound state the switch regions are typically 
disordered, adopting a highly ordered orientation upon GTP binding that allows 
Rab’s to bind specific effectors in their “active” state (Pfeffer, 2005; Stroupe and 
Brunger, 2000). 
 
As well as the N-terminal catalytic core Rab proteins also contain a 
hypervariable C-terminal domain, which early work implicated in the localisation 
of Rab’s to specific target membranes (Chavrier et al., 1991). More recent 
evidence, however, suggests a more complex scenario in which multiple 
regions contribute towards localisation (Ali et al., 2004). In the majority of Rab 
proteins the C-terminal domain terminates with a distinctive cysteine rich motif 
(CC, CCX, CXC, CCXX or CCXXX) (Calero et al., 2003; Leung et al., 2007). 
This motif is required for recognition by Rab geranylgeranyl transferase 
(RabGGT) which catalyses the addition of prenyl groups, essential for 
membrane associate and anchoring of Rabs (Calero et al., 2003; Leung et al., 
2007). A minority of Rab’s possess an alternative CAAX motif more 
representative of other, non-Rab, Ras superfamily members (Calero et al., 
2003; Leung et al., 2007). 
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1.4.1.2. The Function of Rab GTPases; Molecular Switches 
 
As GTPases, Rab proteins function as molecular switches, cycling between 
conformationally distinct GTP-bound “active” and GDP-bound “in-active” states, 
which in turn influences association with effector proteins and localisation 
(Pfeffer, 2005; Stenmark, 2009). Cycling between GTP-bound and GDP-bound 
states occurs in process mediated by Guanine nucleotide exchange factors 
(GEF’s) and GTPase activating proteins (GAP’s) (Fig. 1.8.) and is associated 
with significant conformational alterations in two distinct variable regions, known 
as switch I and switch II (Zhu et al., 2010). 
 
Newly synthesised Rab proteins are recognised by the Rab Escort Protein 
(REP) which, in turn, presents them to RabGGT (Fig. 1.8) (Alexandrov et al., 
1994). RabGGT then acts to catalyse prenylation of the newly synthesized Rab 
through the addition of geranylgeranyl groups to one or two, most commonly 
two, cysteine residues within the hypervariable C-terminus of the Rab protein 
(Hutagalung and Novick, 2011). This irreversible addition of hydrophobic 
gernaylgeranyl groups acts to form an isoprenyl anchor, via which Rab proteins 
associate tightly with their target membrane. Furthermore it has been 
demonstrated that the prenyl groups of GDP-bound Rab proteins are 
recognised by GDP-dissociation inhibitor’s (GDI’s) which, therefore, masks the 
isoprenyl anchor and maintains a cytosolic, membrane dissociated localisation 
of the Rab protein (Grosshans et al., 2006; Rak et al., 2003). In addition to 
maintaining cytosolic localisation of Rab’s it has also been shown that GDI’s are 
actively capable of extracting Rab proteins from target membranes, via a 
‘mobile effector loop’ comprised of an ordered loop of residues that, in the 
absence of prenyl groups remain disordered (Luan et al., 2000). Thus GDI’s 
may have a functional role in the retrieval of Rab proteins from target 
membranes and their relocation to their membrane of origin, a process that is 
essential for many Rab functions, such as delivery of vesicles from one 
compartment to another. In order for Rab’s to be specifically inserted into 
membranes it is essential to release them from the GDI complex and expose 
their isoprenyl anchor. Evidence suggests that this is mediated by another 
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family of proteins termed GDI Displacement factors (GDF’s), which act to 
recognize Rab-GDI complexes and promote GDI displacement, exposing the 
isoprenyl anchor and allowing re-insertion into membranes (Dirac-Svejstrup et 
al., 1997; Hutagalung and Novick, 2011; Stenmark, 2009).  
 
Once associated with their cognate membrane, through their isoprenyl anchor, 
GDP-bound inactive Rab proteins are activated by GEF’s, which act to catalyse 
the exchange of GDP for GTP. It has been demonstrated that GEF’s are 
capable of catalysing nucleotide exchange through varying mechanisms, 
although all appear to be based around the same basic principle. Association of 
GEF’s with their Rab substrates occurs through direct interactions with the 
switch I, switch II and interswitch regions, promoting significant conformational 
changes within these domains (Stein et al., 2012; Wu et al., 2011). 
Conformational changes include displacement of aromatic residues that 
typically act to stabilise nucleotide binding from the switch I region (Wu et al., 
2011). Through these conformational changes the nucleotide binding affinity of 
the Rab protein is reduced, facilitating displacement of GDP. Due to the high 
cytosolic concentration of GTP (~ 1 mM), 10 fold that of GDP, it rapidly 
associates with the Rab protein following GDP dissociation (Wu et al., 2011). 
Conformational changes to the switch regions, associated with GTP binding and 
activation of the Rab protein, allow interaction with multiple Rab effector 
proteins that are involved in diverse processes associated with distinct 
membrane trafficking pathways (Pfeffer, 2005). In order to return the Rab 
protein to its inactive state and continue the cycle bound GTP is hydrolysed to 
GDP through the endogenous GTPase activity of the Rab protein catalysed by 
GTPase activating proteins (GAP’s) (Stenmark, 2009). Once again in an 
inactive GDP-bound state the Rab protein is once again a target for GDI, which 
can facilitate its extraction and relocation to its membrane of origin, allowing the 
cycle to continue.  
 
Through this conformational cycling, and the specific localisation of different 
Rab’s, and the effector proteins they activate and/or recruit, Rab proteins act as 
multifaceted organisers (Ng and Tang, 2008; Stenmark, 2009). As such they 
convey strict regulation to both rate and specificity for almost all trafficking 
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events occurring in eukaryotic cells (Ng and Tang, 2008; Stenmark, 2009). 
These events include vesicle transport, tethering and docking to target 
membranes and exocytosis, via interaction with cytoskeletal motor proteins, N-
ethylmaleimide-sensitive factor (NSF) and Soluble NSF attachment protein 
receptor (SNARE) proteins, respectively (Ng and Tang, 2008; Pfeffer, 2001; 
Stenmark, 2009). When in a GTP-bound active state Rab proteins have been 
shown to activate and recruit numerous distinct effectors including motor 
proteins, tethering factors, adaptor proteins, kinase’s and phosphatase’s. They 
have even been shown to recruit and activate GEF’s that proceed to activate 
other, downstream, Rab proteins (Knodler et al., 2010). Currently more than 70 
Rab proteins have been identified in humans, each localised to distinct 
cytoplasmic membranes of intracellular vesicles and organelles involved in 
cellular endocytic and secretory pathways (Mercer and Helenius, 2009; Ng and 
Tang, 2008; Pfeffer, 2001; Stenmark, 2009). Such distinct intracellular 
localisations are fundamental to Rab functions, conveying specificity to 
trafficking pathways. 
 
Figure 1.8. The Rab GTPase Regulatory Cycle. 
GEF’s catalyse the exchange of GDP for GTP through recognition of specific residues within the 
switch domain’s and promoting conformational changes that facilitate the release of GDP.  
Conformational changes upon GTP binding and activation promote interaction with multiple Rab 
effector proteins involved fundamental to Rab function in membrane trafficking events. Bound 
GTP is hydrolysed to GDP through the GTPase activity of the Rab protein catalysed by GTPase 
activating proteins (GAP’s), releasing free inorganic phosphate (Pi). Newly synthesised Rab 
proteins are recognised by the Rab Escort Protein (REP) and presented to Rab geranylgeranyl 
transferase (RabGGT) which prenylates the C-terminus forming an Isoprenyl anchor, essential 
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for membrane association. Genranlygeranylated, GDP-bound Rab proteins are recognized by 
the Rab GDP dissociation inhibitor (GDI), which extracts Rabs from their associated membrane 
and mask the isoprenyl anchor, therefore promoting cytosolic localisation and continued cycling 
by returning Rab proteins to their membrane of origin.  Evidence suggests that GDI 
Displacement factors (GDF’s) recognize Rab-GDI complexes and promote GDI displacement, 
exposing the isoprenyl anchor and allowing re-insertion into membranes. (Adapted from 
Hutagalung and Novick, 2011). 
 
 
 
1.4.1.3. The Role of Rab GTPases in Disease 
 
 
As multifaceted organisers and master regulators of diverse cellular trafficking 
events it is clear how perturbation to Rab function, either directly or through their 
interacting proteins, may easily lead to disease. Corroborating this a growing 
body of research has implicated Rab GTPases, and their interacting proteins, in 
a large number of disparate human diseases ranging from multifactorial 
diseases such as type 2 diabetes to genetic disorders such as Crohn’s disease 
and infectious pathogenic diseases including measles and influenza (Amorim et 
al., 2011; Murray et al., 2005; Ohira et al., 2009; Thong et al., 2007). It has also 
become apparent that a large number of neurodegenerative diseases show 
aberrant Rab function. Rab GTPases and their interacting proteins, their 
function and their association with specific neurological and neurodegenerative 
diseases are summarized in Table 1.3. Despite their well characterised role in 
such a range of diseases the potential of Rab GTPases, and their interacting 
proteins, as therapeutic targets remains an area of uncertainty, requiring 
significant further investigation. 
 !
 
 
Table 1.3. The Role and Function of Rab GTPases and Their Interacting Proteins in Neurodegenerative Diseases. 
Protein  Localisation, 
Function 
 Disease  Associated Symptoms  Role in Disease  Source(s) 
Rab1  ER to Golgi 
complex 
trafficking 
 Parkinson’s 
Disease 
 Motor Symptoms (resting tremor, 
bradykinesia, hypokinesia, gait 
dysfunction), visual deficits, 
dementia 
 
 
 Alpha synuclein (αSyn) induced 
toxicity and disrupted ER-to-Golgi 
transport can be rescued by 
overexpression of Rab1. 
 
 (Cooper et al., 
2006) 
Rab3a  Exocytosis, 
neurotransmitter 
release 
 Parkinson’s 
Disease 
 Motor Symptoms (resting tremor, 
bradykinesia, hypokinesia, gait 
dysfunction), visual deficits, 
dementia 
 
 
 Rab3a interacts with αSyn in brain 
extracts from mutant PD, but not 
wildtype mice. 
 
 (Aligianis et al., 
2005; Dalfo et 
al., 2004; Gitler 
et al., 2008) 
Rab3 
GAP 
 Rab3 GAP, 
exocytosis 
 Warburg Micro 
Syndrome 
 
 
 
 
 
 
Matsolf 
Syndrome 
 Ocular Defects (microphtalmos, 
microcornea, congenital 
cataracts), neurodevelopmental 
defects (mental retardation, 
spastic cerebral palsy, 
microcephaly) and hypothalamic 
hypogenetalism 
 
Similar to above but milder, 
including mild mental retardation, 
cataracts and hypogonadism 
 Germline-inactivating mutations in 
the genes encoding the regulatory 
catalytic subunit Rab3GAP1 have 
been demonstrated to lead to 
disease. 
 
 
 
Mutations in the non-catalytic 
subunit Rab3GAP2 have been 
identified in patients. 
 
 (Aligianis et al., 
2005) 
 
 
 
 
 
 
(Aligianis et al., 
2006)  
 
Rab4a 
  
Early and 
recycling 
endosomes 
(fast recycling) 
  
Alzheimer’s 
Disease 
 
 
  
Cortical Atrophy, Dementia 
 
 
 
  
Increased expression and altered 
localization of Rab4 is seen in AD 
patient brains, as well as animal and 
cellular models. 
  
(Ginsberg et al., 
2011; Ginsberg 
et al., 2010) 
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Table 1.3. The Role and Function of Rab GTPases and Their Interacting Proteins in Neurodegenerative Diseases. 
Protein  Localisation, 
Function 
 Disease  Associated Symptoms  Role in Disease  Source(s) 
 
Niemann Pick 
 
 
Hepatosplenomegaly, 
thrombocytopenia, neurological 
defects (ataxia, dysarthria, 
dysphagia) 
 
 
Elevated endosomal cholesterol 
levels in Niemann-pick inhibit Rab4 
and perturb membrane recycling 
 
 
(Choudhury et 
al., 2004) 
 
Rab5a 
  
Early endosomes, 
Clathrin-coated 
vesicles 
  
Alzheimer’s 
Disease 
 
 
Parkinson’s 
Disease 
  
Cortical Atrophy, Dementia 
 
 
 
Motor Symptoms (resting tremor, 
bradykinesia, hypokinesia, gait 
dysfunction), visual deficits, 
dementia 
 
 
  
Rab5 is selectively up-regulated in 
the frontal cortex, hippocampus and 
basal forebrain of AD patients. 
 
Rab5 interacts with αSyn in brain 
extracts from mutant PD, but not 
wildtype mice. 
 
  
(Ginsberg et al., 
2011) 
 
 
(Dalfo et al., 
2004) 
 
Rab7  Late endosomes  Charcot-Marie-
Tooth Disease 
Type 2B 
 
 
 
Alzheimer’s 
Disease 
 
 
Batten Disease 
 
 Sensory Neuropathy and peroneal 
muscular atrophy 
 
 
 
 
Cortical Atrophy, Dementia 
 
 
 
Visual degeneration, seizures, 
psychomotor disturbances, 
behavioural aberrations, echolalia 
 
 4 Rab7 mutations have been 
identified in independent CMT2B 
kindred. Mutant Rab7 is 
preferentially GTP-bound and shows 
reduced GTP hydrolysis.  
 
Rab7 is selectively up-regulated in 
the frontal cortex, hippocampus and 
basal forebrain of AD patients. 
 
CLN3 is mutated in Battens disease. 
The CLN3 protein has been show to 
form a complex with Hook1 and 
Rab7. 
 (De Luca et al., 
2008; McCray et 
al., 2010; 
Verhoeven et 
al., 2003) 
 
(Ginsberg et al., 
2011; Ginsberg 
et al., 2010) 
 
(Agola et al., 
2011) 
(Luiro et al., 
2004) 
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Table 1.3. The Role and Function of Rab GTPases and Their Interacting Proteins in Neurodegenerative Diseases. 
Protein  Localisation, 
Function 
 Disease  Associated Symptoms  Role in Disease  Source(s) 
  
 
 
Rab8  TGN to 
basolateral 
membranes, 
Recycling 
endosome 
 Huntington’s 
Disease 
 
 
 
Alzheimer’s 
Disease 
 
 
 
Parkinson’s 
Disease 
 
 
 
 Chorea, dystonia, cognitive 
degeneration, behavioural 
aberrations 
 
 
Cortical Atrophy, Dementia 
 
 
 
Motor Symptoms (resting tremor, 
bradykinesia, hypokinesia, gait 
dysfunction), visual deficits, 
dementia 
 
 The Rab8-optinurin complex is 
disrupted in Huntington’s Disease, 
leading to perturbations to post-
Golgi trafficking. 
 
Rab8 is down-regulated in cells 
expressing mutations associated 
with Alzheimer’s disease 
 
Rab8 interacts with αSyn in brain 
extracts from mutant PD, but not 
wildtype mice. Rab8A suppresses 
toxicity in neuronal models of PD. 
 
 (del Toro et al., 
2009; Hattula 
and Peranen, 
2000) 
 
(Kametani et al., 
2004a) 
 
 
(Dalfo et al., 
2004; Gitler et 
al., 2008) 
 
Rab9  Late endosomes, 
TGN 
 Niemann Pick 
C 
 
 
 
 
Batten Disease 
 
 Hepatosplenomegaly, 
thrombocytopenia, neurological 
defects (ataxia, dysarthria, 
dysphagia) 
 
Visual degeneration, seizures, 
psychomotor disturbances, 
behavioural aberrations, echolalia 
 
 
 Cholesterol accumulation 
sequesters Rab9 in an inactive form 
in NPC Cells. 
 
 
CLN3 is mutated in Battens disease. 
The CLN3 protein has been show to 
form a complex with Hook1 and 
Rab9. 
 
 
 (Ganley and 
Pfeffer, 2006) 
 
 
 
(Agola et al., 
2011) 
(Luiro et al., 
2004) 
 
Rab11  Recycling 
endosome (slow 
recycling), TGN 
 Huntington’s 
Disease 
 
 Chorea, dystonia, cognitive 
degeneration, behavioural 
aberrations 
 Huntington’s mice display impaired 
GDP-to-GTP exchange for Rab11 
whilst expression of a dominant 
 (Li et al., 2009b; 
Li et al., 2009c) 
 38 
!
!
!
!
!
!
!
!
!
!
!
!
!
!
 
 
 
 
 
 
 
 
 
 
 
 
 
  1.Introduction 
 !
 
Table 1.3. The Role and Function of Rab GTPases and Their Interacting Proteins in Neurodegenerative Diseases. 
Protein  Localisation, 
Function 
 Disease  Associated Symptoms  Role in Disease  Source(s) 
 
 
 
 
 
 
Charcot-Marie-
Tooth Disease 
Type 4C 
 
 
 
Batten Disease 
 
 
 
 
 
 
 
Sensory Neuropathy and peroneal 
muscular atrophy 
 
 
 
Visual degeneration, seizures, 
psychomotor disturbances, 
behavioural aberrations, echolalia 
 
negative Rab11 induces 
Huntington’s like neuropathology 
and symptoms. Patient fibroblasts 
also display impaired Rab11-
dependent vesicle formation. 
 
Disease causing mutations within 
SH3TC2 result in a failure of 
SH3TC2 to associate with Rab11, 
inhibiting recycling endosome 
localization. 
 
CLN3 is mutated in Battens disease. 
The CLN3 protein has been show to 
form a complex with Hook1 and 
Rab11. 
 
 
 
 
 
 
 
 
(Roberts et al., 
2010) 
 
 
 
 
(Agola et al., 
2011) 
(Luiro et al., 
2004) 
 
Rab23  Autophagosomes  Carpenter 
Syndrome 
 Mental retardation, congenital 
heart disease, obesity, 
polydactyly, brachydactyly, cranial 
abnormalities 
 
 Carpenter Syndrome patients show 
mutations in Rab23 associated with 
dysregulated hedgehog signalling. 
 (Eggenschwiler 
et al., 2001; 
Jenkins et al., 
2007) 
 
GDIα 
  
Brain enriched 
GDI 
  
X-Linked non-
specific mental 
retardation 
  
Mental Retardation 
  
Mutations in the GD1 gene, which 
encodes the brain enriched GDI 
GDIα, have been identified in 
patients suffering from the disease. 
  
(D'Adamo et al., 
1998) 
           
Alsin  Rab5 GEF  ALS  Progressive motor deficits and 
muscle atrophy  
 ALS2/Alsin is mutated in Jeuvenile 
ALS (ALS2) 
 (Yang et al., 
2001) 39 
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1.4.1.4. Rab8 
Rab8 is a small, approximately 207 amino acid and 23 kDa, protein of the Rab 
subfamily of Ras GTPases. In humans it has two isoforms, Rab8A and Rab8B, 
showing 83 % homology with the majority of variation occurring within the 
hypervariable C-terminal domain (Armstrong et al., 1996; Heidrych et al., 2008; 
Schollenberger et al., 2010). Functional differences between the two isoforms 
remain poorly understood, although more is known about the function of Rab8A 
in vesicular trafficking events than Rab8B, the function of which remains 
unclear. Experimental evidence suggests there to be significant differential 
patterns of tissue expression between Rab8A and Rab8B (Chen et al., 2001). 
For example it has been demonstrated that Rab8B show’s greatest expression 
in the brain and spleen whilst, in contrast, Rab8A displays low expression within 
these regions (Chen et al., 2001). It has also been suggested that expression of 
Rab8A and Rab8B may be regulated by different transcription factors, 
differentiating their function. In contrast to humans Drosophila only possess a 
single Rab8 isoform, displaying approximately 80 % homology to human Rab8 
(www.genecards.org). Drosophila Rab8 is encoded by the Rab8 gene located at 
cytological interval 76D2-76D3 on the left arm of chromosome 3 
(www.flybase.org).  
 
In contrast to the majority of Rab proteins, but in keeping with the majority of 
other proteins belonging to the Ras superfamily, Rab8 contains a C-terminal 
CAAX motif, in which A typically represents an aliphatic residue and X any 
amino acid (Joberty et al., 1993; Leung et al., 2007). In Rab8A the CAAX motif 
is CVLL whilst in Rab8B it is CSLL, with Drosophila Rab8 displaying CSLL, 
homologous to Rab8B (Joberty et al., 1993). The presence of this CAAX motif 
means that Rab8 is only mono-prenylated by a single geranylgeranyl 
modification to the cysteine residue of the CAAX motif, whereas the majority of 
Rab proteins are prenylated twice within CC, CXC or CCXX motifs (Leung et al., 
2007). In a study by Leung et al. 2007 it was demonstrated that this CAAX motif 
was essential for post-prenylation carboxyl methylation of Rab8 and that this 
post-prenyl modification was essential for regulating the cycle of Rab8 
membrane association and retrieval (Leung et al., 2007). 
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Rab8 has been strongly implicated in the regulation of numerous membrane 
trafficking pathways including membrane recycling, exocytosis and ciliogenesis 
(Ang et al., 2004; Grigoriev et al., 2011a; Hattula et al., 2006; Knodler et al., 
2010). Furthermore it has been suggested that through this regulation Rab8 is 
fundamental to the development of polarised cells and the regulation of cell 
shape (For a review see Peränen, 2011) (Peranen, 2011). For example studies 
using over expression of Rab8, Rab8-eGFP or constitutively active Rab8, in 
various cell types, have shown induction of significant alterations to cellular 
morphology, characterised by the formation of distinct cellular protrusions 
(Peränen et al., 1996). Furthermore a significant body of research has 
implicated Rab8 in ciliogenesis (Follit et al., 2010; Knodler et al., 2010; Leung et 
al., 2007; Nachury et al., 2007a; Yoshimura et al., 2007). For example Nachury 
et al. (2007) demonstrated that depletion of the Rab8 GEF Rabbin8, via siRNA, 
resulted in a significant reduction of ciliogenesis (Nachury et al., 2007a). 
Furthermore Knödler et al., 2010 showed the Rab11-Rab8 cascade to be 
essential in cilia formation. 
 
As well as its implication in the regulation of cellular morphology and the 
formation of cellular protrusions, such as cilia, Rab8 has also been shown to 
play an important role in the endosomal recycling pathway. For example Hattula 
et al. (2006) demonstrated Rab8 to be essential for trafficking, but not 
internalization or recycling, of components to the recycling endosome. In this 
study they showed that depletion of Rab8, via siRNA, results in a failure to 
traffic transferrin (Tfn) and the transferrin receptor (TfnR) to peri-nuclear 
recycling endosomal compartments. In contrast expression of the constitutively 
active Rab8, Rab8-Q67L, resulted in an accumulation of Tfn and TfnR within the 
recycling endosome. Corroborating these findings it has also been shown that 
depletion of one of Rab8’s effector proteins, optineurin, also inhibits trafficking 
of Tfn to the recycling endosome compartment (Nagabhushana et al., 2010). 
Further substantiating a role for Rab8 in recycling endosomal traffic Rab8 has 
been shown to co-localise with EHD-1, EHD-3, Arf6, Myo5-b, MHC-I, β1 integrin 
and Rab11, all of which have been implicated in clathrin independent endocytic 
recycling (Hattula et al., 2006; Roland et al., 2007; Sharma et al., 2010; Sharma 
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et al., 2009). In a study by Henry and Sheff, 2008, it was also concluded that in 
fully polarized cells Rab8 regulates the traffic of newly synthesized basolateral 
proteins to the plasma membrane, via the recycling endosome, but does not 
regulate endocytic cargo (Henry and Sheff, 2008). This supports previous 
findings that suggest that recycling endosomes may act as a trafficking 
intermediate between the golgi and plasma membrane (Ang et al., 2004). 
Further implicating Rab8 in endosomal trafficking it has also been shown that 
Rab8 depletion results in a perturbation to normal trafficking leading to an 
accumulation of cholesterol within late endosomes, whilst overexpression of 
Rab8 is capable of rescuing cholesterol accumulation in Niemann-pick type C 
cells (Linder et al., 2007). Cholesterol accumulation has also been shown to 
specifically inhibit Rab4 dependent endosomal recycling (Choudhury et al., 
2004).  
 
A role for Rab8 in normal endosomal trafficking events has also been 
demonstrated through the identification that Rab8 knockdown mice show 
lysosomal accumulation, associated with perturbed apical hydrolase localization 
and microvilli shortening in the gut (Sato et al., 2007b). Furthermore del Toro et 
al. (2009) showed that mutations within the huntingtin (htt) gene disrupted post-
golgi trafficking to the lysosome through a delocalization of the Rab8-Optineurin 
complex from the Golgi, leading to lysosome perturbation (del Toro et al., 2009). 
 
Rab8 has also been implicated in exocytosis with Rab8 forming stable 
associations with exocytic vesicles, in a Rab6 and MICAl3 dependent manner, 
in order to regulate their efficient docking and fusion (Grigoriev et al., 2011b). 
Substantiating these findings a recent study implicates Rab8, acting alongside 
Rab11 and Myo5B, in the promotion of stretch induced exocytosis in bladder 
umbrella cells (Khandelwal et al., 2013). In contrast it has previously been 
shown that Rab8 but not Rab11 knockdown inhibited MT1-MMP exocytic traffic, 
implicating Rab8 but not Rab11 in the regulation of exocytosis (Bravo-Cordero 
et al., 2007). 
 
Taken together these studies suggest a role for Rab8 in the regulation of normal 
endocytic trafficking, a process that is essential and conserved amongst all 
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eukaryotic cells. Furthermore they implicate Rab8 as essential in the 
development of polarised cells, such as neurons. 
 
 
1.4.1.5. The Role of Rab8 in Neurons 
 !
Numerous studies suggest a functional role for Rab8 during normal neuronal 
development and maintenance. For example Huber et al (1995) suggested that 
Rab8 is important for membrane trafficking in developing neurons, 
demonstrating that antisense oligonucleotide suppression of Rab8 prevented 
exocytic vesicle formation and neurite outgrowth, inhibiting maturation of 95% of 
cultured rat hippocampal neurons (Huber et al., 1995b).  Inhibition of neurite 
outgrowth coupled with reduced levels of Rab8 has also been demonstrated in 
cells expressing mutant presenillin-1, further implicating Rab8 in neuronal 
development (Kametani et al., 2004b). Corroborating the role of Rab8 in 
regulating neurite extension it has also been shown that Rab8 localises close 
to, and directly associated with, the PSD where it acts sequentially with Rab11, 
but in distinctly separate spatial functions, in the regulated cycling and delivery 
of AMPA receptors into dendritic spines (Brown et al., 2007b; Gerges et al., 
2004b). Furthermore Rab8 expression decreases mGluR1a-mediated inositol 
phosphate formation and neuronal calcium release in a Protein kinase C (PKC) 
dependent manner (Esseltine et al., 2012). Additionally Rab8 expression also 
appears to decrease endocytosis of mGluR1a receptors from the cell surface. 
Studies have also shown that Rab8 interacts with and regulates transport of 
α2B- and β2-adrenergic receptors, with expression of dominant negative Rab8 
significantly reducing expression of the adrenergic receptors within the 
dendrites of cultured primary thalamic neurons (Dong et al., 2010). 
 
In a recent study it was shown that the evolutionarily conserved Nuclear Dbf2-
related (NDR) 1/2 kinase pathway, which is involved in the regulation of 
polarized development, regulates morphogenesis of dendritic spines (Ultanir et 
al., 2012). In this study it was demonstrated that inhibition of NDR1/2 via a 
kinase dead dominant negative or siRNA resulted in perturbed spine 
morphology coupled with reduced synaptic function both in cultured cells and in 
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vivo. Furthermore it was also shown that Rabin8, a Rab8 GEF and NDR1/2 
substrate, was essential for normal dendritic spine morphogenesis with 
expression of a non-phosphorylatable Rabin8 showing perturbations to dendritic 
spine morphology, in keeping with the loss of function of NDR1/2. In a very 
recent study it was also shown that inhibition of Rabin8 phosphorylation by 
NDR2 resulted in the accumulation of Rab11 positive vesicles at the peri-
centrosome (Chiba et al., 2013). 
 
It has also been shown that perturbation to Rab8 function can lead to 
neurodegeneration. For example Moritz et al., 2001 demonstrated that 
expression a dominant negative Rab8 canine transgene, Rab8-T22N, led to 
rapid degeneration of the highly polarised photoreceptor neurons in Xenopus 
laevis (Moritz et al., 2001). 
 
As well as showing a role in neuronal development, with perturbation causing 
neurodegeneration Rab8 trafficking pathways have also been implicated in a 
number of diseases, including neurodegenerative diseases. 
 
 
1.4.1.6. The Role of Rab8 In Neurological and 
Neurodegenerative Diseases 
 
To date there have been no mutations within either the Rab8A or Rab8B genes 
that have been directly associated with any diseases. However numerous Rab8 
interacting proteins have been implicated in human pathologies. These 
pathologies include Bardet-Biedl syndrome, microvillus inclusion disease, 
polycystic kidney disease, MND, Joubert syndrome, Lowe syndrome, 
Parkinson’s Disease, Cancer, Alzheimer’s disease, retinal degeneration, 
glaucoma, Huntington’s disease and viral infections (Bachmann-Gagescu et al., 
2011; Coon et al., 2012; Dalfo et al., 2004; Del Bo et al., 2011; del Toro et al., 
2009; Gitler et al., 2008; Kametani et al., 2004b; Nachury et al., 2007b; 
Parkhitko et al., 2011; Sato et al., 2007a; Vaibhava et al., 2012). Implication in 
such a broad spectrum of diseases suggests a greater understanding of Rab8 
function may provide significant insight into disease pathology and potential 
treatment. 
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A large number of diseases associated with Rab8 interacting proteins show 
neurodegenerative pathology. For example Oculocerebrorenal syndrome of 
lowe (Lowe Syndrome/LS), a rare X-linked recessive disorder, presents with 
mental retardation, as well as other non-neurological symptoms. LS is 
associated with mutations in the OCRL1 gene, which encodes the inositol-5-
phosphatase OCRL1, and has been implicated in Rab8 and IPIP27 dependent 
cellular trafficking events (Coon et al., 2012). This is further substantiated by the 
identification that OCRL1 interacts with Rab8 directly and that mutations in the 
OCRL1 Rab8 binding domain are associated with LS (Hou et al., 2011). Rab8 
has also been shown to interact with mutant α-syn, with over expression of 
Rab8 alleviating toxicity associated with mutant α-syn in neuronal models of 
Parkinson’s disease (Dalfo et al., 2004; Gitler et al., 2008). Similarly it has also 
been shown that Abelson Helper Integration Site 1 (AHI1), the encoding gene 
for which is mutated in the neurological condition Joubert syndrome, also 
interacts with Rab8 (Hsiao et al., 2009; Valente et al., 2006). AHI1 knockdown 
cells show a destabilization of Rab8 resulting in a failure to localize correctly, 
leading to disruption of endocytic trafficking between the plasma membrane and 
Golgi (Hsiao et al., 2009). Rab8 has also been implicated in Alzheimer’s 
disease where it has been shown that mutant presenilin perturbs transport of 
the Amyloid Precursor Protein (APP) and causes a depletion of Rab8 protein in 
cells (Kametani et al., 2004a). Rab8 has also been associated with Huntington’s 
disease where it has been shown that mutations in the htt gene result in a 
disruption to the Rab8-optineurin complex, leading to aberrations in post Golgi 
trafficking to lysosomes (del Toro et al., 2009). 
 
These studies demonstrated that Rab8, and it’s interacting proteins, play a 
fundamental role in the regulation of intracellular trafficking events that are 
fundamental to normal cellular homeostasis and development, especially within 
polarized cell types such as neurons. Furthermore they reveal that perturbation 
to these processes can lead to numerous human diseases, including a large 
subset that display neurological pathology. As such they suggest that Rab8 
plays an important role in neuronal function, a greater understanding of which 
may help us in the treatment of diseases, such as frontotemporal dementia. 
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1.5. Aims 
 
 
• To perform enhancer and suppressor screens, using a Drosophila model 
of FTD in which CHMP2BIntron5 is expressed in the Drosophila eye, in 
order to identify novel modifiers of CHMP2BIntron5 toxicity. 
 
• To characterize mutations in Rab8, a potent enhancer of CHMP2BIntron5 
toxicity 
 
• To determine the mechanism that contributes to unregulated synaptic 
growth seen in Rab8 mutants 
 
• To characterize a Drosophila model of FTD associated with 
CHMP2BIntron5 and determine whether mechanisms involved in 
unregulated growth in Rab8 mutants also contribute to CHMP2BIntron5 
toxicity. 
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2. Materials and Methods 
!
2.1. Drosophila Husbandry and Genetics 
2.1.1. Drosophila Stocks 
 
Drosophila stocks were purchased from Bloomington Drosophila Stock Centre 
(Indiana University, Bloomington, U.S.A), the Drosophila Genetic Resource 
Center (Kyoto Institute of Technology, Kyoto, Japan) and the Vienna Drosophila 
RNAi Centre (VDRC; Institute of Molecular Biotechnology, Vienna, Austria). 
Additional stocks were generated as part of this work or kindly provided by 
members of the Drosophila community. A detailed summary of stocks can be 
found in Table 2.1. All stocks, without exception, obtained from outside sources 
were quarantined for at least 2 generations and were routinely inspected for the 
presence of mites. Alternatively, stocks were transferred onto fresh media on 
consecutive days for 4-5 days and inspected for mites. Post-quarantine, mite 
free stocks were transferred to the stock rooms. 
 
Stocks were raised at either 18°C or 25°C and were transferred to fresh 
medium every 4 or 2 weeks, respectively. All experimental crosses were raised 
at 25°C, giving a generation time of ~ 10 - 12 days (egg to adult). 
 
 
 
 
 
 
 
 
 
 !
   
 
Table 2.1. Stocks Used During The Course of This Investigation 
Summary of stocks used during this work. Only primary stocks are listed; double balance stocks, stocks combining multiple genetic elements listed 
below, recombinations of genetic elements listed below and deletion stocks used for screening are not included for brevity. 
Stock  Chromosome  Description  Source 
Wildtypes       
Canton S (CS)  n/a  Wildtype, red eyes  Sweeney Lab Stock 
W1118 (w-)  n/a  Wildtype, white eyes  Sweeney Lab Stock 
       
Balancer Stocks       
FM6-GFP/Y  First  First Chromosome Balancer  Kornberg Lab (UCSF, USA)  
FM7-GFP/Y  First  First Chromosome Balancer  Kornberg Lab (UCSF, USA)  
CyO/Sco  Second  Second Chromosome Balancer  Sweeney Lab Stock 
CyO-GFP/Sco  Second  Second Chromosome Balancer  Kornberg Lab (UCSF, USA)  
TM3/TM6b  Third  Third Chromosome Balancer  Sweeney Lab Stock 
TM3/TM6b-GFP  Third  Third Chromosome Balancer  Kornberg Lab (UCSF, USA)  
CyO-GFP/If;TM6b/MKRS  Second and Third  Second and Third Chromosome Balancer  Kornberg Lab (UCSF, USA) 
CyO/If;TM6b/MKRS  Second and Third  Second and Third Chromosome Balancer  Sweeney Lab Stock 
       
Gal4 Stocks       
GMR-Gal4/CyO-GFP  Second  Glass multimer reporter; eye specific driver  Bloomington Stock Centre 
Act-Gal4/CyO-GFP  Second  Actin promoter; global driver  Bloomington Stock Centre 
nSyb-Gal4/CyO-GFP  Second  Neuronal Synaptobrevin promoter; Pan-neuronal 
driver 
 Goodwin Lab (Oxford, UK) 
48 
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Table 2.1. Stocks Used During The Course of This Investigation 
Summary of stocks used during this work. Only primary stocks are listed; double balance stocks, stocks combining multiple genetic elements listed 
below, recombinations of genetic elements listed below and deletion stocks used for screening are not included for brevity. 
Stock  Chromosome  Description  Source 
OK6-Gal4/CyO-GFP  Second  Motor neuronal specific driver  O’Kane Lab (Cambridge, 
UK)  
MHC-Gal4/TM6b  Third  Myosin Heavy Chain Promoter; Muscle specific 
driver 
 Goodman lab stock (UCSF, 
USA) (donation) 
Rab8-Gal4/CyO-GFP  Second  Rab8 promoter  Hiesinger Lab (UT 
Southwestern, USA) 
       
UAS Stocks       
UAS-CHMP2BIntron5/CyO-
GFP 
 Second  CHMP2B mutant transgene  Gao Lab (UMASS, USA) 
(Ahmad et al., 2009) 
UAS-Shrub-GFP/CyO-GFP  Second  GFP tagged Shrub   Sweeney Lab Stock 
UAS-Rab8/Cyo-GFP  Second  Second Chromosome Rab8 Insertion  Generated During This 
Investigation 
UAS-Rab8/TM6b  Third  Third Chromosome Rab8 Insertion  Generated During This 
Investigation 
UAS-Rab8-eGFP/TM6b  Third  Enhanced GFP tagged Rab8  Generated During This 
Investigation 
UAS-Rab8-RNAi(a)/TM6b  Third  Rab8 RNAi  Sweeney Lab Stock 
UAS-Rab8-RNAi(b)/TM6b  Third  Rab8 RNAi  VDRC (Vienna, Austria) 
UAS-NTAP-Rab8/TM6b  Third  N-terminally TAP tagged Rab8  Generated During This 
!
!
!
!
!
!
!
!
!
!
!
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!
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Table 2.1. Stocks Used During The Course of This Investigation 
Summary of stocks used during this work. Only primary stocks are listed; double balance stocks, stocks combining multiple genetic elements listed 
below, recombinations of genetic elements listed below and deletion stocks used for screening are not included for brevity. 
Stock  Chromosome  Description  Source 
Investigation 
UAS-AliX/TM6b  Third  Wildtype ALG2 interacting protein X  Aigaki Lab (Tokyo 
Metropolitan University, 
Japan) 
UAS-AliX-RNAi  Third  AliX-RNAi  Aigaki Lab (Tokyo 
Metropolitan University, 
Japan) 
UAS-ALG2/CyO-GFP  Second  Wildtype Apoptosis linked gene 2  Aigaki Lab (Tokyo 
Metropolitan University, 
Japan) 
UAS-POSH  Second  Wildtype Plenty of SH3’s  Aigaki Lab (Tokyo 
Metropolitan University, 
Japan) 
UAS-POSHMRing/TM3  Third  POSH expressing a mutated zinc ring finger domain 
(C28S/C33S/C36S) 
 Aigaki Lab (Tokyo 
Metropolitan University, 
Japan) 
UAS-HRS/TM6b-GFP  Third  Wildtype HRS/HGS  Bellen Lab (Howard Hughes 
Medical Institute, USA) 
UAS-dTAK1  Third  Wildtype TGFβ-Activated Kinase 1  Stronach Lab (University of 
Pittsburgh, USA) 50 
!
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Table 2.1. Stocks Used During The Course of This Investigation 
Summary of stocks used during this work. Only primary stocks are listed; double balance stocks, stocks combining multiple genetic elements listed 
below, recombinations of genetic elements listed below and deletion stocks used for screening are not included for brevity. 
Stock  Chromosome  Description  Source 
UAS-dTAK1K46R/CyO-GFP  Second  TAK1 Dominant Negative  Stronach Lab (University of 
Pittsburgh, USA) 
UAS-TAK1-RNAi  Third  TAK1-RNAi  Stronach Lab (University of 
Pittsburgh, USA) 
UAS-EIF4-GFP/CyO-GFP  Second  Nuclear GFP  Bloomington Stock Centre 
UAS-MCD8-GFP/CyO-GFP  Second  Membrane Localised GFP  Bloomington Stock Centre 
UAS-FosDN  Second  Fos dominant negative  Bloomington Stock Centre 
UAS-Atg1/TM6b  Third  Wildtype Atg1  Ganetzky Lab (University of 
Wisconsin, USA) 
UAS-Atg5-RNAI  Second  Atg5-RNAi  VDRC (Vienna, Austria) 
UAS-Atg7-RNAi  Second  Atg7-RNAi  VDRC (Vienna, Austria) 
UAS-Atg18-RNAi  Second  Atg18-RNAi  VDRC (Vienna, Austria) 
UAS-Atg5-GFP/TM6b  Third  GFP tagged Atg5  O’Kane Lab (Cambridge, 
UK)  
UAS-Atg8-RFP/CyO-GFP  Second  RFP tagged Atg8/LC3  Hafen Lab (University of 
Zürich, Switzerland) 
UAS-Rheb/CyO-GFP  Second  Wildtype Rheb   Hafen Lab (University of 
Zürich, Switzerland) 
UAS-Rab4-RFP/CyO-GFP  Second  RFP tagged Rab4  Bloomington Stock Centre 
UAS-Rab11-eGFP/CyO-GFP  Second  eGFP tagged Rab11  Bloomington Stock Centre 
!
!
!
!
!
!
!
!
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Table 2.1. Stocks Used During The Course of This Investigation 
Summary of stocks used during this work. Only primary stocks are listed; double balance stocks, stocks combining multiple genetic elements listed 
below, recombinations of genetic elements listed below and deletion stocks used for screening are not included for brevity. 
Stock  Chromosome  Description  Source 
UAS-Spin-RFP/CyO-GFP  Second  RFP tagged Spinster  Sweeney Lab Stock 
       
Mutant Stocks       
Rab81/TM6c  Third  EMS induced Rab8 point mutation  Bloomington Stock Centre 
Rab82/TM6c  Third  EMS induced Rab8 point mutation  Kennison Lab (NIH, USA) 
(donation) 
Rab83/TM6c  Third  EMS induced Rab8 point mutation  Kennison Lab (NIH, USA) 
(donation) 
Rab8Z3007/TM6b  Third  EMS induced Rab8 point mutation  Kennison Lab (NIH, UAS) 
(donation) 
Rab8B229/TM6b  Third  PBac{5HPw+} P-element disruption of Rab8  Bloomington Stock Centre 
OCRL1C52/FM6-GFP  First  dOCRL1 loss of function, imprecise P-element 
excission  
 Sweeney Lab Stock 
OCRL1D40/FM6-GFP  First  dOCRL1 loss of function, imprecise P-element 
excission 
 Sweeney Lab Stock 
AliXEY10362/TM6b  Third  P{EPgy2}AliXEY10362, AliX loss of function, (P-element 
activity) 
 Bloomington Stock Centre 
POSH74/CyO-GFP  Second  POSH Null  Stronach Lab (University of 
Pittsburgh, USA) 
POSHEP1206/CyO-GFP  Second  P{EP}POSHEP1206, POSH loss of function, (P-element  Bloomington Stock Centre 
!
!
!
!
!
!
!
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Table 2.1. Stocks Used During The Course of This Investigation 
Summary of stocks used during this work. Only primary stocks are listed; double balance stocks, stocks combining multiple genetic elements listed 
below, recombinations of genetic elements listed below and deletion stocks used for screening are not included for brevity. 
Stock  Chromosome  Description  Source 
activity) 
POSHEP2248/CyO-GFP  Second  P{EP}POSHEP2248, POSH loss of function, (P-element 
activity) 
 Bloomington Stock Centre 
HRSD28/CyO-GFP  Second  EMS induced HRS loss of function   Bellen Lab (Howard Hughes 
Medical Institute, USA) 
TAK12/FM6-GFP  First  EMS induced TAK1 loss of function   Bloomington Stock Centre 
TAK1179/FM6-GFP  First  EMS induced TAK1 loss of function   Bloomington Stock Centre 
Wnd1/TM6b  Third  EMS induced Wallenda loss of function   DiAntonio Lab (Washington 
University in St. Louis, USA) 
Wnd3/TM6b  Third  EMS induced Wallenda loss of function   DiAntonio Lab (Washington 
University in St. Louis, USA) 
DebraEP9/CyO-GFP  Second  P{EP}DebraEP9, Debra  loss of function, (P-element 
activity) 
 Bloomington Stock Centre 
DebraEY04764/CyO-GFP  Second  P{EPgy2}DebraEY04764, Debra  loss of function, (P-
element activity) 
 Bloomington Stock Centre 
Tkv7/CyO-GFP  Second  EMS induced Thickveins loss of function  Sweeney Lab Stock 
TkvK16713/CyO-GFP  Second  P{LacW}TkvK16713 Thickveins loss of function (P-
element activity) 
 Sweeney Lab Stock 
DadΔIEL/TM6b  Third  Dad271-68 Loss of Function Mutant   Sweeney Lab Stock 
PucE69/TM6b  Third  P{A92}PucE69, Puckered loss of function (P-element  Bloomington Stock Centre 
!
!
!
!
!
!
!
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Table 2.1. Stocks Used During The Course of This Investigation 
Summary of stocks used during this work. Only primary stocks are listed; double balance stocks, stocks combining multiple genetic elements listed 
below, recombinations of genetic elements listed below and deletion stocks used for screening are not included for brevity. 
Stock  Chromosome  Description  Source 
activity) 
Atg1DG/TM6b  Third  Atg1DG23110, Atg1 loss of function (P-element activity)  Bloomington Stock Centre 
Atg1PZ/TM6b  Third  P{PZ}Atg100305, Atg1 loss of function (P-element 
activity)  
 Bloomington Stock Centre 
Atg7D77/CyO-GFP  Second  Atg7 loss of function (P-element activity)  Fanto Lab (Kings College, 
London, UK) 
Atg18KG/TM6b  Third  Atg18KG03090, Atg18 loss of function (P-element 
activity) 
 Bloomington Stock Centre 
Rheb261/TM6b  Third  EMS induced Rheb loss of function   Hafen Lab (University of 
Zürich, Switzerland) 
Rheb3M2/TM6b  Third  EMS induced Rheb loss of function   Hafen Lab (University of 
Zürich, Switzerland) 
       
       
Other Stocks       
Df(3L)ED228/TM6b  Third  3L deletion covering Rab8  Bloomington Stock Centre 
Df(3L)Excel6112/TM6b  Third  Deletion covering Atg18   Bloomington Stock Centre 
Dad-LacZ/TM6b  Third  Dad Reporter   Bloomington Stock Centre !
!
!
!
!
!
!
!
!
!
!
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2.1.2. Drosophila Media 
 
Unless otherwise stated stocks were raised on standard medium (25 g/l 
sucrose, 3.75 g/l agar, 0.125 g/l CaCl2, 0.125 g/l FeSO4, 0.125 g/l MnCl, 0.125 
g/l NaCl, 2 g/l KNaC4H4O6·4H2O). Following autoclaving the medium was 
cooled for 1 hour to ~ 45°C before addition of the antifungal agents Bavistin (1.5 
mg/l in 100 % ethanol; BASF, Auckland, New Zealand) and Nipagin (0.7 mg/l in 
100 % ethanol; Sigma, UK). 7 ml of medium was dispensed into 25x95 mm 
plastic vials (Dutscher Scientific, UK), which were subsequently plugged with 
cotton wool (Fisher Scientific, UK). 
 
TGFβ experiments were performed on Nutri-Fly™ Bloomington Formulation 
medium (Genesee Scientific, San Diego, USA), which was prepared following 
the manufacturers instructions. Medium was dispensed (7 ml) into 25x95 mm 
plastic vials (Dutscher Scientific, UK), which were subsequently plugged with 
cotton wool (Fisher Scientific, UK). 
 
Rapamycin experiments were performed on formula 4-24® instant Drosophila 
medium (Carolina Biological Supply Company, USA). Media was prepared by 
mixing 50:50 with dH2O. 4-24® was used during Rapamycin drug treatment as 
the media does not require cooking, which could affect compound integrity, and 
Rapamycin could be readily mixed with water during preparation of the media. 
 
When required in large numbers stocks were raised in 1/3 pint bottles on a 
maize based medium (119.0 g/l maize meal, 17.5 g/l yeast, 15.9 g/l agar, 103.2 
g/l sucrose). Post-cooking of the primary ingredients media was cooled to 
~45°C and the antifungal agents Nipagin (0.4mg/l in 100 % ethanol; Sigma, UK) 
and propionic acid (0.4 % v/v; Arcos Organics, Geel, Belgium) were added. The 
medium was then dispensed into 1/3 pint glass bottles and the bottles bunged 
using Flugs® (Dutscher Scientific, UK). Bottles containing medium were 
autoclaved at 121°C for 20 minutes 
 
To encourage egg laying medium could be supplemented with dried yeast or 
yeast paste. 
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2.1.3. Anaesthesia 
 
In order to identify gender and genotype adult Drosophila were anaesthetised 
on a porous gas pad using continuous administration of CO2. Anaesthetised 
Drosophila were observed using a dissecting microscope (Zeiss Stemi-2000, 
Carl Zeiss AG, Germany). CO2 was the primary method of anaesthesia, 
however ether was used for imaging of the Drosophila eye in the early stages of 
this investigation. 
 
 
2.1.4. Crossing Techniques 
 
Female Drosophila are capable of storing sperm, therefore in order to have a 
controlled genetic cross females must be isolated as virgins. At 25°C female 
flies will not mate within 8 hours of eclosion. Furthermore, newly eclosed flies 
display pale pigmentation, unexpanded wings and the presence of a meconium, 
visible through the abdominal cuticle, identifying them as virgins. Based on 
these principles virgin females can be collected by completely emptying vials in 
the morning and isolating any virgins based on the presence of the identifying 
features and then collecting any further females that eclose within the 8 hour 
window. 
 
 
2.1.5. Modifier Screens 
 
2.1.5.1 Shrub-GFP 
 
 
Initial unbiased modifier screens were performed by crossing the GMR-Gal4, 
UAS-Shrub-GFP/CyO stock to all 257 individual deletion stocks in the DrosDel 
Deletion collection (University of Cambridge, Cambridge, U.K) (Ahmad et al., 
2009). This collection represented ~75 % of the Drosophila Genome. The 
resultant eye phenotypes were classified as low (+) (< 15 black spots of 
melanisation), medium (++) (> 15 spots of melanisation but < 50 % of the eye 
affected) or high (+++) (> 50 % of the eye subjected to melanisation). 
Phenotypes were compared against GMR-Gal4, UAS-Shrub-GFP/CyO 
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outcrossed to w1118. These initial screens were performed by Dr Sean Sweeney 
in collaboration with Dr Fen-Biao Gao (UMASS, Worcester, USA). Deletion 
regions identified as modifiers of the Shrub-GFP phenotype were subsequently 
narrowed using smaller deletions and, eventually, individual gene loci. Eyes 
were imaged under a dissecting microscope (Zeiss Stemi-2000, Carl Zeiss AG, 
Germany) using an attached AxioCam ERc 5s digital camera (Carl Zeiss AG, 
Germany) and Axiovison 4.8 software (Carl Zeiss AG, Germany).  
 
 
2.1.5.2. CHMP2BIntron5 
 
Following the success of the initial modifier screens against Shrub-GFP more 
precise modifier screens were subsequently performed against CHMP2BIntron5 
by crossing GMR-Gal4, UAS-CHMP2BIntron5/CyO to 98 deletion stocks covering 
the entire left arm of chromosome 2 and 38 deletion stocks covering the entire 
left arm of chromosome 3 (Fig. 3.2.). For a schematic representation of the 
screen see Fig. 2.1. Deletion Stocks were a kind gift from John Roote 
(University of Cambridge, Cambridge, UK) and Guy Tear (Kings College, 
London, UK). Specific enhancers of Shrub-GFP and known genes of interest 
were also screened against CHMP2BIntron5 as part of targeted screens. Eyes 
were scored and imaged as for Shrub-GFP screens (above) 
 
 
 
 
 
 
 
 
Figure 2.1. Schematic Representation of Modifier Screening Against the CHMP2BIntron5 
Phenotype 
GMR-Gal4, UAS-CHMP2BIntron5/CyO flies were crossed to individual deletion stocks and the 
resultant eye phenotypes scored and compared to controls in order to identify modifiers of the 
eye phenotype. 
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2.1.6. Complementation Analysis 
 
Complementation analysis was used to determine whether alleles of an 
identified locus belong to the same complementation group. A failure to 
complement suggests each mutation affects the gene of interest as 
complementation only occurs if mutations are within different genes. 
Complementation assays were performed by crossing different heterozygous 
balanced mutants, proposed to affect a specific gene (e.g Rab8), with each 
other and with a previously characterised mutant affecting that gene. 
Transheterozygous offspring were assayed for lethality or reduced viability, 
indicating a failure to complement. Complementation analysis was used during 
the characterisation of Rab8 mutants, which display a distinct 
transheterozygous pharate lethal phenotype. 
 
2.1.7. Recombination’s 
 
Homologous chromosomal recombination in Drosophila females was utilised in 
order to generate stocks in which two genetic components were present on the 
same chromosome arm, thus allowing the use of 3 or more genetic components 
on a single chromosome. For example this approach was used to recombine 
the Rab8B229 piggyBac mutation with both MHC-Gal4 and the Puc-LacZ reporter 
constructs. Recombination was achieved by mating individual stocks with each 
other and selecting away from balancers to identify virgin female offspring 
carrying both genetic components (e.g Rab8B229/MHC-Gal4). These offspring 
were subsequently crossed to balancer stocks for that chromosome and 
potential recombinant offspring selected. Selection was performed based on 
eye colour, where possible, as well as other characteristic phenotypes. The 
presence of the desired genetic components was confirmed via PCR or 
confirmation of GFP (see sections 2.4.1 and 2.4.2). 
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2.2. Immunohistochemistry and Imaging 
2.2.1. Third Instar Larvae Dissection 
 
Female third instar wandering larvae of the required genotype were transferred 
onto a sylgard dish (Silicone elastromere kit, DowCorning, MI, USA) and 
dissected in either PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4 and 1.8 
mM KH2PO4 in dH2O) or Haemolymph-like buffer (HL3; 70 mM NaCl, 5 mM KCl, 
1 mM CaCl2.2H2O, 10 mM NaHCO3, 5 mM trehalose, 115 mM sucrose and 5 
mM BES in dH2O). Dissections were performed using a dissecting microscope 
(Zeiss Stemi-2000, Carl Zeiss AG, Germany). Larvae were pinned, dorsal side 
up, at both the anterior and posterior ends using minuten pins (Austerlitz Insect 
Pins 0.1 mm diameter, Fine Science Tools, Heidelberg, Germany). An incision 
was made along the dorsal midline of the larvae from the posterior to anterior 
end using Vannas sprung straight bladed dissection scissors (Fine Science 
Tools, Heidelberg, Germany). Forceps were used to remove the internal organs, 
leaving the CNS in situ, and the muscle walls were pinned out. When only 
looking at NMJ’s the CNS was removed. Larvae were fixed in 3.7 % 
formaldehyde (Sigma, UK) in PBS whilst pinned in situ for 7 min. When using 
antibodies for Glutamate receptors larvae were instead fixed in Bouins solution 
(Sigma, UK) for 2 min. Larval preps were unpinned, transferred to a 1.5 ml 
eppendorf tube and washed 3 times in 0.1 % PBS-T/PBT (0.1 % v/v triton X-100 
in PBS) 
 
 
2.2.2. Immunohistochemical Staining Larval NMJ’s and VNC 
 
Following preparation of Drosophila third instar larvae (See above) larval 
preparations were incubated in primary antibodies (see table 2.2.) in 0.1 % PBT 
at 4°C, overnight, in darkness with rocking. Following primary antibody 
incubation preparations were washed 3 times in 0.1 % PBT. Preparations were 
then incubated in secondary antibodies (see table 2.3.)  in 0.1 % PBT for 1 
hour, in darkness, with rocking at room temperature. Preparations were 
subsequently washed 3 times in 0.1 % PBT. Post-washing preparations were 
submerged in 70 % glycerol (70 % v/v in PBS) for 1-2 hours until all the air was 
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displaced from the preparations. Preparations were then mounted in 
Vectashield® (Vector Laboratories LTD, UK), cuticle side down upon a standard 
microscope slide. Cover slips were sealed in place using nail varnish. 
  
Table 2.2. Primary Antibodies Used During The Course of This Investigation 
Antigen 
 
 Dilution  Species/type  Source/Reference 
Atg5  IF 1:300  Rabbit polyclonal  Novus Biological 
Bruchpilot  IF 1:50  Mouse monoclonal  DSHB (NC82) 
Discs large   IF 1:50  Mouse monoclonal  DSHB (4F3) 
Elav  IF 1:50  Mouse monoclonal  DSHB (9F8A9) 
Even Skipped  IF 1:50  Mouse monoclonal  DSHB (3C10) 
Fasciclin II  IF 1:10  Mouse monoclonal  DSHB (3B43) 
Futsch  IF 1:50  Mouse monoclonal  DSHB (22C10) 
GluR IIa  IF 1:20  Mouse monoclonal  DSHB (8B4D2) 
GluR IIb  IF 1:2500  Rabbit polyclonal  Di Antonio et al., 
(1999) 
GluR III  IF 1:2500  Rabbit polyclonal  Di Antonio et al., 
(1999) 
HRP  IF 1:200  Goat polyclonal, Cy3 Conjugate  Stratech scientific 
ltd. 
HRS/HGS  IF 1:200  Guinea Pig polyclonal  Lloyd et al., 2002 
Lac-Z  IF 1:1000  Rabbit polyclonal  Cappel 
Laboratories 
Phosho-JNK  IF 1:1000  Rabbit polyclonal  Promega (V7931) 
Phospho-MAD  IF 1:500  Rabbit polyclonal  Ten Dijke (PS1) 
POSH  IF 1:20  Rabbit polyclonal  Tsuda et al., 2005 
Rab8  IF 1:50  Rabbit polyclonal  Generated during 
this investigation 
Rab11  IF 1:8000  Rabbit polyclonal  Tanaka and 
Nakamura., 2008 
Repo  IF 1:50  Mouse monoclonal  DSHB (AD12) 
Synaptotagmin  IF 1:2000  Rabbit monoclonal  Sweeney Lab 
Ubiquitinylated 
proteins 
 IF 1:2000  Mouse monoclonal  Enzo Life Sciences 
(BML-PW8810-
0500) 
 
Table 2.3. Secondary Antibodies Used During The Course of This Investigation 
Antibody 
 
 Dilution  Source/Reference 
Goat anti-Rabbit Cy3  IF 1:200  Jackson ImmunoResearch 
Goat anti-Rabbit Cy5  IF 1:200  Jackson ImmunoResearch 
Goat anti-Rabbit FITC  IF 1:200  Jackson ImmunoResearch 
Goat anti-Mouse Cy3  IF 1:200  Jackson ImmunoResearch 
Goat anti-Mouse Cy5  IF 1:200  Jackson ImmunoResearch 
Goat anti-Mouse FITC  IF 1:200  Jackson ImmunoResearch 
Goat anti-Guinea Pig Cy3  IF 1:200  Jackson ImmunoResearch 
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2.2.3. Drosophila Retina Dissection 
 
3 days post-eclosion adult flies of the correct genotype were anesthetised by 
CO2 (see section 3.2.1.3). Flies were orientated ventral side up and, using 
forceps the thorax was gently grasped causing an extension of legs and 
proboscis. Whilst maintaining hold of the body forceps, were used to grasp the 
proboscis in order to gently remove the head. The body was discarded and the 
head submerged in a drop of HL3 on a sylgard dish. The eye was carefully 
dissected from the head. This is most easily done by teasing apart the 
connective tissue between the eye and the proboscis and working round gently 
tease the eye from the head. Eyes were transferred into a 0.5 ml eppendorf 
containing 3.7 % formaldehyde in PBS, for 40 min. Eyes were washed 3 times 
(5 min. with rocking) in 0.4 % PBS-T/PBT (0.4 % v/v triton X-100 in PBS). Post-
washing eyes were transferred back onto a sylgard dish and, in a drop of PBS 
or PBT, any excess tissue and the lamina removed from the eyes. Eyes were 
transferred into a 0.5 ml eppendorf containing 0.4 % PBS-T and incubated at 
4°C, overnight, in the dark with rocking in order to remove any auto-fluorescent 
pigment. Following incubation eyes were washed 3 further times in PBT (5 min. 
with rocking). Protocol modified from Williamson and Hiesinger (2010), 
(Williamson and Hiesinger, 2010). 
 
 
2.2.4. Immunohistochemical Staining Drosophila Retinas 
 
Following preparation (see above) Drosophila retinas were incubated in 
rhodamine conjugated phalloidin (1:100 in 0.4 % PBT) overnight, in darkness, 
with rocking at 4°C. After incubation eyes were washed 3 times in 0.4 % PBT 
before being submerged in 70 % glycerol (70 % v/v in PBS) for 1-2 h to displace 
any air from the preparation. Eyes were mounted in Vectashield® (Vector 
Laboratories LTD, UK) on a standard microscope slide. Coverslips were 
elevated, to avoid compressing the eye, on two 22 x 22 mm coverslips fixed 
either side of the preparations. Coverslips were sealed in place using nail 
varnish. 
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2.2.5. Microscopy and Image Analysis 
2.2.5.1. Confocal Microscopy 
 
 
Following immunohistochemical staining Drosophila larval NMJ’s, brains and 
adult retinas were imaged using a Zeiss LSM 710 Axio Observer Z1 confocal 
microscope, using Zen 2009 software (Carl Zeiss AG, Germany). Whole NMJ’s 
were imaged by taking Z-stack images, using a 63x oil immersion objective. Z-
stacked projections of larval VNC’s were imaged using a 40x oil immersion 
objective. Single focal plane images of Drosophila retinas were taken using the 
40x oil objective. Both z-stack and single focal plane images were also taken 
using the 40x, 60x and 100x oil objectives during the course of this 
investigation. When taking confocal images for quantification of fluorescence all 
settings were kept the same between images. 
 
 
2.2.5.2. Calculating Mean Normalised Bouton Number 
 
Drosophila 3rd instar wandering larvae were dissected and 
immunohistochemically labelled (see sections 2.2.3. and 2.2.4.) using HRP-Cy3 
to mark the nervous system and anti-synaptotagmin to label synaptic boutons. 
Synaptic bouton number, at muscle 6/7 and muscle 4, was assessed by 
counting the number of individual synaptotagmin positive swellings visible at 
each NMJ. Counts were made using the 40x objective on an Axiovert 200 invert 
fluorescence microscope (Carl Zeiss AG, Germany).  
 
Synaptotagmin staining results in small amounts of background staining of the 
larval muscles. This was utilised to clearly image muscles 6/7 (see fig. 1.5.C) 
and 4 at hemi-segment A3 using the 10x objective and a AxioCam HRC camera 
(Carl Zeiss AG, Germany) connected to a Axiovert 200 invert fluorescence 
microscope (Carl Zeiss AG, Germany). Using ImageJ the width and length of 
the muscles was measured in pixels. A haemocytometer was imaged under the 
same conditions to allow conversion of pixel measurements to micrometres, 
which were then used to calculate the muscle surface area (MSA). The mean 
MSA of wildtype animals was used to normalise the bouton number of other 
 2. Materials and Methods 
!
   63!
genotypes; the mean wildtype MSA was divided by the MSA of the muscle of 
interest and multiplied by the bouton number corresponding to the muscle of 
interest. As bouton number parallels MSA, normalisation in effect gives the 
bouton number expected if the muscle was a wildtype size. Any genotypes 
displaying a significantly different MSA from wildtypes are indicated. 
 
 
2.2.5.3. Calculating Mean Normalised NMJ Length, Branch 
Number, Satellite Bouton Number and Synaptic Bouton Size 
 
Confocal images of NMJ’s at muscle 4 hemi-segment A3 were taken as 
described in section 2.2.5.1. and processed using ImageJ. The length of each 
NMJ was determined by tracing each NMJ using the NeuronJ ImageJ plugin 
and using the measure tracings setting. NMJ lengths were normalised via the 
same method as for bouton number, described above (section 2.2.5.2) and the 
mean normalised NMJ length determined for each genotype. Images were also 
used to calculate the branch number of each NMJ. Branches originating from 
the original nerve entry point were classified as primary branches with 
subsequent branches defined as strings of at least 2 consecutive boutons 
branching off from another branch (Jin et al., 2009). Branch numbers were 
normalised in the same way as bouton numbers and the mean normalised 
genotypic branch number calculated. Satellite boutons were defined as small 
supernumerary boutons budding from a central parent bouton (Dickman et al., 
2006). Satellite bouton number was normalised as for bouton numbers. 
Synaptic bouton sizes were determined by measuring the diameter of each 
synaptotagmin positive swelling, measured across the widest point, for each 
NMJ. Bouton sizes were normalised and the mean normalised size calculated 
per genotype. 
 
 
2.2.5.4. Assaying Pre-synaptic Retractions and Ghost Boutons 
 
Analysis of pre-synaptic retractions was performed as previously described by 
Eaton et al. (2002) (Eaton et al., 2002). Larvae were dissected as described in 
section 2.2.1. and immunohistochemically labelled (see section 2.2.2.) using 
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both anti-Dlg, labelling the post-synaptic density, and anti-horseradish 
peroxidase (HRP), labelling the pre-synaptic terminal. Sites at which post-
synaptic Dlg staining was observed in the absence of pre-synaptic HRP staining 
were classified as “post-synaptic footprints”, indicating a pre-synaptic retraction 
(Eaton et al., 2002). The number of NMJ’s displaying retractions was recorded 
per genotype. At the same time the presence of ghost-boutons, undifferentiated 
boutons that have failed to mature, was recorded. Ghosts were classified as 
boutons showing pre-synaptic HRP staining in the absence of post-synaptic Dlg 
(Ataman et al., 2006a; Packard et al., 2002). Analysis of pre-synaptic retractions 
and the presence of ghost boutons was performed using a 40x objective on an 
Axiovert 200 invert fluorescence microscope (Carl Zeiss AG, Germany). 
 
 
2.2.5.5. Quantification of Nuclear and Cell Fluorescence. 
 
ImageJ was used to calculate the corrected total cell immuno-fluorescence 
(CTCF) or corrected total nuclear immuno-fluorescence (CTNF) for P-MAD, 
Dad-LacZ, Puc-Lacz and HRS reporters within motor neurons. Third instar 
wandering larvae of the correct genotype were dissected as in section 2.2.1. 
and the CNS left in situ. Immunohistochemical staining of preparations was 
performed as in section 2.2.2. using the appropriate antibodies. All genotypes 
were stained within the same tubes. α-Eve was used to mark motor neuron 
nuclei within the VNC. Confocal microscopy was used to generate z-stacked 
images of the VNC’s (see section 2.2.5.1.) which were processed using imageJ. 
Confocal settings were kept the same for all images. Using the drawing tools in 
imageJ individual motor neuronal nuclei or cell bodies were selected and the 
area, integrated density and mean gray values measured. At least 3 
measurements were also taken from surrounding regions to provide a mean 
background fluorescence reading. CTCF/CTNF was calculated using the 
following formula: CTCF = Integrated density – (Selected Area x Mean 
background fluorescence). 
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2.2.5.6. Transmission Electron Microscopy (TEM) 
2.2.5.6.1. Fixation and Embedding of Drosophila Larval Muscles 
and Brains 
 
Third instar wandering larvae were dissected as in section 2.2.1. and fixed (0.1 
M sodium phosphate buffer (NaPO4, pH 7.4), 1 % gluteraldehyde, 4 % 
methanol-free formaldehyde (pH 7.3)), whilst still pinned to the sylgard plate, for 
7 mins. Larval preps were then transferred into 1.5 ml eppendorf tubes of fix 
and left rocking at 4°C overnight. Whole preps were subsequently washed 3x 
10 mins in 0.1 M sodium phosphate buffer, rocking at room temperature (RT), 
before a 2 hour incubation in 1 % osmium tetroxide (1 % OsO4 in 0.1 M NaPO4, 
RT with Rocking).  3x 10 minute washes in dH2O (RT with rocking) were 
performed prior to incubation in 1 % uranyl acetate (1 % in dH2O, 4°C, overnight 
with rocking). 3x 10 minute washes in dH2O were performed (RT with rocking) 
prior to dehydration. Preps were dehydrated in increasing concentrations of 
ethanol (30 %, 50 %, 70 %, 90 % and 3x 100 % in dH2O, 15 mins each, RT with 
rocking), followed by 2x 15 min. incubation in propylene oxide (100 %, RT with 
rocking). 100 % propylene oxide and ethanol stocks used in this protocol were 
maintained dehydrated using a molecular sieve.  Dehydrated preps were 
subsequently transferred to 7 ml glass snap top vials and incubated in 
increasing concentrations (25 %, 50 %, 75 % and 3x 100 %) of epon araldite 
resin (8 g agar 100, 18 g dodecenyl succinic anhydride (DDSA), 4 g araldite 
CY212, 0.75 ml dimethylbenzylamine (BDMA)) for 30 mins each at 37°C with 
rotation. Post resin incubation whole preps were removed and placed within a 
drop of 100 % epon araldite resin upon a sylgard dish. Fine tungsten needles 
were used to dissect out muscles of interest (muscle 6/7) and whole larval 
brains. These were then transferred into embedding moulds (Silastic J Kit, Dow, 
USA) half filled with pre-semi-polymerised (60°C 4-6 hours) resin.  Moulds were 
then filled with un-polymerised resin and incubated at 60°C for 48 hours to 
complete polymerization. After 48 hours moulds were left to cool before 
removing the polymerized resin blocks. 
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2.2.5.6.2. Sectioning and TEM 
 
Resin blocks containing the preparations were trimmed as close to the 
preparation as possible using a fine-toothed hacksaw. Blocks were then 
secured within a chuck and trimmed using a fine razor blade to leave a small, 
flat-topped pyramid surrounding the preparation. This reduces the subsequent 
cutting area. Blocks were typically trimmed to ~1/3 of the way through the VNC, 
from the posterior end, or ~1/3 through the muscle, from either the posterior or 
anterior end. This provides a start point close to the area of interest at which to 
begin sectioning. 1 μm sections were cut using glass knives upon a microtome 
(Leica Ultracut UCT). Sections were placed within a drop of water upon 
microscope slides and dried on a hot plate at 80°C. Sections were subsequently 
stained in toluidine blue (0.6 % in 0.3 % sodium carbonate, 80°C for ~5 
seconds) rinsed in distilled water and again dried on the hot plate. Stained 
sections were analysed to confirm the region of interest and ascertain the 
quality of the preparation. Having determined positioning and quality fine 
sections (60-70 nm) were cut, as for 1 μm sections, and incubated in uranyl 
acetate (in 50 % ethanol, 10 mins at RT). Sections were subsequently 
submerged in distilled water to wash prior to staining in lead citrate in the 
presence of sodium hydroxide pellets (10 mins, RT) and rinsing in distilled 
water. Sodium hydroxide pellets are used to prevent excessive lead citrate 
precipitation. Sectioning was performed by M. Stark (Technology facility, York).  
 
TEM imaging was performed using analySIS software on a TECNAI G2 
transmission electron microscope (120 kV). Quantification of the number and 
diameter of endosome-like vesicle structures was performed using ImageJ. 
 
 
2.3. Physiological Analysis of Drosophila Larvae 
2.3.1. Larval Locomotion Assay 
 
The larval locomotion assay was conducted at 25°C and all equipment and 
reagents (e.g HL3, petri-dishes) used left to reach this temperature prior to use. 
Female third instar wandering larvae of the appropriate genotype were selected 
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and transferred into HL3 saline to wash off any debris. Using a fine, damp 
paintbrush 2-3 larvae were transferred onto the centre of a 90mm diameter 
petri-dish containing a thin layer of 2% agar and left to acclimatise. The petri 
dish was placed upon a black surface, providing optimal contrast, with a digital 
webcam (Creative labs, UK) vertically above, providing a birds-eye image. In 
the dark a light source was directed at the side of the petri-dish to elicit a 
crawling escape response. Upon initiation of crawling larvae were recorded for 
120 sec. (0.2 frames sec-1) using VirtualDub software. Locomotion was 
analysed using imageJ, with the median and thresh-track plugins, tracking larval 
movement (pixels frame-1) across the X/Y coordinates. Distance travelled was 
calculated using Pythagoras’ theorem (√((X1-X2)2 + (Y1-Y2)2)) and the mean 
velocity (pixels sec-1) calculated. Velocity was converted to mm s-1 using a scale 
imaged under the same conditions. 
 
 
2.4. Molecular Biology 
2.4.1. Antibody Production 
 
Drosophila Rab8 cDNA in the pOT2 plasmid vector was supplied to the York 
Protein Production Service (Technology Facility, York, UK) according to the 
required specifications. Briefly cDNA was subcloned into a plasmid vector 
containing a Glutathione S-transferrase (GST) tag. GST-tagged Rab8 was 
expressed in E. Coli, extracted and purified via large scale glutathione 
sepharose purification. Purified GST tagged Rab8 protein was supplied to the 
Eurogentec Polyclonal Antibody Production service (Eurogentec, Belgium) in 
accordance with the required specifications. Briefly two separate rabbits were 
immunized with 100 μg of the supplied protein at 0, 14, 28 and 56 days, in 
accordance with the Eurogentec 87-Day classical immunization programme. 
Final bleed serum was aliquoted into 500μl aliquots in 1.5 ml eppendorf tubes 
and stored at - 80°C. When required individual aliquots were mixed 50:50 with 
glycerol and stored at 4°C. 
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2.4.2. Extraction of Genomic DNA 
 
DNA was extracted from single adult flies by homogenisation in 50 μl of DNA 
extraction buffer (25 mM NaCl, 10 mM Tris-HCl pH 8.2, 1 mM EDTA, Proteinase 
K 200 μg/ml). Buffer can be stored aliquoted at - 20°C in the absence of 
proteinase K, which must be added fresh. Homogenate was incubated at 37°C 
for 30 min. prior to Proteinase K inactivation by incubation at 85°C, 10 min.. 
Centrifugation at 13000g for 3 min. in a bench-top centrifuge allowed separation 
of particulates. 1-2 μl of supernatant was used as a PCR template. Increased 
concentrations of DNA could be obtained by using multiple flies for extraction. 
 
 
2.4.3.  Polymerase Chain Reaction (PCR) 
 
PCR reactions were run using PCR mastermix (Promega, UK; 25 U/ml Taq 
DNA polymerase, Taq Reaction Buffer, 200 µM of each dNTP, 1.5 mM MgCl2) 
with 1 μM of each primer and 0.5-1 mg of genomic DNA (typically 1-2 μl from fly 
extraction) or 1-2 ng of plasmid DNA. Reactions were run as a total volume of 
20 μl in a Techne TC512 PCR thermocycler (CamLab, UK), typically for 30 
cycles. Annealing temperatures used were 5°C lower than the lowest primers 
melting temperature (Tm) with an extension time of 1 min. per kb (no less than 
30 sec.). Primers were designed using Primer3 software and synthesised by 
Eurogentec (U.K). 
 
 
2.4.4. DNA Agarose Gel Electrophoresis 
 
The DNA products of PCR and restriction enzyme digestions were analysed via 
agarose gel electrophoresis. 1.4 % and 0.7 % agarose gels (in TAE; 40 mM Tris 
acetate, 1 mM EDTA, pH 8.3) were used for small (< 1kb) and large DNA 
products, respectively. Addition of SYBR® safe (Invitrogen, UK; 10 μl/100 ml) to 
the gel allowed for visualisation of the DNA using a blue light transilluminator. 
Bromophenol blue loading dye (0.25% w/v bromophenol blue, 30 % glycerol v/v 
in dH2O) was added to DNA to assist loading. A 1 kb or 100 bp DNA ladder (0.5 
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μg/lane, NEB, UK) was run alongside DNA products in order to determine size. 
Gels were run at ~70-90 V. 
 
 
2.4.5. DNA Purification; Gel Extraction 
 
DNA products required for cloning or sequencing could be excised from 
electrophoresis gels using a sharp scalpel and visualisation by blue light. Gel 
slices were placed into 1.5 ml eppendorf tubes and processed in accordance 
with the QIAquick® gel extraction kit (Qiagen, UK) protocol. Following gel 
extraction DNA concentration could be ascertained using a NanoDrop ND-1000 
spectrophotometer (Thermo Scientific, DE, USA) or by running a small quantity 
on an electrophoresis gel. 
 
 
2.4.6. DNA Sequencing 
 
DNA sequencing was used to confirm the generation of new transgenic flies 
(see section 2.5.) and to characterise the nature of Rab8 mutant alleles. 
Samples were submitted, in accordance with provided guidelines, for 
sequencing by the Technology Facility Sequencing Service (York, UK) using a 
3130XL Genetic Analyzer (Invitrogen, UK). 
 
 
2.4.7. Bacterial Transformation and Amplification of Plasmid 
DNA  
 
In order to generate new transgenic Drosophila lines E. coli was used to amplify 
both the original cDNA containing pOT2 plasmid and the pUASt plasmid 
containing the appropriate inserts following sub-cloning.   
 
Both XL-1 Blue supercompetent and XL-10 Gold ultracompetent E. coli cells 
(Stratagene, CA, USA) were used, depending upon the antibiotic resistance of 
the plasmid. Transformation was achieved via heat-shock in accordance with 
the manufacturers instructions. Both protocols were, however, modified and 
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scaled to use 50 μl of cells as opposed to the recommended 100 μl.  Luria broth 
(LB; 10 g/l tryptone, 10 g/l NaCl, 5 g/l yeast extract) was also used instead of 
SOC or NYZ+ media. For transformation of plasmid from a ligation mix 1 μl of 
the ligation reaction was used, as recommended. For transformation of a 
plasmid from a Whatman® FTA® disc 50 μl of cells were added directly to the 
disc following TE washing (see section 2.5.1.). Post transformation cells were 
plated on LB agar plates (20 g/l agar in LB broth) containing the appropriate 
antibiotics for antibiotic selection, either chloramphenicol (12.5 μg/ml) or 
ampicillin (200 μg/ml), in accordance with the manufacturers instructions. Plates 
were incubated at 37°C overnight. 
 
Individual colonies were harvested from plates using a sterile pipette tip and 
transferred into a sterile 15 ml falcon tube containing 5 ml sterile LB broth and 
the appropriate antibiotic. Cultures were incubated at 37°C overnight (12-16 h) 
with vigorous shaking. Stocks of transformed E. coli were stored long-term at -
80°C by addition of 50 % v/v sterile glycerol. Glycerol stocks were used to 
streak fresh plates when required. 
 
In order to check for the presence of an insert within transformed colonies, for 
example following a ligation during sub-cloning, plasmid DNA must first be 
purified by miniprep (see section 2.4.9.1.) and then the insert presence 
determined by restriction enzyme digestion (see section 2.4.10.) and gel 
electrophoresis (see section 2.4.4.). For minipreps 2 ml of each overnight 
culture was pelleted via centrifugation at 13000 g (2 min., RT), supernatant 
removed and frozen at - 20°C. In order to ascertain those colonies most likely to 
have taken up the insert prior to miniprep, reducing the number of minipreps 
required, colony cracking could be performed using 15 μl of the overnight 
culture (see below). 
 
 
2.4.8. Colony Cracking 
 
Colony cracking was used as a quick method of screening large numbers of 
clones for those that are most likely to have taken up the insert. It relies upon 
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cell lysis using alkaline conditions and identification of positive clones based on 
electrophoretic mobility variance between supercoiled DNA plasmids containing 
the insert and those that don’t. Insert carrying plasmids move slower. Inserts as 
small as 200 bp can be detected.  
 
20 μl of bromophenol blue loading dye was added to 1 ml of 5x cracking buffer 
(25 g sucrose, 5 ml 5 M NaOH, 2.5 ml 10% SDS, 40 ml ddH2O). 5 μl of cracking 
buffer + bromophenol blue loading dye was added to 5 μl of resuspension buffer  
(50 mM Tris-HCL pH 8.0, 10 mM EDTA, 100 μg/ml RNaseA) and mixed with 15 
μl of overnight culture. The mixture was then loaded and run on an 
electrophoresis gel (see section 2.4.4.) using uncut empty plasmid as the 
control, no ladder is required. Alternatively single colonies can be patched and 
used directly for cracking instead of 15 μl of overnight culture. Those colonies 
containing plasmids carrying the insert will show an electrophoretic mobility 
difference to the control plasmid. The plasmid from these was purified via 
miniprep (see below). 
  
 
2.4.9. Plasmid Purification 
2.4.9.1. MiniPrep Purification 
 
The QIAprep spin miniprep kit (Qiagen, UK) was used to purify up to 20 μg of 
molecular biology grade plasmid DNA from E. coli. Frozen pellets produced by 
centrifugation of 2 ml of overnight cultures (see section 2.4.6.) were processed 
in accordance with the manufacturers instructions. Plasmid DNA purified via this 
method was used during sub-cloning of Rab8 from the pOT2 plasmid to the 
pUASt plasmid (see section 2.5.)  
 
 
2.4.9.2. MidiPrep Purification 
 
To provide greater yields and purity of plasmid DNA (up to 200 μg of 
transfection-grade plasmid DNA), for example for microinjection of Drosophila 
embryos, plasmids were purified using the QIAGEN HiSpeed Plasmid Midi Kit. 
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Having confirmed the presence of the appropriate insert via colony cracking, 
miniprep, restriction enzyme digestion and gel electrophoresis 100 μl of the 
appropriate overnight culture (see section 2.4.7.) was used to inoculate 100 ml 
of LB broth containing the appropriate antibiotic. Alternatively, for optimal 
results, a single colony could be picked from a freshly streaked plate, streaked 
from the appropriate glycerol stock, and used to inoculate a 5 ml starter culture 
of LB broth and the appropriate antibiotic. Starter cultures were incubated for 8 
h at 37°C with vigorous shaking before being used to inoculate a 100 ml culture 
(100 μl in 100 ml). 100 ml cultures were incubated at 37°C overnight with 
vigorous shaking. Following incubation 100 ml cultures were centrifuged at 6000 
rpm for 15 min. at 4°C, the supernatant removed and the pellet frozen. The 
frozen pellet was processed in accordance with the QIAGEN HiSpeed Plasmid 
Midi Kit instructions. 
 
 
2.4.10. Restriction Endonuclease Digestion 
 
Plasmids contain restriction sites, typically within multiple cloning sites, that are 
specifically recognised by restriction enzymes. This means that restriction 
enzymes can be used to specifically cleave plasmids, allowing for excision and 
insertion of DNA fragments during sub-cloning. This approach was used to 
excise Rab8, eGFP and NTAP from the donor plasmids and cleave the recipient 
pUASt plasmid for their insertion. Restriction enzymes were also used to cleave 
plasmid DNA from transformed clones in order to check for the presence of the 
plasmid by gel electrophoresis. Restriction enzymes EcoRI, XhoI and NotI 
(Fermentas, UK) were used at concentrations indicated by the supplier. The 
required restriction enzymes were added to the appropriate buffer (Fermentas, 
UK) and DNA with a total reaction volume of 20 μl. DNA was used at an 
appropriate concentration to give at least 20 ng of the smallest fragment, post 
digestion. Reactions were incubated at 37°C for at least 1 h followed by 80°C 
for 20 min. to inactivate enzymes. Restriction products were run on an 
electrophoretic gel (see section 2.4.4.) and, if required, purified (see section 
2.4.5.). 
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2.4.11. DNA Ligation 
 
Purified DNA fragments, previously treated with restriction endonucleases, were 
ligated together and into cleaved vector plasmids using T4 DNA ligase. Ligation 
reactions were typically a 3:1 (insert:vector (ng)) ratio, determined using the 
following formula: Insert mass (ng) = 3 x (insert length bp/vector length bp) x 
vector mass (ng). DNA concentration was ascertained using a NanoDrop ND-
1000 spectrophotometer (Thermo Scientific, DE, USA). 0.2 μl of T4 ligase 
(Fermentas, UK) was mixed with 2 μl of T4 buffer (Fermentas, UK) and the 
DNA in a total reaction volume of 20 μl. Reactions were incubated at 16°C 
overnight followed by a 10 min. 65°C inactivation. 
 
 
2.4.12. Drosophila Larval X-Gal Staining 
 
X-Gal staining was used to confirm recombination (see section 2.1.7.) of the 
Puc-LacZ reporter construct onto the same chromosome arm as Rab8B229. 3rd 
instar wandering larvae from each potential recombinant stock were dissected 
as in section 2.2.1. Dissected larvae were fixed in 1 % glutaraldehyde (1 % in 
PBS) for 15 min. at room temperature, with rocking. Preparations were then 
washed in PBS (3x 10 min. RT, with rocking). Pre-warmed (37°C) LacZ staining 
buffer (20 mM K3[Fe(CN)6], 20 mM K4[Fe(CN)6], 2 mM MgCl2, 0.03% NP-40) 
was mixed with fresh X-gal  (1 mg/ml, 195 mM X-Gal in DMF) and applied to 
larval preparations. Preparations were incubated at 37°C for at least 30 min. 
until colour developed. Preparations were washed with PBS to halt staining. 
 
 
2.5. Generation of Transgenic Drosophila Lines 
2.5.1. Generation of Rab8 pUASt Constructs 
 
During the course of this investigation UAS-Rab8, UAS-eGFP-Rab8 and UAS-
NTAP-Rab8 transgenic Drosophila stocks were generated. UAS-OCRL1, UAS-
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VCPQ1 and UAS-VCPQ2 stocks were also generated via this process but do not 
feature in this investigation and so are not covered directly.  
 
The Whatman® FTA® disc containing the Rab8 cDNA clone, within a pOT2 
plasmid vector, was identified and isolated from the BDGP Gold collection 
(clone: LD44762). In a 0.5 ml eppendorf microfuge tube 50 μl of sterile 1X TE 
(10 mM Tris-HCl, 0.1 mM EDTA, pH 8.0) was added to the disc, mixed and 
removed within 2 seconds. Washing with TE is essential to remove chemicals 
used in the generation of the disc that will inhibit subsequent transformations. 
Prolonged exposure of the disc to TE will result in elution and loss of cDNA from 
the disc. Immediately after TE washing the disc was transferred to a pre-chilled 
14 ml BD Falcon polypropylene round-bottom tube a kept on ice. 50 μl of 
chemically competent Xl-1Blue supercompetent cells (Stratagene, CA, USA) 
were added directly to the disc allowing transformation and amplification of the 
Rab8-pOT2 plasmid as described in section 2.4.7. For Rab8-pOT2 antibiotic 
selection was performed using chloramphenicol at a concentration of 12.5 
μg/ml. Following amplification of the Rab8-pOT2 plasmid purification was 
performed as described in section 2.4.9.1. For the generation of the UAS-Rab8 
construct Rab8 was amplified via PCR (see section 2.4.3.) from the POT2-Rab8 
vector, introducing an upstream EcoRI restriction site and maintaining a 
downstream XhoI site (forward primer (EcoRI); 
CCTACCGCGAATTCACACAAAATG and reverse primer; 
CGTTAGAACGCGGCTACAAT). The Rab8 fragment was purified via gel 
extraction (see sections 2.4.4. and 2.4.5.) and ligated (see section 2.4.11.) into 
the pUASt vector, which had been cut with EcoRI and XhoI (see section 
2.4.10.). For the generation of the eGFP tagged UAS-Rab8 construct the eGFP 
tag was amplified via PCR (see section 2.4.3.) from an existing vector in the 
Sweeney lab collection using primers to introduce NotI and EcoRI restriction 
sites (forward primer (NotI); GATCCACCGGGCGGCCGCATGGTGAGC and 
reverse primer (EcoRI); CTCTAGAGTCGCGGCCGCTTGAATTCACAGCTC). 
The pUASt vector was cut using NotI and XhoI and purified via gel 
electrophoresis and gel extraction (see sections 2.4.4. and 2.4.5.). A three way 
ligation was performed (see section 2.4.11.) in order to directionally clone the 
eGFP tag and the previously PCR amplified and purified Rab8 fragment (EcoRI, 
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XhoI) into the pUASt vector, maintaining the open reading frame and with eGFP 
tag at the N-terminus of Rab8. For the generation of the N-terminally TAP 
tagged (NTAP) UAS-Rab8 construct a pUASt vector containing the TAP tag 
(Kyriakakis et al., 2008) was cut using EcoRI and XhoI (see section 2.4.10.) 
prior to purification via gel electrophoresis and gel extraction (see sections 
2.4.4. and 2.4.5.). Purified, PCR amplified Rab8 (EcoRI, XhoI), as used for the 
UAS-Rab8 and UAS-eGFP-Rab8 constructs, was ligated into the pUASt-NTAP 
vector (see section 2.4.11.) maintaining the open reading frame. Following 
ligation of both the pUASt-eGFP-Rab8 and pUASt-NTAP-Rab8 constructs 
individual ligation reactions were used to transform XL-10 Gold Ultracompetent 
cells (Stratagene, CA, USA) (see section 2.4.7.) which were plated onto LB-
agar plates containing 200 μg/ml ampicillin and incubated at 37°C, overnight. 
Single colonies were then picked and amplified in 5 ml 8 hour cultures (see 
section 2.4.9.2.). The colonies most likely to contain the insert were ascertained 
via colony cracking (see section 2.4.8.). Those identified by colony cracking 
were purified via mini-prep (see section 2.4.8.1.) and the presence of the insert 
confirmed via restriction endonuclease assessment (see section 2.4.10.). 
Having confirmed the presence of the insert 100 μl of the original 8 hour culture 
for that colony was used to seed a 100 ml overnight culture (37°C with shaking). 
Cultures were centrifuged at 6000 rpm for 15 min. at 4°C and the pellet used to 
purify the plasmid using the Qiagen Midi/Maxi kit (see section 2.4.9.2.). 
 
 
2.5.2. Micro-Injection of Drosophila Embryos 
 
Large quantities of w1118 embryos were generated by allowing a high density of 
w1118 adults to lay on apple-juice agar plates (40 g/l sucrose, 16 g/l agar, 20 % 
(v/v) apple juice) within a large embryo collection cage. Plates were changed 
every 24 h, seeded with yeast paste to promote egg laying and flies left to 
acclimatise for 48 h prior to embryo collection.  
 
Embryos must be injected during the syncytial stage and so plates were 
changed every hour. Embryos were collected within the hour by gently 
loosening them from the plate, using a wet paintbrush, and transferring them 
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onto a piece of filter paper. Embryo’s were sandwiched between 2 microscope 
slides lined with non-toxic double sided tape separated by 2 lengths of 15 A 
copper fuse wire laying perpendicular between the slides. Copper wires prevent 
too much pressure being applied to the embryos. Separation of the slides 
dechorionates the embryos. 
 
A 5 mm strip of double sided tape was placed perpendicularly across a fresh 
microscope slide and dechorionated embryos transferred quickly, but carefully, 
to line up along the tape with their posterior overhanging. This process must be 
completed within 7-10 min. at RT to prevent embryos drying out. Embryo’s were 
then covered with non-toxic, 19S technical grade oxygen-permeable voltaleff oil 
to prevent desiccation. 
 
24 h prior to micro-injection ~ 6 μg of the pUASt construct to be injected was co-
precipitated in 1/10th volume of 3 M NaOAc + 2 volumes of 100 % ice cold EtOH 
with 5 μg of the pπΔ2-3 transposase plasmid (Misra and Rio, 1990). Co-
precipitation was incubated at  - 20°C overnight followed by centrifugation at 
13000g for 30 min.. Pellets were rinsed in 100 % ice cold EtOH and air dried. 
Pellets were re-suspended in 5 μl of Spradlings buffer (5 mM KCl, 0.1 mM 
NaH2PO4, pH 7.8) (Rubin and Spradling, 1982; Spradling and Rubin, 1982). 2 
μl of the suspension was loaded into a fine pulled glass needle which was 
loaded onto the micro-injection apparatus. After breaking the end of the needle 
to leave a sharp tip the slide of aligned embryos was placed on the apparatus 
with the posterior end facing the needle. Embryos were injected into the 
posterior end in order to target the posterior pole cells, which are progenitors to 
the gonads. The slide containing injected embryos was placed upon an apple-
juice agar plate seeded with yeast paste in a box lined with damp tissue and left 
at 18°C. 
 
2.5.3. Post-Microinjection Embryo Care 
 
Larvae hatching from microinjected embryos were collected and transferred into 
vials of Drosophila medium. Virgin female and male micro-injected flies were 
collected post-eclosion and crossed to w1118 flies. As microinjection targets the 
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germ line those flies successfully transformed can be ascertained in the 
offspring (F1). As the pUASt plasmid carries a mini-white gene the F1 offspring 
of successful transformants display a pigmented eye phenotype. Those 
displaying a pigmented eye were collected and crossed, individually, to w1118 
flies in order to amplify numbers and generate a stock. The chromosome into 
which the plasmid had inserted was then determined (see below) 
 
 
2.5.4. Identifying the Chromosome of Plasmid Insertion 
 
Virgin females were isolated from the stocks generated via microinjection (see 
above) and crossed to w- balancer chromosomes males for the second 
(CyO/Sco) or third (Tm6b/Tm3) chromosomes. If all male F1 progeny display 
pigmented eyes the insert must be on the first chromosome. If not on first 
offspring will display a mixture of un-pigmented and pigmented eyes. F1 
offspring with pigmented eyes and carrying the appropriate balancer were 
collected and crossed, sibling to sibling, to each other. If the insertion site is on 
the same chromosome as the balancer all F2 offspring shall display a 
pigmented eye. If un-pigmented eyes are visible in the F2 generation the insert 
is not on that chromosome. The balancer prevents loss through homologous 
recombination. 
 
 
2.6. Statistical Analysis 
 
All statistical analysis was performed using JMP®7 (SAS Institute) statistical 
software. Unless otherwise stated the statistical tests performed were analysis 
of variance (ANOVA) with a post-hoc Dunnett’s test to ascertain significance 
between individual genotypes and the wildtype control and post-hoc student t-
tests to ascertain significance between individual genotypes. Error bars 
represent the standard error of mean (± SEM).  
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2.7. Bioinformatics and Computational Analysis 
 
 
During the course of this investigation the following software and online 
resources were used. Unless otherwise stated default settings, assumptions 
and parameters were used.  
 
For predicting the effect of amino acid substitutions upon protein structure and 
function: 
 
• PROVEAN (Protein Variation Effect Analyzer) Protein v1.1.3. 
 (http://provean.jcvi.org) 
 
• PolyPhen-2 (Polymorphism Phenotyping) v2.2.2.!(http://genetics.bwh.harvard.edu/pph2) 
 
• ProSMS 
 (http://babel.ucmp.umu.se/prosms) 
 
For Sequence Alignment: 
 
• ClustalX v2.0. 
 
For Image Processing: 
 
• Zen 2009 Lite Edition v5.5. (Carl Zeiss Microimaging GmbH). 
 
• AxioVision v4.8. (Carl Zeiss Microimaging GmbH). 
 
• AnalySIS v2.18. 
 
• Virtual Dub v1.5.10. (Avery Lee) 
 
• ImageJ v1.46. 
 Plugins:  
  NeuronJ v1.4.2: plugin for facilitating the tracing and   
  quantification of elongated image structures 
 
  Straighten: plugin facilitating the straightening of filamentous 
  particles, or any curved objects in an image 
   
  Median: plugin used during larval locomotion assay 
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  ThreshTrack: plugin used during larval locomotion assay  
   
For Primer Design: 
 
• Primer 3 
 (http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi) 
 
 
DNA Chromatogram Viewer: 
 
• MacSequence View v1.0. (GoToes)
3. Characterisation of Rab8 Mutants Identifies Rab8 as a Potent Regulator of Synaptic Growth 
!
   80!
3. Identification of Novel Modifiers of 
CHMP2BIntron5 Toxicity, Including the Dominant 
Enhancer Rab8 
 
3.1 Introduction  !
Frontotemporal dementia (FTD) is the second most prevalent form of early-
onset dementia, after Alzheimer’s disease, displaying a mean age of onset 
between 46 and 65 (Ratnavalli et al., 2002; Snowden et al., 2002). It has been 
shown to present a strong genetic association with up to 50% of cases showing 
a positive familial history and 7 distinct gene loci implicated in disease 
pathology, to date (see section 1.2.4.) (Chow et al., 1999b; Rosso et al., 
2003b). One of these genes is CHMP2B. CHMP2B has been identified as 
encoding a core component of ESCRT-III, one of 4 ESCRT complexes, 0-III, 
that act in numerically sequential order in the biogenesis of MVB’s (Carlton, 
2010; Skibinski et al., 2005; Stuffers et al., 2009; Wollert et al., 2009b). MVB’s 
act as a nexus during both endosomal-lysosomal and autophagic degradative 
pathways, which are essential for homeostatic regulation within cells 
(Filimonenko et al., 2007a; Gruenberg and Stenmark, 2004a; Piper and 
Katzmann, 2007a; Wollert and Hurley, 2010). Perturbation to these trafficking 
pathways has been associated with a range of human pathologies including 
mucolipidosis, Danon disease, Antiphospholipid syndrome, Niemann Pick, 
Oculocerebrorenal syndrome of Lowe and FTD, to name a few (Coon et al., 
2012; Huang et al., 2005; Kobayashi et al., 1998; Nishino et al., 2000; Skibinski 
et al., 2005; Vergarajauregui et al., 2008; Vergarajauregui and Puertollano, 
2008). However, despite this, the molecular mechanism underlying these 
biological processes and their associated diseases remain to be fully 
elucidated. As such this study looks to identify novel factors implicated in 
frontotemporal dementia pathology, associated with CHMP2B dysfunction, and 
identify their roles within normal endosomal-lysosomal and autophagic 
processes. 
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In this chapter the Drosophila eye is utilised as a model system in which to 
identify novel modifiers of the FTD mutation CHMP2BIntron5. Expression of 
CHMP2BIntron5 in the eye induced a clear phenotype, against which it is possible 
to screen for dominant modifiers of CHMP2BIntron5 toxicity. Using this approach 
we identified the small GTPase Rab8 as a potent enhancer of CHMP2BIntron5 
toxicity, along with the Rab8 effector protein OCRL1. It was also demonstrated 
that a number of CHMP2B interacting proteins implicated in JNK signalling act 
as potent modifiers of CHMP2B. As such this chapter provides a framework for 
the rest of this investigation, elucidating novel factors and their associated 
pathways as specific targets for further investigation. In this way we hope to 
identify novel factors implicated in FTD and elucidate the molecular 
mechanisms behind disease pathology. 
 
 
3.2 Results  !
3.2.1 Rab8 Mutants Dominantly Enhance Shrub-GFP Toxicity !!
Previous investigation has demonstrated that the CHMP2BIntron5 mutation results 
in a failure of CHMP2B to dissociate from the ESCRT-III complex (Han et al., 
2012; Lee et al., 2007). Furthermore the toxic effects of CHMP2BIntron5, leading 
to neurodegeneration and the accumulation of autophagosomes, have been 
associated with the formation of an abnormally avid complex between CHMP2B 
and mSnf7-2/Shrub, another ESCRT-III component that fails to dissociate from 
the complex (Han et al., 2012; Lee et al., 2007). In a study by Han et al. (2012) 
it was also demonstrated that the CHMP2B missense mutation CHMP2BT104N, 
which occurs in the conserved Snf7 binding domain, results in a more avid 
association of CHMP2B with Snf7 and a reduced ability to associate with the 
ATPase Vps4 (Han et al., 2012). This supports previous findings suggesting 
that Vps4 is essential for dissociation of ESCRT-III components from the 
complex (Bodon et al., 2011a; Urwin et al., 2010a). It has also been 
demonstrated that the CHMP2BIntron5 mutation elicits an accumulation of Shrub 
in ubiquitin-positive late endosomes whilst depletion of shrub can also induce 
neurodegeneration (Lee et al., 2007). Work in the Sweeney lab, in collaboration 
with the Gao lab (UMASS, Worcester, USA), has identified that a Shrub-GFP 
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fusion protein acts as a dominant negative, antimorphic form of Shrub. In 
addition it has been demonstrated that when expressed in the fly eye Shrub-
GFP phenocopies the degenerative phenotype associated with expression of 
CHMP2BIntron5 in the eye. As such one may postulate that the GFP tag on Shrub 
may act to perturb normal Vps4 mediated dissociation of the ESCRT-III 
complex, leading to pathology. Therefore, having observed pathology to 
associate with perturbation to normal Shrub-CHMP2B interaction dynamics and 
having demonstrated Shrub-GFP to phenocopy CHMP2BIntron5 initial modifier 
screens were performed against Shrub-GFP. These initial screens were 
performed by Sean Sweeney in collaboration with Fen Biao-Gao and Yubing Lu 
(UMASS, Worcester, USA) using 257 deletion stocks, representing ~ 75 % of 
the Drosophila genome, from the DrosDel collection (University of Cambridge, 
Cambridge, U.K) (Ryder et al., 2007). This initial screen identified 29 potential 
modifiers of the Shrub-GFP phenotype, including Rab8 (personal 
communication, Fen Biao-Gao and Yubing Lu, UMASS, Worcester, USA). 
Currently 2 of these potential modifiers, serpin 5 and syntaxin 12/13, have been 
investigated further and confirmed as modifiers of both Shrub-GFP and 
CHMP2BIntron5 toxicity (Ahmad et al., 2009). Here we look to do the same with 
Rab8. 
 
Having identified Rab8 as a potential modifier of Shrub-GFP toxicity, Rab8 
mutants were confirmed as potent enhancers of the Shrub-GFP phenotype. 
Here an allelic series of 5 Rab8 mutants, a Rab8 deficiency and 2 independent 
Rab8-RNAi lines were all shown to dominantly potentiate Shrub-GFP toxicity 
(Fig. 3.1. A&B). Each demonstrated a clear increase in the number of 
melanised spots present on the eye’s surface, when compared to melanisation 
caused by Shrub-GFP alone (Fig. 3.1.A). Quantification of this phenotype 
reveals that 14.6 % of GMR-Gal4, Shrub-GFP/+ flies present with a “low” 
phenotype classification, with less than 15 melanised spots visible on the eye 
within 3 days of eclosion, whilst the remaining 85.4 % display a medium 
phenotype (more than 15 melanised spots but less than 50 % of the eye 
affected) (Fig. 3.1.B). In contrast expression of Rab8-RNAi, heterozygous 
mutants and a deficiency covering the Rab8 locus in a GMR-Gal4, Shrub-
GFP/+ background resulted in a complete loss of any flies displaying a “low” 
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phenotype. Furthermore many of these genotypes potentiated toxicity 
sufficiently to display a “high” phenotype with > 50 % of the eye affected by 
melanisation (Fig. 3.1.B). Additionally it was also demonstrated that 
overexpression of Rab8 was sufficient to partially rescue Shrub-GFP toxicity, 
with GMR-Gal4,Shrub-GFP/UAS-Rab8 showing 35 % of flies to present with a 
low phenotype classification, with the remaining 65 % classified as “medium”. In 
the absence of Shrub-GFP no Rab8 allele, when heterozygous in the presence 
of the GMR-Gal4 driver, induced an eye phenotype showing any variance from 
a wildtype eye (n = 100 per genotype). This indicates that Rab8 mutants act 
purely as enhancers of Shrub-GFP toxicity.  
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Figure 3.1. Rab8 Mutants Dominantly Enhance Shrub-GFP Toxicity in the Drosophila eye 
(A) Expression of Shrub-GFP in the fly eye, under the control of the eye specific driver GMR-
Gal4, induces a distinct phenotype characterized by the presence of melanised spots across the 
eye’s surface. Expression of Rab8 mutants, a Rab8 deficiency (Df(3L)ED228) and Rab8-RNAi’s 
in a GMR-Gal4, UAS-Shrub-GFP background all potentiate Shrub-GFP toxicity, displaying an 
increase in melanisation. Overexpression of wildtype Rab8 alleviates toxicity. (B) This 
phenotype is quantified as; white = low (+) phenotype (< 15 spots of melanisation), Grey = 
medium (++) phenotype (> 15 spots of melanisation but < 50 % of the eye affected), black = 
high (+++) phenotype (> 50 % of the eye affected by melanisation). No allele induced a 
perturbation to the wildtype eye phenotype in a GMR-Gal4 background, in the absence of 
CHMP2BIntron5  (n = 100 per genotype). 
 
 
 
B 
A 
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3.2.2 Rab8 Mutants Dominantly Enhance CHMP2BIntron5 Toxicity 
 
Having confirmed Rab8 as a dominant enhancer of toxicity associated with 
Shrub-GFP, a second modifier screen was performed in order to identify 
dominant enhancers and suppressors of the CHMP2BIntron5 phenotype. Part of 
this screen included a collection of 38 deletions covering most of the 3rd arm of 
chromosome 3 (Fig. 3.2.A). From these 38 deletions 3 were identified as 
extremely potent enhancers of CHMP2BIntron5 toxicity with over 50 % of flies 
displaying a “high” phenotype classification. One of the 3 most potent enhancer 
deletion regions was identified as Df(3L)ED228, a 701102bp deletion covering 
the cytological region between 76A1 and 76D2. Within this region there are 89 
gene loci, including Rab8 (Fig. 3.2.B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.  Deletion Coverage Map of Chromosome 3L 
(A) Deletion coverage map of the left arm of chromosome 3 displaying those deletions that 
show the greatest enhancement of the CHMP2BIntron5 phenotype, with more than 50 % of flies 
presenting a “high” (more than 50 % of the eye covered by melanisation, +++) phenotype 
classification. (B) One of the 3 most potent enhancers of CHMP2BIntron5 toxicity is Df(3L)ED228 
a 701102bp deletion covering 87 gene loci, including Rab8.  
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* 
* 
DrosDel Deletion 
Mapped by Cytology (grey areas indicate areas of uncertainty) 
≥ 50% High (+++) Phenotype 
* 
3L 
19100K 19900K 
Df(3L)ED228 
Rab8 
A 
B 
3. Characterisation of Rab8 Mutants Identifies Rab8 as a Potent Regulator of Synaptic Growth 
!
   86!
 
Having substantiated the role of Rab8 as a dominant enhancer of Shrub-GFP 
and identified the deficiency region containing the Rab8 gene loci as a potent 
enhancer of CHMP2BIntron5 toxicity investigation looked to determine whether 
Rab8 acted as a dominant enhancer of CHMP2B. Here it is demonstrated that, 
as for Shrub-GFP, Rab8 mutants dominantly enhance toxicity associated with 
the FTD causing CHMP2BIntron5 mutation (Fig. 3.3.A-B). Expression of 
CHMP2BIntron5 in the Drosophila eye, under the control of the eye specific GMR-
Gal4 driver, induced a “medium” eye phenotype in 99.2 % of flies, with just 0.8 
% presenting with a “high” phenotype classification (Fig. 3.3.B). Expression of 
the Rab8-RNAi, mutant and deficiency alleles in a GMR-Gal4, UAS-
CHMP2BIntron5/+ background potentiated toxicity with a notable increase in 
melanisation observed (Fig. 3.3.A). Quantification substantiated the role of 
Rab8 alleles as enhancers of toxicity, inducing a high phenotype in 1 % 
(Rab8B229) to 16.8 % (Rab81) of flies screened (Fig. 3.3.B). No low phenotype 
flies were observed in any genotype. In contrast overexpression of wildtype 
Rab8 in a GMR-Gal4, UAS-CHMP2BIntron5/+ background displayed a notable 
decrease in the melanisation phenotype observed (Fig. 3.3.A), with 
quantification revealing a “medium” phenotype in 100 % of flies screened (Fig. 
3.3.B). This suggests that Rab8 may reduce CHMP2BIntron5 toxicity. 
 
 ! 
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Figure 3.3. Rab8 Mutants Dominantly Enhance CHMP2BIntron5 Toxicity in the Drosophila 
eye 
(A) Expression of CHMP2BIntron5 in the fly eye, under the control of the eye specific driver GMR-
Gal4, induces a distinct phenotype characterized by the presence of melanised spots. 
Expression of Rab8 mutants, a Rab8 deficiency (Df(3L)ED228) and Rab8-RNAi’s in a GMR-
Gal4, UAS-CHMP2BIntron5 background all potentiate toxicity, displaying an increase in 
melanisation. Overexpression of wildtype Rab8 reduces toxicity. (B) This phenotype is 
quantified as; white = low (+) phenotype (< 15 spots of melanisation), Grey = medium (++) 
phenotype (> 15 spots of melanisation but < 50 % of the eye affected), black = high (+++) 
phenotype (> 50% of the eye affected by melanisation). No allele induced a perturbation to the 
wildtype eye phenotype in a GMR-Gal4 background, in the absence of CHMP2BIntron5  (n = 100 
per genotype). 
 
A 
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3.2.3 The Rab8 Effector OCRL Dominantly Enhances 
CHMP2BIntron5 Toxicity !!
OCRL1 is an inositol 5-phosphatase encoded by the OCRL gene that has been 
associated with endosomal trafficking, cytokinesis and ciliogenesis (Ben El 
Kadhi et al., 2012; Coon et al., 2012). It has also been implicated in Rab8 and 
sesquipedalian/27 KDa inositol polyphosphate phosphatase-interacting protein 
(Ses/IPIP27) dependent trafficking through interaction with Rab8 (Coon et al., 
2012; Noakes et al., 2011). Furthermore mutations in the OCRL1 Rab8 binding 
domain have been associated with Lowe syndrome, a neurodegenerative 
disorder (Coon et al., 2012). As such the interacting functions of Rab8 and 
OCRL1, particularly within endosomal trafficking events within neurons, are of 
significant interest. Here it is demonstrated that, like it’s binding partner Rab8, 
OCRL1 acts as a dominant enhancer of CHMP2BIntron5 toxicity. Previous work in 
the Sweeney lab has isolated a series of OCRL1 mutant alleles, including 
OCRL1C52 and OCRL1D40. These mutants were generated by imprecise P-
element excision of the EPgy2 P-element within the 5’ UTR of the 
P{EPgy2}OCRL1EY15890 stock. Subsequent analysis in both the Sweeney and 
Rodal (personal communication Avital Rodal, Brandeis University, MA, USA) 
labs has demonstrated both mutants to be loss of function mutants associated 
with deletions covering the OCRL1 start codon.   Both OCRL1 mutants 
OCRL1C52 and OCRL1D40 show a clear potentiation of toxicity when in a 
CHMP2BIntron5 background, displaying a clear increase in melanisation observed 
across the fly eye (Fig. 3.4.A). Quantification reveals 18.75 % and 60.6 % of 
flies to display a “high” phenotype in OCRL1C52 and OCRL1D40 flies, expressed 
in a GMR-Gal4, UAS-CHMP2Bintron5/+ background, respectively (Fig. 3.4.B). 
The remaining flies presented with a “medium” phenotype. In contrast 100 % of 
GMR-Gal4, UAS-CHMP2Bintron5/+ flies displayed a “medium” phenotype. 
OCRL1C52 and OCRL1D40 mutations alongside the GMR-Gal4 driver alone, in 
the absence of UAS-CHMP2Bintron5, induced no perturbation to a normal eye 
phenotype (n = 100 per genotype), indicating OCRL1 is acting as a dominant 
enhancer of CHMP2B. 
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Figure 3.4. OCRL1 Mutants Dominantly Enhance CHMP2BIntron5 Toxicity in the Drosophila 
eye 
(A) OCRL1 mutants OCRL1C52 and OCRL1D40 induce a notable potentiation of melanisation to 
the Drosophila eye when expressed in a GMR-Gal4,UAS-CHMP2BIntron5 background without 
perturbing the eye in their own right. (B) Expression of OCRL1 mutants in a GMR-Gal4,UAS-
CHMP2BIntron5 background shows a significant increase in the proportion of flies presenting with 
a high phenotype. White = low (+) phenotype (< 15 spots of melanisation), Grey = medium (++) 
phenotype (> 15 spots of melanisation but < 50 % of the eye affected), black = high (+++) 
phenotype (> 50 % of the eye affected by melanisation). No allele induced a perturbation to the 
wildtype eye phenotype in a GMR-Gal4 background, in the absence of CHMP2BIntron5  (n = 100 
per genotype). 
 
 
 
3.2.4 ESCRT-III Interacting Proteins Involved in Innate Immunity 
and JNK Signalling Dominantly Enhance CHMP2BIntron5 Toxicity 
  
 
In order to further elucidate potential pathways involved in CHMP2BIntron5 toxicity 
targeted modifier screens were performed looking at ESCRT-III interacting 
proteins and their associated pathways. Here it is demonstrated that ALG-2-
Interacting Protein X (AliX) acts as a potent enhancer of CHMP2B. ALIX has 
been shown to interact with both ESCRT-I and ESCRT-III, via TSG101/Vps23 
and Shrub/Snf7 respectively (Fisher et al., 2007; Kim et al., 2005b; Strack et al., 
2003). It has also previously been implicated in MVB formation with AliX siRNA 
perturbing normal membrane remodelling events at the late endosome, most 
likely due to an inability to recruit the ESCRT machinery (Matsuo et al., 2004). 
AliX has also been shown to interact with lysobisphosphatidic acid (LBPA), 
which has been implicated in MVB biogenesis and has been demonstrated to 
be capable of inducing spontaneous formation of intraluminal vesicles within 
liposomes, in vitro, in the absence of any other proteins (Chevallier et al., 2008; 
Matsuo et al., 2004). ALIX siRNA also reduces cellular LBPA (Matsuo et al., 
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2004). Expression of UAS-Alix in a GMR-Gal4, UAS-CHMP2BIntron5 background 
induces a high phenotype in 100 % of flies screened (Fig. 3.5.A-B). Flies also 
present with small, irregular eyes. In contrast inhibition of AliX via expression of 
an AliX-RNAi or an AliX mutant (AliXEY10362) in the CHMP2BIntron5 background 
does not alleviate toxicity, instead a mild potentiation is observed. Thus any 
perturbation to AliX appears to enhance CHMP2BIntron5 toxicity, although 
overexpression acts as the most potent enhancer. No heterozygous AliX alleles 
affected the Drosophila eye in a GMR-Gal4 background, in the absence of 
CHMP2BIntron5 (n=100 per genotype), indicating the eye phenotype to result from 
a potentiation of CHMP2BIntron5 toxicity.  
 
 
Figure 3.5. Overexpression of the CHMP2B Interacting Protein AliX Potentiates 
CHMP2BIntron5 Toxicity in the Drosophila eye 
(A) Overexpression of UAS-AliX in a GMR-Gal4, UAS-CHMP2BIntron5 background induced a 
potent potentiation of CHMP2BIntron5 toxicity, displaying a clear increase in melanisation coupled 
with a shrunken eye phenotype. Expression of AliX-RNAi or the AliXEY10362 mutant mildly 
potentiated toxicity. None of the alleles perturbed the normal wildtype eye phenotype when 
expressed in a GMR-Gal4 background, in the absence of CHMP2BIntron5 (n = 100 per genotype). 
(B) Quantification of the eye phenotypes reveals a high phenotype classification in 100 % of 
GMR-Gal4, UAS-CHMP2BIntron5/UAS-AliX flies with a lower high phenotype penetrance in RNAi 
and mutants. White = low (+) phenotype (< 15 spots of melanisation), Grey = medium (++) 
phenotype (> 15 spots of melanisation but < 50 % of the eye affected), black = high (+++) 
phenotype (> 50 % of the eye affected by melanisation). 
 
 
Having identified such a potent enhancement of CHMP2BIntron5 toxicity through 
expression of UAS-AliX it was asked whether specific AliX interacting proteins 
had a role in the potentiation of CHMP2BIntron5 toxicity. As it’s name suggest AliX 
interacts with Apoptosis-Linked Gene 2 (ALG2), which has also been shown to 
interact directly with ESCRT-I component TSG101, in a calcium dependent 
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manner (Mahul-Mellier et al., 2006; Okumura et al., 2009). In fact it has also 
been demonstrated that ALG2 has a calcium dependent role in the AliX-
TSG101 interaction (Okumura et al., 2009). Furthermore, research has shown 
that ALG2 and AliX complex with Plenty of SH3’s (POSH), a multi-domain JNK 
scaffold, in a calcium dependent manner (Tsuda et al., 2006). POSH in turn has 
been implicated as a functional component of regulated neuronal death in 
response to withdrawal of trophic factors and as a regulator of JNK signalling 
(Bruckner et al., 2001; Tsuda et al., 2006). Here it is demonstrated that 
disruption to normal ALG2 or POSH levels have a detrimental effect in the 
Drosophila eye, potentiating toxicity associated with the CHMP2BIntron5 mutation 
(Fig. 3.6.A-B). Whilst GMR-Gal4 induced expression of UAS-ALG2 showed no 
variance from wildtype (100 % wildtype eye phenotype, n = 100) UAS-ALG2 
expression in a GMR-Gal4, UAS-CHMP2BIntron5 background induced a 
dominant enhancement of toxicity with 27.77 % of flies presenting with a high 
eye phenotype and the rest a medium phenotype (Fig. 3.6.B). This contrast with 
just 1.35 % high and 98.65 % medium phenotype in GMR-Gal4, UAS-
CHMP2BIntron5/+ flies (Fig. 3.6.B). Similarly overexpression of POSH also 
potentiated CHMP2BIntron5 toxicity with 17.65 % of flies presenting with a high 
phenotype (Fig. 3.6.B). GMR-Gal4 expression of UAS-POSH in the absence of 
CHMP2BIntron5 elicited a very mild rough eye phenotype in 100 % of flies (n = 
100) (Fig. 3.6.A). Interestingly it was also observed that inhibition of POSH also 
actively enhanced CHMP2BIntron5 toxicity. For example UAS-POSHmring, in which 
the putative zinc ring finger domain involved in E3 ubiquitin ligase activity was 
mutated, the POSH null POSH74 and POSH mutant expression all potentiated 
toxicity. Furthermore enhancement was, with the exception of the POSHEP2248 
mutant, greater than that seen through overexpression of POSH. POSHEP1206 
mutants in a GMR-Gal4 background, in the absence of CHMP2BIntron5, show a 
mild rough eye phenotype in all flies screened (n = 100), all other mutants 
showed no variance from wildtype (n = 100 per genotype). The observation that 
both overexpression of UAS-POSH and the presence of the POSHEP1206 allele in 
a GMR-Gal4 background induced a rough eye phenotype can be explained by 
the nature of the POSHEP1206 mutant. POSHEP1206 is associated with an insertion 
of a P{EP} transposable element upstream of POSH, leading to an inhibition of 
POSH via insertional mutagenesis. However P{EP} elements also carry a UAS 
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sequence meaning that in the presence of a Gal4 promoter, such as the GMR-
Gal4 used here, they can be used to induce regulated expression of the genes 
proximal to the insertion. In this case POSHEP1206 promotes expression of 
POSH giving a rough eye similar to that observed by POSH overexpression 
(Fig. 3.6A). POSHEP2248 which is also a P{EP} element is in the wrong 
orientation, in the minus orientation, to induce expression of POSH and so acts 
as a insertional mutagen.  
 
Figure 3.6. Perturbation to ALG2 and POSH Potentiate CHMP2BIntron5 Toxicity in the 
Drosophila eye 
(A) Overexpression of both ALG2 and POSH or inhibition of POSH using UAS-POSHmring, which 
has a mutated ring domain, a POSH null POSH74 or POSH mutants POSHEP1206 and 
POSHEP2248 all act to potentiate CHMP2BIntron5 toxicity. UAS-POSH and POSHEP1206 both mildly 
perturb the wildtype eye phenotype in a GMR-Gal4 background, in the absence of 
CHMP2BIntron5, no other allele does (n = 100 per genotype). (B) Quantification reveals an 
increased penetrance of flies classified as presenting a high phenotype as a result of 
perturbation to POSH and ALG2 in a GMR-Gal4, UAS-CHMP2BIntron5 background with the 
greatest enhancement elicited by the POSH null, POSH74. White = low (+) phenotype (< 15 
spots of melanisation), Grey = medium (++) phenotype (> 15 spots of melanisation but < 50 % 
of the eye affected), black = high (+++) phenotype (> 50 % of the eye affected by melanisation). 
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Interestingly POSH has also been implicated in the targeted regulation of 
another essential ESCRT component Hepatocyte growth factor-regulated 
tyrosine kinase substrate (HRS/HGS), through its E3 ubiquitin ligase activity 
(Kim et al., 2006). Depletion of HRS has been shown to induce accumulation of 
ubiquitinylated proteins, in particular at early endosomes, leading to 
neurodegeneration (Tamai et al., 2008). Having demonstrated perturbation of 
POSH expression will elicit significant potentiation of CHMP2BIntron5 toxicity it 
was asked whether HRS acts to enhance CHMP2B in a similar fashion. Here it 
is demonstrated that HRS acts as a potent enhancer of CHMP2BIntron5 toxicity 
with both overexpression of HRS or depletion of HRS, using the HRSD28 loss of 
function mutation, causing significant potentiation to the melanisation phenotype 
(Fig. 3.7 A-B). Overexpression of UAS-HRS in a GMR-Gal4, UAS-
CHMP2BIntron5 mutant background induced a semi-lethal phenotype with the 
majority of flies dying within the pupal case as a result of significant 
degeneration of the eye. 100 % of flies surviving post-eclosion presented a  
“high” phenotype (Fig. 3.7.B). GMR-Gal4 expression of UAS-HRS in the 
absence of UAS-CHMP2BIntron5 induced a very mild rough eye phenotype. As 
with POSH and AliX depletion of HRS also potentiated toxicity, however not as 
significantly as overexpression of HRS. HRSD28 loss of function mutants 
potentiated CHMP2BIntron5 with 36.2 % of flies presenting with a high phenotype 
and the remainder a medium phenotype (Fig. 3.7.B). This is in contrast to GMR-
Gal4, UAS-CHMP2BIntron5/+ where 98.65 % of flies presented with a medium 
phenotype, the rest being high. HRSD28 mutants in a GMR-Gal4 background, in 
the absence of CHMP2BIntron5, showed no variance from wildtype (n = 100). 
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Figure 3.7. Overexpression of HRS Potently Enhances CHMP2BIntron5 Toxicity in the 
Drosophila eye 
(A) Both overexpression and inhibition of HRS in a GMR-Gal4, UAS-CHMP2BIntron5 background 
potentiated toxicity, displaying a greater degree of melanisation across the eye. 85 % (n = 
85/100) of GMR-Gal4, UAS-CHMP2BIntron5/UAS-HRS flies died at a pupal stage as a result of 
severe retinal degeneration, those 15 % surviving to adulthood all presented with a “high” 
degenerative eye phenotype.  Overexpression of UAS-HRS in the fly eye in the absence of 
CHMP2BIntron5 elicited a very mild rough eye phenotype in 100 % of flies, whilst the presence of 
HRSD28 in a GMR-Gal4/+ background showed no variation from the wildtype phenotype (n=100 
per genotype). (B) Quantification of the phenotype indicates a clear potentiation by both 
overexpression and inhibition of HRS, with the most severe enhancement associated with 
overexpression. White = low (+) phenotype (< 15 spots of melanisation), Grey = medium (++) 
phenotype (> 15 spots of melanisation but < 50 % of the eye affected), black = high (+++) 
phenotype (> 50 % of the eye affected by melanisation). 
 
 
Previous investigations have demonstrated that both POSH and HRS directly 
interact with and act as functional regulators of the transforming growth factor-
beta-activated kinase 1 (Tak1) (Miura and Mishina, 2011; Tsuda et al., 2005). 
As such, having demonstrated both POSH and HRS as two of the most potent 
enhancers of CHMP2BIntron5 toxicity it was asked whether TAK1 demonstrated a 
comparable enhancement. Here it is demonstrated that co-expression of 
wildtype TAK1 (UAS-TAK1) alongside UAS-CHMP2BIntron5 in the Drosophila eye 
(GMR-Gal4) induces a lethal phenotype, with Drosophila dying at an early pupal 
stage, displaying melanisation throughout the pupae (Fig. 3.8.C). 100 % of flies 
presented a lethal phenotype. It was, however, also shown that UAS-TAK1 
expression in the absence of CHMP2BIntron5, in a GMR-Gal4/+ background also 
elicited a pupal lethal phenotype in 100 % of cases (n=100) (Fig. 3.8.A). 
Lethality and the observation of melanisation throughout the pupae is indicative 
of an over activation of the innate immune system, associated with 
overexpression of TAK1 and TAK1’s known function as a positive regulator of 
innate immunity (Ajibade et al., 2013).  Similarly to HRS it was also shown that 
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depletion of TAK1 through expression of a TAK1-RNAi, a dominant negative 
TAK1 (UAS-dTAK1K46R) or using TAK1 loss of function mutants (TAK12 and 
TAK1179) also potentiated CHMP2BIntron5 toxicity, however not to the point of 
lethality (Fig. 3.8. A-B). No other TAK1 allele affected the eye in the absence of 
CHMP2BIntron5 (n=100 per genotype) (Fig. 3.8.A).  
 
Having demonstrated that depletion of the JNKKK TAK1, via expression of a 
dominant negative TAK1, TAK1-RNAi or using the TAK1179 mutant, potentiated 
CHMP2BIntron5 toxicity it was asked whether the same effect was seen using an 
alternative JNKKK, in this case wnd. Here it is demonstrated that similarly to 
TAK1 wnd mutants are capable of potentiating CHMP2BIntron5 toxicity (Fig. 3.8. 
A-B). As such this suggests that activation of JNK signalling may act to 
potentiate toxicity. 
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Figure 3.8. Perturbation of TAK1 Potently Enhances CHMP2BIntron5 Toxicity in the 
Drosophila eye 
(A) Perturbation to normal levels of TAK1 via overexpression (UAS-TAK1) or inhibition, using a 
TAK1 dominant negative, RNAi and loss of function mutants, in a GMR-Gal4, UAS-
CHMP2BIntron5 background acts to significantly enhance CHMP2BIntron5 toxicity. Wnd loss of 
function mutations also potentiate CHMP2BIntron5 toxicity, most significantly by Wnd3. UAS-TAK1 
in a GMR-Gal4 background, in the absence of CHMP2BIntron5 induced a lethal phenotype 
comparable to that seen in a CHMP2BIntron5 background in 100 % of flies. No other allele 
showed any variance from a wildtype eye phenotype in the absence of CHMP2BIntron5 (n = 100 
per genotype). (B) Overexpression of TAK1 in a GMR-Gal4, UAS-CHMP2BIntron5 or GMR-Gal4/+ 
background induced early pupal lethality characterised by melanisation throughout the pupae. 
This phenotype indicates a potent activation of innate immunity (C) Quantification reveals that 
with the exception of the TAK12 and Wnd3 alleles all the alleles screened induced a clear 
increase in penetrance of the high phenotype, indicating both the TAK1 and wnd JNKKK’s as 
potent enhancers of CHMP2BIntron5 toxicity. White = low (+) phenotype (< 15 spots of 
melanisation), Grey = medium (++) phenotype (> 15 spots of melanisation but < 50 % of the eye 
affected), black = high (+++) phenotype (> 50 % of the eye affected by melanisation). 
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3.2.5. Debra, a Mediator of Lysosomal Degradation and 
Regulator of Long Term Memory, is a Dominant Enhancer of 
CHMP2BIntron5 Toxicity   
 
 
During unbiased modifier screens of the CHMP2BIntron5 phenotype (see section 
3.2.2.) a small deficiency region Df(2L)ED2809 covering 5306 bp at cytological 
position 21B1 was identified as a highly potent enhancer of toxicity. It was 
subsequently demonstrated that this deficiency region only contained two gene 
loci, Galectin and Debra  (Determiner of breaking down of Ci activator). As such 
mutant alleles for both Galectin and Debra were screened against 
CHMP2BIntron5   revealing Debra to be a potent enhancer of CHMP2BIntron5 
toxicity. Debra has been identified as encoding a 1077 amino acid protein that 
localises to the MVB, where it has been implicated as a mediator of protein 
polyubiquitination and degradation by the lysosome (Dai et al., 2003; Kottler et 
al., 2011). Debra has also been identified as playing a functional role during 
Drosophila long-term memory implicating lysosomal protein degradation in 
processes underlying synaptic plasticity and long-term memory (Kottler et al., 
2011). Here it is demonstrated that heterozygous Debra mutants DebraEP9 and 
DebraEX04764 potentiate CHMP2BIntron5 toxicity, without having an affect on the 
eye phenotype on their own (n = 100 per genotype) (Fig. 3.9.A-B). 
Figure 3.9. Modifier Screens Identify Debra as a Potent Enhancer of CHMP2BIntron5 
Toxicity in the Drosophila eye 
(A) Debra loss of function mutants in a GMR-Gal4, UAS-CHMP2BIntron5 background potentiate 
toxicity. Neither allele perturbs the wildtype eye phenotype in the absence of CHMP2BIntron5, in a 
GMR-Gal4 background (n = 100 per genotype). (B) Quantification of the eye phenotypes 
reveals an increased penetrance of the high phenotype in Debra CHMP2BIntron5 double mutants. 
White = low (+) phenotype (< 15 spots of melanisation), Grey = medium (++) phenotype (> 15 
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spots of melanisation but < 50 % of the eye affected), black = high (+++) phenotype (> 50 % of 
the eye affected by melanisation). 
 
 
3.3. Discussion  
 
3.3.1. Rab8, a Novel Enhancer of Frontotemporal Dementia !!
Through unbiased modifier screens Rab8 was initially identified as a potential 
enhancer of Shrub-GFP toxicity. The results described here corroborate this 
initial hypothesis, revealing that heterozygous Rab8 mutants potently enhance 
toxicity associated with both Shrub-GFP and CHMP2BIntron5 toxicity. As such 
these results identify Rab8 as a novel target for the study of FTD, in particular 
associated with endosomal perturbation.  
 
Previous investigation has demonstrated that CHMP2BIntron5 toxicity is 
associated with a failure of CHMP2B to dissociate from the ESCRT-III complex, 
forming an abnormal, more avid association with Snf7-2/Shrub (Lee et al., 
2007). Furthermore Shrub-GFP has been demonstrated to act as a dominant 
negative, phenocopying CHMP2BIntron5 toxicity. These results corroborate this 
previous finding, demonstrating that both CHMP2BIntron5 and Shrub-GFP 
present with a similar phenotype, when expressed in the Drosophila eye, and 
that both are equally affected by perturbation to Rab8. The observation that 
Rab8 mutants potentiate both Shrub-GFP and CHMP2BIntron5 toxicity whilst 
overexpression of wildtype Rab8 may reduce toxicity suggests that Rab8 
functions in the same pathway as CHMP2B and Shrub.  
 
Rab8 has been implicated in the clathrin independent endosomal recycling 
pathway where it has been shown to be recruited to the tubular endosomal 
recycling compartment (ERC) (Hattula et al., 2006; Vaibhava et al., 2012). It has 
also been demonstrated that the ERC plays an important role in the recycling of 
receptors back to the plasma membrane (Vaibhava et al., 2012). Depletion of 
Rab8 has been shown to perturb normal trafficking events associated with 
membrane and receptor recycling through the recycling endosome (Hattula et 
al., 2006; Linder et al., 2007). As such one may postulate that perturbation to 
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Rab8 dependent endosomal recycling may perturb the normal dynamics of the 
entire endosomal trafficking pathway. For example lysosomal storage disorders, 
in which lysosome function is affected, result in “traffic jams”, burdening the 
endosomal pathway (Fraldi et al., 2010). Similar disruption as a result of 
perturbed recycling may explain why Rab8 potentiates toxicity associated with 
mutations in CHMP2B, which is essential for MVB formation at the late 
endosome  
 
Mutations in Rab8 may also directly affect MVB biogenesis, which is regulated 
by normal ESCRT function. For example previous studies have shown that 
depletion of Rab8 promotes cholesterol accumulation within late 
endosomes/lysosomes (Linder et al., 2007). Furthermore cholesterol has been 
demonstrated as critical for MVB formation and function (Kobuna et al., 2010). 
As such one may postulate that cholesterol accumulation within late endosomes 
may associate with a perturbation to normal MVB biogenesis at the late 
endosome. If correct and Rab8 plays an essential role in normal MVB formation 
this may also explain why Rab8 mutants potentiate both Shrub-GFP and 
CHMP2BIntron5 toxicity 
 
The observation that the Rab8 effector, OCRL1, also potentiates CHMP2BIntron5 
toxicity, in fact to a greater extent than Rab8 mutants, may provide an insight 
into the role of Rab8 as an enhancer of CHMP2B. OCRL1 has been shown to 
interact with numerous Rab proteins from different Rab families including Rab1, 
Rab5, Rab6 and Rab8 (Hou et al., 2011; Hyvola et al., 2006). However its 
greatest affinity is for Rab8 (Hou et al., 2011). It has also been demonstrated 
that the OCRL1 F668V mutation, which is implicated in Lowe Syndrome, affects 
a key residue essential for Rab8 binding, leading to a 5.8 fold reduction in Rab8 
binding affinity (Hou et al., 2011). The observation that this neurodegenerative 
disease causing mutation inhibits Rab8-OCRL1 interaction implicates this as a 
key complex in normal neuronal development and function. As such this 
substantiates a role for Rab8 in normal neuronal activity, supporting our 
observations that Rab8 mutants enhance toxicity associated with another 
neurodegenerative disease causing mutation, CHMP2BIntron5.  
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OCRL1 has also been implicated in Rab8 and Ses/IPIP27 dependent endocytic 
trafficking (Coon et al., 2012; Noakes et al., 2011). As such perturbation to 
either Rab8 or OCRL1 is likely to perturb this process and may explain the role 
of both as enhancers of CHMP2B. It is also interesting to note that Rab8, 
OCRL1 and Ses have all been shown to localise to the TGN (Choudhury et al., 
2005; Dressman et al., 2000; Huber et al., 1993; Noakes et al., 2011). Depletion 
of Rab8 inhibits normal TGN to plasma membrane trafficking whilst Ses and 
OCRL1 depletion have been shown to inhibit endosome to TGN trafficking 
(Choudhury et al., 2005; Huber et al., 1995b; Noakes et al., 2011). As such it 
may be important to determine whether a perturbation to this trafficking pathway 
is specifically involved in potentiation of CHMP2BIntron5 toxicity. 
 
It is important to note that the two OCRL1 mutations used in this study, 
OCRL1D40 and OCRL1C53, are yet to be fully characterised. Both mutations were 
generated by P-element mobilisation of the P{EPgy2} P-element within the 5’ 
UTR region of the Drosophila OCRL1 gene. Both mutations induced deletions 
covering the start codon of OCRL1, thus producing null-alleles. Whilst the C52 
mutation has been mapped and shown to affect the first 6 exons of the OCRL1 
gene resulting in a complete null, as shown by western blotting (personal 
communication Avital Rodal, Brandeis University, Massachusetts, USA) the 
D40 mutation has not been fully characterised. Work in the Sweeney Lab has 
shown the D40 deletion to remove the start codon for the upstream eukaryotic 
initiation factor 2B-epsilon (eIF-2Bε) gene, which may explain it’s more potent 
enhancement of CHMP2BIntron5 toxicity than the C52 mutation, which does not. 
Further investigation must look to further characterise these OCRL1 mutants as 
well as determine whether any other known OCRL1 mutations, such as the 
F668V mutation involved in Rab8 binding, potentiate CHMP2BIntron5 toxicity.  
 
Taken together these results demonstrate that mutations in Rab8, which has 
been implicated in neuronal development, and mutations in OCRL1, a Rab8 
effector that has been implicated in the neurodevelopmental disorder Lowe 
Syndrome, both potentiate CHMP2BIntron5 toxicity. As such this strongly 
implicates Rab8 and OCRL1, and their associated trafficking pathways, as 
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novel targets for the study of neuronal development and neurodegenerative 
diseases including both Lowe Syndrome and FTD. 
 
 
3.3.2. Modifier Screens Identify Endosomal POSH and HRS 
Regulation of TAK1 as a Potential Novel Pathway Involved in 
CHMP2BIntron5 Toxicity 
 
 
AliX has been shown to associate with the ESCRT machinery via direct 
interaction with both ESCRT-III component Shrub and ESCRT-I component 
TSG101 (Fisher et al., 2007; Kim et al., 2005b; Strack et al., 2003). Furthermore 
AliX has been implicated in MVB biogenesis through its interaction with LBPA, 
which plays a fundamental role in the formation of the intraluminal vesicles 
characteristic to MVB’s (Chevallier et al., 2008; Matsuo et al., 2004). As such 
the observation that disruption to AliX, through both overexpression and 
depletion, potentiated CHMP2BIntron5 toxicity was unsurprising due to its likely 
effect in perturbing normal MVB biogenesis. However the observation that 
overexpression of AliX induces a more potent enhancement of CHMP2BIntron5 
toxicity than depletion via RNAi or a loss of function mutation suggests that 
toxicity is associated with driving MVB formation. This supports the hypothesis 
that the CHMP2BIntron5 mutation promotes maintenance of CHMP2B in a 
permanently active state as a result of the C-terminal truncation preventing both 
CHMP2B autoinhibition and Vps4 mediated dissociation of the ESCRT-III 
complex. In this state ESCRT components are likely to become sequestered in 
complex, being unable to be recycled. Further support for the hypothesis that 
CHMP2BIntron5 toxicity is associated with driving MVB formation comes from the 
observation that overexpression of HRS, which promotes MVB formation, elicits 
the most potent enhancement of CHMP2BIntron5 toxicity, leading to a semi-lethal 
phenotype. 
 
Further to the observation that AliX potentiates CHMP2BIntron5 toxicity these 
results also reveal a role for the AliX-ALG2-POSH complex, and it’s interacting 
factors associated with innate immunity and JNK signalling, in CHMP2B mutant 
toxicity. Previous investigation in the Sweeney and Gao labs have 
demonstrated that CHMP2B may act as a mediator of innate immune 
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responses through regulation of Toll signalling (Ahmad et al., 2009). In this work 
it was demonstrated that Toll signalling, an activator of innate immune 
responses, was misregulated as a result of CHMP2BIntron5 toxicity, with 
CHMP2BIntron5 mutants displaying increased Toll activation (Ahmad et al., 
2009). Furthermore Serpin5, a major regulator of Toll signalling, was identified 
as a modifier of the CHMP2BIntron5 phenotype (Ahmad et al., 2009). Results 
presented here provide support for the role of innate immunity in CHMP2BIntron5 
toxicity. For example in addition to the role of HRS in MVB formation it has also 
been identified as a positive regulator of TAK1, a key regulator of innate 
immunity, interacting directly with TAK1 and localising it to the early endosome 
in order to promote its activation (Miura and Mishina, 2011). As such the 
observation that overexpression of HRS induces potent enhancement of 
CHMP2BIntron5, eliciting a semi-lethal phenotype, may associate with an 
activation of TAK1 and a potentiation of the innate immune response observed 
in CHMP2BIntron5 mutants. As such as well as promoting MVB formation HRS 
overexpression is likely to promote an increase in innate immune responses 
through induction of pathways downstream of TAK1, including the nuclear factor 
kappa-B (NFκB) and JNK signalling pathways (Tsuda et al., 2005). However 
whilst overexpression of HRS induced potent enhancement of toxicity, leading 
to lethality, the opposite cannot be said for depletion of HRS and TAK1. The 
results presented here demonstrate that inhibition of HRS and TAK1, with the 
exception of the TAK12 mutant, elicit a potentiation of CHMP2BIntron5 toxicity, 
albeit not to the severity of overexpression. These findings suggest that TAK1 
and HRS may be under tight regulation in order to maintain specific 
physiological levels, with perturbation either way affecting normal function. Such 
strict regulation may, in part, be controlled by POSH. Previous investigations 
have shown that POSH acts as a regulator of TAK1 mediated signalling, 
through its activity as an E3 ubiquitin ligase, targeting both HRS and TAK1 for 
proteasomal degradation (Kim et al., 2006; Tsuda et al., 2005). POSH also 
undergoes auto-inhibition, maintaining tight regulation upon its own activity 
(Tsuda et al., 2005). It must also be noted that whilst POSH inhibits the JNKKK 
TAK1, and therefore inhibits JNK signalling it has also been shown to act as a 
JNK scaffold and therefore promote JNK signalling (Xu et al., 2003). As such 
POSH has been shown to facilitate both rapid activation and inactivation of JNK 
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and NFKB signalling pathways and thus acts as a central component in 
maintaining this tightly regulated process (Tsuda et al., 2005; Tsuda et al., 
2006; Xu et al., 2003). As such this may provide an explanation to why, similarly 
to HRS and TAK1, both overexpression and inhibition of POSH resulted in 
potentiation to CHMP2BIntron5 toxicity. What is apparent is that the POSH null, 
POSH74, exhibits the most potent dominant enhancement of toxicity of all the 
POSH alleles, indicating an important role for POSH in the CHMP2BIntron5 
induced phenotype. 
 
Having demonstrated that altered expression of the JNKKK TAK1 potently 
affects CHMP2BIntron5 toxicity it was asked whether an alternative JNKKK wnd, 
which has been implicated in the regulation of synaptic growth, would act in the 
same manner (Collins et al., 2006). The results show that similarly to TAK1 
mutants wnd loss of function mutants display a variable effect upon 
CHMP2BIntron5 toxicity with wnd1 showing little variance from CHMP2BIntron5/+ 
whilst the wnd3 mutation significantly enhances toxicity. This enhancement 
corroborates the suggestion that potentiation of toxicity may be associated with 
perturbation to normal JNK signalling. However due to the striking variance 
between the two alleles it is possible that one allele possesses a second site 
mutation affecting CHMP2BIntron5 toxicity. In order to elucidate whether wnd truly 
acts as a modifier of CHMP2B additional alleles need to be screened against 
CHMP2B.       
 
Taken together the results presented here provide further support for the roll of 
innate immunity in CHMP2BIntron5 toxicity, potentially acting via endosomal 
localisation of TAK1 and POSH and their regulation of innate immune 
responses via the JNK signalling pathway. These results identify a series of 
interconnected novel factors associated with CHMP2BIntron5 toxicity that may 
provide the framework for further investigation into the molecular mechanisms 
associated with CHMP2B toxicity in FTD and other models of 
neurodegeneration. 
 
It is also interesting to note that Rab8, AliX, POSH and the ESCRT machinery 
have all been shown to be manipulated by viruses in order to promote viral 
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budding and infection (Ariumi et al., 2011; Rowe et al., 2008; Shtanko et al., 
2011; Votteler et al., 2009). As such it is possible to see how under normal 
physiological conditions each component may contribute to an innate immune 
response, potentially acting through TAK1, in response to a viral infection. As 
such this may provide some explanation as to why each potentiates 
CHMP2BIntron5 toxicity, which has previously been demonstrated to present an 
activated innate immune response.  
 
 
3.3.3. Debra Implicates Perturbation to Normal Endosomal-
Lysosomal Trafficking in CHMP2B Associated FTD 
 
 
During unbiased modifier screens of the CHMP2BIntron5 phenotype Debra was 
identified as a potent enhancer of toxicity. Currently Debra remains relatively 
poorly understood, with no known mammalian orthologue. However work in 
Drosophila has identified that Debra localises to MVB’s where it has a functional 
role in the regulation of lysosomal degradation (Dai et al., 2003; Khokhar et al., 
2008; Kottler et al., 2011). For example it was demonstrated that Debra is 
involved in the targeting of the transcription factor Cubitus interruptus (Ci), a 
mediator of hedgehog signalling, to the lysosome for degradation (Dai et al., 
2003). Furthermore it has been proposed that Debra’s role in the regulation of 
protein degradation, via the lysosome, plays a fundamental role in the 
modulation of synaptic plasticity associated with long-term memory (Kottler et 
al., 2011). Support for this role in synaptic development can also be shown by 
the observation that Debra has been identified as interacting with IGF-II mRNA 
binding protein (Imp) and small nuclear ribonucleoprotein D3 polypeptide 18 
kDa (SmD3), both of which have been implicated in synaptic growth and 
development of the nervous system (Boylan et al., 2008; Guruharsha et al., 
2011; Schenkel et al., 2002). Interestingly Debra has previously been identified 
as a potent enhancer of both Ataxin-3 neurodegeneration associated with 
Spinocerebellar ataxia type-3 (SCA3) and parkin loss of function associated 
with Parkinson’s disease (Bilen and Bonini, 2007; Fernandes and Rao, 2011). 
As such the results presented here provide further information to a growing 
body of evidence that suggests that Debra plays a fundamental role in normal 
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neuronal function, potentially acting at the MVB to regulate lysosomal 
degradation. In addition the observation that mutations in Debra, which has 
been implicated in MVB function and endosomal-lysosomal trafficking, 
potentiates CHMP2BIntron5 toxicity provides support to previous findings 
identifying HRS, which is also essential to MVB function, as a modifier of 
CHMP2B. As such this further implicates perturbation to endosomal-lysosomal 
trafficking pathways in CHMP2BIntron5 toxicity. Furthermore these results identify 
Debra as a novel enhancer of neurodegenerative disease, acting to enhance 
Drosophila models of Parkinson’s disease, SCA3 and now FTD. As such this 
provides support for a role of protein degradation via the lysosome in synaptic 
plasticity and associated neurodegeneration as a result of endosomal-
lysosomal defects.  
 
Taken together this chapter provides a framework, identifying novel factors 
implicated in the enhancement of CHMP2BIntron5 toxicity. From this individual 
modifiers can be investigated further in order to identify their role in neuronal 
development and synaptic plasticity with the goal of elucidating pathways 
associated with normal synaptic development and those that may be perturbed 
during FTD. In the long term this may provide novel pathways in which to 
identify potential therapeutic targets for the treatment of FTD and other 
neurodegenerative diseases. 
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4. Characterisation of Rab8 Mutants Identifies 
Rab8 as a Potent Regulator of Synaptic Growth 
 
4.1. Introduction  !!
As discussed in Chapter 1 Rab8 is one of more than 60 identified Rab proteins 
belonging to the Rab subfamily of Ras GTPases (Diekmann et al., 2011; 
Schwartz et al., 2007). As a GTPase Rab8 acts as a molecular switch, cycling 
between active GTP-bound and inactive GDP-bound states. Through this 
conformational cycling, the specific localisation of different Rab’s and the 
effector proteins they activate and/or recruit, Rab proteins act as multifaceted 
organisers (Ng and Tang, 2008; Stenmark, 2009). As such they convey strict 
regulation to both rate and specificity for almost all trafficking events occurring 
in eukaryotic cells (Ng and Tang, 2008; Stenmark, 2009). 
 
Rab8 has been implicated in membrane trafficking events fundamental to 
polarised cell development and the regulation of cell shape. For example during 
membrane recycling, exocytosis and ciliogenesis (Follit et al., 2010; Nachury et 
al., 2007a; Peranen, 2011). Furthermore Rab8 has been implicated in essential 
trafficking events involved in normal neuronal development and maintenance. 
For example it has been shown to be important for neurite outgrowth as well as 
for the regulation of glutamatergic neurotransmitter receptor abundance at the 
cell surface (Brown et al., 2007a; Gerges et al., 2004a; Huber et al., 1995a). 
Rab8 has also been shown to be enriched within the nervous system, with the 
mammalian Rab8B isoform showing enrichment within the brain (Chan et al., 
2011; Lau and Mruk, 2003). 
 
Having identified Rab8 mutants as a potent enhancer of toxicity associated with 
the FTD mutation CHMP2BIntron5, the focus of this chapter is the characterization 
of Rab8 mutants and their effects upon the nervous system. Previously, little 
characterisation of Rab8 mutants in any model organism has been performed. 
Characterisation that has been carried out often focused upon the role of Rab8 
in ciliogenesis as opposed to neurodegeneration. In fact the study of Rab8 
4. Characterisation of Rab8 Mutants Identifies Rab8 as a Potent Regulator of Synaptic Growth 
!
   107!
function has often been hampered in higher organisms due both to genetic 
redundancy and the fact that Rab8 mutant mice die, within 3-4 weeks of birth, 
as a result of perturbations to normal ciliogenesis within the intestine (Sato et 
al., 2007a).  
 
Here we identify and characterise Rab8 mutations. The mutations we identify 
are shown to affect regions essential to protein function that are highly 
conserved across species, and across the Rab family of GTPase’s. In addition 
mutations are demonstrated to cause significant perturbations to normal 
neuronal morphology, as observed using the Drosophila larval NMJ as a model 
system. These mutants are shown to display a general unregulated growth 
phenotype characterised by significant synaptic overgrowth, in terms of synaptic 
bouton number and NMJ length, with a reduction in synaptic bouton size. 
Furthermore Rab8 mutants are shown to display major ultrastructural 
aberrations, despite showing limited perturbation at a histological level. 
 !
4.2. Results  !
4.2.1. Genetic Characterisation of Rab8 Mutants; Identified 
Mutations in Rab8 Affect Highly Conserved Amino Acid 
Residues. !!
Having demonstrated, in the previous chapter, that an allelic series of proposed 
Rab8 mutants act to significantly enhance toxicity of the FTD causing mutation 
CHMP2Bintron5 here we look to characterise the nature of these mutations. As 
mentioned in Chapter 1 classical forward genetic approaches often utilize 
random mutagenesis screens in which the Drosophila genome is subjected to 
mutagenesis, typically by ionizing radiation or chemicals such as EMS (St 
Johnston, 2002). The subsequent mutants can then be screened for a 
phenotype of interest. This approach produces a large number of mutants (~10-
4), many of which will not be involved in the investigators area of interest. As 
such unwanted mutants are often, subsequently, roughly mapped to 
complementation groups and donated to Drosophila stock centres. In such a 
way stock centres build up large collections of roughly mapped, but otherwise 
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uncharacterised, mutants. Rab8 mutants Rab81, Rab82, Rab83 and Rab8Z3007 
are 4 such, EMS induced, uncharacterised mutations. Here complementation 
analysis was performed by crossing each of the proposed Rab8 mutant 
genotypes to each other, as well as to the deficiency loci to which they have 
been mapped (Df(3L)ED228), and to Pbac{5HPw+}Rab8B229 (Rab8B229), a 
known Rab8 mutant caused by a transposable element piggyBac insertion into 
the Rab8 loci. Complementation analysis reveals that each mutation fails to 
complement each other, as well as the deficiency, (Table 4.1.) and results in a 
distinctive pharate lethal phenotype (Fig. 4.1.). This confirms that each mutation 
independently affects, and therefore maps to, the same gene. Failure to 
complement Rab8B229 strongly suggests this gene to be Rab8. Furthermore 
lethality indicates the gene affected to be essential for normal development and 
survival. The distinctive late pharate lethal phenotype identified is one that has 
proven to be commonly associated with Drosophila models of 
neurodegenerative diseases, including Huntington’s and Alzheimer’s diseases 
(Colodner and Feany, 2010; Torroja et al., 1999; Weiss et al., 2012). In some 
instances a very small number of flies were capable of completing eclosion and 
escaping from their pupal case. However these flies showed a number of 
distinct physiological deficits including an inability to expand their wings, post-
eclosion, coupled with almost complete immobility, remaining motionless upon 
the substrate and dying within 24 hours of eclosion. These flies were recorded 
as semi-lethal (Table 4.1). Lowering the temperature at which flies were raised 
(18°C instead of 25°C) showed a marginal increase in those flies classified as 
semi-lethal rather than pharate-lethal, although they still presented almost 
complete inactivity and died within 24 h of eclosion. Complementation analysis 
also reveals a reduced number, less than the ~ 33 % predicted by Mendelian 
laws of inheritance, of Rab8 transheterozygous flies surviving to the pharate 
stage. Whilst there was no clearly distinct earlier stage at which larvae were 
dying these results suggest transheterozygous Rab8 mutations convey a 
detrimental effect to survival, with those surviving past larval and pupal stages 
dying at the pharate stage. 
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Figure 4.1. Rab8 Mutants Display Pharate Lethality 
Complementation analysis reveals that transheterozygous Rab8 mutants display distinctive late 
pharate lethality, characterised by an inability of adult flies to complete eclosion, becoming 
trapped and ultimately dying semi-emerged from the pupal case. !!
With complementation analysis substantiating that all proposed Rab8 alleles 
independently affect the same gene and that it is most likely Rab8, each of the 
4 randomly induced Rab8 mutant genotypes were sequenced in order to identify 
the nature of the mutations. Sequencing revealed each mutation to be caused 
by single, independent point mutations present within the Rab8 gene locus (Fig. 
4.2.). Three of these point mutations were C-to-T substitutions, typical of EMS 
induced mutagenesis which induces C/G-to-T/A transitions in 69.9-100 % of 
cases (Bentley et al., 2000; Blumenstiel et al., 2009; Cooper et al., 2008; 
Winkler et al., 2005). The other mutant, Rab8Z3007, displays a T-to-A 
substitution. Such changes have been shown to be induced by EMS in 
Drosophila at a lower frequency (~ 15 %) (Cooper et al., 2008; Winkler et al., 
2005). 
 
 
 
 
Table 4.1. Rab8 Mutant Alleles Fail to Complement Each Other 
  Rab8
1 
 Rab82  Rab83  Rab8 
Z3007 
 Rab8B229  Df(3L) 
ED228 
Rab81  -  Semi-
Lethal 
 Semi-
Lethal 
 Pharate 
Lethal 
 Pharate 
Lethal 
 Pharate 
Lethal 
Rab82  -  -  Pharate 
Lethal 
 Pharate 
Lethal 
 Semi-
Lethal 
 Pharate 
Lethal 
Rab83  -  -  -  Pharate 
Lethal 
 Pharate 
Lethal 
 Pharate 
Lethal 
Rab8Z3007  -  -  -  -  Pharate 
Lethal 
 Pharate 
Lethal 
Rab8B229  -  -  -  -  -  Pharate 
Lethal 
Df(3L) 
ED228 
 -  -  -  -  -  - 
Rab81/Rab82 Rab81/Rab8B229 
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Further analysis of these mutations demonstrates that each of the 4 point 
mutations result in an alteration to the Drosophila Rab8 amino acid sequence; 
Rab81: S17F, Rab83: T40I, Rab8Z3007: M85K and Rab82: S95F. Functional 
analysis of the effect of these mutations upon protein stability and function, 
using in silico analysis, suggest all 4 mutations to be “probably damaging” and 
having a deleterious effect upon protein function (PolyPhen-2, PROVEAN). 
However only the Rab8Z3007 mutation is predicted to cause a significant 
destabilisation to protein stability (ProSMS). 
 
Further analysis reveals that these mutations affect residues that are both 
highly conserved across species (Fig. 4.3.) but also across the Rab sub-family 
of GTPases (Fig. 4.4.). Rab8 is highly conserved across species, with the only 
region of significant variation being the hyper variable C-terminal domain (Fig. 
4.3.). It is also apparent that both the Rab81 and Rab83 mutations induce amino 
acid substitutions within 2 of the 5 highly conserved polypeptide loops, or G-
domains G1-G5, that are essential to GTPase function (Okai et al., 2004). The 
Rab81 mutation falls within the G1 domain, a conserved motif comprising of the 
sequence GXXXXGKS/T (Bourne et al., 1991). Rab83 results in a substitution of 
the conserved threonine residue, within the G2 motif, that is responsible for 
Mg2+ binding (Bourne et al., 1991). In contrast the Rab82 and Rab8Z3007 
mutations fall in regions that, whilst conserved, are not obvious functional 
domains. As such it can be inferred that Rab81 and Rab83 mutations are most 
likely to be detrimental to Rab8 function through disruption of Rab8’s normal 
GTPase activity, via direct perturbation of the GTPase domain. In contrast 
Rab8Z3007 is suggested to destabilize the Rab8 protein, affecting normal 
function, whist the deleterious effect of the Rab83 mutations appears less 
definitive.  !!!!!!!!
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Figure 4.2. Identification of Point Mutations in the Rab8 Locus. 
Complementation mapping identified four specific ethyl methanesulfonate (EMS) induced 
mutations likely to be present within the Rab8 gene locus. (A) DNA sequence analysis revealed 
each Rab8 mutant genotype to be associated with single independent point mutations within the 
Rab8 locus. (B) Mapping of these mutations identified their positions within the Rab8 locus and 
revealed each mutation induced a specific alteration to the Rab8 amino acid sequence, 
highlighted in blue. The wildtype amino acid sequence is shown (bottom) for comparison. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Wildtype!
Rab81! Rab83!
Wildtype! Wildtype!
Rab8Z3007!
Wildtype!
Rab82!
A 
B 
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Figure 4.3. Identified Mutations in Rab8 Affect Residues Conserved Across Species. 
Sequence alignment of Rab8 from different species. Location of Rab8 mutants are shown. Rab8 
is highly conserved across all species with the only region of variability being that of the 
hypervariable C-terminal domain. Yellow indicates regions of 100 % conservation, blue 80 % 
conservation. Accession numbers: C. elegans; BAD07034.1, C. lupus; CAB56776.1, D. rerio; 
AAI34060.1, D. melanogaster; BAD07038.1, H. sapiens; AAM21091.1, M. musculus; 
NP_075615.2, R. Norvegicus; AEJ31940.1 and X. laevis; NP_001087273.1. 
 
 
 
 
 
Rab81! Rab8
3!
Rab8Z3007! Rab82!
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                                      !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
 
 
 
 
 
 
 
Figure 4.4. Mutations in Rab8 Affect Functional Regions Highly Conserved Across The 
Rab Subfamily of GTPases 
Sequence alignment of Drosophila Rab family members, showing the location of the identified 
mutations in Rab8. Underlined regions indicate the location of the 5 G-domains G1-5 in 
sequential order. Yellow indicates regions of 100 % conservation, blue 80 % conservation. 
Rab83007! Rab82!
Rab81!
Rab83!
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Accession numbers: Rab1; AAF55873.1, Rab2; BAA21706.1, Rab3; AAF58762.1, Rab4; 
AAF57831.1, Rab5; AAN85553.1, Rab6; AAF53168.1, Rab7; AAF56218.1, Rab8; BAD07038.1, 
Rab9; AAF53798.1, Rab10; AAF50924.1 and Rab11; BAA21708.1. 
 !
4.2.2. Rab8 is Neuronally Enriched and Expressed in 
Drosophila Motor Neurons !!
Having identified the nature of the mutations present within an allelic series of 
Rab8 mutants this investigation looked to further characterise Rab8 by 
analysing the expression pattern of the Rab8 gene. Using data obtained from 
the BDGP RNA In situ hybridization database it is clear that Rab8 is 
ubiquitously expressed, in Drosophila embryos, with regions of enrichment 
within the CNS (Fig. 4.5.A). CNS enrichment is substantiated by data obtained 
from the FlyAtlas gene expression database (www.flyatlas.org) which reveals 
Rab8 to be enriched within the larval CNS and adult brain (Chintapalli et al., 
2007; Robinson et al., 2013).  
 
In order to further characterize Rab8’s expression within the Drosophila third 
instar larval CNS nuclear (eif4-GFP, Fig. 4.5.B-C) and cell membrane (mcd8-
GFP, Fig. 4.5.D) UAS-GFP markers were expressed under the control of the 
Rab8 specific driver Rab8-Gal4 (Chan et al., 2011). Here it is demonstrated that 
Rab8 is expressed in both neurons (Fig. 4.5.C) and glia (Fig. 4.5.B). However 
there appears to be a far greater number of elav positive cells co-localising with 
Rab8 expressing cells than repo positive cells that do. This suggests that whilst 
expressed in both neuronal and glial cell types Rab8 is predominantly 
expressed in neurons. In order to determine whether Rab8 was expressed in 
the motor neurons responsible for the innervation of the dorsal muscle field 
even-skipped (eve) was used as a motor neuronal marker. Eve is expressed in 
pCC (posterior corner cell), fpCC (friend of pCC), aCC (anterior corner cell), 
RP2 and U/CQ neurons which, with the exception of pCC and fpCC 
interneurons, are all motor neurons (Bossing et al., 1996; Broadus et al., 1995; 
Landgraf et al., 2003a). All eve positive cells within the Drosophila third instar 
larval ventral nerve cord co-localised with cells positive for mcd8-GFP under the 
control of the Rab8 driver (Fig. 4.5.D). Therefore Rab8 must be expressed in 
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Drosophila larval motor neurons and so the NMJ can be utilised to study the 
role of Rab8 in neurons. 
 
In order to further characterise the localisation and distribution of Rab8 both a 
Rab8-eGFP and an anti-Rab8 antibody were also generated (see sections 
2.4.1. and 2.5.). Unfortunately neither was sufficient to elucidate a sub-cellular 
localisation of Rab8 with both demonstrating a diffuse and ubiquitous 
distribution pattern. 
 !
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 !
 
Figure 4.5. Rab8 is Neuronally Enriched Displaying Expression Predominantly in 
Neurons, Although Also in Glia. 
(A) Rab8 RNA in situ hybridization in a stage 13-16 Drosophila embryo (viewed from lateral 
(left) and dorsal (right) orientations) reveals Rab8 expression to be ubiquitous, although 
enriched within the central nervous system, as seen in the embryonic brain (asterisks) and 
ventral nerve cord (arrow heads) (Image courtesy of and adapted from The Berkeley Drosophila 
Genome Project, (BDGP, 2013; Tomancak et al., 2002; Tomancak et al., 2007). (B) Rab8 is 
strongly expressed in some, but not all glial cells within the Drosophila third instar larval ventral 
nerve cord. Expression of the nuclear maker eif4-GFP under the control of the Rab8 specific 
driver Rab8-GAL4 partially co-localises with the glial marker anti-repo. (C) Rab8 shows pan-
neuronal expression with Rab8-GAL4-eif4-GFP co-localising with the pan-neuronal marker anti-
elav. (D) Rab8 is expressed in motor neurons. The aCC/pCC motor- and inter-neuron marker 
Rab8-GAL4! Repo! Composite!
Rab8-GAL4! Elav! Composite!
Rab8-GAL4! Even Skipped! Composite!
B!
C!
D!
A!
*! *!
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anti-even skipped localises to cells expressing the membrane marker mcd8-GFP under the 
control of Rab8-GAL4, indicating Rab8 expression in both interneurons and motor neurons.  
Scale Bars = 10 μm. !
 
4.2.3. Rab8 Mutants Display Perturbed Synaptic Growth !!
4.2.3.1. Rab8 Mutants Display a Significant Increase in Synaptic 
Bouton Number !!
Having identified that transheterozygous Rab8 mutants display pharate lethality, 
characteristic of neurodegenerative disease models in Drosophila, and having 
shown Rab8 to be expressed and enriched within the nervous system, this 
investigation looked to determine whether Rab8 mutants showed any 
perturbation to normal neuronal morphology and function. Using the 3rd instar 
larval muscle 6/7, hemi-segment A3, NMJ as a model synapse here it was 
demonstrated that all 15 Rab8 transheterozygous mutant genotypes display a 
significant increase in synaptic bouton number, compared to wildtype, indicative 
of synaptic overgrowth (Fig. 4.6.A-B). Heterozygous Rab8 mutants showed no 
overgrowth phenotype. Synaptic bouton number was normalized against the 
wildtype control to account for variations in larval size and muscle surface area 
(MSA). It is well established that during synaptic growth and development the 
number of synaptic boutons increases proportionally to the muscle size 
(Lnenicka and Keshishian, 2000; Schuster et al., 1996). Here it was 
demonstrated that the majority of Rab8 transheterozygous mutants showed no 
significant difference in MSA, compared to wildtype (Fig. 4.6C). Subsequently 
all mutants show a significant increase in bouton number both post-
normalisation (Fig. 4.6.B) and prior to normalization (post-hoc Dunnett’s 
comparison to wildtype p < 0.001 for all genotypes prior to normalization). 
Therefore all Rab8 transheterozygous mutants display a synaptic overgrowth 
phenotype, characterised by a significant increase in synaptic bouton number. 
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Figure 4.6. Rab8 Mutants Display a Significant Increase in Synaptic Bouton Number 
(A-B) All transheterozygous combinations of Rab8 mutants display a significant (ANOVA: F(d.f. 
15) = 10.14; p < 0.001 with post hoc Dunnett’s comparison to wildtype control, *** p < 0.001 vs 
WT) increase in synaptic bouton number at muscle 6/7, hemi-segment A3 of 3rd Instar larvae. 
Bouton number ranges from a 70.58 % to a 166.76 % increase in number compared to wildtype. 
Synaptic bouton numbers were normalised against wildtype to account for variations in muscle 
surface area (MSA). Scale bar = 10 μm. (C) Rab8 transheterozygous mutants show significant 
variance in MSA between genotypes (ANOVA: F(d.f. 15) = 7.27; p < 0.001) with only 1/3 of 
genotypes showing significant variance from wildtype (post-hoc Dunnetts’s comparison to 
wildtype control * p < 0.05, ** p < 0.01, *** p < 0.001).   
 
 
 
4.2.3.2. Increased Bouton Number in Rab8 Mutants Can be 
Rescued By Pre-Synaptic Expression of Rab8 
 
Having established that Rab8 mutants present a synaptic overgrowth 
phenotype, characterised by an increase in synaptic bouton number at muscle 
6/7, analysis looked to determine whether this phenotype was conserved at 
alternative NMJ’s and whether overexpression of wildtype Rab8, in specific 
tissues, could rescue the overgrowth phenotype observed. In order to perform 
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rescue experiments transgenic UAS-Rab8 Drosophila lines were first generated 
through microinjection of a pUASt construct, into which Drosophila Rab8 had 
been cloned, into w1118 Drosophila embryos (as described in section 2.5.). The 
pUASt plasmid construct contains UAS sequences upstream of the multiple 
cloning site, allowing for controlled expression of Rab8 using the UAS/GAL4 
system once integrated into the genome. Having isolated transformants, 
determined the chromosome onto which the transgene had inserted and 
stabilized individual stocks UAS-Rab8 could be expressed globally/ubiquitously 
(actin-Gal4), pan-neuronally (nSyb-Gal4) or post-synaptically in muscles (MHC-
Gal4).  
 
The Rab81/Rab8B229  transheterozygous mutant genotype was selected as a 
genotype representative of all Rab8 transheterozygous mutants. Analysis 
reveals that Rab81/Rab8B229 mutants show an overgrowth phenotype, displaying 
a significant increase in synaptic bouton number, at muscle 4 (hemi-segment 
A3) comparable to that seen at muscle 6/7 (Fig. 4.7.A-C). Thus synaptic 
overgrowth appears to be conserved across NMJ‘s of differing size and 
morphology. It was also demonstrated that expression of UAS-Rab8 under the 
control of the global driver actin-Gal4 was sufficient to rescue increased 
synaptic bouton number in Rab81/Rab8B229 mutants at both muscle 4 and 6/7 
(Fig. 4.7.A-C). Global rescues showed no significant difference from wildtype 
(Dunnett's post-hoc comparison to wildtype control; N/S) or actin-Gal4/UAS-
Rab8 controls (Student t-test post-hoc comparison between groups; N/S) yet a 
significant difference from Rab8 mutants (Student t-test post-hoc comparison 
between groups; p < 0.001).  
 
Having confirmed overgrowth in Rab8 mutants could be rescued by expression 
of wildtype Rab8, and having previously shown Rab8 to be enriched within the 
CNS, rescue experiments were performed in order to elucidate whether a pre- 
and/or post-synaptic complement of Rab8 would be sufficient to rescue the 
increase in synaptic bouton number seen in Rab8 mutants. Pan-neuronal, pre-
synaptic, expression of UAS-Rab8 was sufficient to completely rescue the 
increase in synaptic bouton number seen in Rab8 mutants (Fig. 4.7.A-C); no 
significant difference in synaptic bouton number was seen between wildtype,  
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nsyb-Gal4/UAS-Rab8 control and nsyb-Gal4/UAS-Rab8;Rab81/Rab8B229 mutant 
flies, at either muscle 6/7 or 4. However a significant difference was seen 
between the Rab8 mutants and the neuronal rescues (Student t-test post-hoc 
comparison between groups; p < 0.001). 
 
In contrast, muscle expression of UAS-Rab8 was only sufficient to partially 
rescue the increase in synaptic bouton number seen in Rab81/Rab8B229 
mutants. At muscle 6/7 muscle rescues show a significant difference to Rab8 
mutants (Post-hoc students t-test; p < 0.001) with no significant variance from 
wildtype (Fig. 4.7.A-B). However in comparison to MHC-Gal4/UAS-Rab8 
controls muscle rescues show a significant difference (Post-hoc students t-test; 
p < 0.001) indicating an inability to completely rescue to control levels. 
Corroborating these findings analysis of muscle 4 NMJ’s reveals that whilst 
muscle rescues show a significant difference from Rab8 mutants (Post-hoc 
students t-test; p < 0.01) they show an equally significant variance from both 
wildtype (Post-hoc Dunnett's; p < 0.001) and MHC-Gal4/UAS-Rab8 controls 
(Post-hoc students t-test; p < 0.001) (Fig. 4.7.A&C). 
 
Taken together these results demonstrate that expression of Rab8 globally or 
pre-synaptically can completely rescue increased synaptic bouton number 
induced by the Rab81/Rab8B229 transheterozygous mutation, however post-
synaptic expression can only induce a partial rescue. !
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Figure 4.7. Pre-synaptic, Neuronal Expression of Rab8 is Sufficient to Completely 
Rescue Increased Synaptic Bouton Number In Rab8 Mutants. 
 
(A) Confocal images show Rab8 mutants display an overgrown NMJ phenotype that is 
conserved at both muscle 6/7 and 4, hemi-segment A3 of 3rd instar larvae. Overgrowth can be 
rescued by global (actin-Gal4) and pre-synaptic pan-neuronal (nSyb-Gal4) expression of 
wildtype Rab8. Post-synaptic (MHC-Gal4) expression of Rab8 only induces a partial rescue. 
Scale bars = 10 μm. (B-C) Quantification of normalized synaptic bouton number at muscle 6/7 
(B) (ANOVA: F(d.f. 7) = 36.8975; p < 0.001 with post-hoc Dunnett’s comparison to control (WT) 
*** p < 0.001 and post-hoc student t-test comparison between groups, ### p < 0.001) and 
muscle 4 (C) NMJ’s. (ANOVA: F(d.f. 7) = 19.95; p < 0.001 with post-hoc Dunnett’s comparison 
to control (WT) *** p < 0.001 and post-hoc student t-test comparison between groups, ### p < 
0.001, ## p < 0.01). 
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4.2.3.3. Rab8 Mutants Display Further Perturbation to Synaptic 
Growth, Including Increased NMJ length and Reduced Bouton 
Size !
 
A significant increase in synaptic bouton number has been demonstrated in 
numerous Drosophila mutants including spin, hiw, Rab11, endophilin, dap160 
and nervous wreck (nwk) (Khodosh et al., 2006; O'Connor-Giles et al., 2008; 
Sweeney and Davis, 2002; Wan et al., 2000). However whilst these mutants all 
show a synaptic overgrowth phenotype in terms of synaptic bouton number they 
show significantly different NMJ morphologies. For example the endocytic 
mutants Rab11, endophilin and dap160 are primarily characterised by a 
dramatic increase in satellite boutons, which contribute to the increase in 
synaptic bouton number seen (Dickman et al., 2006; Khodosh et al., 2006). 
Satellite boutons are classified as small supernumerary boutons that bud from a 
central parent bouton on the primary axon terminal (Dickman et al., 2006; Sarthi 
and Elefant, 2011). In contrast hiw mutants show a generalised overgrowth 
phenotype characterised by a significant increase in synaptic bouton number, 
overall NMJ length and number of branches, as well as a dramatic reduction in 
the size of synaptic boutons (Collins et al., 2006; Wan et al., 2000). Spin 
mutants display a similar, although not as dramatic overgrowth phenotype to 
hiw (Sweeney and Davis, 2002). 
 
In order to comprehensively characterise the overgrowth phenotype seen in 
Rab8 mutants NMJ morphology was further analysed based upon a range of 
attributes including NMJ length, branch number, number of satellite boutons, 
bouton size and cumulative bouton size. This analysis was all performed at 
muscle 4 (Hemi-segment A3), due its smaller and thus more amenable size.  
 
Quantification of NMJ length reveals Rab8 mutants (Rab81/Rab8B229) to show a 
significant increase in NMJ length compared to wildtype (Dunnett's post-hoc 
comparison to wildtype p < 0.001) (Fig. 4.8.A). This increase in NMJ length (~ 
173 % of wildtype) appears to be comparable to the increase in bouton number 
(~ 194 % of wildtype). As with synaptic bouton number the increase in NMJ 
length seen in Rab8 mutants appears to be completely rescued by the global 
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expression of Rab8, with global rescues showing no significant variance from 
wildtype or actin-gal4/UAS-Rab8 controls, whilst showing a significant 
difference to Rab8 mutants (Post-hoc students t-test; p < 0.01) (Fig. 4.8.A). 
Similarly pre-synaptic pan-neuronal expression of Rab8 is again sufficient to 
completely rescue the increase in NMJ length overgrowth phenotype (Fig. 
4.8.A). No significant variance in NMJ length is seen between neuronal rescues 
and wildtypes or nSyb-Gal4/UAS-Rab8 controls whilst rescues show a 
significant difference from the Rab8 mutants (Post-hoc students t-test; p < 
0.05). Substantiating the results for bouton number rescues expression of UAS-
Rab8 under the control of the MHC muscle driver in a Rab8 mutant background 
is only sufficient to partially rescue increased NMJ length (Fig. 4.8.A). Muscle 
rescues show a small but significant variance from both wildtypes (Dunnett's 
post-hoc comparison to wildtype p < 0.05) and from the MHC-Gal4/UAS-Rab8 
controls (Post-hoc students t-test; p < 0.05) and no significant difference from 
Rab8 mutants. Despite showing no significant variance from Rab8 mutants the 
rescues show a less significant variance from wildtype than Rab8 mutants do, 
again indicating a partial rescue. 
 
Whilst Rab8 mutants display a significant increase in both NMJ length and 
synaptic bouton number they show no significant variance in branch number 
(Fig. 4.8.B), with no significant difference seen between any genotype and the 
wildtype control (Dunnett’s post-hoc comparison to wildtype control). 
 
In contrast to branch number, Rab8 mutants display a significant increase in the 
number of satellite boutons (~ 329 % of wildtype) observed compared to 
wildtype  (Dunnett's post-hoc comparison to wildtype p < 0.01) (Fig. 4.8.C). 
Again global rescues show no significant variance from wildtype or actin-
Gal4/UAS-Rab8 controls, yet a significant difference from Rab8 mutants (post-
hoc student t-test p < 0.05). Thus global expression of Rab8 appears to rescue 
the increase in satellite bouton number seen in Rab8 mutants. Similarly post-
synaptic neuronal rescues show no significant variance from wildtypes or nSyb-
Gal4/UAS-Rab8 controls, indicating neuronal expression of Rab8 rescues the 
increase in satellite bouton number seen in Rab8 mutants (Fig. 4.8.C). 
However, whilst not significantly variant from controls neuronal rescues also 
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show no significant variance from Rab8 mutants suggesting the rescue may 
only be partial. MHC-Gal4 driven muscle rescues on the other hand show no 
ability to rescue increased satellite bouton number, showing a satellite bouton 
number comparable to Rab8 mutants and significantly different from wildtypes 
(Dunnett's post-hoc comparison to wildtype p < 0.01) (Fig. 4.8.C). 
 
This data so far implicates Rab8 as a regulator of NMJ growth and development 
with Rab8 mutants displaying a significant increase in synaptic bouton number, 
satellite bouton number and NMJ length. Here it is further demonstrated that 
Rab8 has a functional role in the regulation of normal NMJ growth with Rab8 
mutants displaying synaptic bouton sizes significantly reduced from wildtype 
(Dunnett's post-hoc comparison to wildtype p < 0.01) (Fig. 4.8.D). It was also 
demonstrated that pan-neuronal expression of UAS-Rab8 induces an opposing 
effect, displaying significantly enlarged synaptic bouton sizes when compared to 
wildtype (Dunnett's post-hoc comparison to wildtype p < 0.001) (Fig. 4.8.D). In 
contrast global and muscle expression of UAS-Rab8 in a wildtype background 
show no significant difference in bouton size, compared to wildtype. Both global 
and pan-neuronal expression of Rab8 in a Rab8 mutant background are 
sufficient to rescue reduced synaptic bouton size displaying no significant size 
difference when compared to wildtype and a significant difference to Rab8 
mutants (post-hoc student t-test p < 0.001) (Fig. 4.8.D). Global expression of 
Rab8 in a Rab8 mutant background also shows no significant bouton size 
difference from the actin-gal4/UAS-Rab8 global controls. In contrast neuronal 
rescues show a significant difference to the nSyb-gal4/UAS-Rab8 controls 
(post-hoc student t-test p < 0.001). As neuronal rescues show no variance from 
wildtype we can infer that this significant size difference observed is due to the 
enlarged bouton size seen in the neuronal controls. 
 
Following the trend observed in other aspects of NMJ morphology it is 
demonstrated that whilst muscle expression of Rab8 in a wildtype background 
has no effect on bouton size, showing no variance from wildtype (Dunnett's 
post-hoc comparison to wildtype control), muscle expression of Rab8 in a Rab8 
mutant background does not rescue reduced bouton size, showing a significant 
variance from wildtype (Dunnett's post-hoc comparison to wildtype p < 0.001) 
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and MHC-gal4/UAS-Rab8 controls (post-hoc student t-test p < 0.001) (Fig. 
4.8.D). Interestingly muscle expression of Rab8 in a Rab8 mutant background 
actually shows a potentiation of the reduced bouton size, showing a significantly 
smaller bouton size than the Rab8 mutants (post-hoc student t-test p < 0.001) 
(Fig. 4.8.D).  
 
With Rab8 mutants displaying a significant increase in synaptic bouton number 
but a reduction in synaptic bouton size the question was asked as to whether 
they display a cumulative bouton size comparable to wildtypes. Here it is 
demonstrated that whilst boutons are significantly smaller the greater increase 
in bouton number means that Rab8 mutants display a cumulative bouton size 
significantly larger than wildtypes (Dunnett's post-hoc comparison to wildtype p 
< 0.001) (Fig. 4.8.E). Again it is observed that both global and pan-neuronal 
expression of Rab8 in a Rab8 mutant background is sufficient to rescue the 
significantly increased cumulative bouton size seen in Rab8 mutants, with 
rescues showing no significant difference to wildtypes or controls yet a 
significant difference to Rab8 mutants (post-hoc student t-test p < 0.001 for 
both) (Fig. 4.8.E). Muscle expression of Rab8 in a Rab8 mutant background 
again appears to show only a partial rescue displaying a significant difference 
from Rab8 mutants (post-hoc student t-test p < 0.001) and no significant 
difference from wildtypes, although a small variance from the MHC-gal4/UAS-
Rab8 control (post-hoc student t-test p < 0.05) (Fig. 4.8.E). 
 
Taken together the results for characterisation of Rab8 mutant NMJ morphology 
and rescue experiments suggests that Rab8 mutants display a significant 
perturbation to normal NMJ growth and development, displaying a significant 
increase in bouton number, NMJ length, satellite bouton number and cumulative 
bouton size. They also display a reduction in bouton size, although no apparent 
variation in branching. Rescues also suggest that expression of Rab8 globally 
and pre-synaptically is sufficient to rescue the morphological perturbations seen 
in Rab8 mutants. In contrast muscle rescues were only capable of inducing, at 
best, a partial rescue. 
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Figure 4.8. Rab8 Mutants Display a Comprehensive Unregulated NMJ Growth Phenotype 
Quantification of NMJ morphology at muscle 4, hemi-segment A3, of 3rd instar larvae.  (A) Rab8 
mutants (Rab81/Rab8B229) show a significantly increased mean normalized NMJ length (μm) 
that can be completely rescued by global (actin-gal4) and pre-synaptic pan-neuronal (nSyb-
Gal4) expression of Rab8. Muscle expression (MHC-Gal4) of Rab8 induces a partial rescue.  
(ANOVA: F(d.f. 7) = 5.2069; p < 0.001 with post-hoc Dunnett’s comparison to control (WT) *** p 
< 0.001, * p < 0.05  and post-hoc student t-test comparison between groups, ## p < 0.01, # p < 
0.05. (B) Rab8 mutants show no significant variation in mean normalized branch number 
compared to wildtype controls (ANOVA: F(d.f. 7) = 2.2562; p < 0.05 with post-hoc Dunnett’s 
comparison to control (WT), n/s between any genotype and WT. (C) Rab8 mutants show a 
significant increase in the number of mean normalized satellite boutons compared to wildtypes. 
This increase can be rescued by global and pre-synaptic expression of Rab8, but not by post-
synaptic Rab8 expression (ANOVA: F(d.f. 7) = 2.6923; p < 0.05 with post-hoc Dunnett’s 
comparison to control (WT), ** p < 0.01 and post-hoc student t-test comparison between 
groups, # p < 0.05. (D) Rab8 mutants show significantly reduced mean normalized synaptic 
bouton size, compared to wildtypes. This overgrowth can be rescued by global and pre-synaptic 
expression of Rab8 but not by post-synaptic expression of Rab8, which actually potentiates 
reduced bouton size. Neuronal Expression of Rab8 induces a significant increase in synaptic 
bouton size, compared to wildtype. (ANOVA: F(d.f. 7) = 48.1829; p < 0.001 with post-hoc 
Dunnett’s comparison to control (WT) *** p < 0.001, ** p < 0.01  and post-hoc student t-test 
comparison between groups, ### p < 0.001. (E) Despite showing reduced bouton size the mean 
normalised cumulative bouton size in Rab8 mutants is significantly increased compared to 
wildtypes, a phenotype that can be completely rescued by global and neuronal expression of 
Rab8 and partially rescued by post-synaptic expression of Rab8 (ANOVA: F(d.f. 7) = 5.9508; p 
< 0.001 with post-hoc Dunnett’s comparison to control (WT) *** p < 0.001  and post-hoc student 
t-test comparison between groups, ### p < 0.001, # p < 0.05. 
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Drosophila larval muscles are innervated by differential populations of synaptic 
boutons of variable size, for example type-Is and type-Ib (Gramates and Budnik, 
1999). As such, having observed a reduction in mean normalised bouton size in 
Rab8 mutants it proves useful to analyse the distribution of bouton sizes. Here it 
is demonstrated that not all Rab8 mutant boutons are smaller, rather reduced 
mean bouton size is associated with an increase in the population of small, 2 to 
3 μm diameter, boutons (Fig. 4.9.). These bouton sizes correspond 
approximately with those of type-Is boutons, however the estimated size of 
type-Is boutons varies between studies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9. Rab8 Mutants Display an Increased Percentage of Smaller Boutons 
Frequency distribution of bouton sizes demonstrates that Rab8 mutants show an increased 
percentage of boutons of 2-3 μm diameter whilst wildtypes show more larger diameter boutons. 
 
 
4.2.4. Rab8 Mutants Display Limited Disruption to Pre- and 
Post-Synaptic Markers at a Histological Level !!
Rab8 has, previously, been implicated in the regulated cycling and trafficking of 
AMPA receptors during both constitutive receptor recycling and during long-
term potentiation events (Brown et al., 2007b; Gerges et al., 2004b). 
Furthermore expression of Rab8 has been shown to increase mGluRIA cell 
surface expression, through antagonisation of receptor endocytosis, and 
attenuate intracellular calcium release, through inhibition of mGluRIA induced 
ionositol phosphate formation (Esseltine et al., 2012). Five ionotropic glutamate 
receptor subunits are expressed at the Drosophila NMJ, GluRIIA, GluRIIB, 
GluRIIC (also known as GluRIII), GluRIID and GlurIIE (Featherstone et al., 
0!
5!
10!
15!
20!
25!
30!
35!
40!
1! 2! 3! 4! 5! 6! 7! 8! 9! 10!
%
 B
ou
to
ns
!
Bouton&Diameter&(μm)&
Wildtype!
Rab81/Rab8B229!
4. Characterisation of Rab8 Mutants Identifies Rab8 as a Potent Regulator of Synaptic Growth 
!
   127!
2005). Each receptor forms a tetrameric complex composed of core subunits 
GluRC-E and either GluRIIA or GluRIIB (Featherstone et al., 2005). In order to 
determine whether Rab8 is involved in GluR trafficking and localisation at the 
Drosophila NMJ the localisation and distribution of these receptors was 
observed in Rab8 mutants and compared to wildtypes. Here it is demonstrated 
that there is no obvious perturbation to GluRIIA or GluRIIB (Fig.4.10.) 
localisation and distribution at the NMJ in Rab8 mutants. There was also no 
disruption seen to GluRIIC. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10. Glutamate Receptors at the Drosophila NMJ Show no Perturbation to 
Localisation and Distribution in Rab8 Mutants.  
Glutamate receptor distribution at the 3rd instar larval m6/7, hemi-segment A3, NMJ. HRP was 
used to stain the NMJ (green in composite). Scale Bar = 2 μm. 
 
 
With no apparent perturbation to normal GluR localisation at the NMJ analysis 
turned to the pre-synaptic nerve terminal. Glutamate receptors cluster at the 
post-synaptic density directly apposing glutamatergic active zones, the sites of 
neurotransmitter release (Kim et al., 2012).  Analysis of the presynaptic active 
zone marker nc82, which identifies the active zone protein bruchpilot, again 
showed no obvious disruption to normal bruchpilot distribution (Fig.4.11.). 
Similarly other presynaptic markers including the microtubule associated protein 
Futsch/22c10, a marker of presynaptic microtubule bundle integrity, and HRP 
showed no discernable perturbation in Rab8 mutants. Neither did the pre- and 
post-synaptic cell adhesion molecule Fasciclin-II (Fas-II), which is essential for 
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postembryonic development of the NMJ (Kohsaka et al., 2007; Sanchez-
Soriano and Prokop, 2005). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11. Rab8 Mutants Display no Notable Disruption to Active Zone Localisation and 
Distribution. 
Rab8 mutant larvae show no clear disruption to normal distribution and localisation of the active 
zone marker nc82, which labels bruchpilot, at the muscle 6/7 hemi-segment A3 NMJ of 3rd instar 
larvae. Scale Bar = 2 μm. 
 
 
 
Structural alterations at the NMJ are an essential part of the dynamic processes 
associated with synaptic growth and remodelling, with synaptic boutons 
continuously added and eliminated at the NMJ (Chung and Barres, 2009; 
Fuentes-Medel et al., 2009). This allows for modulation of connectivity between 
the pre-synaptic nerve terminal and the post-synaptic muscle and is often 
regulated by neural activity (Chung and Barres, 2009; Fuentes-Medel et al., 
2009). Interestingly it has been shown that addition of new synapses, at the 
NMJ, is a relatively wasteful process, associated with a production of significant 
amounts of pre-synaptic debris and the detachment of undifferentiated boutons 
known as “ghost boutons” (Fuentes-Medel et al., 2009). Production and 
clearance of debris and ghost boutons has been shown as fundamental to 
regulating normal NMJ expansion (Fuentes-Medel et al., 2009). Ghost boutons 
appear to be undifferentiated boutons that have failed to mature, containing 
some components of a mature bouton but remaining devoid of both pre- and 
post-synaptic compartments (Ataman et al., 2006a; Packard et al., 2002). They 
fail to recruit post-synaptic proteins or associate with the post-synaptic density 
Wildtype! Rab81/Rab8B229!
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and, as such, are readily identifiable as synaptotagmin positive boutons lacking 
post-synaptic Dlg immunoreactivity (Ataman et al., 2006a; Packard et al., 2002). 
Dlg, a PDZ domain containing scaffolding protein and orthologue of mammalian 
PSD-95, has been implicated as a regulator of normal synaptic assembly and 
function through regulation of PSD assembly (Ataman et al., 2006b; Zhang et 
al., 2007). In order to determine whether increased synaptic expansion in Rab8 
mutants is associated with a perturbation to the normal clearance of 
undifferentiated ghost boutons the number of ghosts was compared between 
mutants and wildtypes. No variance was observed (Table. 4.2.). Identification of 
ghost-boutons also allows for simultaneous observation of synaptic retractions. 
As mentioned Dlg is a scaffolding protein within the PSD and has been 
implicated in the clustering and stabilization of GluRIIB, as well as regulating the 
expansion and development of the SSR. SSR development and clustering of 
proteins, including Dlg, within the PSD has been shown to require neuronal 
innervation of the muscle (Featherstone et al., 2002). As such it has been 
established that the presence of assembled highly organized Dlg at the PSD 
unapposed by a pre-synaptic terminal identifies a location where a pre-synaptic 
terminal formed and since retracted, this is termed a “footprint” (Eaton et al., 
2002). Again it is demonstrated that Rab8 mutants show no significant variation 
in the number of synaptic retractions observed when compared to wildtypes 
(Table. 4.2.). 
 
 
Table 4.2. Rab8 Mutants Shown no Variance in the Number of Ghost-boutons or Synaptic 
Retractions Observed, Compared to Wildtype 
 
Genotype  NMJ’s Showing Ghost Boutons  
NMJ’s Showing Synaptic 
Retraction 
Wildtype  0/100  1/100 (1%) 
Rab81/Rab8B229  0/103  1/103 (0.97%) 
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4.2.5. Rab8 Mutants Display Ultrastructural Aberrations !
 
Having observed little disruption to either pre- or post-synaptic markers, at a 
histological level, the ultrastructure of Rab8 mutants was examined. TEM 
analysis of individual synaptic boutons revealed that Rab8 mutants displayed a 
significantly increased abundance of large clear vesicles (ANOVA: F(d.f. 1) = 
4.9635; p < 0.05) (Fig. 4.12.A-B), a number of which contain further 
intralumenal vesicular structures, that can often be observed budding from the 
primary vesicle membrane (Fig. 4.12.D). Whilst visible in wildtype sections 
these large clear vesicles were significantly more abundant in mutant sections. 
Furthermore quantitative analysis reveals that these vesicles are, on average, 
significantly larger in Rab8 mutants than wildtypes (ANOVA: F(d.f. 1) = 55.1122; 
p < 0.001) (Fig. 4.12.C).  
 
At an ultrastructural level Drosophila active zones are characterised by the 
presence of electron dense membrane as well as electron dense specialisations 
known as T-bar ribbons or T-bars (Clarke et al., 2012; Zhai and Bellen, 2004). 
T-bars are so called due to their characteristic appearance in TEM sections, 
comprised of a pedestal with a large overhanging top giving rise to their T 
appearance. During analysis of TEM sections it was noted that numerous Rab8 
mutant sections showed the presence of T-bars containing 2 distinct pedestals, 
a phenotype that was never observed in wildtype sections (Fig. 4.12.E).!
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Figure 4.12. Rab8 Mutants Show Large Clear Vesicles Within Synaptic Boutons 
 (A) Rab8 mutant synaptic boutons at muscle 6/7, hemi-segment A3, of 3rd instar larvae show 
ultrastructural aberrations characterised by (B) a significant increase in large clear vesicles 
(ANOVA: F(d.f. 1) = 4.9635; p < 0.05) that display (C) a significant increase in mean diameter 
(ANOVA: F(d.f. 1) = 55.1122; p < 0.001). (D) Large clear vesicles often display smaller 
intralumenal vesicles seen budding from the primary diameter membrane. (E) Rab8 mutants 
also display the presence of T-bar ribbons displaying double pedestal. Scale bar = 500 nm. 
 
 
 
Further to ultrastructural perturbations seen within Rab8 mutant boutons 
abnormalities were also observed within the CNS, within cell bodies in the VNC. 
Here a number of large, multi-lamellar, membranous, electron-dense structures 
were observed. These structures were often seen budding from the cell plasma 
membrane (Fig. 4.13. arrow head) and frequently contained smaller 
membranous structures and vesicles (Fig. 4.13. arrows). Such structures were 
rarely seen within wildtypes, and when they were they were typically smaller 
and less complex. Similar multi-lamellar structures were also observed within 
the muscles of Rab8 mutants (Fig. 4.14.A-C). Furthermore large clear vesicle 
structures often containing small intraluminal vesicles similar, but much larger, 
to those observed within the Rab8 mutant boutons were also observed in 
mutant muscles (Fig. 4.14.D-E). 
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Figure 4.13. Rab8 Mutants Display Large, Multi-lamellar, Membranous Structures Within 
Cell Bodies in the Ventral Nerve Cord 
TEM analysis of cell bodies within the ventral nerve cord (VNC) of 3rd instar wandering larvae 
revealed that Rab8 mutants display a large number of multi-lamellar structures, that can be 
seen budding from the cell membrane. Scale Bar = 200 nm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.14. Rab8 Mutants Display Large, Multi-lamellar, Membranous Structures and 
Large Vesicular Structures Within Abdominal Muscles 
(A-C) Rab8 mutants display large multi-lamellar structures and (D-E) clear vesicle structures 
within the muscles of 3rd instar wandering larvae. Scale Bars: A-C = 500 nm, D-E = 200 nm. 
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Additionally examination of Rab8 mutant muscle ultrastructure also revealed a 
distinctive mitochondrial phenotype, characterised by mitochondria that appear 
stretched and interconnected by long projections. These mitochondria appear to 
have undergone division yet have failed to segregate through normal 
mitochondrial scission. Such mitochondria were observed, to different degrees 
of severity, within all Rab8 mutants analysed, however were never seen in 
wildtypes. Mitochondria morphology appeared to only be perturbed within 
mutant muscles. 
 
Figure. 4.15. Rab8 Mutants Show Abnormal Mitochondrial Morphology Within Larval 
Muscles. 
Drosophila 3rd instar wandering larvae show mitochondrial aberrations in Rab8 mutants. Muscle 
sections shown are from muscle 6/7, hemi-segment A3. Scale Bar = 200nm 
 
 
 
 
4.2.6. Rab8 Mutants Display Perturbations to Normal 
Endosomal-Lysosomal and Autophagic Markers 
 
 
Having observed enlarged endosome-like vesicles and multi-lamellar structures, 
at an ultrastructural level, in Rab8 mutants’ investigation moved to determine 
whether mutants display a perturbation to normal endosomal-lysosomal and 
autophagic markers.  
 
Previous investigation has identified a role for Rab8 in endocytic recycling, 
where it has been shown to localise to recycling endosomes (Hattula et al., 
2006; Roland et al., 2007). It has also been demonstrated that recycling can 
Wildtype! Rab81/Rab8B229!
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occur via different pathways. For example fast recycling occurs in a Rab4 and 
Rab35 dependent manner, trafficking components from the early endosome to 
the plasma membrane (Kouranti et al., 2006; Macia et al., 2012). In contrast 
slow recycling involves trafficking of cargo from the early endosome to an 
endosomal recycling compartment (ERC) (Grant and Donaldson, 2009). It has 
been proposed that this ERC forms during maturation of the early endosome 
with the main body of the early endosome becoming a MVB with tubular 
structures separating off to become the tubular ERC (Grant and Donaldson, 
2009; Horgan et al., 2010). The ERC and the slow recycling pathway can be 
identified by the presence of Rab11 (Horgan et al., 2010). Here it is 
demonstrated that markers of both fast (Fig. 4.16.A-B) and slow (Fig. 4.17.A-C) 
recycling appear decreased in both the VNC and NMJ’s of Rab8 mutants. 
Rab4, and therefore fast recycling, appears to be more significantly depleted 
than Rab11 (slow recycling). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.16. Rab8 Mutants Display a Reduction in the Fast Endocytic Recycling Marker 
Rab4 
Confocal immunofluorescence images of Rab4-RFP, expressed under the control of the pan-
neuronal driver nSyb-Gal4, in (A) the ventral nerve cord and (B) NMJ of wildtype and Rab8 
mutant (Rab81/Rab8B229) 3rd instar larvae. HRP is used as a marker of the NMJ. NMJ’s are 
muscle 4,hemi-segment A3. Scale bars = 10 μm. 
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Figure 4.17. Rab8 Mutants Display a Reduction in the Slow Endocytic Recycling Marker 
Rab11 
Confocal immunofluorescence images of Rab11-eGFP, expressed under the control of the pan-
neuronal driver nSyb-Gal4, in (A) the ventral nerve cord, (B) motor neuronal cell bodies and (C) 
NMJ’s of wildtype and Rab8 mutant (Rab81/Rab8B229) 3rd instar larvae. Eve is used as a marker 
of motor neurons, HRP is used as a marker of the NMJ. NMJ’s are muscle 6/7, hemi-segment 
A3. Scale bars; (A) = 10 μm, (B-C) = 2 μm.  
 
In contrast to recycling endosome markers (Rab4-RFP and Rab11-eGFP) a 
marker of the late endosome (Spin-RFP) showed no variance between wildtype 
and Rab8 mutants in either the VNC or NMJ. However a small reduction in the 
early endosome marker anti-Rab5 was observed at the NMJ (Fig. 4.18.).  
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Figure 4.18. Rab8 Mutants Display a Reduction in the Early Endosomal Marker Rab5 at 
the Larval NMJ 
Confocal immunofluorescence images of anti-Rab5 at third instar larval, muscle 4, hemi-
segment A3, NMJ’s. NMJ is labelled with HRP. Scale bar = 10 μm. 
 
 
Perhaps the most significant perturbation was observed in the late 
endosome/lysosome marker LAMP-GFP, which displayed aggregations 
throughout the VNC, predominantly in the neuropil region, and in axon bundles 
projecting from the VNC in Rab8 mutants (Fig. 4.19.A). In addition to 
perturbations to endosomal and lysosomal-markers there was also 
demonstrated to be a significant diminution in the autophagosome marker Atg8-
RFP, observed in the VNC of Rab8 mutants, when compared to wildtypes (Fig. 
4.19.B). 
 
 
 
 
 
 
 
 
 
Figure 4.19. Rab8 Mutants Display Abnormal Accumulations of the Late 
Endosome/Lysosome Marker LAMP and a Decrease in the Autophagosome Marker Atg8  
Confocal immunofluorescence images of (A) the late endosomal/lysosomal marker LAMP-GFP, 
expressed under the control of the pan-neuronal marker nSyb-Gal4, focusing on accumulations 
within the neuropil. Scale Bar = 2μm. (B) The autophagosome marker Atg8/LC3-RFP, under the 
control of nSyb-Gal4, in the ventral nerve cord of 3rd instar larvae. Scale bar = 10 μm. 
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Taken together the results presented here demonstrate that Rab8 mutants 
display a clear perturbation to normal endosomal-lysosomal and autophagic 
trafficking pathways. In comparison to wildtypes, mutants show an apparent 
diminution of recycling endosome (Rab4 and Rab11), early endosome (Rab5) 
and autophagosome (Atg8/LC3) markers. In addition they display an 
accumulation of late endosome/lysosome (LAMP) aggregations.  
 
 
4.2.7. Rab8 Mutants Display Perturbed Synaptic Transmission 
That Does Not Affect Physiological Crawling Behaviour   
 
4.2.7.1. Unregulated NMJ Growth Does Not Affect Larval 
Crawling  
 
 
Drosophila larval locomotion is a relatively complex and highly regulated 
behavioural process characterised by distinct subsets of behaviour, including 
linear crawling and burrowing (Heckscher et al., 2012). The former typically 
occurs when larvae are exploring their environment in search of nutrition or 
during an escape response, with larvae observed to crawl faster when starved 
(Koon et al., 2011; Steinert et al., 2006). Larval crawling occurs through 
bilaterally synchronized peristaltic waves of muscle contraction propagating 
longitudinally through abdominal segments along the larval body, in the 
direction of movement (Hughes and Thomas, 2007). For example from posterior 
to anterior when crawling forward. This process is highly coordinated through 
controlled communication and functional activity of both central and peripheral 
synapses, as well as functional muscle activity (Hughes and Thomas, 2007). It 
has, however, been shown that coordinated propagation can occur in the 
absence of sensory feedback and descending input from the brain due to 
regulation by autonomous neuronal circuitry associated with a central pattern 
generator (CPG) (Gjorgjieva et al., 2013). Larval crawling provides a robust 
measure of physiological output relating to NMJ activity, with crawling activity 
demonstrated to act as a modulator of NMJ growth (Tsai et al., 2012). Here it is 
demonstrated that the unregulated growth observed in all Rab8 
transheterozygous mutants does not correlate with perturbations to larval 
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crawling velocity, with only one transheterozygous Rab8 mutant genotype 
displaying a significant reduction in larval crawling speed (Fig. 4.20.). 
 
 
  !
 
 
 
 
 
 
 
 
 
Figure 4.20. Rab8 Mutants do Not Show a Conserved Perturbation to Locomotor Activity 
Rab8 mutant third instar larvae show limited perturbation to normal NMJ physiological output 
with only one transheterozygous genotype (Rab81/Rab83) displaying a significant reduction in 
larval crawling speed (ANOVA: F(d.f. 4) = 8.2890; p < 0.001 with post-hoc Dunnett’s 
comparison to control (WT); *** p < 0.001). 
 
 
4.2.7.2. Rab8 Mutants Show Aberrations to Normal Synaptic 
Transmission 
 
 
Larval crawling provides a relatively simple and robust readout of physiological 
function. It is, however, a highly complex process regulated by intricate 
interconnected neural pathways and, as such, must be used in conjunction with 
other approaches in order to fully elucidate the effect of mutations upon normal 
neural function. Here electrophysiological recordings were used in order to 
determine the effect of mutant Rab8 upon normal synaptic transmission. These 
recordings were conducted by Bruno Marie (University of Puerto Rico, Puerto 
Rico). Here it is shown that Rab8 mutants (Rab81/Rab8B229) display a significant 
reduction in the amplitude of mini excitatory post-synaptic potential’s (mEPSP’s) 
(student t-test p < 0.001) (Fig. 4.21.). A mEPSP correlates to the spontaneous 
fusion of a single synaptic vesicle with the pre-synaptic membrane, releasing 
neurotransmitter into the synapse, in the absence of presynaptic stimulation 
(Schwarz, 2006). This data also reveals that Rab8 mutants display a 
significantly increased evoked EPSP amplitude (student t-test p < 0.05) coupled 
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with a significant increase in quantal content (student t-test p < 0.001). Quantal 
content can be defined as the number of effective synaptic vesicles released in 
response to presynaptic stimulation and can be quantified by measuring the 
EPSP and dividing it by the mEPSP (Schwarz, 2006). Taken together these 
data suggest that mutations in Rab8 induce an aberration to normal synaptic 
transmission, associated with synaptic overgrowth, however normal 
physiological function, in terms of larval crawling, remains unaffected. 
 
Figure 4.21. Rab8 Mutants Display Aberrations to Normal Synaptic Transmission 
Rab8 mutants (Rab81/Rab8B229) display a significant reduction in normal mini excitatory post-
synaptic potential (mEPSP) amplitude coupled with an increase in both EPSP amplitude and 
quantal content. The frequency of mEPSP’s showed no variance from wildtypes (w-). n = 20 per 
genotype. Statistical analysis = student t-test, *** p < 0.001, * p < 0.05. Electrophysiology and 
production of this figure was by Bruno Marie (University of Puerto Rico, Puerto Rico). 
 
 
4.3. Discussion !
4.3.1. Mutations in Rab8 Affect Conserved Functional Domains 
and Are Detrimental to Survival 
 
Currently there are very few Rab8 mutants, within any in vivo system, in which 
to study Rab8 function. Furthermore, to a certain degree the study of Rab8 
function in many higher organisms is hindered both by genetic redundancy and 
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the known role of Rab8 in ciliogenesis. For example it has been demonstrated 
that both Rab8 mutant and knock-out mice present with shortening of microvilli 
within the intestines leading to a marked reduction in nutrient absorption, 
diarrhoea and, ultimately, premature death 3 to 5 weeks after birth (Sato et al., 
2007a). In contrast Drosophila do not possess intestinal cilia with cilia restricted 
to just two specific cell types; spermatozoa and sensory neurons (Ma and 
Jarman, 2011). As such Rab8 mutants in Drosophila may provide an insightful 
model in which to study the role of Rab8 outside of ciliogenesis and within other 
polarized cell types, such as neurons.  This research presents, to our 
knowledge, the first known characterisation of Rab8 mutants in Drosophila. 
 
Complementation analysis reveals that all 4 randomly induced point mutations 
fail to complement one another as well as the Rab8B229 piggyBac insertion, 
indicating each of these mutations affects Rab8 gene function in their own right. 
Furthermore complementation reveals a distinct pharate lethal phenotype 
indicating that Rab8 is essential for normal viability. Whilst Rab8 mutant mice 
die prematurely due to perturbations in nutrient uptake it can be hypothesised 
that this is not the cause of lethality in Drosophila. Late pharate lethality 
indicates that mutants are capable of progressing through the larval stages, at 
which point normal nutrient uptake is essential. Furthermore as mentioned 
previously Drosophila do not possess primary cilia within the intestine, 
eliminating perturbed ciliogenesis of intestinal villi as a cause of lethality. 
Instead lethality suggests a further essential role of Rab8 in viability, potentially 
within the development of other polarized cell types such as neurons. Such a 
hypothesis is supported by observation of the pharate lethal phenotype, which 
has been commonly associated with Drosophila models of neuronal and/or 
muscle dysfunction (Colodner and Feany, 2010; Torroja et al., 1999; Weiss et 
al., 2012). This is corroborated by identification of neuronal perturbations in 
Rab8 mutants, which shall be discussed in detail in the following section 
(4.3.2.). 
 
Sequence analysis of Rab8 mutants corroborates complementation analysis, 
demonstrating that each mutation independently affects the Rab8 gene locus. 
Furthermore they provide significant insight into the effect of each mutation 
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upon Rab8 function. For example both Rab81 and Rab83 display an alteration to 
amino-acid residues located within the G-domains, essential for normal GTPase 
activity. Interestingly whilst these results reveal the Rab81 mutation falls within 
the G1 motif the specific residue it affects is not conserved in the Rab family (Li 
and Liang, 2001; Urano et al., 2000). It has, however, been demonstrated that 
within other Ras-superfamily members including Ras, Rho and Ran this residue 
is a highly conserved and functionally important glycine (Li and Liang, 2001; 
Urano et al., 2000). The lack of conservation of this residue in Rab proteins has 
long been noted as surprising due to its importance in other Ras proteins (Li 
and Liang, 2001). It has, however, been noted that the same mutation as seen 
in Rab81, S17F, in Rab5 results in a significant loss of function, indicating that 
whilst not conserved in Rabs this residue is of functional significance (Li and 
Liang, 2001). In contrast to Rab81 the results show that the Rab83 mutation 
affects a highly conserved threonine residue, within the G2 motif, that has a 
proven essential role in Mg2+ binding and GTPase activity (Bourne et al., 1991). 
All Rab proteins require Mg2+ as a cofactor for GTPase activity (Zhang et al., 
2000). For example it has been demonstrated that Mg2+ depletion abolishes 
GTP binding by Rab3, resulting in undetectable levels of intrinsic GTPase 
activity (Burstein and Macara, 1992; Zhang et al., 2000). Thus we can infer that 
the Rab83 mutation is likely to significantly perturb normal Rab8 GTPase 
function. Contrary to both the Rab81 and Rab83 mutations the effect of the 
Rab82 and Rab8Z3007 mutations is far less obvious. The results of in silico 
analysis suggests that Rab8Z3007 acts to destabilise Rab8 protein structure, 
however further analysis will have to be carried out to confirm the specific 
effects of this mutation upon protein structure. In contrast whilst both 
experimental evidence and in silico analysis demonstrate the Rab82 mutation to 
have a deleterious effect upon Rab8 function the cause of such an effect is 
unclear. In silico analysis suggests this mutation does not destabilize protein 
function however unlike Rab81 and Rab83 it does not fall within one of the 5 G-
motifs fundamental for GTPase function. Further observations also show that 
this mutation does not fall within any known protein binding sites within the 
Rab8 sequence. One may postulate that the nature of the amino acid 
substitution from a hydrophilic serine residue to a hydrophobic phenylalanine is 
likely to induce steric hindrance and perturb the normal protein.  
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Whist these findings provide a useful characterisation of the nature of each 
mutation, revealing a deleterious effect of each upon Rab8 function further 
analysis will be required to fully elucidate their effect upon protein structure and 
function. During this investigation an antibody was raised against Rab8 (see 
section 2.4.1.) however it proved unsuccessful for determination of levels of 
Rab8 protein via western blotting in Drosophila. Similarly commercial Rab8 
antibodies (BD, Transduction Laboratories) were unsuccessful for western 
blotting. As such whilst further analysis is required for determination of the effect 
of each mutation on protein structure and function the focus of this investigation 
is to determine the effect of these mutations on neuronal development and 
function and thus elucidate the role of Rab8 in neurons. 
 
 
4.3.2 A Pre-Synaptic Complement of Rab8 is Essential For 
Normal NMJ Growth 
 
It has previously been demonstrated that Rab8 is enriched within the nervous 
system, with the mammalian Rab8B isoform found in greatest abundance within 
the brain (Chan et al., 2011; Lau and Mruk, 2003). The results of this 
investigation substantiate these previous findings showing enrichment of Rab8 
within the Drosophila nervous system. Furthermore they demonstrate Rab8 to 
be expressed throughout the larval brain with significant expression within 
neurons, although also expressed in glia. Having identified this neuronal pattern 
of expression Rab8 was subsequently shown to be expressed in motor 
neuronal subtypes. This allowed for use of the Drosophila larval NMJ as a 
model system to characterise the effects of Rab8 mutations upon neuronal 
morphology and function. 
 
Rab8 has been implicated in the development of polarised cells, including 
neurons. For example it has been demonstrated to be important for normal 
neurite outgrowth as well as the regulated cycling and delivery of AMPA 
receptors into dendritic spines (Brown et al., 2007a; Gerges et al., 2004a; Huber 
et al., 1995a). With this previous implication in neuronal development and 
having shown here that Rab8 mutants display a pharate lethal phenotype, a 
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phenotype commonly implicated in neuronal or muscle dysfunction, it was 
investigated whether Rab8 mutants showed any perturbation to normal NMJ 
development (Colodner and Feany, 2010; Torroja et al., 1999; Weiss et al., 
2012). The results of this investigation implicate Rab8 as a potent regulator of 
normal NMJ development, with all transheterozygous Rab8 mutants displaying 
a significant synaptic overgrowth phenotype at multiple model NMJ’s (4 and 
6/7).  
 
Rab8 has previously been implicated in a “Rab cascade” acting sequentially 
with Rab11 in a number of biological processes conserved within eukaryotic 
cells (Khandelwal et al., 2013; Knodler et al., 2010; Westlake et al., 2011). For 
example in neurons Rab8 has been shown to act sequentially with Rab11 in the 
regulated cycling and delivery of AMPA receptors into dendritic spines (Brown 
et al., 2007b; Gerges et al., 2004b). Furthermore Rab11 has been implicated as 
a regulator of the Rab8 GEF, rabbin8 (Knodler et al., 2010). Rab8 and Rab11 
have also been shown to act in combination to regulate slow recycling within the 
endocytic pathway (Grant and Donaldson, 2009; Rowe et al., 2008). As such it 
is interesting to observe that whilst Rab8 and Rab11 mutants both show 
significant synaptic overgrowth the overgrowth phenotype seen is significantly 
different between the two. For example whilst we show here that Rab8 mutants 
display a general overgrowth phenotype, characterised by increased NMJ 
length, bouton number, satellite bouton number and cumulative bouton size, as 
well as reduced individual bouton sizes, Rab11 mutants, in contrast, are 
characterised by an increase in branching and overproliferation of satellite 
boutons, a hallmark of endocytic mutants (Khodosh et al., 2006). These findings 
suggest that Rab8 and Rab11 may not necessarily act within the same pathway 
in the regulation of normal neuronal growth and development. Interestingly the 
overgrowth phenotype observed in Rab8 is more akin to the overgrowth 
phenotypes observed in other Drosophila mutants, including the late 
endosomal/lysosomal protein spin and the E3 ubiquitin-protein ligase hiw. 
Analogous to Rab8 mutants both spin and hiw mutants display an increase in 
synaptic bouton number and NMJ length coupled with a reduction in synaptic 
bouton size (Collins et al., 2006; Milton et al., 2011; Sweeney and Davis, 2002; 
Wan et al., 2000). In contrast, however, to Rab8 mutants these mutants also 
4. Characterisation of Rab8 Mutants Identifies Rab8 as a Potent Regulator of Synaptic Growth 
!
   144!
display an increase in branching. Spin and Rab8 show similar sized 
overgrowths in terms of increased bouton number and NMJ length whilst 
overgrowth in hiw is significantly greater. The similarity in the overgrowth 
phenotypes seen in Rab8, spin and hiw mutants may suggest a conserved 
mechanism behind the overgrowth. This shall be explored in detail in the 
following chapter. 
 
A notable difference between spin and hiw is their site of action in the regulation 
of synaptic growth. For example hiw has been shown to act entirely pre-
synaptically whilst spin acts within both the pre- and post-synaptic 
compartments equally (McCabe et al., 2004; Sweeney and Davis, 2002; Wan et 
al., 2000). The experimental evidence presented here suggests that Rab8 acts 
predominantly within the presynaptic compartment with pre-synaptic expression 
of wildtype Rab8 sufficient to rescue all aspects of the Rab8 mutant overgrowth. 
In contrast post-synaptic expression of Rab8 is only sufficient to partially rescue 
overgrowth, rescuing increased bouton number at muscle 6/7 but only partially 
rescuing increased bouton number at muscle 4. Similarly postsynaptic 
expression of Rab8 also only partially rescues NMJ length, and cumulative 
bouton size whilst showing no ability to rescue increased satellite bouton 
number. This observation that post-synaptic expression of Rab8 is capable of 
partially rescuing some aspects of the overgrowth phenotype, despite 
presynaptic expression completely rescuing overgrowth, suggests a possible 
post-synaptic function for Rab8 in the regulation of NMJ growth. This may be 
explained by the ultrastructural phenotypes observed in Rab8 mutant muscles, 
discussed in detail in section 4.3.4. Here it was demonstrated that Rab8 
mutants show significant perturbations to normal mitochondrial morphology. 
Such mitochondrial disruption would likely cause significant levels of oxidative 
stress, which has previously been shown to induce synaptic overgrowth from a 
post-synaptic compartment, for example in spin mutants (Milton et al., 2011). 
Oxidative stress would likely act to potentiate overgrowth induced by pre-
synaptic Rab8 dysfunction, in a non-autonomous manner. Similarly neuronal 
expression of Rab8 would likely provide robust protection against postsynaptic 
oxidative stress, explaining why presynaptic expression of Rab8 offers a 
complete rescue whilst a partial rescue can be induced by a postsynaptic 
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complement of Rab8. Alternatively Rab8 may have a role in the regulation of 
post-synaptic processes that provide a retrograde signal to the developing 
presynaptic nerve terminal with a degree of redundancy to the potent pre-
synaptic signals. In order to elucidate the post-synaptic role of Rab8 in the 
regulation of NMJ development future investigation may look to determine 
whether Rab8 mutants present with an oxidative stress burden. For example by 
using the cap‘n’collar glutathione S-transferase D (GST-D) GFP reporter 
construct (Sykiotis and Bohmann, 2008, 2010). GST-D is an antioxidant 
expressed under oxidative stress conditions and has been previously shown to 
be unregulated in Drosophila mutants displaying synaptic overgrowth 
associated with oxidative stress burdens (Milton et al., 2011; Sykiotis and 
Bohmann, 2008, 2010). 
 
The observation that Rab8 mutants display a reduced bouton size whilst 
presynaptic overexpression of Rab8 in a wildtype background induces a 
significant increase in synaptic bouton size strongly substantiates a presynaptic 
role for Rab8 in the regulation of normal bouton development. This is further 
corroborated by the identification of significant perturbations to normal bouton 
ultrastructure in Rab8 mutants, discussed in detail in the following section 4.3.3. 
 
Interestingly Rab8 mutants show no apparent gross perturbation to pre- or post-
synaptic markers at a histological level. As such we can infer that unregulated 
growth is unlikely to be associated with perturbation to normal assembly of 
either presynaptic active zones or the postsynaptic density. Such an 
observation provides little support for the role of Rab8 in the regulated trafficking 
of AMPA receptors (Brown et al., 2007b; Gerges et al., 2004b). However from 
this we may infer that the unregulated growth phenotype observed is more likely 
to associate with perturbations to normal growth signalling pathways rather than 
being a compensation to account for disruptions to normal active zones or the 
PSD. The perturbation of growth signalling pathways in Rab8 mutants is 
investigated in detail in the following chapter. 
 
Taken together these findings implicate Rab8 as a potent regulator of normal 
synaptic growth at the Drosophila NMJ. Furthermore they demonstrate that, 
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although ubiquitously expressed, Rab8 enrichment within the nervous system 
associates with a predominantly presynaptic function in the regulation of normal 
synaptic growth and development. Furthermore unregulated growth is likely to 
associate with perturbed growth signalling in Rab8 mutants. 
 
 
4.3.3 Rab8 Mutants Display Perturbed Endosomal-Lysosomal 
and Autophagic Trafficking !
Ultrastructural analysis of pre-synaptic boutons revealed a significant increase 
in the size and abundance of large clear vesicle structures, often containing 
further intralumenal vesicles. These structures are clearly distinct from MVB’s. 
However they show a notable similarity to structures previously observed in the 
synaptic boutons of Drosophila expressing a dominant negative Rab5, 
(Rab5S43N) under the control of the pan-neuronal driver elav-Gal4 (Fig. 4.22.) 
(Wucherpfennig et al., 2003). Such structures have also been observed in 
mammalian Rab5S43N models and have been identified as endocytic recycling 
intermediates associated with perturbation to normal homotypic endosome 
fusion, a process that is regulated by Rab5 (Bucci et al., 1992; Wucherpfennig 
et al., 2003).  
 
 
 
 
 
 
 
Figure 4.22. Expression of Dominant Negative Rab5 Neuronally Induces Accumulation of 
Endocytic Intermediates Identical to Those Observed in Rab8 Mutants 
Expression of the dominant negative Rab5 Rab5-S43N pan-neuronally using elav-Gal4 induced 
accumulation of endosomal intermediate structures with a distinct similarity to those observed in 
Rab8 mutants. Scale Bar =100 nm. (Adapted From Wucherpfennig et. al (2003)) 
 
 
Similar structures have also been observed in Syndapin-I mutant mice (Koch et 
al., 2011). Syndapin-I has been identified as a neurally enriched isoform of 
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syndapin, a protein implicated in vesicle trafficking, neuronal morphogenesis 
and endocytosis, including clathrin-independent activity-dependent bulk 
endocytosis (ADBE), both pre- and post-synaptically (Quan and Robinson, 
2013). During ADBE bulk endosomes are generated, through invagination of 
large regions of the plasma membrane, to form large endosomes (>100nm in 
diameter) (Quan and Robinson, 2013). Subsequently synaptic vesicles bud 
from activity dependent bulk endosomes forming a new population of synaptic 
vesicles to join the recycling pool. As such one might propose that the large 
endosome structures observed in Rab8 mutants represent bulk endosomes 
associated with ADBE and that Rab8 has a role in regulation of this process. 
This supports previous hypotheses that Rab8 may act in an endosomal 
recycling process independent of clathrin mediated recycling. For example 
Rab8 has been shown to localize with Arf6, a known regulator of clathrin 
independent recycling (Hattula et al., 2006). Furthermore Rab8 has been 
implicated in the regulated delivery of AMPA receptors to dendritic spines, with 
evidence from C. elegans suggesting AMPA receptor pools are endocytosed in 
a clathrin independent, cholesterol dependent manner (Brown et al., 2007a; 
Gerges et al., 2004a; Glodowski et al., 2007). As previously mentioned Rab8 
depletion has also been shown to induce endosomal accumulation of 
cholesterol (Linder et al., 2007). The observation of similar endosome-like 
structures in the muscles of Rab8 mutants supports the hypothesis that these 
structures are more likely associated with endosomes than directly with a 
perturbation to normal synaptic vesicles. A perturbation to endosomal trafficking 
is supported by the results of immunofluorescence analysis of endosomal 
markers. The observation that both Rab4 and Rab11 recycling endosome 
markers appear decreased in Rab8 mutants further supports a role for Rab8 in 
the recycling endosome pathway. It has also previously been shown, in 
separate studies, that depletion of Rab8 results in an accumulation of cellular 
cholesterol, which in turn inhibits Rab4 and disrupts normal membrane recycling 
(Choudhury et al., 2004; Linder et al., 2007). As such the results presented here 
support previous findings. Furthermore it has subsequently been shown that 
recycling endosomes contribute towards the formation of autophagosomes and 
as such an inhibition of endosomal recycling in Rab8 mutants could explain the 
simultaneous decrease in autophagosome markers (Longatti et al., 2012; Puri 
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et al., 2013). It has also been shown that conversely, overexpression of the 
Rab8 effector optineurin regulates autophagosome formation, supporting the 
hypothesis that Rab8 is required for both endosomal recycling and 
autophagosome formation (Wild et al., 2011). 
 
The observation of multi-lamellar, membranous structures in both the CNS and 
the muscles of Rab8 mutants may further suggest a functional role for Rab8 in 
the regulation of endosomal-lysosomal and autophagic processes. For example 
Lee et al. (2007) demonstrated that perturbation to normal ESCRT-III function, 
through depletion of the essential ESCRT-III component mSnf7-2 or expression 
of the FTD mutation CHMP2BIntron5, induced significant neuronal degeneration, 
coupled with accumulation of autophagosomes. In this study they propose that 
autophagosome accumulation is likely the result of abnormal fusion between 
autophagosomes and late endosomes or lysosomes, and that this contributes to 
FTD pathogenesis. The autophagosome structures observed by Lee et al. 
(2007) show significant similarity to the multi-lamellar structures observed here 
in Rab8 mutants (Fig. 4.23.). As such one may postulate that perturbation to 
normal autophagic processes in both CHMP2BIntron5 and Rab8 mutants may 
explain why Rab8 mutants potentiate the FTD toxicity of CHMP2BIntron5, as well 
as Shrub-GFP. However as previously mentioned the autophagosome marker 
Atg8 was observed to be decreased in the VNC of Rab8 mutants and therefore 
it is unlikely that these structures relate to mature autophagosomes. However 
one may postulate that these structures could represent immature 
autophagophore’s or autophagic intermediates, supporting the idea that 
autophagosome formation may require the recycling endosome. Corroborating 
this hypothesis preliminary experiments have demonstrated that decreasing 
autophagy through introduction of the homozygous Atg7 mutant Atg7D77, in a 
Rab8 mutant background, alleviates the Rab8 mutant NMJ overgrowth 
phenotype. Future investigation shall look to further substantiate these findings 
through further genetic manipulation of the autophagic pathway in Rab8 
mutants whilst also looking to identify the nature and origin of multilamellar 
structures. Alternatively one may postulate that multilamellar structures may 
relate to cholesterol accumulation that has been previously identified to occur as 
a result of Rab8 depletion, leading to perturbations to normal endosomal 
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recycling (Choudhury et al., 2004; Linder et al., 2007). For example it has been 
shown that similar multilamellar structures are observed in NPC cells where 
they have been proposed to act as sites of cholesterol deposition as a result of 
defective NPC1, where they have also been associated with autophagosome 
formation (Choudhury et al., 2004; Linder et al., 2007; Longatti et al., 2012; Puri 
et al., 2013). Similar multilamellar structures have also been observed in 
Drosophila models of lysosomal dysfunction, including spin mutants. 
 
 
 
 
 
 
 
 
Figure 4.23. Depletion of ESCRT-III Function Induces Accumulation of Autophagosomes 
Comparable to the  Multilamellar Structures Observed in Rab8 Mutants 
SiRNA mediated depletion of mSnf7-2 (the mouse orthologue of Drosophila Shrub) induced 
autophagosome accumulation in cortical neurons, as does CHMP2BIntron5 transfection of 
HEK293 cells. (Adapted from Lee et. al (2007)).  
 
 
 
4.3.4 Ultrastructure Analysis Reveals Mitochondrial 
Aberrations 
 
 
The final phenotype observed during ultrastructural analysis was that of 
abnormal mitochondrial morphology in the muscles of Rab8 mutants. These 
mitochondria displayed significant morphological perturbation characterised by 
significant elongation, with a number of mitochondria appearing to be separated 
yet still attached by a long projection. Interestingly this phenotype shows a 
marked similarity to that observed in C. elegans Dynamin related protein 1 
(Drp1) mutants (Fig. 4.24.) (Breckenridge et al., 2009). Drp1 is a GTPase that 
has a functional role in mitochondrial and peroxisome division as well as normal 
brain and neural tube development (Koch et al., 2003; Smirnova et al., 2001; 
Wakabayashi et al., 2009). It has also been shown to associate with mutant htt, 
which potentiates Drp1 enzymatic activity (Song et al., 2011). Htt in turn has 
been shown to associate with Rab8, via the Rab8 effector optineurin (Sahlender 
CHMP2BIntron5!mSnf7-2 SiRNA!
4. Characterisation of Rab8 Mutants Identifies Rab8 as a Potent Regulator of Synaptic Growth 
!
   150!
et al., 2005). As such one may postulate that Rab8 may have a role in the 
regulation of normal mitochondrial fission and fusion events, potentially through 
Drp1. Future experimentation may look to elucidate this function through 
dissection of this potential pathway. S-nitrosylation of Drp1, mediated by the 
beta-amyloid protein, has also been shown to lead to the promotion of 
mitochondrial fission, synaptic loss and neuronal damage, implicating this as a 
potential target pathway in the study of Alzheimer’s disease, and perhaps other 
neurodegenerative diseases (Cho et al., 2009). 
 
 
  
 
 
 
 
 
 
 
 
 
Figure 4.24. Dynamin Related Protein 1 (Drp1) Mutant C. elegans Display Elongated 
Mitochondria Similar to Those Observed in Rab8 Mutant Drosophila  
Scale bar = 2 μm. (Adapted from Breckenridge et al. (2009)). 
 
 
 
4.3.5. Rab8 Mutants Display Impaired Physiology 
 
Having observed significant perturbations to normal NMJ growth coupled with 
ultrastructural aberrations investigation looked to determine whether Rab8 
mutant synapses were physiologically functional. Observation of crawling speed 
revealed that the majority of Rab8 transheterozygous mutants showed no 
perturbation to larval locomotion. As such it may be inferred that whilst 
overgrown, synapses are functionally normal. This may allude to overgrowth 
being a compensatory mechanism, growing larger with an increased number of 
synaptic terminals upon the muscle to compensate for a molecular dysfunction 
within the neuron.  
 
The one transheterozygous combination displaying reduced larval locomotion is 
likely to result from the generation of both lines, by EMS, from the same 
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background stock in the same laboratory. As such second site mutations may 
be present in both stocks that are not complemented by outcrossing to each 
other. Alternatively it may be argued that this transheterozygous combination, 
Rab81/Rab83, contains the mutations that are both present in functional GTPase 
motifs and, as such, may display significant functional inactivity. However one 
may postulate this is unlikely to be the case as this combination shows no more 
significant perturbation to NMJ morphology, whilst the Rab81/Df(3L)ED228 
transheterozygous mutant, which equates to Rab81/-, shows no perturbation to 
larval crawling speed. These findings suggest synaptic overgrowth does not 
directly correlate with a reduction or increase in crawling speed. For example in 
contrast to Rab8 mutants spin mutants, which display synaptic overgrowth, 
display reduced crawling speed. 
 
In contrast to the observation of limited perturbation to normal physiological 
function, in terms of larval crawling speed, Rab8 mutant larvae display 
significant disruption to normal synaptic transmission (Bruno Marie, University 
of Puerto Rico). The reduced mEPSP amplitude observed suggests that either 
less neurotransmitter is released in response to presynaptic stimulation by an 
action potential or that the muscle is eliciting an attenuated response to the 
normal amount of neurotransmitter. The latter typically occurs due to a reduction 
in the size of the post-synaptic receptor field and a decrease in glutamate 
receptor abundance (Heckscher et al., 2007). However our previous 
observations suggest that there is no perturbation to normal GluR localisation 
and distribution and as such one may postulate that reduced mEPSP amplitude 
most likely associates with reduced neurotransmitter release. This also 
corroborates the findings that Rab8 has a predominantly pre-synaptic function, 
with pre-synaptic but not post-synaptic expression of Rab8 capable of rescuing 
synaptic overgrowth. Future investigation shall look to determine the effects of 
pre- and post-synaptic rescues upon electrophysiological phenotypes in order to 
substantiate this hypothesis. Reduced mEPSP amplitude also supports the 
previous hypothesis that large vesicles observed in synaptic boutons are not 
synaptic vesicles and are in fact associated with endosomal recycling 
intermediates, similar to those associated with expression of dominant negative 
Rab5 (Wucherpfennig et al., 2003). 
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Rab8 mutants also presented with an increased EPSP, correlating with the 
synaptic overgrowth observed and suggesting that although synaptic bouton 
size is reduced the increased bouton number and cumulative bouton size elicits 
an increased evoked response in the postsynaptic muscle. A reduced quantal 
content is observed as a result of the reduction in mEPSP amplitude coupled 
with increased EPSP in Rab8 mutants. Elevated EPSP may also contribute 
towards the reduction in mEPSP observed. 
 
Interestingly the observed aberrations to synaptic function are in stark contrast 
to those observed in other models of synaptic overgrowth including hiw, which 
displays a marked reduction in quantal content and EPSP amplitude, and spin 
mutants, which display a 50 % reduction in quantal content but a normal EPSP 
amplitude (Sweeney and Davis, 2002; Wan et al., 2000). Taken together these 
findings support the hypothesis that synaptic overgrowth does not directly 
correlate with synaptic function, with different models of synaptic overgrowth 
displaying distinct physiological variance. 
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5. Unregulated Growth in Rab8 Mutants Requires 
Synergistic JNK and TGFβ Signalling !
5.1. Introduction  !!
Growth, development and the continuous homeostatic modulation of the 
Drosophila NMJ, in response to both internal and external cues, is regulated by 
a series of interconnected, bi-directional, pre- and post-synaptic signalling 
pathways. These include both TGFβ and JNK signalling (see Chapter 1). 
 
Both TGFβ and JNK signalling have been implicated in the growth and 
development of the Drosophila larval NMJ. For example a significant body of 
evidence exists demonstrating that the TGFβ ligand and BMP family protein 
Gbb is secreted by the muscle, binding pre-synaptically expressed TGFβ 
receptors and providing a retrograde signal to the developing pre-synaptic 
terminal (Marques, 2005; Marques et al., 2003; McCabe et al., 2003). Evidence 
suggests that ligand bound receptors are then endocytosed and trafficked to the 
cell body, where they induce activation and nuclear localisation of P-MAD 
allowing transduction of the TGFβ signal to promote synaptic growth (Smith et 
al., 2012).  It has also been demonstrated that TGFβ signalling at the NMJ can 
be modulated by glia (Fuentes-Medel et al., 2012). Glia release the TGFβ ligand 
Maverick (Mav) which is thought to induce muscle expression of the TGFβ type-
II receptor Punt, resulting in a potent modulation of retrograde Gbb release 
(Fuentes-Medel et al., 2012). Similarly a significant body of evidence has 
implicated JNK signalling in synaptic over-growth (Collins et al., 2006; Milton et 
al., 2011). JNK signalling has been implicated in stress responses within cells, 
responding to a range of endogenous and environmental insults (see Chapter 
1). For example previous work in the Sweeney lab has demonstrated that JNK 
signalling is activated in response to an oxidative stress burden in spin mutants, 
leading to unrestricted synaptic growth (Milton et al., 2011). In addition research 
has shown that synaptic overgrowth in hiw mutants is associated with increased 
activation of the JNK signalling pathway (Collins et al., 2006). It has been 
demonstrated that hiw acts in the degradation of the JNKKK wnd and as such 
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hiw mutants display reduced restraint upon wnd leading to increased JNK 
activation (Collins et al., 2006).  
 
Despite significant evidence implicating both TGFβ and JNK signalling in NMJ 
development, with both implicated in a number of synaptic overgrowth models, 
and despite significant evidence in other contexts demonstrating that these 
signalling pathways act synergistically there is currently little evidence 
supporting a synergistic mode of action at the Drosophila NMJ. Here evidence 
is provided to suggest that both TGFβ and JNK signalling contribute towards 
the synaptic overgrowth phenotype observed in Rab8 transheterozygous 
mutants. In addition it is shown that TGFβ and JNK signalling act synergistically 
in the physiological regulation of NMJ growth. In keeping with this we propose a 
mechanism by which ectopic TGFβ signalling, resulting from perturbation to 
endosomal recycling in Rab8 mutants, promotes JNK signalling via the JNKKK 
TAK1, scaffolding upon the endosomal JNK scaffolding protein POSH.    
 !
5.2. Results  !
5.2.1. TGFβ Activity is Up-regulated in Rab8 Mutants and 
Required for Unrestricted NMJ Growth  !!
Having demonstrated, in the previous chapter, that Rab8 mutants display an 
unrestricted synaptic growth phenotype the focus of this chapter was to identify 
the molecular mechanism behind the overgrowth. Previous studies have 
demonstrated endocytic trafficking to play a critical role in regulating nervous 
system development through the modulation of growth factor receptors, 
including TGFβ (Fuentes-Medel et al., 2012; O'Connor-Giles et al., 2008; Rodal 
et al., 2011; Smith et al., 2012; Sweeney and Davis, 2002). For example it has 
been shown that activated TGFβ receptor complexes are endocytosed, in an 
activity dependent manner, at the synaptic terminal and retrogradely 
transported to the cell body where the TGFβ signal transduction cascade 
promotes transcription of factors involved in synaptic plasticity and NMJ growth 
(Smith et al., 2012). As such TGFβ signalling promotes synaptic modulation in 
an activity dependent manner. It has also been demonstrated that aberration to 
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normal endosomal trafficking can result in misrelated TGFβ signalling, leading 
to synaptic overgrowth at the Drosophila NMJ (Kim et al., 2010; Korolchuk et 
al., 2007; O'Connor-Giles et al., 2008; Rodal et al., 2011; Sweeney and Davis, 
2002). For example Sweeney and Davis (2002) demonstrated that mutations in 
the gene encoding the late endosomal/lysosomal protein spin induce significant 
synaptic overgrowth associated with misregulated TGFβ signalling. Similarly 
mutations in other endosomal proteins including Ema and Vps35 elicit TGFβ 
dependent synaptic overgrowth (Kim et al., 2010; Korolchuk et al., 2007). It was 
also demonstrated that inhibition of spicthyin, an early endosomal protein 
involved in the endocytosis of BMP receptors, promotes up-regulation of BMP 
signalling leading to expansion of the Drosophila NMJ (Wang et al., 2007). In 
addition it was recently shown that mutations in Brain tumor (Brat), a regulator 
of synaptic endocytosis, and Spartin, which promotes endocytic degradation of 
Wit, elicit synaptic overgrowth at the Drosophila NMJ (Nahm et al., 2013; Shi et 
al., 2013). As such, having observed significant perturbation to normal 
endosomal markers it was asked whether this led to a disruption of normal 
TGFβ activity and whether TGFβ signalling contributed towards the unrestricted 
growth phenotype observed in Rab8 mutants.  
 
In the data presented here it is demonstrated that functional TGFβ signalling is 
required for the synaptic overgrowth phenotype observed in Rab8 
transheterozygous mutant larvae. Previous studies have shown that certain 
synaptic overgrowth phenotypes, such as that of spin, are associated with 
perturbed TGFβ signalling (Sweeney and Davis, 2002). Furthermore these 
studies show that overgrowth can be alleviated through inhibition of TGFβ 
signalling. Development and expansion of the Drosophila NMJ has been shown 
to be regulated by retrograde TGFβ signalling involving muscle secreted BMP 
Gbb binding the type-II TGFβ receptor Wit (Marques et al., 2003; McCabe et al., 
2003). Wit in turn forms an active tetrameric receptor complex with Type-I 
receptors, including Tkv. As such TGFβ signalling at the NMJ can be inhibited 
by expression of Tkv loss of function mutants. Previous studies have shown that 
heterozygous, hypomorphic Tkv mutants elicits no alteration in NMJ size whilst 
transheterozygous or homozygous Tkv mutants induce an ~ 50 % reduction in 
bouton number (Sweeney and Davis, 2002). The same trend was also observed 
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for inhibition of TGFβ signalling using sax or wit mutants. Here these findings 
are recapitulated with the presence of mutant Tkv in a Rab8 transheterozygous 
mutant background alleviating synaptic overgrowth in a dose dependent 
manner (Fig. 5.1.).  For example Tkv7/+ in a Rab8 mutant background partially 
rescues overgrowth whilst the presence of Tkv7/TkvK16713 completely rescues 
Rab8 mutant overgrowth to wildtype levels. The requirement of normal TGFβ 
signalling, signalling through the Tkv receptor, in Rab8 mutant overgrowth is 
supported by analysis of muscle 4 where it is demonstrated that heterozygous 
TkvK16713 in a transheterozygous Rab8 mutant background is sufficient to 
completely rescue both increased bouton number and NMJ length (Fig. 5.2.A-
B). Heterozygous TkvK16713 also rescued the reduced synaptic bouton size seen 
in Rab8 mutants (Fig. 5.2.C). Interestingly TkvK16713/+;Rab81/Rab8B229 mutant 
larvae actually showed a bouton size significantly greater than that of wildtypes 
whilst TkvK16713/+ larvae showed boutons with a size no different to wildtype 
(Fig. 5.2.C). This study also revealed that whilst heterozygous Rab8 mutants do 
not display synaptic overgrowth they do show a reduced synaptic bouton size 
comparable to that of Rab8 transheterozygotes (Fig. 5.2.C.). 
 
The role for TGFβ signalling in Rab8 mutant overgrowth is further supported by 
the demonstration that inhibition of the inhibitory-SMAD Dad through 
heterozygous expression of the Dad loss of function mutant DadΔIEL alongside 
heterozygous Rab81 is sufficient to induce a significant increase in synaptic 
bouton number at both muscle 6/7 and 4 (Fig. 5.1. and 5.2.). Heterozygotes of 
Rab81 and DadΔIEL alone have no effect upon bouton number. Synaptic 
overgrowth in Rab81/DadΔIEL double heterozygotes is further supported by a 
significant increase in NMJ length at muscle 4, again comparable to Rab8 
transheterozygous mutants (Fig. 5.2.B). Rab81/DadΔIEL double heterozygotes 
also display a reduced mean normalised synaptic bouton size, however this is 
significantly larger than that of Rab81 heterozygotes and not significantly 
different to DadΔIEL heterozygotes suggesting that reducing Dad inhibition of 
TGFβ signalling does not potentiate the reduced bouton size already observed 
in Rab8 heterozygotes (Fig.5.2.C). 
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Figure 5.1. Increased Synaptic Bouton Number In Rab8 Mutants Requires Functional 
TGFβ Signalling 
(A-B) Inhibition of TGFβ signalling through expression of Tkv loss of function mutants in a Rab8 
transheterozygous mutant background rescues increased synaptic bouton number, in a dose 
dependent manner. Heterozygous expression of Tkv mutants in a wildtype background elicits no 
variance in bouton number whilst transheterozygous Tkv mutants display a 38.35 % reduction in 
synaptic bouton number, compared to wildtype. Suppression of TGFβ inhibition through 
heterozygous expression of a Dad loss of function mutant has no effect upon synaptic bouton 
number, however when combined with a heterozygous Rab8 mutant  induces a significant 
increase in bouton number comparable to Rab8 transheterozygotes. Heterozygous Rab8 
mutants show no variance from wildtype. Scale bar = 10 μm. (ANOVA: F(d.f. 10) = 27.8476; p < 
0.001 with post-hoc Dunnett’s comparison to wildtype control *** p < 0.001, * p < 0.05 and 
student t-test comparison between genotypes ### p < 0.001, ## p < 0.01, # p < 0.05 ). 3rd instar 
larvae, muscle 6/7 hemi-segment A3.  
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Figure 5.2. Unrestricted Growth In Rab8 Mutants Requires Functional TGFβ Signalling!
Corroborating observations at muscle 6/7 analysis of muscle 4, 3rd instar larvae hemi-segment 
A3, demonstrates that TGFβ signalling is essential for the overgrowth phenotypes observed in 
Rab8 mutants. (A) Inhibition of TGFβ signalling in Rab8 transheterozygous mutants, through 
heterozygous expression of the Tkv loss of function mutation TkvK16713, rescues increased 
bouton number.  Heterozygous expression of TkvK16713 in a wildtype background shows no 
variance from wildtype. Suppression of TGFβ inhibition through heterozygous expression of the 
Dad loss of function mutant DadΔIEL in a Rab8 heterozygous mutant background induced an 
increase in synaptic bouton number comparable to muscle 7 and Rab8 transheterozygous 
mutants. Heterozygous Rab81 and DadΔIEL alone show no variance from wildtype. (ANOVA: 
F(d.f. 6) = 24.9310; p < 0.001 with post-hoc Dunnett’s comparison to wildtype control *** p < 
0.001, and student t-test comparison between genotypes ### p < 0.001). (B) NMj length is 
affected in the same manner with heterozygous expression of TkvK16713 in a transheterozygous 
Rab8 mutant background rescuing increased NMJ length. Rab81/DadΔIEL double mutants also 
display increased NMJ length comparable to Rab8 transheterozygotes whilst heterozygous 
Rab81 and DadΔIEL have no effect alone. (ANOVA: F(d.f. 6) = 7.5526; p < 0.001 with post-hoc 
Dunnett’s comparison to wildtype control *** p < 0.001, ** p < 0.01 and student t-test 
comparison between genotypes ### p < 0.001, # p < 0.05). (C) Reduced bouton size in Rab8 
mutants can be alleviated by inhibition of TGFβ through heterozygous expression of TkvK16713, 
which alone shows no variance from wildtype. Similarly TkvK16713/Rab81 double mutants show 
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reduced bouton size. However whilst heterozygous DadΔIEL shows no variance in bouton size 
from wildtype heterozygous Rab81 show a reduced bouton size comparable to Rab8 
transheterozygotes. (ANOVA: F(d.f. 6) = 71.3031; p < 0.001 with post-hoc Dunnett’s 
comparison to wildtype control *** p < 0.001, * p < 0.05 and student t-test comparison between 
genotypes ### p < 0.001, ## p < 0.01). 
 
 
Having demonstrated TGFβ signalling to be essential for the synaptic 
overgrowth phenotype observed in Rab8 transheterozygous mutants it was then 
asked whether these mutants displayed an abnormal up-regulation of TGFβ 
signalling. The data presented here confirms TGFβ signalling to be up-
regulated in Rab8 mutants both at the cellular and transcriptional level. MAD is 
the Drosophila orthologue of the R-SMAD, SMAD1 and, as such, is activated by 
phosphorylation by Tkv in response to ligand mediated receptor activation (see 
section 1.3.9.). Therefore levels of phosphorylated MAD (p-MAD) can be used 
as an indicator of TGFβ activity. Here it is demonstrated that nuclear p-MAD 
levels, in eve positive motor-neurons, are increased by 99.53 % in Rab8 
mutants (Rab81/Rab8B229), compared to wildtype (Fig. 5.3. A-B). This indicates 
an increase in TGFβ activity at the point of receptor phosphorylation of the R-
SMAD. Analysis of p-MAD immunofluorescence also revealed an accumulation 
of p-MAD positive aggregates within the VNC and axon bundles of Rab8 
mutants. Such accumulations were not observed in wildtype animals (Fig.5.4.). 
It was also noted that these axonal p-MAD aggregates showed partial co-
localisation with HRS, an endosomally localised ESCRT-0 component. 
 
Having demonstrated increased TGFβ activity at the point of receptor 
phosphorylation of the R-SMAD, MAD it was then determined whether the 
TGFβ pathway was transcriptionally more active. As the TGFβ pathway 
transcriptionally activates the inhibitory SMAD, Dad, Dad-LacZ can be used as 
a reporter of TGFβ activity. Again TGFβ activity is shown to be up-regulated in 
Rab8 mutants, displaying an 846.84 % increase in nuclear Dad-driven LacZ 
fluorescence within the larval VNC, when compared to wildtype (Fig. 5.3 C-D). 
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Figure 5.3. Rab8 Mutants Display Increased Levels of TGFβ Activity 
(A-B) Rab8 mutants show a significant increase in nuclear phosphorylated MAD, Drosophila 
SMAD1, within eve positive motor neurons in 3rd instar larvae, when compared to wildtype. 
Scale Bar = 2 μm. (ANOVA: F(d.f. 1) = 92.3468; p < 0.001). (C) Rab8 mutants also show a clear 
increase in levels of Dad, the Drosophila inhibitory-SMAD, which is transcriptionally activated by 
the TGFβ signalling pathway throughout the ventral nerve cord of 3rd instar larvae (Scale Bar = 
10μm). (D) Quantification of Dad-LacZ levels reveals a significant increase in Dad-LacZ in Rab8 
mutants, compared to wildtype. (ANOVA: F(d.f. 1) = 257.76; p < 0.001). !!!!!!!!!!!!!!
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Figure 5.4. Rab8 Mutants Display Accumulations of p-MAD Partially Co-localising With 
HRS In Axon Bundles.  
Immunofluorescence imaging of p-MAD and HRS reveals that as well as showing increased 
nuclear p-MAD fluorescence Rab8 mutants show accumulations of p-MAD throughout the 
ventral nerve cord (VNC) and within axon bundles (arrow head and box) projecting from the 
VNC. P-MAD accumulations also co-localise with the endosomal protein HRS. Scale Bars = 10 
μm. 
 
 
During analysis to determine whether accumulations of p-MAD in Rab8 mutant 
axon bundles co-localised with endosomes, using HRS and an endosomal 
marker, it was also noted that HRS fluorescence appeared reduced in the VNC 
of Rab8 mutants. As such further analysis looked to quantify HRS levels. This 
analysis reveals a significant decrease in HRS within the cell bodies of eve 
positive motor neurons (Fig 5.5). This suggests that Rab8 mutants present with 
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a depletion of HRS or that HRS is sequestered elsewhere, perhaps within axons 
where p-SMAD accumulations are observed partially co-localising with HRS.  
 !!!!!!!!!!!!
 
 
 
 
Figure 5.5. Rab8 Mutants Show Reduced HRS Fluorescence Within Eve Positive Motor 
Neuronal Cell Bodies Within the Ventral Nerve Cord 
(A-B) Immunohistochemical analysis of HRS in Drosophila eve positive motor neuronal cell 
bodies reveals a significant decrease in HRS within Rab8 mutants. Eve positive motor neurons 
within the ventral nerve cord of 3rd instar larvae. Scale Bar = 2 μm. (ANOVA: F(d.f. 1) = 
215.8528; p < 0.001). 
  
 
 
 
5.2.2. JNK Signalling is Up-regulated in Rab8 Mutants and 
Required for Unrestricted NMJ Growth !
 
Synaptic growth and plasticity requires regulation by a multitude of intricate and 
interconnected signalling pathways. As such it was asked whether synaptic 
overgrowth in Rab8 mutants was associated with perturbation to any other 
developmental pathways, other than TGFβ. One alternative pathway that has 
been implicated as a potent regulator of synaptic growth and development at 
the Drosophila NMJ is that of JNK/AP-1 signalling (Collins et al., 2006; Etter et 
al., 2005; Milton et al., 2011; Sanyal et al., 2002). AP-1 is a transcription factor 
comprised of hetro- or homo-dimers of Fos and Jun which, once activated, 
translocate to the nucleus promoting transcriptional activation of mediators of 
synaptic growth and function, as well as other tissue specific responses 
including apoptosis and autophagy (Collins et al., 2006; Milton et al., 2011; 
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Perkins et al., 1990). Genes encoding AP-1 components, including Fos and 
Jun, are classified as immediate-early genes, the transcription of which can be 
rapidly induced independently of de novo protein synthesis (Karin, 1996). JNK 
is a central component of the JNK signalling cascade leading to activation of 
AP-1 in response to a variety of both intracellular and extracellular cues, 
including oxidative stress (Derijard et al., 1994; Hibi et al., 1993; Milton et al., 
2011; Pantos et al., 2003; Silverman et al., 2003; Yoshida et al., 2005). For 
example recent work in the Sweeney lab has shown that spin mutants display 
an oxidative stress burden, as a result of endosomal-lysosomal dysfunction, 
leading to up-regulated JNK/AP-1 signalling and eliciting a synaptic overgrowth 
phenotype (Milton et al., 2011). This overgrowth was shown to be alleviated by 
inhibition of the JNK/AP-1 pathway. With Rab8 mutants presenting a synaptic 
overgrowth phenotype similar to that observed in spin mutants and with both 
mutant overgrowths showing the requirement for a permissive TGFβ signal it 
was asked whether JNK signalling contributed towards overgrowth in Rab8 
mutants, as with spin. 
 
Through inhibition of JNK signalling using either pan-neuronal (nSyb-Gal4) or 
motor neuronal (OK6-Gal4) driven expression of a dominant negative form of 
Fos (UAS-FosDN) it was shown that functional JNK signalling was essential for 
the unrestricted synaptic growth phenotype observed in Rab8 mutants. Pan-
neuronal and motor neuronal expression of UAS-FosDN had no effect upon 
synaptic bouton number when expressed in a wildtype background (Fig. 5.6.).  
However when expressed in a Rab8 transheterozygous mutant background 
both pan-neuronal and motor neuronal expression of FosDN was sufficient to 
completely rescue increased bouton number, showing no variance from 
wildtype but a significant difference to Rab81/Rab8B229 (Fig. 5.6.). In addition it 
was also shown that inhibition of puckered, a negative regulator of JNK 
signalling, using a heterozygous loss of function Puc mutant PucE69 in a 
heterozygous Rab8 mutant background induced an increase in synaptic bouton 
number comparable to both Rab8 transheterozygotes and Rab81/DadΔIEL 
double heterozygotes (Fig. 5.6.). In contrast the presence of heterozygous 
PucE69 or Rab81 alone showed no variance in synaptic bouton number, 
compared to wildtype (Fig. 5.6.).  Therefore as with TGFβ signalling JNK 
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signalling contributes towards the synaptic overgrowth phenotype observed in 
Rab8 mutants.!!
Figure 5.6. Unrestricted NMJ Growth in Rab8 Mutants Requires Functional JNK 
Signalling 
(A-B) Inhibition on JNK signalling through pan-neuronal (nSyb-Gal4) or Motor neuronal (OK6-
Gal4) driven expression of a dominant negative Fos, UAS-FosDN, in a transheterozygous Rab8 
mutant background rescues the increased bouton number observed in Rab8 transheterozygous 
mutants. Pan-neuronal and motor neuronal expression of UAS-FosDN in a wildtype backgrounds 
shows no variance in bouton number compared to wildtypes. Suppression of JNK inhibition 
through the presence of a heterozygous puckered loss of function mutant, PucE69, alongside 
heterozygous Rab81 induces an overgrowth phenotype comparable to that seen in Rab8 
transheterozygous mutants whilst heterozygous Rab81 and PucE69 alone show no variance from 
wildtype. Scale bar = 10 μm. (ANOVA: F(d.f. 8) = 36.4999; p < 0.001 with post-hoc Dunnett’s 
comparison to wildtype control *** p < 0.001 and student t-test comparison between genotypes 
### p < 0.001). 
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In order to substantiate the observed role of JNK signalling in Rab8 mutant NMJ 
overgrowth it was asked whether Rab8 mutants display an increased activation 
of the JNK signalling pathway. Puc has been shown to be transcriptionally 
activated by the JNK/AP-1 pathway, providing a feedback loop in order to 
modulate JNK signalling (Martin-Blanco et al., 1998). As such Puc-LacZ can be 
used as a reporter of JNK activity. Here it is shown that transheterozygous 
Rab8 mutants display a significant increase in JNK activity, displaying a clear 
increase in nuclear Puc driven –LacZ expression in eve positive motor neurons 
(Fig. 5.7. A-B).!!!!!!
 
 !
 
 
 
 !!
 
 
 
Figure 5.7. Rab8 Mutants Display Increased Levels of JNK Activity 
(A) Rab8 mutants display a clear increase in nuclear Puckered-LacZ (puc-lacZ) staining, a 
reporter of JNK activity, within eve positive motor neurons in 3rd instar larval ventral nerve cords. 
Scale bar = 2 μm. (B) Quantification of nuclear puc-lacZ in eve positive motor neurons reveals a 
significant increase in Rab8 mutants, compared to wildtypes (ANOVA: F(d.f. 1) = 53.6294; p < 
0.001). 
 !
 
5.2.3. TGFβ and JNK Signalling Act Synergistically in Normal 
Physiological Regulation of NMJ Growth !
 
Here it has been demonstrated that both TGFβ and JNK signalling are up-
regulated in transheterozygous Rab8 mutants. In addition it is shown that 
suppression of inhibition of JNK or TGFβ in a heterozygous Rab8 mutant 
background induces synaptic overgrowth comparable to transheterozygous 
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Rab8 mutants. As such it was asked whether TGFβ and JNK signalling might 
act synergistically in the regulation of normal physiological NMJ growth. 
Previous studies have shown that, in other contexts, TGFβ and JNK signalling 
display direct and mutual interaction (Liu et al., 2012; Mao et al., 2011; Perlman 
et al., 2001; Sorrentino et al., 2008). For example it has been shown that TGFβ 
is capable of activating JNK in a SMAD-independent, TRAF6 and TAK1 
dependent manner (Sorrentino et al., 2008). Operating in a mechanism that is 
proposed to show similarity to that of the Toll-like receptor pathway. Conversely 
it has been shown that JNK signalling can also activate TGFβ with AP-1 
components directly interacting with SMAD’s and that JNK can regulate TGFβ 
in a SMAD2 dependent manner (Derynck and Zhang, 2003; Engel et al., 1999). 
The results presented here provide support for the hypothesis that TGFβ and 
JNK signalling pathways may act synergistically in the regulation of 
developmental processes, including synaptic growth at the Drosophila NMJ. As 
mentioned previously, in sections 5.2.1. and 5.2.2., Dad and Puc act as 
negative mediators of TGFβ and JNK signalling, respectively. Furthermore if 
either is inhibited, through the heterozygous presence of a loss of function 
allele, in a Rab8 heterozygous mutant background synaptic overgrowth is 
induced. Here it is shown that whilst neither heterozygous PucE69 or DadΔIEL 
loss of function mutants induce synaptic overgrowth PucE69/DadΔIEL 
heterozygous double mutants display synaptic overgrowth comparable to that 
seen in PucE69/Rab81 and DadΔIEL/Rab81 double mutants, as well as in Rab8 
transheterozygous mutants (Fig. 5.8.). Synaptic overgrowth in PucE69/DadΔIEL 
heterozygous double mutants is characterised by an increase in synaptic 
bouton number (Fig. 5.8.A-C), which is conserved across NMJ’s at both muscle 
6/7 and 4, as well as an increase in NMJ length (Fig. 5.8.D) and a reduction in 
synaptic bouton size (Fig. 5.8.E). Interestingly these results also demonstrate 
that whilst bouton number and NMJ length are unaffected bouton size is 
reduced in PucE69/+ heterozygous mutants (71.5 % of wildtype) to 
approximately the same degree as PucE69/DadΔIEL double mutants (72.8 % of 
wildtype) as well as Rab8 heterozygous (76.9 % of wildtype) and 
transheterozygous (77.2 % of wildtype) mutants observed previously. This 
suggests that JNK signalling may play a potent role in the regulation of bouton 
size and the reduced bouton size seen in Rab8 mutants. 
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Figure 5.8. TGFβ and JNK Signalling Act Synergistically to Regulate Normal NMJ Growth 
(A) Heterozygous combinations of Dad and Puc loss of function mutants together reduce Dad 
and Puc inhibition of the TGFβ and JNK signalling pathways, respectively. In doing so this 
elicits a clear synaptic overgrowth phenotype comparable to that seen in Rab8 
transheterozygous mutants. Images on the left represent muscle 6/7 and those on the right 
muscle 4, hemi-segment A3 of 3rd instar larvae. Scale bar = 10 μm. (B) Quantification of 
synaptic bouton number at muscle 6/7 reveals that DadΛIEL/PucE69 heterozygous double mutants 
show a significant increase in mean normalised synaptic bouton number compared to wildtype 
and heterozygous DadΔIEL and PucE69 single mutants, which show no variance from wildtype. 
(ANOVA: F(d.f. 3) = 28.0239; p < 0.001 with post-hoc Dunnett’s comparison to wildtype control 
*** p < 0.001 and student t-test comparison between genotypes ### p < 0.001). (C) The same 
trend is observed at muscle 4 with DadΔIEL/PucE69 double mutants displaying a significant 
increase in mean normalised bouton number compared to wildtypes and both DadΔIEL and 
PucE69 single mutants, which display no variance from wildtype. (ANOVA: F(d.f. 3) = 21.5592; p 
< 0.001 with post-hoc Dunnett’s comparison to wildtype control *** p < 0.001 and student t-test 
comparison between genotypes ### p < 0.001). (D) DadΔIEL/PucE69 double mutants also display 
a significant increase in mean normalised NMJ length when compared to wildtype and to both 
heterozygous single DadΔIEL and PucE69 mutants, which display no significant variance from 
wildtype. (ANOVA: F(d.f. 3) = 9.5010; p < 0.001 with post-hoc Dunnett’s comparison to wildtype 
control *** p < 0.001 and student t-test comparison between genotypes ### p < 0.001, ## p < 
0.01). (E) DadΔIEL/PucE69 double mutants also display a significantly reduced mean normalised 
synaptic bouton size compared to wildtypes and to DadΔIEL heterozygotes, which show no 
variance from wildtype. However in contrast PucE69 heterozygous mutants show a significantly 
reduced bouton size, compared to wildtype, equal to that of DadΔIEL/PucE69 double mutants. !
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5.2.4. Rab8 Mutants Reveal a Role for the Endosomal JNK 
Scaffold POSH and the JNKKK TAK1 in Synapse Growth !!
Previous findings in this investigation demonstrate that Rab8 mutants display 
unrestricted synaptic overgrowth associated with up-regulated TGFβ and JNK 
signalling, as well as perturbations to normal endosomal trafficking.  
Furthermore these results suggest that TGFβ and JNK signalling act 
synergistically to regulate synaptic growth. POSH has previously been identified 
as a potent regulator of JNK signalling acting both as a JNK scaffold and as a 
modulator of TAK1, a known JNKKK (Tapon et al., 1998; Tsuda et al., 2005; 
Tsuda et al., 2006; Xu et al., 2003). It has been demonstrated that POSH 
actively binds to TAK1, targeting it for proteasomal degradation through the E3 
ubiquitin ligase activity of the POSH zinc finger ring domain (Tsuda et al., 2005). 
In addition in other contexts TAK1 has, as its names suggests, been shown to 
be directly activated by the TGFβ signalling pathway (Shibuya et al., 1998; 
Sorrentino et al., 2008; Yamaguchi et al., 1995). Ligand mediated activation of 
the TGFβ receptor complex promotes dimerisation and auto-ubiquitylation of 
TRAF6 leading to the ubiquitylation and activation of TAK1, which has been 
shown to associate directly with the TGFβ type-I receptor (Sorrentino et al., 
2008). TAK1 is then capable of further auto-phosphorylation and activation of 
downstream JNK signalling. Alternatively it has been proposed that under un-
stimulated conditions TAK1 stably associates with the TGFβ type-I receptor, 
however upon activation TAK1 dissociates and is activated via TAB-1 mediated 
auto-phosphorylation (Kim et al., 2009). Whilst the exact mechanism remains to 
be fully elucidated these previous findings suggest that TGFβ activation may 
lead to downstream activation of the JNK signalling pathway via TAK1, a protein 
that is regulated by the E3 ubiquitin ligase activity of the JNK scaffolding protein 
POSH. POSH has also been shown to associate with HRS on early 
endosomes, where it plays an essential role, through its E3 ubiquitin ligase 
activity, in the regulation of HRS stability (Kim et al., 2006). HRS in turn directly 
associates with TAK1 where it has been shown to be essential for both the 
localisation of TAK1 to the endosome and the activation of both TAK1 and 
TGFβ SMAD’s (Miura and Mishina, 2011).   
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Based on the previously identified roles for POSH, and it’s associated factors, it 
was proposed that POSH may act as a central point in the regulation of synaptic 
growth, acting to scaffold JNK signalling and conveying transduction of a 
signalling cascade from TGFβ to JNK, via TAK1. The results here provide 
support for this hypothesis demonstrating that both inhibition and neuronal 
overexpression of POSH rescue the synaptic overgrowth observed in Rab8 
transheterozygous mutants. Here it was demonstrated that inhibition of POSH 
through the use of POSH mutants POSHEP1206 and POSHEP2248 either 
homozygously or transheterozygously in a transheterozygous Rab8 mutant 
background showed no significant variance in synaptic bouton number to their 
controls, in a wildtype background (Fig. 5.9.). In addition all POSH Rab8 double 
mutants displayed a significantly reduced number of synaptic boutons 
compared to Rab8 transheterozygous mutants. Furthermore, with the exception 
of homozygous POSHEP1206, no allelic combination of POSH mutants displayed 
any variance from wildtype in either a wildtype or Rab8 mutant background (Fig. 
5.9.).  As such, taken together, it can be inferred that inhibition of POSH is 
sufficient to alleviate increased synaptic bouton number in Rab8 mutants.  In 
addition it was also demonstrated that pan-neuronal expression of UAS-POSH, 
which showed no variance to wildtype in a wildtype background, was sufficient 
to completely rescue increased synaptic bouton number in a Rab8 mutant 
background (Fig. 5.9.). nSyb-Gal4/UAS-POSH;Rab81/Rab8B229 larvae showed 
no variance in synaptic bouton number to wildtype or the UAS-POSH control, 
yet a significant variance to the transheterozygous Rab8 mutants (Fig. 5.9.).  
Taken together these results indicate a fundamental role for POSH in the 
regulation of synaptic growth. 
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Figure 5.9. Perturbation of POSH Alleviates Increased Synaptic Bouton Number in Rab8 
Mutants 
Increased normalised synaptic bouton number in Rab8 transheterozygous mutants can be 
alleviated through expression of POSH mutants POSHEP1206 and POSHEP2248 either 
homozygously or transheterozygously in a Rab8 mutant background. All POSH Rab8 double 
mutants show a significant variance in synaptic bouton number to Rab8 transheterozygous 
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mutants. In addition each displays no significant variance to its representative POSH mutant 
control (in a wildtype background). Both POSHEP1206/POSHEP1206;Rab81/Rab8B229 double 
mutants and POSHEP1206/POSHEP1206 controls presented a small but significant variance to 
wildtype. All other double mutants and their controls showed no significant variance in synaptic 
bouton number to wildtype. Similarly overexpression of UAS-POSH, under the control of the 
pan-neuronal driver nSyb-Gal4, showed no effect upon synaptic bouton number alone, however 
was sufficient to completely rescue increased bouton number in a Rab8 mutant background. 
Neuronal expression of UAS-POSH in a Rab8 mutant background showed no significant 
variance to either the UAS-POSH control or wildtypes. Analysis was of muscle 6/7, hemi-
segment A3 in 3rd instar wandering larvae. Scale bar = 10 μm. (ANOVA: F(d.f. 9) = 24.0378 p < 
0.001 with post-hoc Dunnett’s comparison to wildtype control *** p < 0.001 and student t-test 
comparison between genotypes ### p < 0.001).   
 
 
Having demonstrated that both overexpression and inhibition of POSH in a 
Rab8 transheterozygous mutant background is sufficient to rescue synaptic 
overgrowth analysis looked to determine whether there was any perturbation to 
normal POSH distribution in Rab8 mutants. Here it is shown that in Rab8 
transheterozygous mutants POSH displays an altered distribution pattern, 
displaying increased intensity and accumulations within axon bundles projecting 
from the VNC (Fig. 5.10.).  
 
 
 
 
!
!
 
Figure 5.10. POSH Accumulates in Axons of Transheterozygous Rab8 Mutants 
Anti-POSH immunohistochemical staining reveals accumulations of POSH within axon bundles 
of transheterozygous Rab8 mutant larvae. Accumulations were not seen in wildtype larvae. 
Scale bar = 10 μm. 
 
!
Having identified a role for POSH in the regulation of synaptic growth, with both 
POSH mutants and neuronal expression of POSH alleviating synaptic 
overgrowth in Rab8 mutants, it was asked whether either TAK1 or HRS 
contribute towards synaptic growth. The results presented here demonstrate 
that TAK1 acts as a potent regulator of synaptic growth. For example whilst 
heterozygous expression of the TAK1 loss of function mutant TAK1179 shows no 
variance in synaptic bouton number from wildtypes, introduction of TAK1179/+ 
into a Rab81/Rab8B229 mutant background shows a significant variance from 
Rab81/Rab8B229 mutants and no variance from wildtypes (Fig. 5.11). 
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TAK1179/+;Rab81/Rab8B229 mutants do, however show a small, but significant, 
variance from TAK1179/+ controls suggesting this may not be a full rescue. This 
does however demonstrate that TAK1 is essential for the overgrowth phenotype 
observed in Rab8 transheterozygous mutants. Corroborating these findings it 
was also shown that neuronal (nSyb-Gal4) expression of either a TAK1-RNAi or 
a kinase dead TAK1 dominant negative allele (UAS-TAK1K46R, (Mihaly et al., 
2001)) could completely alleviate increase synaptic bouton number in Rab8 
transheterozygotes (Fig. 5.11.). Neuronal expression of either in a Rab8 mutant 
background showed a significant variance in synaptic bouton number from 
Rab8 transheterozygous mutants but no variance to either wildtypes or nSyb 
driven TAK1-RNAi or TAK1 dominant negative controls (Fig. 5.11.). In addition it 
was also shown that neuronal overexpression of wildtype TAK1 could elicit a 
potent synaptic overgrowth phenotype (Fig. 5.11.). This overgrowth displayed 
phenotypic characteristics visibly comparable to Rab8 mutants, including a 
prevalence of small boutons. 
 
In addition to a role for TAK1 in the regulation of synaptic growth these results 
also reveal a role for HRS. Here it is demonstrated that whilst presence of the 
heterozygous HRS loss of function mutant HRSD28 has no effect upon synaptic 
bouton number HRSD28/Rab81 transheterozygous mutants show a significant 
increase in synaptic bouton number, compared to wildtype (Fig. 5.11.). Rab81 
heterozygotes were again shown to have no effect upon synaptic bouton 
number in their own right (Fig. 5.11.). Synaptic overgrowth observed was not as 
severe as that seen in Rab8 transheterozygotes. These results support 
previous findings that Rab8 transheterozygous mutants display a significant 
reduction in HRS within motor neuronal cell bodies and suggest that HRS 
contributes towards the regulation of NMJ growth.  
 
Taken together these results identify POSH and TAK1 as novel regulators of 
synaptic growth. In addition they reveal a potential role for the POSH complex 
as a nexus in the regulation of growth signals, potentially modulating 
transduction of TGFβ signals, via TAK1, to JNK.!!
!
!
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Figure 5.11. TAK1 and HRS Contribute Towards Synaptic Overgrowth in Rab8 Mutants 
(A) Inhibition of TAK1 via heterozygous expression of the loss of function mutation TAK1179 or 
pan-neuronal expression of a dominant negative TAK1 or a TAK1-RNAi in a transheterozygous 
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Rab8 mutant background alleviates the increase in synaptic bouton number seen in Rab8 
mutants. Overexpression of TAK1 induces a synaptic overgrowth comparable to Rab8 
transheterozygotes. Similarly inhibition of HRS via transheterozygous expression of the loss of 
function mutant HRSD28 alongside Rab81 elicits a synaptic overgrowth phenotype. Heterozygous 
expression of either HRSD28 or Rab81 alone has no effect upon bouton number. Scale bar = 10 
μm. (B) Quantification of synaptic bouton number. (ANOVA: F(d.f. 11) = 24.2733; p < 0.001 with 
post-hoc Dunnett’s comparison to wildtype control *** p < 0.001 and student t-test comparison 
between genotypes ### p < 0.001, # p < 0.05).   !!!
5.3. Discussion 
 
5.3.1. TGFβ and JNK Signalling Are Required for Unrestricted 
Growth in Rab8 Mutants !!
Previous studies have demonstrated that both TGFβ and JNK signalling play a 
fundamental role in the development of the nervous system (Bjorkblom et al., 
2005; Gomes et al., 2005; Kim et al., 2005a; Mecha et al., 2008; Sun et al., 
2013; Unsicker and Strelau, 2000; Vogel et al., 2010). Furthermore they have 
shown that perturbations to either pathway can have significant implications 
upon neuronal development leading to neurodegeneration and 
neurodegenerative diseases. For example in a study by Lee et al. (2010) it was 
shown that TGFβ activity promoted aggregation of TGF-β1-induced anti-
apoptotic factor (TIAF1) leading to the accumulation and aggregation of amyloid 
plaques, characteristic of Alzheimer’s disease, and the induction of apoptotic 
cell death (Lee et al., 2010). Furthermore other studies have demonstrated that 
TGFβ signalling is up-regulated in the brains of Alzheimer’s patients, although 
whether this is pathological or a neuroprotective response has yet to be fully 
elucidated (Chao et al., 1994; Flanders et al., 1995). Similarly studies have also 
shown that increased JNK signalling results in an aberrant accumulation of both 
amyloid and Tau aggregates in models of Alzheimer’s disease (Dias-Santagata 
et al., 2007; Shen et al., 2008). Furthermore, as for TGFβ signalling, JNK 
signalling has been shown to be elevated in the brains of Alzheimer’s patients 
(Bomfim et al., 2012; Zhu et al., 2003). Perturbations to both TGFβ and JNK 
signalling has also been observed in patients suffering from other 
neurodegenerative diseases including Parkinson’s disease and ALS (Ilzecka et 
al., 2002; Mogi et al., 1995; Peng and Andersen, 2003). TGFβ and JNK 
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signalling have also been implicated in a broad array of processes essential for 
development of the nervous system including facilitation of dendritic 
development, synapse development, axon path-finding, development of the 
cerebellum and neuronal differentiation, and neuronal migration, apoptosis and 
development, for TGFβ and JNK respectively (Charron and Tessier-Lavigne, 
2007; Constam et al., 1994; Heupel et al., 2008; Li et al., 2009a; Sun et al., 
2007; Yi et al., 2010). 
 
Studies in Drosophila have demonstrated that both the TGFβ and JNK 
signalling pathways display a contributory role in the regulation of normal NMJ 
assembly and function. For example inhibition of normal TGFβ signalling has 
been shown to elicit a significant synaptic undergrowth phenotype in wildtype 
larvae (Aberle et al., 2002; O'Connor-Giles et al., 2008; Sweeney and Davis, 
2002). In addition a permissive TGFβ signal has been demonstrated to be 
essential in a number of synaptic overgrowth models, including spin, nwk and 
Ema, with inhibition of TGFβ alleviating overgrowth in a dose dependent 
manner (Kim et al., 2010; O'Connor-Giles et al., 2008; Sweeney and Davis, 
2002). Similarly JNK has been revealed to be a positive regulator of NMJ 
growth with inhibition of JNK signalling alleviating NMJ overgrowth in both spin 
and hiw mutants (Collins et al., 2006; Milton et al., 2011).  As such the 
observation that both TGFβ and JNK signalling are essential for the unregulated 
synaptic growth phenotype observed in Rab8 mutants and that both pathways 
appear to be actively up-regulated in these mutants provides further support to 
a growing body of evidence for the involvement of these pathways in NMJ 
development. In addition to corroborating previous findings that both TGFβ and 
JNK signalling have a functional role in the regulation of NMJ development the 
results presented here reveal that NMJ expansion and synaptic bouton size 
appear to be regulated semi-autonomously from one another. For example it is 
demonstrated that whilst overgrowth phenotypes, including increased NMJ 
length and bouton number, require transheterozygous mutation of Rab8, 
reduced synaptic bouton size is observed in Rab8 homozygotes. In addition 
alleviating inhibition upon TGFβ signalling by inhibiting Dad, which potentiates 
all other unregulated growth phenotypes observed, does not potentiate reduced 
bouton size. Furthermore it was shown that heterozygous puc mutants, which 
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essentially show reduced JNK inhibition, display significantly reduced synaptic 
bouton sizes comparable to Rab8 transhetrozygotes, but no overgrowth 
phenotypes. As such taken together these findings suggest that reduced 
synaptic bouton size, which is observed in numerous Drosophila mutants 
displaying unregulated NMJ growth and is a hallmark of hiw mutants, may be 
regulated semi-autonomously from NMJ expansion phenotypes and potentially 
by JNK signalling independently of TGFβ.  
 
As well as elevated levels of TGFβ activity, indicated by significant increases in 
levels of nuclear P-MAD and nuclear Dad-LacZ, Rab8 mutants were shown to 
display accumulations of P-MAD within axon bundles projecting from the VNC. 
In a recent study Smith et al. (2012) demonstrated that active TGFβ receptor 
complexes are endocytosed and trafficked, retrogradely and in an activity 
dependent manner, from the Drosophila NMJ to the cell body in order to 
modulate TGFβ activity at the synapse. As such one may postulate that 
accumulations of P-MAD visible within the axon may relate to P-MAD in 
complex with the active TGFβ receptor complex being trafficked from the 
synapse. However Smith et al. (2012) showed no evidence that P-MAD was 
transported along axons, inferring that P-MAD at the synaptic terminal and cell 
body represent two distinct populations. Indeed here we show no evidence of P-
MAD in the axons of wildtype animals, suggesting that under normal 
physiological conditions P-MAD is not transported along axons, at least not at 
visible levels. As such it may be inferred that either Rab8 mutants perturb 
normal P-MAD localisation resulting in axonal accumulations or that maybe 
such elevated levels of P-MAD in Rab8 mutants allows for visualisation of 
axonally transported P-MAD. One may also propose that axonal accumulations 
may associate with the perturbation to normal endosomal trafficking previously 
observed in Rab8 mutants (Chapter 4).       
 
 
5.3.2. TGFβ and JNK Signalling Act Synergistically in The 
Regulation of NMJ Growth 
 
As mentioned previously both TGFβ and JNK signalling have already been 
implicated in the regulation of Drosophila NMJ assembly and function. In fact it 
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has been shown that synaptic overgrowth in an increasing number of mutants, 
including spin, hiw and now Rab8, can be alleviated by inhibition of either 
pathway. However, despite this, there has been little evidence to date that 
TGFβ and JNK act synergistically during the regulation of NMJ growth. In 
contrast a significant body of evidence exists to show that in many other 
contexts TGFβ and JNK act synergistically, with significant degrees of crosstalk 
(Liu et al., 2012; Liu et al., 2007; Pardoux and Derynck, 2004; Shim et al., 2005; 
Ventura et al., 2004; Yamashita et al., 2008). For example Adachi-Yamada et 
al. (1999) demonstrated that, in Drosophila, overexpression of a constitutively 
active Tkv promoted JNK activation and induction of downstream apoptotic 
responses (Adachi-Yamada et al., 1999). Similarly Yang and Su (2011) 
demonstrated that ectopic TGFβ expression lead to JNK-dependent activation 
of apoptosis in Drosophila cardiac tissue (Yang and Su, 2011). Furthermore 
they showed that the TGFβ ligand (dpp) potentiated it’s own expression, 
through TAK1, resulting in hyperactivity of JNK under pathological conditions. 
As such the observation, in this investigation, that under normal physiological 
conditions simultaneously reducing the restraint maintained upon both the 
TGFβ and JNK signalling pathways can elicit a synaptic overgrowth phenotype 
provides evidence that, as within other systems, TGFβ and JNK act 
synergistically in the regulation of NMJ development. Overgrowth observed in 
this investigation was characterised by a significant increase in both synaptic 
bouton number and NMJ length, as well as a reduction in synaptic bouton size, 
a phenotype comparable to that observed in Rab8 mutants. 
 
 
5.3.3. Rab8 Mutants Reveal a Role for the Endosomal JNK 
Scaffold POSH and the JNKKK TAK1 in Synapse Growth 
 
Numerous studies have implicated Rab8 as playing an essential role in the 
trafficking of endosomal cargo to the recycling endosome (Henry and Sheff, 
2008; Linder et al., 2007; Vaibhava et al., 2012). In addition results presented 
previously in this investigation (Chapter 4) demonstrate that Rab8 mutants 
display significant perturbation to endosomal trafficking. This included a 
significant reduction of the recycling endosomal marker Rab4. In a study by 
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Rodal et al. (2011) it was demonstrated that inhibition of endosomal recycling 
contributed towards aberrant accumulation of active, ligand bound, TGFβ 
receptors within the early endosome. Furthermore ectopic TGFβ signalling 
within the endosome promoted significant synaptic overgrowth. This 
observation supports a growing body of evidence demonstrating that TGFβ 
receptors continue to signal within the endosome and that this can contribute 
towards unrestricted synaptic growth in a number of mutant models displaying 
endosomal perturbation (Rodal et al., 2011; Sweeney and Davis, 2002; Wang et 
al., 2007). In fact it has also been shown that TGFβ signalling is actively up-
regulated in the early endosome due to early-endosomal enrichment of SARA, a 
protein involved in trafficking R-SMAD’s to the TGFβ receptors (Di Guglielmo et 
al., 2003; Hayes et al., 2002). As discussed earlier recent evidence also 
suggests that ligand bound TGFβ receptors are actively endocytosed at the 
synaptic terminal and transported to the cell body to convey signal transduction 
essential for the modulation of synaptic growth (Smith et al., 2012). As such it is 
clear that recycling of TGFβ receptors via the recycling endosome is essential 
to return receptors to the synaptic terminal, maintaining synaptic homeostasis. 
Assimilation of these previous findings with the observation that Rab8 mutants 
display significantly elevated levels of TGFβ signalling, coupled with endosomal 
perturbation, provide support for the hypothesis that synaptic overgrowth in 
Rab8 mutants is associated with aberrant endosomal processing of TGFβ. In 
addition to elevated TGFβ signalling Rab8 mutants display significant up-
regulation of JNK signalling, coupled with accumulation of the endosomal JNK 
scaffolding protein POSH within axonal projections. As such based upon 
previous literature and the results presented here we propose a model by which 
endosomal accumulation of active TGFβ receptors promotes synaptic 
overgrowth via transduction of ectopic expression via TAK1 to activate JNK, 
scaffolding upon the endosomal JNK scaffold POSH (Fig. 5.12.). We propose 
that ectopic TGFβ expression within early endosomes promotes activation of 
the JNKKK TAK1, as discussed previously in section 2.5.4.. TAK1 in turn 
associates with the JNK scaffold POSH promoting activation of JNK. This 
ectopic activation promotes unrestricted growth in Rab8 mutants. In addition 
TAK1 has been implicated in a feedback loop promoting TGFβ activation 
through interaction with the downstream SMAD proteins. As such this may 
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further potentiate ectopic expression of the TGFβ and JNK signalling pathways, 
potentiating synaptic growth. The observations made in this chapter support this 
model. For example TGFβ and JNK signalling were shown to be elevated in 
Rab8 mutants and be required for synaptic overgrowth. In addition they were 
demonstrated to act synergistically in the regulation of synaptic growth. 
Furthermore inhibition of TAK1 alleviates synaptic overgrowth in Rab8 mutants 
whilst overexpression of TAK1 in a wildtype background promotes synaptic 
overgrowth comparable to that seen in Rab8 mutants. It was also shown that 
both inhibition and overexpression of POSH could alleviate overgrowth. This 
can be explained by the fact that inhibition of POSH inhibits the role of POSH as 
a central scaffold but also that if overexpressed POSH is likely to titrate out the 
associated factors reducing the ectopic induction of JNK at the endosome. 
Overexpression of POSH may also promote POSH mediated degradation of 
TAK1 via the E3-ubiquitin ligase activity of this protein (Tsuda et al., 2005). In 
order to provide support for this model future investigation shall look to 
ascertain levels of TGFβ and JNK signalling in Rab8 transheterozygous 
mutants in a POSH null background. Similarly levels of TGFβ and JNK 
signalling should be determined in TAK1,Rab8 double mutants. Unfortunately 
due to the generation times required this analysis could not be performed in 
time to contribute towards this data chapter.  
 
 
 
 
 
 
 
 
 
 
 
Figure 5.12. Proposed Model For POSH As a Regulator of Synaptic Growth 
Mutations in Rab8 induce perturbation to normal endosomal trafficking, potentially through 
disrupting Rab8’s role in promoting endosomal traffic to the recycling endosome. This 
perturbation promotes accumulation of endocytosed ligand bound, active TGFβ receptors within 
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the early endosome. Rab8 mutants also display accumulation of the early-endosomal protein 
POSH with axon bundles projecting from the ventral nerve cord. Active TGFβ receptors promote 
activation of the JNKKK TAK1, which, in complex with the JNK scaffold POSH promotes ectopic 
activation of the JNK signalling pathway. TAK1 may also promote activation of autophagy, 
which has also been implicated in JNK activation. TAK1 can also promote further TGFβ 
signalling, acting in a feedback loop via the SMAD proteins involved in TGFβ signal 
transduction. POSH has also been shown to act as an E3 ubiquitin ligase promoting the 
degradation of HRS. Ectopic degradation of HRS, alongside Rab8 mutants creates a further 
burden upon the endosomal pathway inhibiting both endosomal-lysosomal degradation of ligand 
bound receptors and recycling via the recycling endosome. As such this potentiates TGFβ 
accumulation within early endosomes potentiating the pathological cycle.  
 
 
In addition to the role of POSH as a JNK scaffold it has been demonstrated that 
POSH acts as an E3 ubiquitin ligase, promoting the degradation of HRS at early 
endosomes (Kim et al., 2006). The results presented in this chapter 
demonstrate that Rab8 transheterozygous mutants display a significant 
reduction in motor neuronal HRS. In addition inhibition of HRS in a 
heterozygous Rab8 mutant background was sufficient to promote synaptic 
overgrowth. As such one may postulate that accumulation of POSH in Rab8 
mutants promotes POSH mediated degradation of HRS, leading to the 
reduction in HRS observed. In a previous study by Rodal et al. (2011) it was 
demonstrated that whilst HRS mutants do not display any perturbation to 
synaptic growth alone, HRS,Snx16 double mutants display a synaptic 
overgrowth phenotype. In this study they suggested that inhibition of Snx16 
perturbed nwk dependent endosomal trafficking to the recycling endosome 
whilst HRS mutants inhibit MVB formation. As such double mutants prevent 
endosomal recycling and degradation of TGFβ receptors leading to an 
accumulation of active TGFβ receptors within the early endosome. In turn 
ectopic TGFβ signalling promoted synaptic overgrowth. With previous studies 
implicating Rab8 in the recycling endosomal pathway taken together these 
findings support the proposed mechanism for synaptic overgrowth in Rab8 
mutants. This may also suggest why Rab8 mutants potentiate CHMP2BIntron5 
toxicity, as Rab8 CHMP2B double mutants would perturb both recycling 
endosomal traffic and MVB formation. In order to substantiate the role of POSH 
in the degradation of HRS, future investigation may look to determine whether 
heterozygous expression of a POSH null in a transheterozygous Rab8 mutant 
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background is sufficient to rescue reduced motor neuronal HRS levels observed 
in Rab8 mutants. 
 
In a study by Criollo et al. (2011) it was demonstrated that TAK1 may act as a 
regulator of autophagy (Criollo et al., 2011). For example they demonstrated 
that TAK1 depletion or expression of a TAK1 dominant negative inhibited 
autophagy in cell culture. In addition they reported that TAK1 was required for 
optimal induction of autophagy in response to a number of stimuli, including 
TGFβ signalling. Corroborating these findings a number of other studies have 
substantiated the role for TAK1 as a regulator of autophagy (Herrero-Martin et 
al., 2009; Shin et al., 2013). Previous studies have also shown that autophagy 
acts as a potent regulator of synaptic growth at the Drosophila NMJ (Milton et 
al., 2011; Shen and Ganetzky, 2009). For example it has been demonstrated 
that autophagy degrades hiw, relieving its inhibition upon JNK signalling, 
promoting synaptic overgrowth (Shen and Ganetzky, 2009). Furthermore 
inhibition of autophagy can alleviate synaptic overgrowth in spin mutants (Milton 
et al., 2011). As such one may postulate that autophagy may contribute towards 
synaptic overgrowth in Rab8 mutants and future investigation should look to 
determine whether inhibition of autophagy could alleviate synaptic overgrowth in 
Rab8 mutants. In fact preliminary evidence has shown that inhibition of 
autophagy by homozygous expression of a loss of function mutant of the 
essential autophagy gene Atg7 can inhibit increased mean normalised synaptic 
bouton number in transheterozygous Rab8 mutants (wt = 110.2 ± 3.7, n = 16. 
Rab81/Rab8B229 = 199.8 ± 13.7, n = 10. Atg7D77/Atg7D77 = 99.1 ± 6.03, n = 5. 
Rab81/Rab8B229; Atg7D77/Atg7D77 = 106.1 ± 7.9, n = 6). Future investigation shall 
look to build upon these preliminary findings by increasing the data set and 
including a range of autophagy related genes. 
 
 !!!!!!!
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5.3.4. Summary 
 
Taken together the results presented in this chapter demonstrate that synaptic 
overgrowth in Rab8 mutants requires TGFβ and JNK signalling and that both of 
these signalling pathways are elevated in Rab8 mutants. Furthermore they 
demonstrated that JNK and TGFβ signalling act synergistically in the regulation 
of synaptic growth and development. This synergism is potentially regulated by 
the activity of POSH as a central JNK scaffold, mediating a signal transduction 
pathway between TGFβ and JNK, via TAK1. Ectopic accumulation of POSH 
may also promote degradation of HRS, inhibiting MVB formation further 
potentiating ectopic TGFβ activity. 
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6. Characterisation of CHMP2BIntron5 and The 
Role of Rab8 In CHMP2BIntron5 Toxicity 
 
6.1. Introduction  !!
Previous studies have implicated CHMP2B in the regulation of normal neuronal 
development and morphology, which is perturbed by the FTD associated 
CHMP2BIntron5 mutation (Belly et al., 2010; Lee et al., 2012; Lee et al., 2007). As 
such we asked whether neuronal expression of CHMP2BIntron5 in Drosophila 
larvae would elicit a perturbation to the normal assembly and function of the 
NMJ. In addition, having previously identified Rab8 as both a potent regulator of 
NMJ growth and as a dominant enhancer of CHMP2BIntron5 expression in the fly 
eye, it was asked whether expression of Rab8 could alleviate any CHMP2BIntron5 
related perturbation observed. In this chapter we demonstrate that neuronal 
expression of CHMP2BIntron5 elicits a synaptic overgrowth phenotype at the 
Drosophila larval NMJ and that overexpression of Rab8 is sufficient to alleviate 
all aspects of this overgrowth phenotype. 
 
FTD-3 associated with the CHMP2BIntron5 mutation is classified, based upon the 
presence and composition of neuronal inclusions, as FTLD-UPS (Holm et al., 
2009; Isaacs et al., 2011). That is to say that patients, and model organisms, 
displaying the CHMP2BIntron5 mutation typically present with ubiquitin-positive 
neuronal inclusions. The formation of such inclusions has typically been 
associated with perturbation to homeostatic protein quality control systems 
including the ubiquitin proteasome system and autophagy (Chen et al., 2011; 
Takalo et al., 2013). In addition previous studies have revealed that mutations in 
CHMP2B, and other ESCRT components, elicit significant aberration to normal 
autophagic processes (Filimonenko et al., 2007a; Lee et al., 2007; Lee and 
Gao, 2008). Autophagy itself can be defined simply as a homeostatic catabolic 
process by which cellular components are recycled through targeted 
degradation by the lysosome. It has been demonstrated to serve as an 
essential protective response during periods of cell stress (Altman and 
Rathmell, 2012). In addition it has been implicated as a potent regulator of 
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synaptic growth at the Drosophila NMJ (Milton et al., 2011; Shen and Ganetzky, 
2009; West and Sweeney, 2012). However it is a matter of debate as to 
whether autophagy contributes towards the toxicity associated with the 
CHMP2BIntron5 mutation. As such in this chapter the investigation looks to 
determine whether autophagy contributes towards the toxicity of the 
CHMP2BIntron5 eye and NMJ phenotypes. 
 
 
6.2. Results  !
6.2.1. Neuronal Expression of CHMP2BIntron5 Elicits a Synaptic 
Overgrowth Phenotype That Can be Alleviated by Rab8 !
 
Previous studies have shown that expression of the CHMP2BIntron5 mutant 
transgene within cultured neurons results in a significant perturbation to normal 
neuronal morphology, prior to neuronal death (Belly et al., 2010; Lee et al., 
2007). For example Belly et al. (2011) demonstrated that transfection of primary 
rat hippocampal neurons with CHMP2BIntron5 induced a 25 % reduction in 
dendritic branching coupled with a 64 % increase in the density of dendritic 
spines. Spines were also, on average, 40 % smaller than those observed in 
wildtypes. In addition Lee et al. (2007) demonstrated that transfection of 
CHMP2BIntron5 into cultured cortical neurons elicited a significant dendritic 
retraction phenotype, presenting with an 80 % reduction in dendritic length prior 
to eventual neuron death within 2 - 3 days. In contrast, whilst CHMP2BIntron5 has 
been shown to induce a reduction in dendritic branching it has been 
demonstrated that mutations in the gene encoding the CHMP2B interacting 
protein Shrub elicit an increased branching phenotype in Drosophila larval class 
IV dendritic arborizing neurons (Sweeney et al., 2006). Increased branching 
was associated with a significant increase in the number of fine higher-order 
branches. With previous data implicating CHMP2B in the regulation of neuronal 
development analysis looked to determine whether expression of 
CHMP2BIntron5, in an in vivo Drosophila model, would elicit perturbations to 
normal neuronal morphology, focusing on the NMJ. The results presented here 
demonstrate that neuronal expression of UAS-CHMP2BIntron5, under the control 
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of the pan-neuronal driver nSyb-Gal4, induced a significant increase (35.3 %) in 
synaptic bouton number, when compared to wildtype, at muscle 6/7 hemi-
segment A3 of 3rd instar larvae (Fig. 6.1.).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1. Neuronal Expression of CHMP2BIntron5 Elicits a Significant Increase in 
Synaptic Bouton Number 
(A-B) Overexpression of the UAS-CHMP2BIntron5 mutant transgene under the control of the pan-
neuronal driver nSyb-Gal4 induces a synaptic overgrowth phenotype characterised by a 
significant increase in synaptic bouton number. 3rd instar larvae muscle 6/7, hemi-segment A3. 
Scale Bar = 10 μm. (ANOVA: F(d.f. 3) = 18.6926; p < 0.001 with post-hoc Dunnett’s comparison 
to wildtype control *** p < 0.001). 
 
 
Having observed a significant increase in synaptic bouton number at muscle 
6/7, hemi-segment A3, as result of pan-neuronal expression of the 
CHMP2BIntron5 mutant transgene, muscle 4 was used as a more amenable 
synapse to further characterise synaptic overgrowth. During the course of this 
investigation it has been demonstrated that Rab8 mutants act as dominant 
enhancers of CHMP2BIntron5 toxicity (Chapter 3), whilst Rab8 has been identified 
as a potent regulator of synaptic growth (Chapters 4 and 5). As such it was also 
asked whether expression of wildtype Rab8 could alleviate the overgrowth 
phenotype observed as a result of neuronal CHMP2BIntron5 expression.  
 
The results presented here demonstrate that the increased synaptic bouton 
number, associated with neuronal expression of CHMP2BIntron5, observed at 
muscle 6/7 is conserved at muscle 4 (Fig. 6.2.). For example a significant 
increase in synaptic bouton number, compared to wildtype, was observed at 
0!
20!
40!
60!
80!
100!
120!
140!
W"#(WT)# nSyb"GAL4/+(CS)# UAS#CHMP2BIntron5/+# nSyb"GAL4"UAS#CHMP2BIntron5#
M
ea
n 
No
rm
ali
se
d 
Bo
ut
on
 
Nu
m
be
r! 13!
13!
14!
11!
Wi
ldty
pe!
nS
yb-
Ga
l4/+
!
UA
S-C
HM
P2
BI
ntr
on5
/+!
nS
yb-
Ga
l4/U
AS
-CH
MP
2B
Intr
on5
!
***!
Wildtype!
nSyb-Gal4/UAS-CHMP2BIntron5!
A B 
6. Characterisation of CHMP2BIntron5 and The Role of Rab8 In CHMP2BIntron5 Toxicity 
!
   186!
both muscle 6/7 and 4 (Fig. 6.2.). In addition it was demonstrated that co-
expression of UAS-Rab8, which had no effect on synaptic bouton number 
alone, could alleviate increased bouton number associated with neuronal 
expression of the CHMP2BIntron5 mutant transgene (Fig. 6.2.). At muscle 6/7 a 
partial rescue was observed with nSyb-Gal4/UAS-CHMP2BIntron5;UAS-Rab8/+ 
NMJ’s showing a synaptic bouton number significantly less than nSyb-
Gal4/UAS-CHMP2BIntron5 NMJ’s, however still significantly greater than both 
wildtype and nSyb-Gal4/+;UAS-Rab8/+ controls (Fig. 6.2.B). In contrast at 
muscle 4 a complete rescue was observed with Rab8 rescues showing a 
significantly lower bouton number than nSyb-Gal4/UAS-CHMP2BIntron5 NMJ’s, 
and no significant variance from wildtypes (Fig. 6.2.A&C). Rescues did, 
however, show a small significant variance from nSyb-Gal4/+;UAS-Rab8/+ 
control’s, which showed a slightly increased, but not significant, number of 
boutons compared to wildtype. Overall these results suggest that neuronal co-
expression of wildtype Rab8 is sufficient to curtail increased synaptic bouton 
number induced by expression of the CHMP2BIntron5 mutant transgene. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2. Co-Expression of Wildtype Rab8 Can Alleviate Increased Synaptic Bouton 
Number Associated With Neuronal Expression of CHMP2BIntron5 
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(A) Neuronal expression of UAS-CHMP2BIntron5 under the control of the pan-neuronal driver 
nSyb-Gal4 induces a significant synaptic overgrowth phenotype that can be rescued by co-
expression of UAS-Rab8. Neuronal expression of UAS-Rab8 alone does not affect NMJ growth. 
Scale bar = 10 μm. (B-C) Increased synaptic bouton number associated with neuronal 
expression of the CHMP2BIntron5 mutant transgene can be alleviated by co-expression of UAS-
Rab8 at both muscle 6/7 and muscle 4, hemi-segment A3, in 3rd instar larvae. B: ANOVA: F(d.f. 
3) = 25.2705; p < 0.001 C: ANOVA: F(d.f. 3) = 6.3774; p < 0.001  with post-hoc Dunnett’s 
comparison to wildtype controls *** p < 0.001, ** p < 0.01, * p < 0.05 and student’s t-test 
between genotypes ### p < 0.001, ## p < 0.01, # p < 0.05). 
 
 
Analysis of muscle 4 also demonstrated that neuronal expression of the 
CHMP2BIntron5 mutant transgene elicited other synaptic overgrowth phenotypes, 
in addition to increased synaptic bouton number. For example nSyb-Gal4 driven 
expression of UAS-CHMP2BIntron5 induced a significant increase in mean 
normalised NMJ length (Fig. 6.3.A). Increased NMJ length was completely 
rescued by co-expression of wildtype Rab8. In contrast to Rab8 mutants’ nSyb-
Gal4/UAS-CHMP2BIntron5 larvae displayed a significant increase in NMJ 
branching (Fig. 6.3.B). This was, again, rescued by co-expression of Rab8. 
Comparable to Rab8 mutants neuronal expression of CHMP2BIntron5 induced a 
proliferation in the mean number of satellite boutons observed (Fig. 6.3.C). In 
contrast to many endocytic mutants this increase in satellite boutons does not 
account, entirely, for the increase in total bouton number observed. As with the 
other synaptic overgrowth phenotypes displayed increased satellite bouton 
number could be rescued through co-expression of Rab8 (Fig. 6.3.C). In 
contrast to Rab8 mutants, which display a reduced synaptic bouton size, 
neuronal expression of CHMP2BIntron5 has no effect upon the synaptic bouton 
size observed (Fig.6.3.D). As such cumulative bouton size was not analysed. 
Interestingly neuronal co-expression of Rab8 and the CHMP2BIntron5 mutant 
transgene elicited a significant increase in synaptic bouton number, compared 
to wildtype and UAS-Rab8 or UAS-CHMP2BIntron5 expressed alone (Fig.6.3.D). 
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Figure 6.3. Neuronal Expression of CHMP2BIntron5 Induces Unrestricted Synaptic Growth 
That Can be Rescued Through Co-Expression of Wildtype Rab8 
(A) Neuronal Expression of UAS-CHMP2BIntron5, using the pan neuronal driver nSyb-Gal4, 
induces a significant increase in mean normalised NMJ length compared to wildtypes and 
neuronally expressed Rab8, which shows no variance from wildtype. Increased NMJ length is 
rescued by co-expression of UAS-Rab8 with nSyb-Gal4/UAS-CHMP2BIntron5;UAS-Rab8/+ larvae 
showing no variance in NMJ length from wildtype or Rab8 controls, yet a significant variance 
from neuronally expressed CHMP2BIntron5.  ANOVA: F(d.f. 3) = 5.4519; p < 0.01  with post-hoc 
Dunnett’s comparison to wildtype controls ** p < 0.01 and student’s t-test between genotypes ## 
p < 0.01, # p < 0.05. (B) Neuronal expression of UAS-CHMP2BIntron5 elicits a significant increase 
in mean normalised branch number compared to wildtype and neuronally expressed Rab8 
controls. Increased branching is also rescued by co-expression of Rab8 with nSyb-Gal4/UAS-
0!
1!
2!
3!
4!
5!
6!
CS/W%& nsyb%GAL4/Rab83B& nsyb%GAL4/&UAS%&CHMP2BIntron5& nsyb%GAL4/&UAS%&CHMP2BIntron5;UAS%Rab83b&M
ea
n 
No
rm
ali
se
d 
Br
an
ch
 N
um
be
r!
Wi
ldty
pe!
nS
yb-
Ga
l4/+
;UA
S-R
ab8
/+!
nS
yb-
Ga
l4/U
AS
-CH
MP
2B
Intr
on5
!
nS
yb-
Ga
l4/U
AS
-CH
MP
2B
Intr
on5
;UA
S-R
ab8
/+!
*!
#! ###!
11! 10!
10!
10!
0!
2!
4!
6!
8!
10!
12!
CS/W%& nsyb%GAL4/Rab83B& nsyb%GAL4/&UAS%&CHMP2BIntron5& nsyb%GAL4/&UAS%&CHMP2BIntron5;UAS%Rab83b&M
ea
n 
No
rm
ali
se
d 
Sa
te
llit
e 
Bo
ut
on
 
Nu
m
be
r!
Wi
ldty
pe!
nS
yb-
Ga
l4/+
;UA
S-R
ab8
/+!
nS
yb-
Ga
l4/U
AS
-CH
MP
2B
Intr
on5
!
nS
yb-
Ga
l4/U
AS
-CH
MP
2B
Intr
on5
;UA
S-R
ab8
/+!
**!
###!
#!
13!
10!
10!
14!
Wi
ldty
pe!
nS
yb-
Ga
l4/+
;UA
S-R
ab8
/+!
nS
yb-
Ga
l4/U
AS
-CH
MP
2B
Intr
on5
!
nS
yb-
Ga
l4/U
AS
-CH
MP
2B
Intr
on5
;UA
S-R
ab8
/+!0!
0.5!
1!
1.5!
2!
2.5!
3!
3.5!
4!
4.5!
CS/W%& nsyb%GAL4/Rab83B& nsyb%GAL4/&UAS%&CHMP2BIntron5& nsyb%GAL4/&UAS%&CHMP2BIntron5;UAS%Rab83b&M
ea
n 
No
rm
ali
se
d 
Bo
ut
on
 S
ize
 (μ
m
)!
***!
###! ###!
185!
253! 463!
242!
0!
20!
40!
60!
80!
100!
120!
140!
160!
180!
CS/W%& nsyb%GAL4/Rab83B& nsyb%GAL4/&UAS%&CHMP2BIntron5& nsyb%GAL4/&UAS%&CHMP2BIntron5;UAS%Rab83b&
M
ea
n 
No
rm
ali
se
d 
Le
ng
th
 (μ
m
)! **!
##! #!
Wi
ldty
pe!
nS
yb-
Ga
l4/+
;UA
S-R
ab8
/+!
nS
yb-
Ga
l4/U
AS
-CH
MP
2B
Intr
on5
!
nS
yb-
Ga
l4/U
AS
-CH
MP
2B
Intr
on5
;UA
S-R
ab8
/+!
11! 10!
13!
14!
A B 
D C 
6. Characterisation of CHMP2BIntron5 and The Role of Rab8 In CHMP2BIntron5 Toxicity 
!
   189!
CHMP2BIntron5;UAS-Rab8/+ larvae showing no variance in branch number from controls yet a 
significant variance from nSyb-Gal4/UAS-CHMP2BIntron5. ANOVA: F(d.f. 3) = 5.4544; p < 0.01  
with post-hoc Dunnett’s comparison to wildtype controls * p < 0.05 and student’s t-test between 
genotypes ### p < 0.001, # p < 0.05. (C) Neuronal expression of CHMP2BIntron5 promotes a 
proliferation of satellite boutons showing a significant increase in satellites compared to 
wildtypes but not nSyb-Gal4/+;UAS-Rab8/+ controls which show an increased, although not 
significantly different from wildtype, number of satellite boutons. Increased satellite bouton 
number can again be rescued by co-expression of Rab8. Rescues show no variance from 
wildtype and a significant variance from neuronally expressed CHMP2BIntron5. Rescues also 
show a significant variance from nSyb-Gal4/+;UAS-Rab8/+ controls. ANOVA: F(d.f. 3) = 6.5642; 
p < 0.001  with post-hoc Dunnett’s comparison to wildtype controls ** p < 0.01 and student’s t-
test between genotypes ### p < 0.001, # p < 0.05. (D) Neuronal expression of CHMP2BIntron5 
has no effect upon synaptic bouton size showing no variance to wildtype of neuronally 
expressed Rab8 controls. Neuronal co-expression of Rab8 and CHMP2BIntron5 elicited an 
increase in mean normalised synaptic bouton size showing a mean bouton size significantly 
greater than all other genotypes. ANOVA: F(d.f. 3) = 12.9398; p < 0.001  with post-hoc 
Dunnett’s comparison to wildtype controls *** p < 0.001 and student’s t-test between genotypes 
### p < 0.001. All analysis was performed on NMJ’s at muscle 4, hemi-segment A3 in 3rd instar 
wandering larvae. 
 
 
 
6.2.2. Neuronal Expression of CHMP2BIntron5 Induces Increased 
TGFβ Activity That Can be Rescued By Expression of Rab8 
 
In the previous chapter it was shown that NMJ synaptic overgrowth in Rab8 
mutants required a permissive TGFβ signal and that mutants presented with 
increased TGFβ activity. Having demonstrated here that neuronal expression of 
the CHMP2BIntron5 mutant transgene elicited a synaptic overgrowth phenotype 
that could be rescued through expression of wildtype Rab8 it was asked 
whether increased TGFβ activity was also observed as a result of neuronal 
expression of CHMP2BIntron5. The results here show that pan-neuronal 
expression of CHMP2BIntron5, under the control of nSyb-Gal4, results in a 
significant increase in nuclear p-MAD within eve positive motor neurons (Fig. 
6.4.). In addition it was demonstrated that co-expression of wildtype Rab8 
alongside the CHMP2BIntron5 mutant transgene was sufficient to completely 
rescue elevated nuclear P-MAD (Fig. 6.4.). It is interesting to note that neuronal 
(nSyb) expression of Rab8 alone resulted in the accumulation of P-MAD at a 
peri-nuclear localisation, although levels of nuclear P-MAD showed no variance 
from wildtype (Fig. 6.4.). In addition co-expression of Rab8 and CHMP2BIntron5 
rescues both reduced nuclear P-MAD in CHMP2BIntron5 and peri-nuclear 
accumulation of P-MAD associated with Rab8 overexpression.  
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Figure 6.4. Neuronal Expression of CHMP2BIntron5 Induces Increased Levels of Nuclear P-
MAD That Can be Alleviated by Co-Expression of Wildtype Rab8 
(A-B) Neuronal Expression of CHMP2BIntron5 under the control of the pan-neuronal driver nSyb-
Gal4 elicits a significant increase in levels of nuclear P-MAD within eve positive motor neurons, 
in 3rd instar larvae. Elevated levels of nuclear P-MAD can be alleviated by co-expression of 
wildtype Rab8. Whilst nuclear expression of Rab8 shows no variance in nuclear levels of P-
MAD compared to wildtype it does result in a peri-nuclear accumulation of P-MAD. This is not 
observed when co-expressed with CHMP2BIntron5. Scale bar = 2 μm. ANOVA: F(d.f. 3) = 
18.8731; p < 0.001  with post-hoc Dunnett’s comparison to wildtype controls *** p < 0.001 and 
student’s t-test between genotypes ### p < 0.001. 
 
 
6.2.3. Neuronal Expression of CHMP2BIntron5 Induces a 
Locomotor Deficit That Can Not be Rescued By Rab8 !
Having observed a synaptic overgrowth phenotype associated with neuronal 
expression of the CHMP2BIntron5 mutant transgene it was asked whether 
synaptic overgrowth was associated with a perturbation to physiological 
function. As for Rab8 mutants, see Chapter 4, NMJ functionality was assessed 
using a crawling assay to look at locomotor function. Whilst synaptic overgrowth 
in Rab8 mutants was not associated with a reduction in locomotor function here 
it is observed that pan-neuronal expression of the CHMP2BIntron5 mutant 
transgene results in a 46.94 % reduction in larval velocity, compared to wildtype 
(Fig. 6.5.). Furthermore whilst synaptic overgrowth phenotypes and elevated 
levels of nuclear P-MAD in nSyb-Gal4/UAS-CHMP2BIntron5 larvae can be 
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rescued by overexpression of wildtype Rab8 it is shown here that co-expression 
of wildtype Rab8 alongside CHMP2BIntron5 is not sufficient to rescue the 
locomotor deficit, showing no variance from nSyb-Gal4/UAS-CHMP2BIntron5 
mutants and a significant variance from wildtype. As such this suggests that the 
locomotor deficit observed in CHMP2BIntron5 mutants may not be directly 
associated with the synaptic overgrowth phenotype. 
 !
 
 
 
 
 
 
 !!!
 !!!!
 
 
 
 
 
Figure 6.5. Neuronal Expression of CHMP2BIntron5 Induces a Locomotor Deficit That Can 
Not be Alleviated by Expression of Rab8. 
Pan-neuronal expression of the CHMP2BIntron5 mutant transgene under the control of nSyb-Gal4 
results in a locomotor deficit showing a significantly reduced mean crawling velocity of third 
instar larvae when compared to wildtype controls. Co-expression of wildtype Rab8 does not 
rescue the reduced crawling velocity in CHMP2BIntron5 mutants.  (ANOVA: F(d.f. 4) = 19.7039; p 
< 0.001 with post-hoc Dunnett’s comparison to wildtype control *** p < 0.001 and student’s t-test 
comparison between groups). 
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6.2.4. Neuronal Expression of CHMP2BIntron5 Induces 
Accumulation of Ubiquitinylated Proteins Within the Larval 
Ventral Nerve Cord !!
As mentioned previously, in Chapter 1, FTD is a highly heterogeneous disease 
that can, in part, be classified into neuropathological subtypes based upon the 
prevalence and composition of neuronal inclusions. FTD-3, associated with the 
CHMP2BIntron5 mutation, is classified as FTD-UPS; displaying tau-negative, 
TDP-43-negative, FUS-negative and ubiquitin-positive neuronal inclusions. As 
such it was asked whether neuronal expression of the CHMP2BIntron5 mutant 
transgene could induce an accumulation of ubiquitinylated protein aggregates 
within the larval brain. Here it is demonstrated that expression of CHMP2BIntron5 
under the control of the pan-neuronal driver nSyb-Gal4 results in the 
accumulation of mono- and poly-ubiquitnylated proteins within cells of the larval 
VNC (Fig. 6.6.). Such aggregates were not observed within wildtype larval 
VNC’s. It is also interesting to note that neuronal expression of CHMP2BIntron5 
also led to a perturbation to HRP staining, which is used as a marker of the 
Drosophila nervous system. Anti-HRP was originally identified as being able to 
stain the nervous system of Drosophila and grasshoppers by Jan and Jan 
(1982), and has since become an essential tool in the study of the Drosophila 
nervous system (Jan and Jan, 1982). Subsequent studies have revealed the 
immunoreactivity of anti-HRP to be with the carbohydrate epitopes of the 
nervous system specific glycoprotein Nervana (Sun and Salvaterra, 1995a, b). 
Here it was shown that CHMP2BIntron5 expression lead to aggregation of anti-
HRP staining within specific cells and that this partially co-localised with 
aggregates of mono- and poly-ubiquitinylated proteins. 
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Figure 6.6. Ubiquitinylated Proteins Aggregate in The Ventral Nerve Cord of Larvae 
Neuronally Expressing CHMP2BIntron5 
Neuronal expression of CHMP2BIntro5 under the control of the pan-neuronal driver nSyb-Gal4 
leads to the accumulation of mono- and poly-ubiquitinylated protein aggregates within cells of 
the larval ventral nerve cord (Arrow Heads and zoomed in box). Similar accumulations were not 
observed in wildtype animals where staining appeared diffuse. Expression of CHMP2BIntron5 also 
appears to perturb normal HRP staining, which marks the nervous system, with aggregates 
showing partial co-localisation with ubiquitin aggregates. Scale bars; whole VNC = 10 μm, close 
up of aggregates = 2 μm. 
 
 
6.2.5. CHMP2BIntron5 Mutants Show Autophagic Defects !
6.2.5.1. Inhibition of Autophagy Related Genes Alleviates 
CHMP2BIntron5 Toxicity in The Drosophila Eye !
 
Abnormal accumulation and aggregation of proteins, forming neuronal 
inclusions, is seen as a hallmark of many neurodegenerative diseases, 
including Parkinson’s, Huntington’s, Alzheimer’s, ALS and FTD (Adachi et al., 
2009; Bigio et al., 2004; Pedersen and Heegaard, 2013; Ross and Poirier, 
2004; Rosso et al., 2001). As such it has been proposed that impaired protein 
degradation and clearance may provide a conserved mechanism behind 
neurodegenerative diseases. 
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Previous studies have hypothesised that the accumulation of ubiquitin positive 
neuronal aggregates in FTD, associated with CHMP2B mutations, are the result 
of perturbations to the autophagic protein degradation pathway (Filimonenko et 
al., 2007a) (Lee et al., 2007). For example Lee et al. (2007) demonstrated that 
transfection of cortical neurons, in culture, with either CHMP2BIntron5 or mSnf7-2 
siRNA resulted in the accumulation of autophagosomes and abnormal multi-
lamellar structures. CHMP2BIntron5 expression also promoted sequestration of 
mSnf7-2 into ubiquitin positive endosomes. Similar observations were also seen 
through overexpression of either CHMP2BIntron5 or Shrub-RNAi within the 
Drosophila eye. In addition transfection of cortical neurons with mSnf7-2 siRNA 
or CHMP2BIntron5 also promoted severe dendritic retraction and cell death. 
However, despite the observation of autophagic disruption in CHMP2B mutants 
it has been argued that perturbation to autophagy may not be the causative 
factor in CHMP2B associated neurodegeneration. For example it has been 
shown that other CHMP2B mutants including CHMP2BΔ10 display autophagic 
disruption akin to that seen in CHMP2BIntron5 without presenting 
neurodegeneration and cell death (Belly et al., 2010; Filimonenko et al., 2007a). 
As such, having observed the accumulation of ubiquitin positive inclusions 
within the VNC of larvae neuronally expressing the CHMP2BIntron5 transgene, 
analysis looked to elucidate whether autophagy has a role in CHMP2BIntron5 
associated neurodegeneration within this system.  
 
Here the Drosophila eye is once again utilised as a model system to screen for 
modifiers of the CHMP2BIntron5 phenotype in a targeted screen of known 
autophagy genes. With previous studies showing CHMP2BIntron5 toxicity to be 
associated with an abnormal association between CHMP2B and Shrub and that 
Shrub inhibition promotes autophagic defects similar to CHMP2BIntron5 
autophagy genes were also screened against the Shrub-GFP dominant 
negative eye phenotype (Ahmad et al., 2009; Lee et al., 2007; Lee and Gao, 
2009). 
 
The results presented here provide support for the hypothesis that autophagy 
contributes towards the toxicity observed in CHMP2BIntron5 and shrub-GFP 
mutants. For example reduction of autophagy via the introduction of 
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heterozygous mutations, or RNAi transgenes directed against the autophagy 
related genes (Atg’s) results in a decrease in the severity of the CHMP2BIntron5 
eye phenotype (Fig. 6.7.). For these experiments we targeted Atg1, Atg7 and 
Atg18, which have all been identified as highly conserved and essential 
autophagy genes (Nakatogawa et al., 2009; Obara et al., 2008). Quantification 
of the CHMP2Bintron5 eye phenotype revealed an increased prevalence of the 
mild (low; +) eye phenotype when the function of the Atg genes was reduced in 
a GMR-Gal4, UAS-CHMP2BIntron5 background. Reduction of Atg function alone 
showed no effect on eye development in the absence of CHMP2BIntron5. 
Expression of Atg18-RNAi in the CHMP2BIntron5 eye showed the greatest 
alleviation of toxicity. Further supporting these findings it was observed that 
increasing autophagy through overexpression of UAS-Atg1 potentiated the 
CHMP2BIntron5 eye phenotype. However it must be noted that Atg1 
overexpression in the absence of CHMP2BIntron5 induced a rough eye 
phenotype in its own right. Interestingly it was also observed that inhibition of 
Rheb, which is known to promote autophagy through alleviating Rheb mediated 
activation of TOR, an autophagic inhibitor, showed little effect upon 
CHMP2BIntron5 toxicity. In contrast overexpression of Rheb, which should inhibit 
autophagy, actually potentiated toxicity, demonstrating an opposing effect to 
inhibiting autophagy through inhibition of Atg genes.  
 
In contrast to the results observed in the GMR-Gal4, UAS-CHMP2BIntron5 
background, inhibition of Atg genes in a GMR-Gal4, UAS-Shrub-GFP 
background appeared to have little ability to reduce toxicity (Fig. 6.7.). In 
contrast overexpression of both Atg1 and Rheb potentiated toxicity. Inhibition of 
Rheb also potentiated toxicity, reducing the number of flies classified as 
presenting a low phenotype. These results suggest that CHMP2BIntron5 and the 
dominant negative Shrub-GFP may differentially affect autophagy.   
 
Taken together these results suggest that autophagy may contribute to the 
degeneration observed in CHMP2BIntron5 mutants. However, our data suggests 
a possible discrepancy between the toxic effects of CHMP2BIntron5 and Shrub-
GFP. 
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Figure 6.7. Inhibition of Atg Genes Alleviates CHMP2BIntron5 But Not Shrub-GFP Toxicity 
A targeted modifier screen of known autophagy genes against GMR-Gal4, UAS-CHMP2BIntron5/+ 
and GMR-Gal4, UAS-Shrub-GFP/+ reveals that inhibition of autophagy related genes (Atg’s) 
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alleviates toxicity associated with CHMP2BIntron5 but not with Shrub-GFP. In contrast inhibition of 
autophagy through overexpression of Rheb potentiates toxicity associated with both. 
Potentiation of autophagy through overexpression of Atg1 potentiates both Shrub-GFP and 
CHMP2BIntron5 toxicity whilst Rheb mutants only potentiate Shrub-GFP. Quantification: White = 
low (+) phenotype (< 15 spots of melanisation), Grey = medium (++) phenotype (>15 spots of 
melanisation but < 50 % of the eye affected), Black = high (+++) phenotype (> 50 % of the eye 
affected by melanisation). n = 100 per genotype. 
 
 
6.2.5.2. Expression of CHMP2BIntron5 in The Drosophila Eye 
Severely Perturbs The Internal Eye Structure and Distribution 
of Autophagic Markers 
 
Having demonstrated that, in general, inhibition of autophagy alleviates the 
severity of the CHMP2BIntron5 eye phenotype, we used the autophagic marker 
Atg5-GFP to visualise autophagy within the CHMP2BIntron5 eye. Atg5 has 
previously been shown to play a fundamental role during normal 
autophagosome maturation (Chen and Zhong, 2012; Fujita et al., 2008). 
Following activation by Atg7 Atg5 forms a stable complex with Atg12 and Atg16 
where it plays a functional role during elongation of the isolation membrane to 
form an autophagosome, although the mechanisms involved in this process 
remain unclear (Fujita et al., 2008). Here it is demonstrated that whilst Atg5-
GFP displays an even, diffuse distribution throughout the Drosophila wildtype 
eye, expression of CHMP2BIntron5 severely perturbs the normal eye structure, 
resulting in a re-distribution of Atg5-GFP (Fig.6.8.). Due to the severity of the 
eye disruption it proves difficult to ascertain the effect of CHMP2BIntron5 upon 
Atg5-GFP distribution alone. It is, however, clear that Atg5-GFP re-distributes, 
predominantly surrounding areas where degeneration is most severe and 
melanisation is present. 
 
Aside from autophagic perturbation these results also further reveal the severity 
of degeneration associated with expression of the CHMP2BIntron5 transgene. 
Rhodamine conjugated phalloidin was used to stain the actin rich rhabdomeres 
within the 8 photoreceptor neurons (R1-R8) of each ommatidium. Only 7 
rhabdomeres are visible as R8 lies directly beneath R7, see Chapter 1. As such 
7 clustered photoreceptors can be observed within each ommatidia, of which 
there are ~ 760, repeated in a highly organised manner across the wildtype eye. 
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In contrast GMR-Gal4 expression of CHMP2BIntron5 severely perturbs the normal 
internal eye structure, resulting in a complete loss of normal photoreceptor 
distribution and organisation (Fig. 6.8). It must be noted that whilst eye specific 
GMR-Gal4 drives expression within supporting cells and not just neurons. 
These results support previous light microscopy observations, demonstrating 
severe degeneration to the normal highly organised eye structure as a result of 
GMR-Gal4 driven expression of the CHMP2BIntron5 transgene.        
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.8. CHMP2BIntron5 Expression Perturbs Autophagy Within the Drosophila Eye 
Expression of the CHMP2BIntron5 mutant transgene within the Drosophila eye, under the control 
of the eye specific driver GMR-Gal4, perturbs the normally highly regular and ordered internal 
structure of the eye. Rhodamine conjugated phalloidin was used to stain the actin rich 
rhabdomeres within each ommatidium of the flies photoreceptor neurons. This allowed 
visualisation of 7 distinct puncta clustered in a highly regular pattern repeating throughout the 
eye, as seen in wildtypes. Expression of CHMP2BIntron5 completely disrupts this normal 
distribution pattern. Atg5-GFP was used as a marker of autophagy and can be seen to be 
evenly and diffusely distributed throughout the wildtype eye. Expression of CHMP2BIntron5 
perturbs this pattern with autophagic activity re-distributed to specific localisations, 
predominantly surrounding melanised spots. Scale bar = 10 μm. 
 
 
6.2.5.3. Inhibition of Autophagy Alleviates Synaptic Overgrowth 
Associated With CHMP2BIntron5  
 !
Having demonstrated that CHMP2Bintron5 expression induced overgrowth at the 
larval neuromuscular synapse we looked to establish whether autophagy had a 
contributory role in the synaptic overgrowth observed. Previous studies have 
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demonstrated that autophagy acts as a potent regulator of synaptic growth. For 
example studies have shown that increasing autophagy promotes a synaptic 
overgrowth phenotype, whilst inhibition of autophagy reduces synaptic 
overgrowth (Milton et al., 2011; Shen and Ganetzky, 2009). In addition 
preliminary investigation demonstrated previously, in Chapter 5, that inhibition 
of autophagy alleviated synaptic overgrowth in Rab8 mutants. As such it was 
asked, having demonstrated that inhibition of autophagy alleviated the 
CHMP2BIntron5 eye phenotype, whether inhibition of autophagy could rescue 
synaptic overgrowth. Atg18 has been demonstrated to be an essential 
autophagy gene (Nakatogawa et al., 2009; Obara et al., 2008). In addition 
previous work by Milton et al. (2011) demonstrated that inhibition of Atg18, via 
the presence of the Atg18 loss of function mutant Atg18KG transheterozygously 
with a deficiency allele null for Atg18 (Df(3L)Excel6112), was sufficient to 
rescue synaptic overgrowth in spin mutants. Here it is demonstrated that whilst 
Atg18KG/Df(3L)Excel6112 larvae show no effect upon synaptic bouton number 
alone Atg18KG/Df(3L)Excel6112 in the background of neuronally expressed 
CHMP2BIntron5 was sufficient to completely alleviate increase synaptic bouton 
number (Fig. 6.9). nSyb-Gal4/UAS-CHMP2BIntron5 larvae displayed a significant 
increase in synaptic bouton number compared to all other genotypes, which 
showed no significant variance from one another.  
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Figure 6.9. Inhibition of Autophagy Alleviates Increased Synaptic Bouton Number 
Associated With Neuronal Expression of CHMP2BIntron5 
Neuronal expression of CHMP2BIntron5, under the control of the pan-neuronal driver nSyb-Gal4, 
induced a significant increase in synaptic bouton number in 3rd instar larvae at muscle 6/7, 
hemi-segment A3. Inhibition of Atg18 by the introduction of the Atg18KG/Df(3L)Excel6112 
transheterozygous mutant combination had no effect upon synaptic bouton number alone, 
however alleviated increased bouton number in a nSyb-Gal4/UAS-CHMP2BIntron5 background. 
Scale bar = 10 μm. (ANOVA: F(d.f. 3) = 52.1556; p < 0.001 with post-hoc Dunnett’s comparison 
to wildtype control *** p < 0.001 and student’s t-test comparison between groups ### p < 0.001). !!!
6.2.5.4. Rapamycin Induced Autophagy Potentiates Synaptic 
Overgrowth Associated With Expression of Shrub-GFP But Not 
CHMP2BIntron5  
 
Target of Rapamycin (TOR) has been identified as a conserved kinase and 
negative regulator of autophagy (Chang et al., 2009). It is the catalytic subunit of 
two TOR complexes (TORC), TORC1 and TORC2, of which TORC1 has been 
shown to be sensitive to rapamycin (Loewith et al., 2002). Treatment with 
rapamycin has been shown to inhibit TORC1, therefore reducing inhibition of 
autophagy. Furthermore potentiation of autophagy through rapamycin treatment 
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has been shown to induce synaptic overgrowth at the Drosophila NMJ in 
numerous studies (Knox et al., 2007; Shen and Ganetzky, 2009). The results 
presented here substantiate these previous findings demonstrating that 
rapamycin treatment elicits a synaptic overgrowth phenotype in wildtype larvae 
(Fig. 6.10). These results also demonstrate that, as for pan-neuronal 
expression, motor neuronal specific expression of both CHMP2BIntron5 and 
Shrub-GFP, using the motor neuronal driver OK6-Gal4, induce a significant 
increase in synaptic bouton number, when compared to wildtype. In addition it 
was demonstrated that whilst rapamycin treatment significantly potentiates 
increased bouton number associated with motor neuronal expression of Shrub-
GFP, treatment elicits no effect upon CHMP2BIntron5 synaptic overgrowth. This in 
part supports modifier screen findings where activation of autophagy through 
inhibition of Rheb, a negative regulator of TOR, potentiated Shrub-GFP toxicity 
but not CHMP2BIntron5 toxicity. 
 
Taken together this analysis of autophagy substantiates a role for autophagy in 
the toxicity associated with both Shrub-GFP and CHMP2BIntron5. However it is 
clear that there are discrepancies between the observations for Shrub-GFP and 
those for CHMP2BIntron5. 
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Figure 6.10. Activation of Autophagy by Rapamycin Treatment Potentiates Shrub-GFP 
but Not CHMP2BIntron5 Induced Synaptic Overgrowth 
Drosophila larvae were raised on 4 μM Rapamycin (in DMSO 0.4 % v/v of food) or just DMSO 
(controls) until the 3rd instar wandering stage, at which point they were dissected. Rapamycin 
treatment elicits a synaptic overgrowth phenotype characterised by a significant increase in 
synaptic bouton number in wildtype larvae. Motor neuronal expression (OK6-Gal4) of Shrub-
GFP induced an increase in bouton number equivalent to that of wildtypes. This overgrowth 
could be significantly potentiated by rapamycin treatment. Motor neuronal expression of 
CHMP2BIntron5 induced a significant increase in synaptic bouton compared to wildtype and 
rapamycin treated wildtype larvae. Rapamycin treatment had no effect upon of CHMP2BIntron5, 
showing no significant variance between treated and untreated animals. Scale Bar = 10 μm. 
(ANOVA: F(d.f. 5) = 128.1793; p < 0.001 with post-hoc Dunnett’s comparison to wildtype DMSO 
treated controls *** p < 0.001 and student’s t-test comparison between groups # p < 0.001). 
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6.3. Discussion !
6.3.1. Rab8 Alleviates Synaptic Overgrowth Phenotypes But 
Not Deficits in Function Associated With Neuronal Expression 
of CHMP2BIntron5  !
In the previous chapters Rab8 was identified as a potent regulator of synaptic 
growth. It was shown that Rab8 mutants display a significant synaptic 
overgrowth phenotype associated with endosomal perturbations and disruption 
to normal TGFβ and JNK signalling pathways.  In addition Rab8 was identified 
as a dominant enhancer of CHMP2B, with Rab8 mutants potentiating toxicity 
associated with expression of the CHMP2BIntron5 mutant transgene. As such in 
this chapter it was asked whether neuronal expression of the CHMP2BIntron5 
would perturb normal NMJ growth and if so whether expression of wildtype 
Rab8 could alleviate this perturbation. 
 
Here it is shown that pan-neuronal expression of CHMP2BIntron5 does elicit a 
synaptic overgrowth phenotype characterised by a significant increase in 
synaptic bouton number, NMJ length and satellite bouton number. Such 
phenotypes were also observed in Rab8 mutants, however in contrast neuronal 
expression of CHMP2BIntron5 also induces a significant increase in branching. 
Increases in both branching and satellite bouton number are, as mentioned 
previously in Chapter 4, characteristic of endocytic mutants and, as such, are in 
keeping with the known role of CHMP2B within the endocytic pathway.  
 
Despite variances in the synaptic overgrowth phenotypes observed between 
Rab8 mutants and neuronally expressed CHMP2BIntron5 the results presented 
here demonstrate that co-expression of Rab8 alongside CHMP2BIntron5 is 
sufficient to rescue all aspects of the synaptic overgrowth observed in 
CHMP2BIntron5. These findings provide significant support for previous 
observation that Rab8 acts as a potent regulator of synaptic growth and is a 
dominant modifier of CHMP2B.   
 
Previously (Chapters 4 and 5) we have demonstrated that synaptic bouton size 
is sensitive to Rab8 perturbation, with Rab8 mutants displaying a significant 
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reduction in synaptic bouton size, compared to wildtype. In addition the results 
presented suggest that synaptic bouton size may be more sensitive to inhibition 
of Rab8 than other NMJ phenotypes, including bouton number. For example 
reduced bouton size was observed in heterozygous Rab8 mutants whilst, in 
contrast, aberration to all other growth phenotypes including elevated bouton 
number and NMJ length were only observed when Rab8 was 
transheterozygously mutated. It was also previously demonstrated that neuronal 
expression of UAS-Rab8, using a UAS-Rab8 stock on the second chromosome, 
induced a mild increase in synaptic bouton size. This is in contrast to the 
observation seen here, using a UAS-Rab8 on the third chromosome, that 
neuronal expression of Rab8 has no effect upon bouton size. This may suggest 
that the UAS-Rab8 used here is less potent than that used previously. Taken 
together these results suggest that Rab8 may regulate NMJ development in a 
dose dependent manner with bouton size being more sensitive to Rab8 loss 
than other NMJ characteristics, such as bouton number, branching and NMJ 
length. Alternatively this may suggest that bouton size is regulated 
independently from other NMJ characteristics, although all are dependent upon 
Rab8. Support for this hypothesis may come from previous observations 
(Chapter 5) that heterozygous Puc mutants, which display reduced inhibition 
upon the JNK signalling pathway, show a significantly reduced synaptic bouton 
size but no other perturbations to NMJ growth. In contrast reducing inhibition 
upon both JNK and TGFβ signalling through pucE69/DadΔIEL double mutants 
elicits a general unregulated growth phenotype characterised by reduced 
bouton size, increased bouton number and increased NMJ length. 
 
One may also postulate that increased bouton size observed when co-
expressing CHMP2BIntron5 and Rab8 relates to an ability of Rab8 to rescue 
synaptic growth but not other aspects of cellular deficits. For example the role of 
Rab8 as a potent regulator of synaptic growth may mean it can alleviate the 
general overgrowth phenotype without resolving aspects of the underlying 
endosomal trafficking deficit, leading to a manifestation of overgrowth as 
enlargement to synaptic boutons. Again this suggests that regulation of synaptic 
bouton size may be somewhat independent from general NMJ size and bouton 
number. Support for the hypothesis that Rab8 acts to rescue growth 
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phenotypes without fully rescuing the molecular deficit associated with 
CHMP2BIntron5 comes from the observation that neuronal expression of 
CHMP2BIntron5 elicits a significant reduction in larval crawling velocity, a 
phenotype that cannot be rescued by co-expression of Rab8. In contrast Rab8 
mutants show no perturbation to normal larval crawling. Further investigation 
may look to characterise synaptic function in larvae neuronally expressing 
CHMP2BIntron5 using electrophysiological recordings of muscle activity. This may 
provide a greater understanding of Rab8’s function in alleviation of synaptic 
overgrowth. 
 
 
6.3.2. Rab8 Expression Alleviates Elevated P-MAD Associated 
With Neuronal Expression of CHMP2BIntron5  
 
Greater understanding of the role of Rab8 as a regulator of synaptic growth may 
come from the observation that Rab8 can alleviate elevated levels of nuclear P-
MAD observed in motor neurons of larvae neuronally expressing CHMP2BIntron5. 
Elevated levels of P-MAD are indicative of increased TGFβ activity, which has 
been shown to result in synaptic overgrowth in numerous Drosophila mutants, 
including in this study in Rab8 mutants (Aberle et al., 2002; O'Connor-Giles et 
al., 2008; Rodal et al., 2011; Sweeney and Davis, 2002). As such these results 
suggest that both CHMP2B and Rab8 play an essential role in the regulation of 
TGFβ. These findings support previous studies identifying endosomal trafficking 
as an essential pathway for the regulation of TGFβ signalling (Di Guglielmo et 
al., 2003; Miaczynska et al., 2004). For example it has been demonstrated that 
endocytic internalisation of active TGFβ receptor complexes is both essential to 
initiate downstream signalling processes but also for down-regulation of 
signalling (Miaczynska et al., 2004). In fact studies have revealed that early 
endosomes provide an environment that actively promotes TGFβ signalling, 
being enriched with SARA, a protein that facilitates R-SMAD association with 
the active receptor complex (Di Guglielmo et al., 2003; Itoh et al., 2002; 
Miaczynska et al., 2004; Tsukazaki et al., 1998). Early endosomes also facilitate 
down-regulation of signalling by targeting receptor cargo internalisation into 
MVB’s, which in turn fuse with lysosomes to promote degradation (Di Guglielmo 
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et al., 2003; Kavsak et al., 2000). As such it is clear how the CHMP2BIntron5 
mutation, which inhibits MVB formation, could promote aberrant elevated TGFβ 
activity by both inhibiting endosomal-lysosomal down-regulation of TGFβ and 
causing an accumulation of active TGFβ receptors within the early endosome. 
In addition it has been demonstrated that endosomes provide a route by which 
TGFβ receptors can be recycled back to the plasma membrane, via Rab11 
positive recycling endosomes (Mitchell et al., 2004; Yin et al., 2013). In fact in a 
recent study Yin et al. (2013) showed that delivery of TGFβ receptors to 
recycling endosome was essential to maintain a polarized, steady-state 
expression of TGFβ within epithelial cells. As discussed previously, in Chapter 
1, Rab8 has been shown to play an important role in the endosomal recycling 
pathway with depletion of Rab8 inhibiting endosomal trafficking to peri-nuclear 
recycling endosomes. Rab8 has also been shown to co-localise, and function in 
the same pathways, as Rab11. As such one may postulate that overexpression 
of Rab8 may act to increase trafficking of TGFβ receptors from early 
endosomes into recycling endosomes, alleviating the burden induced by the 
CHMP2BIntron5 mutation and the inability to traffic TGFβ receptors to the 
lysosome. 
 
The observation that overexpression of Rab8 induces an accumulation of P-
MAD at a peri-nuclear location poses an interesting question as to the role of 
Rab8 in P-MAD localisation. Previous investigations have also shown that 
TGFβ signalling can be regulated through proteasomal degradation of SMAD1, 
the mammalian orthologue of MAD (Fuentealba et al., 2007; Gruendler et al., 
2001). In these studies it was demonstrated that activated P-SMAD was 
targeted to a peri-nuclear location, proposed to be the centrosome, in order for 
proteasomal degradation to occur. As such it may be inferred that Rab8 plays a 
regulatory role in the trafficking of P-MAD to the centrosome, promoting 
proteasomal degradation. This could explain why Rab8 mutants show elevated 
levels of P-MAD, which contributes to synaptic overgrowth, and why 
overexpressing Rab8 results in P-MAD accumulation at a peri-nuclear location. 
It has also been suggested that the proteasome is actually localised at a peri-
nuclear location juxtaposed to the centrosome within what is termed an 
aggresome (Corboy et al., 2005; Olzmann et al., 2008; Pandit et al., 2009). It 
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has been suggested that aggresomes form a compartment in which misfolded 
proteins and protein aggregates are sequestered, both protecting the cell from 
the deleterious effect of such aggregates and bringing them into close 
association with the proteasome to promote degradation (Olzmann et al., 2008). 
Aggresomes can also be targeted for autophagic clearance by the cell, 
especially when the proteasome is impaired, further promoting degradation. As 
such one may propose that Rab8 acts in the trafficking of components to, or the 
formation of, aggresomes. Support for this hypothesis comes from a study by 
Baron Gaillard et al. (2011) in which they demonstrated that Rab8 complexes 
with peri-centriolar material protein 1 (PCM1) and Hook2, a protein that has 
been implicated in protein transport to peri-centrosomal aggresomes (Baron 
Gaillard et al., 2011). As such Rab8 may act to target P-MAD to aggresomes, 
where it can be sequestered and targeted for proteasomal degradation. In order 
to substantiate this hypothesis future investigation must look to determine 
whether P-MAD accumulations co-localise with aggresome markers, such as 
HSP70, HDAC6, proteasomal components and ubiquitinylated proteins. 
 
 
6.3.3. Autophagy Contributes To CHMP2BIntron5 Toxicity  
 
As with many neurodegenerative diseases the presence and composition of 
neuronal inclusions are a hallmark of FTD. In addition they have become a 
common method by which to classify FTD into neuropathological subtypes 
(Mackenzie et al., 2011; Mackenzie et al., 2010). In this investigation it was 
demonstrated that larvae pan-neuronally expressing the CHMP2BIntron5 mutant 
transgene presented with accumulations of mono- and poly-ubiquitinylated 
proteins with the VNC. Such an observation, mimicking the inclusion phenotype 
observed previously in cell culture, in mice models and within FTD-UPS 
patients, provides credence to this as a viable model of FTD-3. 
 
Accumulation of neuronal inclusions, including ubiquitin positive aggregates 
observed in FTD, has been associated with perturbations to homeostatic protein 
quality control mechanisms within cells (Chen et al., 2011; Takalo et al., 2013). 
The two most significant of these mechanisms being the ubiquitin proteasome 
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system (UPS) and autophagy. In healthy cells it is estimated that up to 30 % of 
newly synthesised proteins are incorrectly processed and misfolded and, as 
such, require processing and recycling via either the UPS or autophagic-
lysosomal degradative pathway (Schubert et al., 2000). Therefore inhibition or 
disruption to either pathway can elicit a significant accumulation of misfolded 
and aggregated proteins within cells. This in turn creates a burden of protein 
aggregates that overwhelm the degradative systems further potentiating the 
problem, inducing cellular stress and leading to the eventual cell death 
observed in neurodegenerative diseases. However, whilst it has been shown 
that CHMP2B mutations associated with FTD display ubiquitin positive 
aggregates, perturbation to autophagy and neuronal death it is a topic of debate 
as to whether or not autophagy actually contributes towards the toxicity of 
CHMP2BIntron5. For example, as mentioned previously, other CHMP2B mutants 
have been shown to display perturbations to autophagy, akin to those seen in 
CHMP2BIntron5, but in the absence of neurodegeneration.  
 
Here it was demonstrated that inhibition of autophagy through the presence of 
either loss of function Atg mutants or Atg-RNAi’s alleviated CHMP2BIntron5 
toxicity within the Drosophila eye. This observation supports previous findings 
by Lee et al. (2009) where it was demonstrated that inhibition of autophagy via 
siRNA knock-down of Atg5 or Atg7 or the administration of an autophagy 
inhibitor significantly improved the survival rate of rat cortical neurons 
expressing CHMP2BIntron5. Similarly they also showed that cortical neurons 
isolated from Atg5 -/- mice displayed greater resistance to CHMP2BIntron5 
mediated cell death. As such one may infer that autophagy contributes towards 
the toxicity associated with the CHMP2BIntron5 mutation. This is further 
corroborated by the observation that activation of autophagy through 
overexpression of Atg1 potentiates toxicity in the CHMP2BIntron5 eye. However 
one must take into account that Atg1 expression in the eye, in the absence of 
CHMP2BIntron5, elicits a rough eye phenotype when expressed alone. 
 
 
Whilst inhibition of autophagy through expression of Atg mutants alleviated 
CHMP2BIntron5 toxicity in the Drosophila eye overexpression of Rheb, a negative 
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regulator of autophagy, actually potentiated CHMP2BIntron5 toxicity. Whilst this 
result appears somewhat paradoxical it actually supports previous findings 
showing that Rheb has a differential effect upon synaptic terminal growth to 
manipulation of autophagy (Knox et al., 2007). For example overexpression of 
Rheb, which should inhibit autophagy, within the Drosophila motor neuron 
induces synaptic overgrowth whilst Rheb mutants display synaptic undergrowth 
(Knox et al., 2007). In contrast inhibition of autophagy via mutations in essential 
autophagy genes induces mild synaptic undergrowth whilst overexpression of 
Atg1 or activation of autophagy through Rapamycin treatment induce 
overgrowth (Knox et al., 2007; Shen and Ganetzky, 2009). Currently the reason 
for the somewhat paradoxical effect of Rheb upon synaptic development is yet 
to be elucidated. In addition the general role of autophagy in neurodegeneration 
remains unclear and, like the role of Rheb, slightly paradoxical. For example 
inhibition of autophagy has been shown to both simulate neurodegenerative 
lysosomal storage disorders (LSD’s) and alleviate LSD phenotypes (Sweeney 
Lab data) (Milton, 2011).   
 
Substantiating the role of autophagy in CHMP2BIntron5 toxicity it was observed 
that inhibition of Atg18 was sufficient to alleviate synaptic overgrowth 
associated with pan-neuronal expression of CHMP2BIntron5. Whilst this indicates 
autophagy to be a contributory factor in CHMP2BIntron5 toxicity it also 
corroborates previous findings implicating autophagy as a potent regulator of 
synaptic growth (Milton et al., 2011; Shen and Ganetzky, 2009). For example 
Milton et al. (2011) demonstrated that introduction of autophagy mutants into a 
spin mutant background was sufficient to completely rescue synaptic 
overgrowth. In addition it has been shown that autophagy acts to degrade the 
E3 ubiquitin ligase hiw releasing its inhibition upon the JNKKK wallenda (Collins 
et al., 2006). Thus overexpression of autophagy promotes synaptic overgrowth 
via disinhibition of the JNK/AP-1 pathway. Therefore having observed neuronal 
expression of CHMP2BIntron5 to induce elevated levels of P-MAD coupled with 
synaptic overgrowth which can be alleviated by expression of Rab8 or inhibition 
of autophagy one may propose JNK signalling is likely to contribute towards 
synaptic overgrowth in CHMP2BIntron5. As such future investigation should look 
to combine the Puc-LacZ reporter with CHMP2BIntron5 mutant expression in 
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order to determine whether neuronal expression of CHMP2BIntron5 induces 
elevate JNK signalling as well as TGFβ. In addition these observations support 
previous preliminary findings demonstrating that inhibition of autophagy in a 
Rab8 transheterozygous mutant background alleviates synaptic overgrowth. As 
such this further implicates autophagy as a regulator of synaptic growth, 
potentially contributing towards overactive JNK signalling.  
 
Further corroborating a perturbation to normal autophagic processes in 
CHMP2BIntron5 mutants it was demonstrated that eye specific expression of 
CHMP2BIntron5 resulted in significant disruption to the autophagic marker Atg5-
GFP. Whilst diffusely and evenly distributed throughout the wildtype eye Atg5-
GFP appears to localise specifically surrounding regions of melanisation within 
the GMR-Gal4/UAS-CHMP2BIntron5 eye. Melanisation accompanied by 
autophagy is indicative of an innate immune response in Drosophila, supporting 
previous observations that CHMP2B mutant toxicity is associated with an innate 
immune response (Ahmad et al., 2009). Analysis of the internal structure of the 
Drosophila eye in response to CHMP2BIntron5 expression also revealed a 
significant disruption to the normal distribution and localisation of photoreceptor 
neurons. This observation indicates that degeneration observed across the eye 
surface is associated with more significant internal degeneration. Furthermore 
this supports previous observations that CHMP2BIntron5 toxicity is associated 
with perturbation to normal neuronal structures. It must also be considered that 
this degree of disruption is likely to account for some of the perturbation to Atg5-
GFP localisation observed.  
 
 
6.3.4. Autophagy Differentially Regulates Phenotypes 
Associated With CHMP2BIntron5 and Shrub-GFP Expression   
 
Previous work in the Sweeny and Gao labs has demonstrated that the Shrub-
GFP fusion protein acts as a dominant negative, antimorphic version of Shrub. 
It has also been demonstrated that the CHMP2BIntron5 mutation results in a 
failure of CHMP2B to dissociate from the ESCRT-III complex, forming an 
abnormally stable association with Shrub (Lee et al., 2007). In addition it has 
been shown that Shrub-GFP phenocopies CHMP2BIntron5 in a number of ways. 
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For example Ahmad et al. (2009) demonstrated that when expressed in the 
Drosophila eye Shrub-GFP and CHMP2BIntron5 display similar phenotypes, 
which were equally affected by the same genetic modifiers. Such an 
observation has also been made during the course of this investigation (see 
Chapter 3). They also demonstrated that both Shrub-GFP and CHMP2BIntron5 
elicited an accumulation of cleaved späetzle protein, indicating Toll pathway 
activation. As such it has been proposed that Shrub-GFP directly phenocopies 
CHMP2BIntron5. Here we provide further support for this hypothesis 
demonstrating that when expressed specifically within motor-neurons, under the 
control of OK6-Gal4, both Shrub-GFP and CHMP2BIntron5 display synaptic 
overgrowth comparable to each other. However treatment with rapamycin, 
which has previously been shown to induce autophagy and promote significant 
synaptic overgrowth at the Drosophila NMJ, significantly potentiated synaptic 
overgrowth in Shrub-GFP expressing and wildtype larvae but not CHMP2BIntron5 
expressing larvae. As such this suggests autophagy affects Shrub-GFP and 
CHMP2BIntron5 differently, or at least to differing degrees. Interestingly a 
discrepancy between Shrub-GFP and CHMP2BIntron5 was also observed during 
modifier screens where inhibition of autophagy alleviated CHMP2BIntron5 toxicity 
but not that of Shrub-GFP. As CHMP2BIntron5 associated NMJ and eye 
phenotypes can be alleviated, to some degree, by inhibiting autophagy but not 
significantly potentiated by promoting autophagy and vice versa for Shrub-GFP 
one may postulate that autophagy may be more active in CHMP2BIntron5 than in 
Shrub-GFP expressing animals. As such it can be inferred that autophagy is 
likely to contribute towards toxicity in CHMP2BIntron5 and that Shrub-GFP does 
not directly phenocopy CHMP2BIntron5 in all aspects. Future investigation may 
look to further characterise the role of autophagy in Shrub-GFP, in comparison 
to CHMP2BIntron5 in order to elucidate the mechanism behind this variance. This 
may also be essential to ascertain the validity of Shrub-GFP as a comparable 
model to CHMP2BIntron5. Due to the nature of the Shrub-GFP allele, acting as a 
dominant negative due to the GFP fusion, future investigation should also look 
to corroborate the findings of this investigation using Shrub loss of function 
alleles or Shrub-RNAi constructs.   
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7. Discussion and Future Research 
 
7.1. Introduction  !!
At the start of this investigation the following primary questions were asked: 
 
1. Can a Drosophila Model of FTD in which the CHMP2BIntron5 mutant 
transgene is expressed in the Drosophila eye be used to identify 
novel modifiers of CHMP2BIntron5 Toxicity? 
2. How do mutations in Rab8, modifiers of CHMP2BIntron5 toxicity, affect 
synaptic development and the nervous system? 
3. What is the mechanism behind synaptic overgrowth observed in 
Rab8 Mutants? 
4. Does neuronal expression of CHMP2BIntron5 in Drosophila provide a 
representative model of FTD-3 and how does Rab8 affect 
CHMP2BIntron5 mutant phenotypes?   
 
This final chapter looks to determine which of these questions have been 
answered, providing a comprehensive, succinct overview of all the data 
generated as part of this investigation. It also looks to pose further questions 
and areas for future investigation. 
 
 
7.2. Identification of Novel Modifiers of CHMP2BIntron5 Toxicity 
  
There currently exists a growing body of evidence demonstrating that the 
Drosophila eye provides an elegant and powerful system in which modifiers of 
disease causing human mutations can be unbiasedly screened for (Jackson et 
al., 2002; Pandey et al., 2007; Shulman and Feany, 2003; St Johnston, 2002). 
Such approaches have already proven highly successful in the identification of 
novel interacting partners of α-syn, β-amyloid and tau (Butler et al., 2012; 
Jackson et al., 2002; Shulman and Feany, 2003; van de Hoef et al., 2009). 
Furthermore they have contributed significantly to the understanding of a range 
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of neurodegenerative disorders including Alzheimer’s disease, Huntington’s, 
IBMPFD and Parkinson’s disease, to name a few (Butler et al., 2012; Jackson 
et al., 2002; Ritson et al., 2010; Shulman and Feany, 2003; van de Hoef et al., 
2009; Zhang et al., 2010). During this investigation the CHMP2BIntron5 mutant 
transgene was expressed in the Drosophila eye generating a distinctive 
phenotype against which modifiers could be screened for. Using a combination 
of unbiased and targeted screens a number of potent modifiers of 
CHMP2BIntron5 toxicity were identified, one of which was Rab8. Subsequent 
characterisation during the course of this investigation demonstrated that Rab8 
acts as a potent regulator of synaptic development and neuronal morphology. It 
was also demonstrated that a number of other CHMP2B modifiers identified 
contribute towards the mechanism responsible for synaptic overgrowth in Rab8 
mutants. As such one may stipulate that modifier screens using CHMP2BIntron5 
provide a versatile system by which to identify novel factors implicated in 
neuronal development and disease. In addition the identification of dominant 
modifiers during these screens provides an essential framework for further 
investigation into the molecular mechanisms associated with CHMP2BIntron5 
toxicity and the role of the modifiers identified in the normal maintenance of 
neuronal development and function. Corroborating these observations and the 
versatility of modifier screens additional research in the Sweeney and Gao labs 
have utilised modifier screens of CHMP2BIntron5 as the foundation for 
characterising the involvement of both syntaxin 12/13 and serpin5 in 
CHMP2BIntron5 associated toxicity (Ahmad et al., 2009). Taken together the 
results of this investigation, alongside these other studies, provide credence to 
the power of modifier screens as a tool for identification of novel targets for 
investigation. As such future analysis must look to characterise the remaining 
positive “hits” from the modifier screens performed. 
 
Whilst the results of this and previous investigations in the Sweeney and Gao 
labs have identified clear modifiers of CHMP2BIntron5 toxicity it is essential that, 
following characterisation of these modifiers in flies, future analysis looks to 
characterise their function in higher order models of FTD. For example in order 
to definitively implicate identified molecular pathways in FTD pathology we must 
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ascertain whether these pathways are similarly affected in both vertebrate 
models of FTD and, in the long term, in FTD patients. 
 
 
7.3. Rab8, a Regulator of Synaptic Growth    !!
The predominant focus of this investigation has been on characterisation of 
Rab8 mutants, having identified them to be potent enhancers of CHMP2BIntron5 
toxicity in the Drosophila eye. As a result we have clearly demonstrated that 
Rab8 acts as a potent pre-synaptic regulator of NMJ growth. In addition we 
have shown synaptic overgrowth to be associated with elevated and synergistic 
activity of the TGFβ and JNK signalling pathways. This observation contributes 
towards a significant, and growing, body of evidence demonstrating that TGFβ 
and JNK signalling act as regulators of NMJ development and plasticity (Collins 
et al., 2006; Marques, 2005; Marques et al., 2003; McCabe et al., 2003; Milton 
et al., 2011; O'Connor-Giles et al., 2008; Sweeney and Davis, 2002). However 
these findings provide a number of new insights into this regulation. For 
example despite significant evidence showing synergistic activity of the two 
pathways in other contexts and both pathways being implicated in numerous 
models of Drosophila NMJ overgrowth there has been little direct evidence 
indicating a synergistic activity of the two pathways within neurons (Liu et al., 
2012; Mao et al., 2011; Perlman et al., 2001; Sorrentino et al., 2008). The 
observation in this study that the two pathways act synergistically supports 
previous findings in the Sweeney lab where it has been shown that activation of 
JNK, via oxidative stress, alone cannot induce synaptic overgrowth (Milton et 
al., 2011). However synaptic overgrowth is observed in spin mutants, which 
display an oxidative stress burden leading to elevated JNK signalling coupled 
with perturbed endosomal trafficking resulting in elevated TGFβ activity (Milton 
et al., 2011). In addition synaptic overgrowth in Rab8 mutants also identifies 
POSH and TAK1 as novel regulators of synaptic growth, revealing POSH as a 
potential nexus linking TGFβ and JNK signalling, via TAK1. The involvement of 
the endosomal JNK scaffold POSH and the observation that Rab8 mutants 
display perturbed endosomal-lysosomal trafficking also supports previous 
evidence indicating that perturbation of endosomal trafficking inhibits correct 
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processing and recycling of TGFβ receptors (Rodal et al., 2011; Sweeney and 
Davis, 2002; Wang et al., 2007). In order to further substantiate these 
observations future investigation shall look to determine whether TGFβ 
receptors can be observed to accumulate within endosomes of Rab8 mutants.  
 
In addition to the observation of synaptic overgrowth, associated with elevated 
TGFβ and JNK signalling, in Rab8 mutants this study also demonstrated that 
overexpression of wildtype Rab8 in a neuronally expressed CHMP2BIntron5 
background could alleviate synaptic overgrowth and elevated levels of nuclear 
p-MAD. As such these findings implicate Rab8 as a potent regulator of synaptic 
growth and also of TGFβ signalling. Such observations provide further support 
for a role of normal endosomal trafficking in the homeostatic regulation of TGFβ 
signalling within neurons (Chen, 2009; O'Connor-Giles et al., 2008; Sweeney 
and Davis, 2002). In addition previous studies have shown that expression of 
Rab8 is also sufficient to alleviate neuronal cell death in models of Parkinson’s 
disease (Gitler et al., 2008). As such this raises the question as to whether 
Rab8 has a neuro-protective function, potentially through its role in regulating 
endosomal traffic. In order to test this hypothesis future investigation shall look 
to determine whether overexpression of Rab8 can alleviate toxicity associated 
with other Drosophila models of neurodegeneration. During the course of this 
investigation it was also observed that overexpression of wildtype Rab8 alone 
resulted in aggregation of p-MAD at a peri-nuclear location within motor 
neurons. In order to determine the mechanism by which Rab8 can alleviate 
toxicity associated with CHMP2BIntron5 and models of Parkinson’s disease future 
investigation must look to determine the identity of this peri-nuclear organelle. 
One possibility, as discussed in Chapter 6, is that this represents an 
aggresome, an intermediate in the regulation of cellular proteostasis acting 
during periods of elevated stress upon the protein degradation systems within 
cells, and potentially under normal physiological conditions (Corboy et al., 2005; 
Olzmann et al., 2008; Pandit et al., 2009). Identification of this organelle as 
either an aggresome or an alternative structure may provide novel targets for 
both the study of disease and for the development of possible therapeutics.     
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Taken together the results of this investigation reveal Rab8, and its associated 
molecular pathways, as a novel regulator of NMJ growth and development and 
identify Rab8 as a novel target for the study of neurodegenerative diseases in 
general. 
  
 
7.4. Is Rab8 a Regulator of Innate Immune Responses in 
Neurons? !!
During the course of this investigation a number of factors implicated in innate 
immunity have been identified as either potent modifiers of CHMP2BIntron5 
toxicity, in the Drosophila eye, or as factors involved in synaptic overgrowth in 
Rab8 mutants. For example there exists a significant body of evidence 
demonstrating that both POSH and TAK1 act as regulators of innate immunity 
(Ajibade et al., 2013; Lennox and Stronach, 2010; Sato et al., 2005; Tsuda et 
al., 2005). In a study by Tsuda et al. (2005) POSH null mutants were shown to 
display immune defects, in response to bacterial infection, associated with a 
delayed induction followed by aberrantly sustained activation of JNK signalling. 
Furthermore they suggested that abnormal immune responses in POSH 
mutants associated with a perturbation of POSH E3 ubiquitin ligase mediated 
regulation of TAK1. TAK1 has, in turn, been identified as an upstream activator 
of immune signalling with previous investigations demonstrating that TAK1 is 
activated in response to the activation of Toll like receptors (TLR’s) during 
immune responses (Irie et al., 2000; Sato et al., 2005). In addition the TAK1-
JNK cascade has been identified as an essential signalling pathway in the 
activation of innate immune responses (Zhang et al., 2009). Previous work in 
the Sweeney and Gao labs has also demonstrated that CHMP2B may act as a 
mediator of innate immunity through regulation of Toll signalling (Ahmad et al., 
2009). For example they demonstrated that Toll signalling was up-regulated 
when CHMP2BIntron5 was expressed in the fly eye and identified Serpin5, a 
regulator of Toll signalling, as a modifier of the CHMP2BIntron5 phenotype 
(Ahmad et al., 2009). As such having shown that Rab8, POSH and TAK1 all act 
as modifiers of CHMP2BIntron5 and that TAK1 and POSH are essential for 
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synaptic overgrowth in Rab8 mutants the results of this investigation suggest a 
potential role for Rab8 as a regulator of innate immune responses in neurons.      
 
Having identified a potential association between Rab8 and the regulation of 
innate immune responses in neurons, as well as having demonstrated that JNK 
signalling is elevated in Rab8 mutants and required for synaptic overgrowth 
here we suggest a potential mechanism for Rab8 in regulating the innate 
immune TAK1-JNK cascade. Previous studies have demonstrated that GTP-
bound active Rab8 complexes with MAPK Kinase Kinase Kinase 2 (MAP4K2), 
also known as Rab8-interacting protein (Rab8ip) (Ren et al., 1996). In addition it 
has been demonstrated that whilst expression of wildtype Rab8 in MDCK cells 
results in a nuclear localisation of MAP4K2, expression of a dominant negative 
form of Rab8, which fails to associate with MAP4K2, leads to a cytoplasmic 
localisation of MAP4K2 (Bruce, 2009). As previous findings have shown that 
MAP4K2 is inactivated by nuclear sequestration this suggests that Rab8 is 
acting to silence MAP4K2 activity (Bruce, 2009; Massa et al., 2011; Rees et al., 
2012). As such one would expect that in Rab8 mutants MAP4K2 activity would 
be elevated, leading to activation of the TAK1 mediated JNK signalling pathway. 
A BLAST (Basic Local Alignment Tool) analysis of the human MAP4K2 
sequence identifies the Drosophila MAP4K’s happyhour, hippo, germinal centre 
kinase 3 and misshapen (msn) to be the most likely Drosophila orthologues of 
MAP4K2. Msn has in turn been implicated in innate immune responses in 
Drosophila acting upstream of TAK1 (Takatsu et al., 2000). As such we propose 
that Rab8 may act to regulate TAK1 mediated JNK signalling, associated with 
innate immunity, in neurons via modulation of MAP4K2 activity (Fig. 7.1.) In 
order to test this hypothesis future investigation shall look to determine whether 
inhibition of any of the Drosophila MAP4K’s can alleviate synaptic overgrowth in 
Rab8 mutants. In addition we shall look to determine whether Rab8 mutants 
display a redistribution of the relevant MAP4K to a cytoplasmic localisation and 
determine whether, if so, this promotes increased activation. Experimentation 
shall also look to use the TAP-tagged Rab8 constructs generated during this 
investigation to perform immunoprecipitation experiments. This shall hopefully 
allow conformation of Rab8 interaction with the relevant MAP4K under GTP-
bound conditions. 
   7. Discussion and Future Research 
!
   218!
Figure 7.1. Proposed Mechanism for Rab8 Mediated Regulation of The TAK1-JNK 
Cascade 
A. GTP-bound active Rab8 associates with the Drosophila MAP4K2 orthologue promoting its 
nuclear sequestration and inhibition. B. In Rab8 mutants or when GDP-bound, Rab8 fails to 
associate with MAP4K resulting in a cytosolic accumulation of MAP4K. MAP4K in turn activates 
the JNKKK TAK1, promoting activation of the JNKK hemipterous (hep), leading to activation of 
the Drosophila JNK (basket, bsk). JNK activation promotes activation of AP-1 leading to its 
translocation to the nucleus to promote transcription of downstream genes leading to induction 
downstream processes, including NMJ growth. 
 
 
Supporting a role for Rab8 as a potential regulator of innate immunity in 
neurons work in the Sweeney lab has demonstrated that larvae presenting 
mutations in OCRL1, a Rab8 effector, display significant melanisation coupled 
with a reduction in the volume of the larval VNC. Preliminary findings also 
suggest a possible inappropriate activation of innate immunity leading to 
aberrant invasion of the VNC by immune cells. Future investigation shall look to 
determine whether this apparent activation of innate immunity associates with 
the identified interaction between OCRL1 and Rab8.    
 
 !
7.5. Does Expression of the CHMP2BIntron5 Mutant Transgene in 
Drosophila Provide a Representative Model of FTD? 
 
During the course of this investigation, it has been demonstrated that 
expression of CHMP2BIntron5 in the Drosophila eye provides a robust model in 
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NMJ Growth!
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which we have been able to identify novel enhancers of CHMP2BIntron5 toxicity. 
In addition we have shown that many of the identified modifiers, including Rab8, 
and their associated molecular pathways have a role in the regulation of 
neuronal development. It was also demonstrated that neuronal expression of 
CHMP2BIntron5 perturbed normal synaptic growth, eliciting a synaptic overgrowth 
phenotype at the larval NMJ, coupled with a reduction in synaptic function, 
indicated by a locomotor deficit in larvae. However, despite this, it is important 
to remember that this is an overexpression model in an invertebrate system. As 
such here we discuss whether this system provides a representative model of 
FTD and ask how future investigation should look to substantiate the 
observations made during this investigation.  
 
During this investigation we have demonstrated that larvae pan-neuronally 
expressing the CHMP2BIntron5 mutant transgene display a synaptic overgrowth 
phenotype coupled with elevated levels of nuclear P-MAD. In addition it was 
demonstrated that both these phenotypes could be rescued through expression 
of Rab8, mutants of which themselves display elevated TGFβ signalling and 
synaptic overgrowth. As such these findings implicate CHMP2B as a regulator 
of TGFβ signalling within neurons and suggest that neuronal pathology 
observed in FTD may associate with perturbations to normal endosomal 
regulation of TGFβ. Support for this hypothesis comes from observations that 
TGFβ levels have been shown to be elevated in patients suffering from a range 
of neurodegenerative diseases including Parkinson’s, Alzheimer’s and FTD 
(Chao et al., 1994; Flanders et al., 1995; Mogi et al., 1995; Sjogren et al., 2004). 
For example Sjörgen et al. (2004) demonstrated that TGFβ levels were elevated 
in the cerebrospinal fluid (CSF) of FTD patients (Sjogren et al., 2004). In order 
to corroborate the observations made in this Drosophila model of FTD-3, and 
substantiate its role as a representative model of the disease, future 
investigation shall look to determine whether CHMP2BIntron5 mutant mice also 
display elevated levels of TGFβ signalling. This could be determined through 
analysis of both brain tissue and CSF via histological staining and High-
performance liquid chromatography. In addition, having observed a synergistic 
activity of TGFβ and JNK signalling in the regulation of NMJ growth in both 
Rab8 mutants and under normal physiological conditions future analysis shall 
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also look to determine whether JNK signalling is elevated in both Drosophila 
and mice models of CHMP2BIntron5 associated FTD. In the long-term the same 
analysis could also be conducted using tissue or CSF from FTD-3 patients 
presenting with the CHMP2BIntron5 mutation. Such observations would help to 
determine the true versatility and reliability of this Drosophila model as a 
representative model of FTD.       
 
In addition to elevated levels of TGFβ signalling larvae pan-neuronally 
expressing CHMP2BIntron5 were also show to display accumulations of 
ubiquitinylated proteins within the VNC. Such an observation provides support 
for the validity of this as a model of FTD-3, which has been identified as a UPS-
FTD; displaying ubiquitin positive neuronal inclusions (Holm et al., 2009; Isaacs 
et al., 2011). Having demonstrated that expression of Rab8 can alleviate 
synaptic overgrowth and elevated TGFβ associated with expression of 
CHMP2BIntron5 in Drosophila, future investigation shall look to determine whether 
expression of Rab8 can also alleviate ubiquitinylated protein aggregates. Such 
an observation would support a role for Rab8 in regulating protein degradation 
pathways, possibly through the interaction of the endosomal-trafficking pathway 
with autophagy.      
 
Taken as whole the observations of this investigation demonstrate that 
Drosophila can provide a robust model in which we can identify potential 
molecular mechanism associated with FTD pathology. Furthermore these 
observations provide testable hypotheses for analysis in higher order model 
organism or within human tissues. As such this suggests that whilst this model 
relies upon overexpression of CHMP2BIntron5 within an invertebrate system it 
can provide an essential tool for the elucidation of molecular mechanisms 
involved in FTD pathology. 
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7.6. Future Investigation 
 
In addition to the experimental approaches listed for future investigation 
throughout the course of this dissertation the observations of this investigation 
as a whole pose interesting objectives for future investigation. 
 
During initial modifier screens both Rab8 and the Rab8 effector OCRL1 were 
identified as potent modifiers of the FTD CHMP2BIntron5 Drosophila eye 
phenotype. As mentioned previously OCRL1 encodes an inositol phosphatase, 
a protein essential for the regulation of phosphoinositide (PI) lipids (Pirruccello 
and De Camilli, 2012). PI’s have been demonstrated to play a plethora of 
diverse and essential roles throughout the cell including signal transduction, 
membrane trafficking, exocytosis and endocytosis (Pirruccello and De Camilli, 
2012). As such perturbation of inositol phosphatases has been implicated in a 
range of disparate human pathologies, including cancer, diabetes and 
neurodegenerative disease (Choudhury et al., 2005; Coon et al., 2012; Hou et 
al., 2011; Pirruccello and De Camilli, 2012). For example, as discussed in 
Chapters 1 and 3, mutations in OCRL1 have been implicate in the 
neurodevelopmental disorder Lowe Syndrome (LS) (Choudhury et al., 2005; 
Coon et al., 2012; Hou et al., 2011). In addition to a number of studies showing 
that Rab8 and OCRL1 form a physical interaction it has also been 
demonstrated that certain OCRL1 mutations, associated with LS, inhibit this 
interaction (Hou et al., 2011). As such this indicates that the physical 
association between Rab8 and its effector OCRL1 plays an essential role in the 
regulation of normal neuronal health. Despite this the physiological role of this 
interaction remains to be elucidated. Having demonstrated, during the course of 
this investigation, both OCRL1 and Rab8 to be dominant enhancers of 
CHMP2BIntron5 toxicity and having identified Rab8 to be a potent regulator of 
neuronal development we further implicate the interaction between Rab8 and 
OCRL1 as a potential target for the study of neurodegeneration and as a key 
interaction in the maintenance of neuronal health. Having developed a range of 
tools for the study of both Rab8 and OCRL1 and possessing a range of both 
Rab8 and OCRL1 alleles we are in advantageous position for studying the role 
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of the Rab8-OCRL1 interaction and the importance of this interaction in 
endosomal trafficking events associated with neuronal development and 
function. As such I propose that future investigation should look to characterise 
the nature of this interaction utilising a number of approaches demonstrated 
throughout this investigation. For example investigation could look to 
characterise the effect of the OCRL1 F668V mutant, which elicits a 5.8 fold 
reduction in Rab8 binding affinity, upon synaptic development, analysing the 
NMJ and CNS at both a histological and ultrastructural level (Hou et al., 2011). 
 
In addition study in the Sweeney lab has demonstrated that OCRL1 mutant 
larvae display what appears to be an aberrant innate immune response, 
displaying melanisation throughout the larvae. As such any future investigation 
into the role of the Rab8-OCRL1 interaction should also look to determine 
whether neuronal dysfunction and pathology associates with an activation of 
innate immune response, potentially acting through the TAK1-JNK cascade. 
Overall I believe that future investigation into the role of the OCRL1-Rab8 
interaction may provide great insight into the molecular mechanisms underlying 
pathology in both FTD and LS and, therefore, help to elucidate molecular 
pathways associated with neuronal pathology in a range of neurological, neuro-
developmental and neurodegenerative diseases. !!
7.7. Summary !
The key results and conclusions of this study are summarised as follows: 
 
1. Expression of the CHMP2BIntron5 mutant transgene in the Drosophila eye 
provides a robust model for conducting modifier screens, identifying 
novel enhancers and suppressors of a model of FTD. 
 
2. Rab8 mutants dominantly enhance CHMP2BIntron5 toxicity. 
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3. Rab8 is a potent, pre-synaptic, regulator of neuronal growth and 
development with mutants displaying unregulated growth at the 
Drosophila larval NMJ. 
4. Rab8 mutants display a significant disruption to normal endosomal-
lysosomal trafficking, most likely associated with Rab8’s role in recycling 
endosomal trafficking 
 
5. Rab8 mutants display elevated TGFβ signalling, which is essential for 
the unregulated synaptic growth phenotypes observed. 
 
6. Rab8 mutants display elevated JNK signalling, which is essential for the 
unregulated synaptic growth phenotypes observed. 
 
7. TGFβ and JNK signalling act synergistically to regulate synaptic 
development under normal physiological conditions. 
 
8. The endosomal JNK scaffold POSH and associated JNKKK TAK1 are 
essential for unregulated NMJ growth in Rab8 mutants. As such this 
observation identifies novel regulators of NMJ growth and provides a 
mechanism for endosomal synergistic activity of TGFβ and JNK in 
synaptic overgrowth. 
 
9. Rab8 alleviates synaptic overgrowth associated with neuronal expression 
of CHMP2BIntron5 
 
10. Rab8 may act as a regulator of JNK signalling in response to innate 
immune activation in neurons. 
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Appendix 1. Muscle 6/7 Bouton Numbers and MSA’s 
! !
Mean Bouton 
Number MSA 
Mean Normalised 
Bouton Number !
Figure Genotype Number SEM MSA (μm2) SEM Number SEM n 
Fig.4.6. w- (WT) 110.19 3.75 78704.43 2254.96   16 
 Rab81/Rab82 146.08 4.33 64807.39 3669.02 182.41 9.78 12 
 Rab81/Rab83 149.44 5.58 64279.49 2931.12 185.34 9.03 9 
 Rab81/Rab8Z3007 193.89 12.77 71153.24 4764.09 223.97 21.57 9 
 Rab81/Rab8B229 186.60 6.81 76540.78 5648.26 199.83 13.72 10 
 Rab81/Df(3L)ED228 157.33 6.66 73156.17 2467.23 170.94 10.19 9 
 Rab82/Rab83 128.50 4.11 66621.42 3115.65 155.48 10.13 10 
 Rab82/Rab8Z3007 193.33 5.00 83125.83 5527.39 186.60 11.43 6 
 Rab82/Rab8B229 157.25 5.53 89367.03 3609.99 143.22 9.06 16 
 Rab82/Df(3L)ED228 158.07 7.85 68128.31 1700.72 161.13 10.29 10 
 Rab83/Rab8Z3007 181.00 4.71 94816.57 2533.56 151.08 5.75 9 
 Rab83/Rab8B229 162.88 3.30 88690.26 5045.49 147.64 8.40 8 
 Rab83/Df(3L)ED228 157.29 3.43 83473.04 5016.93 152.08 11.22 7 
 Rab8Z3007/Rab8B229 152.91 9.18 78842.15 2489.86 153.93 10.67 11 
 Rab8Z3007/Df(3L)ED228 172.63 7.12 75135.52 3321.20 183.96 12.71 8 
 Rab8B229/Df(3L)ED228 170.50 5.37 89360.33 2182.09 150.39 4.77 6 
Fig.4.7. CS/w- 91.85 4.95 86103.90 2747.84   14 
 act-GAL4/UAS-Rab8;Rab81/Rab8B229 87.50 3.48 82552.02 1541.03 91.22 2.94 10 
 act-GAL4/UAS-Rab8 77.53 3.30 81498.42 2729.90 83.77 4.73 19 
 nsyb-GAL4/UAS-Rab8 84.36 4.72 72068.27 3141.27 100.68 7.29 14 224 
!
!
!
!
!
!
!
!
!
!
!
!
!
!
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Appendix 1. Muscle 6/7 Bouton Numbers and MSA’s 
! !
Mean Bouton 
Number MSA 
Mean Normalised 
Bouton Number !
Figure Genotype Number SEM MSA (μm2) SEM Number SEM n 
 nSyb-GAL4/UAS-Rab8;Rab81/Rab8B229 89.30 6.86 90024.34 2174.91 86.22 7.27 10 
 Rab81/Rab8B229 186.60 6.81 76540.78 5648.26 218.61 15.01 10 
 UAS-Rab8/+; +/MHC-GAL4 70.92 4.22 78981.53 2663.66 77.78 4.40 13 
 UAS-Rab8/+; MHC-GAL4,Rab8B229/Rab81 123.33 5.44 95673.86 2864.16 112.82 6.84 12 
Fig.5.1. CS/w- 75.80 4.33 80863.85 4153.72   10 
 Tkv7/+ 78.30 8.03 89562.38 1884.31 70.93 8.11 10 
 Tkvk16713/+ 87.00 5.81 78984.32 2243.15 89.27 3.83 11 
 Tkv7/Tkvk16713 45.10 2.86 80381.12 4906.80 46.73 3.79 10 
 DadΔIEL/+ 79.47 4.44 83485.52 2713.06 77.41 4.16 15 
 Rab81/+ 78.23 3.09 82083.26 2716.88 78.49 4.75 13 
 Rab81/Rab8B229 143.73 5.21 81541.12 3050.38 141.16 6.16 11 
 Tkv7/+;Rab81/Rab8B229 104.00 4.49 75562.63 3014.65 112.31 4.75 13 
 Tkvk16713/+;Rab1/Rab8B229 86.64 6.89 87026.61 4308.22 80.44 3.35 11 
 Tkv7/Tkvk16713;Rab1/Rab8B229 66.09 3.20 82987.38 2873.68 64.62 2.29 11 
 DadΔIEL/Rab81 138.33 5.83 87477.40 2735.39 130.21 6.16 27 
Fig.5.6. CS/w- 75.80 4.33 80863.85 4153.72   10 
 nSyb-Gal4/UAS-FOSDN 79.75 4.04 92494.61 3297.05 70.40 3.91 12 
 OK6-Gal4/UAS-FOSDN 68.42 2.34 74016.46 1396.04 75.06 3.01 12 
 PucE69/+ 86.00 4.73 83338.40 1935.46 84.01 6.03 9 
 Rab81/+ 78.23 3.09 82083.26 2716.88 78.49 4.75 13 
 Rab81/Rab8B229 143.73 5.21 81541.12 3050.38 141.16 6.16 11 
 nSyb-Gal4/UAS-FOSDN;Rab81/Rab8B229 68.80 3.90 84748.00 7828.09 70.75 7.07 10 
 OK6-Gal4/UAS-FOSDN;Rab81/Rab8B229 83.00 4.85 76540.98 2805.56 88.95 6.48 10 
 Rab81/PucE69 150.92 5.24 78425.50 1721.76 156.71 6.96 13 225 
!
!
!
!
!
!
!
!
!
!
!
!
!
!
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Appendix 1. Muscle 6/7 Bouton Numbers and MSA’s 
! !
Mean Bouton 
Number MSA 
Mean Normalised 
Bouton Number !
Figure Genotype Number SEM MSA (μm2) SEM Number SEM n 
Fig.5.8. cs/w- 75.80 4.33 80863.85 4153.72   10 
 DadΔIEL/+ 79.47 4.44 83485.52 2713.06 77.41 4.16 15 
 PucE69/+ 86.00 4.73 83338.40 1935.46 84.01 6.03 9 
 PucE69/ DadΔIEL 142.30 5.47 75600.75 4892.19 159.68 13.48 10 
Fig.5.9. CS/w- 76.61 5.29 80859.33 848.59   11 
 POSHEP1206/POSHEP1206 92.30 5.65 71263.36 2234.03 105.05 6.13 10 
 POSHEP2248/POSHEP2248 73.83 3.18 67718.39 1469.48 89.22 5.10 12 
 POSHEP2248/POSHEP1206 72.92 5.66 70693.15 4040.47 85.52 7.53 12 
 nSyb-GAL4/UAS-POSH 84.69 3.86 101543.38 4206.43 68.45 3.42 13 
 Rab81/Rab8B229 155.40 6.13 74126.50 2948.01 171.22 8.07 10 
 POSHEP1206/POSHEP1206;Rab81/Rab8B229 94.50 8.18 67971.30 2103.63 111.80 8.22 14 
 POSHEP2248/POSHEP2248;Rab81/Rab8B229 83.40 4.99 74655.60 2839.92 90.27 4.16 10 
 POSHEP2248/POSHEP1206;Rab81/Rab8B229 98.50 5.50 82160.36 1913.35 96.85 4.62 10 
 nSyb-GAL4/UAS-POSH;Rab81/Rab8B229 74.58 5.15 94655.08 2429.82 63.73 4.05 12 
Fig.5.11. CS/w- 76.61 5.29 80859.33 848.59   11 
 TAK1179/+ 66.36 3.34 87614.70 4191.05 62.59 4.17 11 
 nSyb-GAL4-TAK1-RNAi 99.93 6.69 87732.40 2113.24 92.23 5.86 15 
 nSyb-TAK1DN 77.80 7.13 76946.94 3995.27 81.35 4.70 10 
 nSyb-TAK1 130.27 9.51 60521.87 2189.13 177.48 15.97 11 
 HRSΔ28/+ 89.60 6.57 88520.02 2689.01 81.54 4.13 10 
 Rab81/+ 78.23 3.09 82083.26 2716.88 78.49 4.75 13 
 Rab81/Rab8B229 155.40 6.13 74126.50 2948.01 171.22 8.07 10 
 TAK1179/+;Rab81/Rab8B229 96.91 6.57 95052.49 3554.07 83.54 6.45 11 
 nSyb-GAL4-TAK1-DN;Rab81/Rab8B229 89.17 6.43 76892.81 3702.22 95.29 6.38 12 226 
!
!
!
!
!
!
!
!
!
!
!
!
!
!
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Appendix 1. Muscle 6/7 Bouton Numbers and MSA’s 
! !
Mean Bouton 
Number MSA 
Mean Normalised 
Bouton Number !
Figure Genotype Number SEM MSA (μm2) SEM Number SEM n 
 nSyb-GAL4-TAK1-RNAi;Rab81/Rab8B229 89.14 7.38 81661.76 1886.03 89.83 8.08 14 
 HRSΔ28/+;Rab81/+ 135.50 6.68 85269.37 2011.78 128.14 4.94 10 
Fig.6.1. CS/w- 93.07 3.22 85356.83 2331.64   16 
 nSyb-GAL4-UAS-CHMP2BIntron5 134.92 3.37 78414.07 2495.31 148.02 4.41 13 
 nSyb-GAL4/+ 100.43 5.83 86103.90 2747.84 99.62 5.37 14 
 UAS-CHMP2BIntron5/+ 97.82 4.94 75706.29 2885.37 111.34 5.82 11 
Fig.6.2. CS/w- 93.5 4.66 89387.87 1917.01   10 
 nsyb-Gal4/+;UAS-Rab8/+ 88.73 3.65 80472.34 3058.53 99.83 4.35 15 
 nsyb-Gal4/UAS-CHMP2BIntron5 128.00 4.01 79581.75 3066.97 149.79 5.79 17 
 nsyb-Gal4/UAS-CHMP2BIntron5;UAS-Rab8/+ 100.09 3.37 78492.23 1975.21 114.89 3.99 22 
Fig.6.9. CS/w- 93.50 4.66 89387.87 1917.01   10 
 nsyb-Gal4/UAS-CHMP2BIntron5 130.82 3.90 79037.47 2671.74 149.79 5.79 17 
 nsyb-Gal4/+;UAS-Rab8/+ 88.73 3.65 80472.34 3058.53 99.83 4.35 15 
 nsyb-Gal4/UAS-CHMP2BIntron5;UAS-Rab8/+ 100.09 3.37 78492.23 1975.21 114.89 3.99 22 
 CS/w- 77.91 4.80 80890.07 3084.52   10 
 nsyb-Gal4/UAS-CHMP2BIntron5 130.82 3.90 79037.47 2244.71 135.55 5.24 17 
 Atg18/Df(3L)Exel6112 71.75 5.21 94206.78 2995.77 62.42 4.95 12 
 nsyb-Gal4/UAS-CHMP2BIntron5;Atg18/Df(3L)Exel6112 76.44 4.92 91701.30 2104.27 67.81 4.43 10 
Fig.6.10. w- (DMSO) 81.71 2.08 75755.92 1823.81   24 
 w- (Rapamycin) 107.74 3.60 72019.06 2390.42 113.33 3.78 19 
 OK6-Gal4/UAS-Shrub-GFP (DMSO) 122.00 4.41 75061.93 4084.46 123.13 4.45 7 
 OK6-Gal4/UAS-Shrub-GFP (Rapamycin) 195.10 7.01 64208.41 1833.90 230.19 8.28 10 
 OK6-Gal4/UAS-CHMP2BIntron5 (DMSO) 108.29 3.48 58242.69 4133.66 140.85 4.52 7 
 OK6-Gal4/UAS-CHMP2BIntron5 (Rapamycin) 112.13 5.81 67870.72 6676.73 125.15 6.48 8 227 
!
!
!
!
!
!
!
!
!
!
!
!
!
!
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Appendix 2. Muscle 4 Bouton Numbers and MSA’s 
  
Mean Bouton 
Number MSA 
Mean Normalised 
Bouton Number  
Figure Genotype Number SEM MSA (μm2) SEM Number SEM n 
Fig.4.7. CS/w- 23.13 2.17 59605.83 2203.45   15 
 Rab81/Rab8B229 43.81 2.02 59035.38 1467.24 44.94 2.71 16 
 act-GAL4/UAS-Rab8;Rab81/Rab8B229 21.75 1.37 55775.50 1932.60 23.34 1.33 14 
 nsyb-Gal4/UAS-Rab8; Rab81/Rab8B229 24.20 1.72 59234.54 2876.80 24.58 1.86 10 
 UAS-Rab8/+; MHC-GAL4,Rab8B229/Rab81 39.55 4.66 65638.86 3230.70 35.90 2.88 11 
 nsyb-Gal4/UAS-Rab8 20.33 1.93 61336.18 2774.42 19.90 1.26 12 
 act-Gal4, UAS-Rab8 21.69 1.89 63996.76 2827.40 20.65 1.56 13 
 UAS-Rab8/+; +/MHC-GAL4 20.40 2.29 57514.18 3866.51 21.46 1.95 10 
Fig.5.2. CS/w- 19.50 1.21 55748.16 1765.22   14 
 Rab81/Rab8B229 35.36 2.57 59234.58 2223.92 33.57 1.68 11 
 Tkvk16713/+ 18.75 1.84 53493.82 1585.27 19.48 1.75 12 
 Tkvk16713/+;Rab1/Rab8B229 19.00 1.00 56854.89 2689.94 18.89 1.22 10 
 DadΔIEL/+ 23.30 2.11 57510.52 3001.22 23.41 2.51 10 
 DadΔIEL/Rab81 32.25 1.40 58493.07 2523.80 31.34 2.33 8 
 Rab81/+ 20.73 2.41 61734.38 2830.39 19.10 1.74 11 
Fig.5.8. CS/w- 19.50 1.21 55748.16 1765.22   14 
 DadΔIEL/+ 23.30 2.11 57510.52 3001.22 23.41 2.51 10 
 PucE69/+ 22.50 1.34 66396.44 3801.50 19.41 1.37 10 
 PucE69/DadΔIEL 40.78 3.44 54520.38 931.12 41.90 3.74 10 
Fig.6.2. CS/w- 22.53 2.02     17 
 nsyb-GAL4/Rab8 25.40 2.01 66934.40 4287.16 24.73 2.01 10 
 nsyb-GAL4/UAS-CHMP2BIntron5 34.31 2.75 66446.84 2378.43 32.88 3.17 13 
 nsyb-GAL4/UAS-CHMP2BIntron5;UAS-Rab8 17.29 1.27 62417.20 2116.69 17.53 1.37 14 228 
!
!
!
!
!
!
!
!
!
!
!
!
!
!
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Appendix 3. Muscle 4 NMJ Lengths and MSA’s 
  Mean NMJ Length   
Mean Normalised NMJ 
Length  
Figure Genotype 
Length 
(μm2) SEM MSA (μm2) SEM Length (μm2) SEM n 
Fig.4.7. CS/w- 88.94 9.41 61164.76 2052.23   11 
 Rab81/Rab8B229 157.49 6.70 61673.74 1461.63 157.51 8.85 10 
 act-GAL4/UAS-Rab8;Rab81/Rab8B229 105.17 9.44 57942.99 1082.90 114.91 9.50 10 
 nsyb-Gal4/UAS-Rab8; Rab81/Rab8B229 118.86 11.05 59234.54 2876.80 123.66 10.96 10 
 UAS-Rab8/+; MHC-GAL4,Rab8B229/Rab81 139.37 13.87 65638.86 3230.70 131.83 15.80 11 
 nsyb-Gal4/UAS-Rab8 103.10 11.58 61586.01 3335.34 118.26 9.32 11 
 act-Gal4, UAS-Rab8 108.96 8.61 64885.34 2744.38 104.10 10.05 10 
 UAS-Rab8/+; +/MHC-GAL4 89.85 13.14 57514.18 3866.51 96.41 11.09 10 
Fig.5.2. CS/w- 95.52 7.28 56585.38 2102.45   11 
 Rab81/Rab8B229 168.00 13.53 57939.67 1513.73 166.36 15.31 9 
 Tkvk16713/+ 79.02 4.78 53247.20 1742.30 85.17 6.05 12 
 Tkvk16713/+;Rab1/Rab8B229 105.50 7.65 55897.96 2666.47 108.89 9.43 9 
 DadΔIEL/+ 116.06 13.09 57510.52 3001.22 115.88 14.17 10 
 DadΔIEL/Rab81 157.32 12.54 58493.07 2523.80 156.58 15.42 7 
 Rab81/+ 104.18 7.23 61734.38 2830.39 97.86 8.56 11 
Fig.5.8. CS/w- 95.52 7.28 56585.38 2102.45   11 
 DadΔIEL/+ 116.06 13.09 57510.52 3001.22 114.16 13.96 10 
 PucE69/+ 92.46 7.92 66396.44 3801.50 79.01 7.04 10 
 PucE69/DadΔIEL 170.54 22.77 54520.38 931.12 174.84 23.20 10 
Fig.6.2. CS/w- 87.87 9.25 63419.92 2401.31   11 
 nsyb-GAL4/Rab8 87.88 6.84 66934.40 2988.98 86.51 8.06 10 
 nsyb-GAL4/UAS-CHMP2BIntron5 153.24 14.27 66488.64 2366.26 146.47 15.43 13 
 nsyb-GAL4/UAS-CHMP2BIntron5;UAS-Rab8 100.85 8.43 62417.20 2116.69 106.51 12.14 14 229 
!
!
!
!
!
!
!
!
!
!
!
!
!
!
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Appendix 4. Muscle 4 Branch Numbers and MSA’s 
  
Mean Branch 
Number   
Mean Normalised Branch 
Number  
Figure Genotype Number SEM MSA (μm2) SEM Number SEM n 
Fig.4.7. CS/w- 2.53 0.24 59605.83 2203.45   15 
 Rab81/Rab8B229 3.30 0.37 61673.74 1461.63 3.23 0.41 10 
 act-GAL4/UAS-Rab8;Rab81/Rab8B229 2.83 0.21 55775.50 1932.60 3.08 0.26 12 
 nsyb-Gal4/UAS-Rab8; Rab81/Rab8B229 2.80 0.20 59234.54 2876.80 2.89 0.26 10 
 UAS-Rab8/+; MHC-GAL4,Rab8B229/Rab81 3.36 0.42 65638.86 3230.70 3.07 0.39 11 
 nsyb-Gal4/UAS-Rab8 2.58 0.34 61164.20 3138.30 2.56 0.29 12 
 act-Gal4, UAS-Rab8 2.00 0.21 64885.34 2744.38 1.86 0.25 10 
 UAS-Rab8/+; +/MHC-GAL4 2.40 0.22 57514.18 3866.51 2.51 0.21 10 
Fig.6.2. CS/w- 2.60 0.31 61312.30 3009.17   11 
 nsyb-GAL4/Rab8 2.70 0.30 66934.40 4287.16 2.61 0.32 10 
 nsyb-GAL4/UAS-CHMP2BIntron5 4.30 10.00 63818.84 2487.00 4.19 0.71 10 
 nsyb-GAL4/UAS-CHMP2BIntron5;UAS-Rab8 1.80 0.25 62012.40 2775.25 1.80 0.25 10 !
Appendix 5. Muscle 4 Satellite Bouton Numbers and MSA’s 
  
Mean Satellite 
Bouton Number   
Mean Normalised Satellite 
Bouton Number  
Figure Genotype Number SEM MSA (μm2) SEM Number SEM n 
Fig.4.7. CS/w- 2.50 0.70 61723.62 2479.20   10 
 Rab81/Rab8B229 8.40 1.41 61284.39 1061.78 8.51 1.45 10 
 act-GAL4/UAS-Rab8;Rab81/Rab8B229 4.67 0.74 55775.50 1932.60 4.91 0.77 12 
 nsyb-Gal4/UAS-Rab8; Rab81/Rab8B229 5.80 1.14 59234.54 2876.80 6.16 1.39 10 
 UAS-Rab8/+; MHC-GAL4,Rab8B229/Rab81 9.64 2.87 65638.86 3230.70 8.84 2.43 12 
 nsyb-Gal4/UAS-Rab8 6.07 0.84 63186.83 2350.89 5.92 0.77 14 
 act-Gal4, UAS-Rab8 4.36 1.09 64007.11 2822.47 4.43 1.22 11 
 UAS-Rab8/+; +/MHC-GAL4 9.64 2.87 65638.86 3230.70 8.84 2.43 11 
Fig.6.2. CS/w- 3.23 0.79 65403.36 2444.50   13 
 nsyb-GAL4/Rab8 6.00 1.04 66934.40 2988.98 6.16 1.11 10 
 nsyb-GAL4/UAS-CHMP2BIntron5 8.00 1.34 63818.84 2487.00 8.53 1.65 10 
 nsyb-GAL4/UAS-CHMP2BIntron5;UAS-Rab8 2.64 0.66 62417.20 2116.69 2.70 0.66 14 
!
!
!
!
!
!
!
!
!
!
!
!
!
!
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Appendix 6. Muscle 4 Bouton Sizes and MSA’s 
  
Mean Bouton 
Size   
Mean Normalised Bouton 
Size  
Figure Genotype Size (μm) SEM 
MSA 
(μm2) SEM Size (μm) SEM n 
Fig.4.7. CS/w- 3.31 0.11 63419.92 2401.31   185 
 Rab81/Rab8B229 2.87 0.07 61284.39 1061.78 3.00 0.07 358 
 act-GAL4/UAS-Rab8;Rab81/Rab8B229 3.49 0.13 56729.97 425.89 3.91 0.15 157 
 nsyb-Gal4/UAS-Rab8; Rab81/Rab8B229 3.40 0.10 59234.54 2876.80 3.69 0.12 242 
 UAS-Rab8/+; MHC-GAL4,Rab8B229/Rab81 2.52 0.05 65638.86 3230.70 2.30 0.05 435 
 nsyb-Gal4/UAS-Rab8 4.53 0.13 61325.77 3138.30 4.67 0.15 162 
 act-Gal4, UAS-Rab8 3.95 0.13 64682.62 2791.88 3.97 0.13 121 
 UAS-Rab8/+; +/MHC-GAL4 1.27 0.09 57514.18 3866.51 3.26 0.10 214 
Fig.5.2. CS/w- 3.75 0.11 56585.38 2102.45   205 
 Rab81/Rab8B229 2.97 0.07 57939.67 1513.73 2.94 0.07 314 
 Tkvk16713/+ 3.88 0.13 53247.20 1742.30 4.15 0.15 175 
 Tkvk16713/+;Rab1/Rab8B229 4.36 0.11 55897.96 2666.47 4.51 0.12 172 
 DadΔIEL/+ 3.28 0.10 57510.52 3001.22 3.52 0.12 149 
 DadΔIEL/Rab81 3.43 0.11 58493.07 2523.80 3.39 0.11 256 
 Rab81/+ 3.11 0.07 61734.38 2830.39 2.93 0.08 228 
Fig.5.8. CS/w- 3.75 0.11 56585.38 2102.45   205 
 DadΔIEL/+ 3.28 0.10 57510.52 3001.22 3.52 0.12 149 
 PucE69/+ 3.12 0.07 66396.44 3801.50 2.68 0.06 224 
 PucE69/DadΔIEL 2.65 0.06 54520.38 931.12 2.73 0.06 369 
Fig.6.2. CS/w- 3.31 0.11 63419.92 2401.31   185 
 nsyb-GAL4/Rab8 3.13 0.08 66934.40 2988.98 3.19 0.09 253 
 nsyb-GAL4/UAS-CHMP2BIntron5 3.36 0.07 65875.83 2274.82 3.25 0.07 463 
 nsyb-GAL4/UAS-CHMP2BIntron5;UAS-Rab8 3.76 0.09 62417.20 2116.69 3.86 0.11 242 
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Abbreviations  
αSyn Alpha-Synuclein 
aCC anterior Corner Cell 
AD Alzheimer's Disease 
ADBE Activity-Dependent Bulk Endocytosis 
Ahi1 Abelson's helper integration 1 
ALG Apoptosis Linked Gene 
ALIX Apoptosis Linked gene-2- Interacting protein X 
ALS Amyotrophic Lateral Sclerosis 
AMPA α-Amino-3-hydroxy-5-Methyl-4-isoxazolepropionate 
ANOVA Analysis Of Variance 
AP-1 Activator Protein-1 
ApoE Apoliprprotein E 
APP Amyloid Precursor Protein 
Arf6 Adenosine diphosphate-ribosylation factor 6 
ATG Autophagy related Gene 
BDMA Dimethylbenzylamine 
BES Bacterial artificial chromosome End Sequences 
BMP Bone Morphogenic Protein 
bp base pairs 
bvFTD behavioural variant Frontotemporal Dementia 
C9ORF72 Chromosome 9 Open Reading Frame 72 
Caz Cabexa 
CBD Corticobasal Degeneration 
cDNA complementary DNA 
CG Computed Gene 
CHMP Charged Multivesicular body Protein 
CHMP2B Charged Multivesicular body Protein 2B 
Ci Cubitus interruptus 
CLN3 Ceroid-Lipofuscinosis, Neuronal 3 
CMT2B Charcot-Marie-Tooth Disease type 2B 
CNS Central Nervous System 
co-SMAD co-factor-S Mother's Against Decapentaplegic 
CPG Central Pattern Generator 
CTCF Corrected Total Cell Fluorescence  
CTNF Corrected Total Nuclear immunofluorescence 
Cy3 Cyanine 3 
CyO Curly of Oster 
Dad Daughters Against Decapentaplegic 
ddH2O double distilled water 
DDSA Dodecenyl Succinic Anhydride 
dH2O distilled water 
Dlg Discs Large 
DMF Dimethylformamide 
DMSO Dimethyl Sulphoxide 
dNTP deoxyribonucleotide Triphosphate 
DPP Decapentaplegic 
Drp1 Dynamin related protein 1 
Abbreviations    
!
   233!
EAP Ebony Activating Protein 
EDTA Ethylenediaminetetraacetic acid 
eGFP enhance Green Fluorescent Protein  
EHD EH Domain containing protein 
eIF-2Bε eukaryotic Initiation Factor 2B-epsilon 
Ema Endosomal maturation defective 
EMS Ethyl Methane Sulphonate 
EPSP Excitatory Post-Synaptic Potential 
ER Endoplasmic Reticulum 
ERC Endosomal Recycling Compartment 
ESCRT Endosomal Sorting Complex Required for Transport 
EtOH Ethanol 
Fas II Fasciclin II 
FM  Frequency-Modulated 
fpCC friend of posterior Corner Cell 
FTD Frontotemporal Dementia 
FTD-3 Frontotemporal Dementia associated with chromosome 3 
FTLD Frontotemporal Lobar Degeneration 
FTLD-FUS FTLD-Fused in Sarcoma  
FTLD-Tau FTLD-Tau 
FTLD-TDP FTLD-Trans-activation response DNA-binding Protein 43  
FTLD-UPS FTLD-Ubiquitin Proteasome System 
FUS Fused in Sarcoma  
GAP GTPase Activating Proteins 
Gbb Glass bottom boat 
GDF Guanosin diphosphate-Dissociation Inhibitors Displacement Factors 
GDI Guanosin diphosphate-Dissociation Inhibitors 
GDP Guanosin Diphosphate 
GEF Guanine nucleotide Exchange Factor 
GFP Green Fluorescent Protein 
GluR Glutamate Receptor 
GMR Glass Multimer Reporter 
GRN/PGRN Progranulin 
GSK-3 Glycogen Synthase Kinase 3 
GST Glutathione S-Transferase 
GTP Guanosin-5'-Triphosphate 
HDAC Histone Deacetylase 
HGS Hepatocyte Growth factor-regulated tyrosine kinase Substrate 
hiw highwire 
HL3 Hemolymph Like-3 saline 
HRP Horseradish Peroxidase 
HRS Hepatocyte growth factor-Regulated tyrosine kinase Substrate 
HSE Heat Shock Elements 
HSP Heat Shock Protein 
Htt Huntingtin 
IGF Insulin-like Growth Factor 
ILV Intraluminal Vesicles 
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Imp IGF-II mRNA binding protein 
IPIP27 27 kDa Inositol Polyphosphate phosphatase-Interacting Protein 
ISN Intersegmental motor Nerve 
JNK Jun N-terminal Kinase 
JNKKK Jun N-terminal Kinase Kinase Kinase 
Jra Jun-related antigen 
kb kilobase 
LB Luria Broth 
LBPA Lysobisphosphatidic Acid 
LS Lowe Syndrome 
LSD's Lysosomal Storage Disorders 
Lsn Larsen 
LTP Long Term Potentiation 
MAD Mothers Against Decapentalegic 
MAPK Mitogen-Activated Protein Kinase 
MAPT Microtubule Associated Protein Tau 
Mav Maverick 
mEPSP mini Excitatory Post-Synaptic Potential 
MHC Major Histocompatibility Complex 
MICAl3 Microtubule-associated monoxygenase, calponin and LIM domain containing 3 
MIM Microtubule interacting and transport Interacting Motif 
MIT Microtubule Interacting and Transport 
MND Motor Neuron Disease 
mRNA messenger RNA 
MSA Muscle Surface Area 
MT1-MMP Type I Transmembrane Matrix Metalloproteinase 
MVB Multivesicular Bodies 
Myo5-b & -c MyosinV-b & -c 
NFκB Nuclear Factor kappa-B 
NMJ Neuromuscular Junction 
NPC Niemann Pick C 
NSF N-ethylmaleimide-Sensative Factor 
nSyb neuronal Synaptobrevin    
NTAP N-terminal Tandem Affinity Purification 
nwk nervous wreck 
OCRL1 Oculocerbrorenal syndrome of Lowe 1 
OK6 O'Kane 6 
PBS Phosphate Buffered Saline 
PBS-T Phosphate Buffered Saline with detergent Tween 20 
PBT Phosphate Buffered Saline with detergent Tween 20 
pCC posterior Corner Cell 
PCM1 Peri-Centriolar Material protein 1 
PCR Polymerase Chain Reaction 
PD Parkinson's Disease 
PDZ Post synaptic density protein, Drosophila disc large tumor suppressor,  Zonula occludens-1 protein 
PEL Post Egg Laying 
PKC Protein Kinase C 
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P-MAD Phospho-/Phosphorylated- Mothers Against Decapentaplegic 
PNFA Progressive Non-Fluent Aphasia 
POSH Plenty Of SH3's 
PS Position Specific 
PSD Post Synaptic Density 
PSEN1 Presenillin-1 
PSP Progressive Supranuclear Palsy 
Puc Puckered 
Rab Ras related in Brain 
RabGGT Rab Geranyl Geranyl Transferase 
REP Rab Escort Protein 
RNAi RNA interference 
ROS Reactive Oxygen Species 
R-SMADs Receptor SMAD 
RT Room Temperature 
SARA SMAD Anchor for Receptor Activation 
sax Saxophone 
SCA3 Spinocerebella Ataxia type-3 
SD Semantic Dementia 
SDS Sodium Dodecyl Sulphate 
SEM Standard Error of Mean 
Ses Sesquipedalian 
SH3TC2 SH3 domain and Tetratricopeptide repeats-Containing protein 2 
siRNA small interferring RNA 
SMAD SMA + MAD 
SmD3 Small nuclear ribonucleoprotein D3 polypeptide 18 kDa 
SNa-d Segmental Nerves a-d 
SNARE Soluble N-ethylmaleimide-sensitive factor attachment protein Receptor 
SNX Sorting Nexin 
SOC Super Optimal broth with Catabolite repression 
SOD Superoxide Dismutase 
spin spinster 
SSR Subsynaptic Reticulum 
STAM Signal Transducing Adaptor Molecule 
TAB Transforming Growth Factor Beta Activated Kinase 1 binding Protein 
TAK Transforming growth factor beta-Activated Kinase 
TAP Tandem Affinity Purification 
TAR Trans-Activation Response 
TARDBP Trans-Activation Response DNA-Binding Protein 43 
TBPH Trans-activation response DNA Binding Protein 43 Homolog 
TDP-43 Trans-activation response DNA-binding Protein 43 
TE Buffer Tris-EDTA Buffer 
TEM Transmission Electron Microscopy 
TER Transitional Endoplasmic Reticulum 
TOR Target of Rapamaycin 
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TORC Target of Rapamaycin Complex 
Tfn Transferrin 
TfnR Transferrin Receptor 
TGFβ Transforming Growth Factor Beta 
TGN Trans-Golgi Network 
TIAF1 Transforming Growth Factor Beta1 Induced Antiapoptotic Factor 
Tkv Thick Veins 
Tm melting Temperature 
TN Transverse Nerve 
TRAF Tumor Necrosis Factor Receptor 
Tris-HCl tris(hydroxymethyl)aminomethane hydrochloride 
TSG101 Tumour Susceptibility Gene 101 
UAS Upstream Activator Sequence 
UPS Ubiquitin Proteasome System 
VCP Valosin Containing Protein 
VNC Ventral Nerve Cord 
Vps Vacuolar Protein Sorting  
Vsp Very small puparia 
Wit Wishful Thinking  
Wnd Wallenda 
WT Wildtype !!
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